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Molecular detection of microbes
P941
Direct detection of Salmonella spp. in faecal
specimens by real-time PCR assay
I. Pachiadakis, V. Karavassilis, A. Vasdeki, A. Melidou,
A. Goudouva, P. Lisgara, E. Petinaki, A. Maniatis (Larissa, GR)
Objective: To evaluate a commercial kit for the detection of
Salmonella spp. in faecal specimens based on Real-Time PCR
(Real-Art TM Salmonella RG PCR Kit).
Methods: A total of 1000 faecal specimens obtained
consecutively from individual patients of Thessalia (Central
Greece) were included in this study. Genomic DNA extractions
were performed by use of commercially available isolation kits,
while the commercial kit described above, according to the
instructions of the manufacturer did real-time PCR. Results
obtained from Real-Time PCR assay were compared with
bacterial culture results to determine sensitivity and speciﬁcity.
Results: According to the results obtained by Real-Time PCR,
ﬁfty-three of 1000 faecal specimens were positive for Salmonella
spp. Salmonella was detected by bacterial cultures in all, except
two, the positive specimens. Repetition of two negative cultures
after enrichment detected the pathogenic micro organisms. The
mean time for the detection of Salmonella by Real-Time PCR was
approximately 5–6 hours, while detection by traditional culture
methods required 2–3 days.
Conclusion: The high sensitivity and speciﬁcity of this Real-
Time PCR assay emphasizes the need of its application in a
routine clinical laboratory for the rapid and accurate detection of
Salmonella in faecal specimens.
P942
Multicentric evaluation of Onychodiag for
diagnosis of dermatophyte onychomycosis by
PCR-ELISA
C. Savin, S. Huck, C. Rolland, M. Benderdouche, O. Faure,
G. Noacco, J. Menotti, E. Candolﬁ, H. Pelloux, R. Grillot,
F. Derouin, S. Coupe´ (Emerainville, Strasbourg, Grenoble, Paris, FR)
Objective: To prospectively assess the performance of a PCR-
ELISA assay (Onychodiag, Bio Advance, France) for diagnosis
of onychomycosis due to dermatophytes.
Patients/Methods: Three-university hospital labs specialized in
medical mycology participated to the study. In each lab, nail
samples (NS) were collected from patients (pts) suspected for
onychomycosis (n = 404) or healthy controls (n = 108). In labs A
and B, trained mycologists taking care to collect the sample as
close as possible to the lesion collected NS. In lab C, NS were
collected by other physicians and referred to the lab. Each NS
was processed by classical mycological techniques i.e. direct
examination (DE) and culture (Cult) and tested by Onychodiag
blindly to the results of mycology. For 75 pts, an additional distal
sample (DS), obtained by clipping the nail plate, was collected
from the same dystrophic nail and tested by Onychodiag only,
as such sample is improper for mycology. Onychodiag
processed each NS as follow: DNA extraction, ampliﬁcation by
PCR, hybridization with a labelled dermatophyte-speciﬁc probe
and immobilization in a microplate well recoated with a capture
probe. Results were expressed as OD values and considered
positive for OD > 0.5, negative for OD < 0.3 and borderline (grey
zone) for 0.3 < OD < 0.5.
Results: See table In pts with a culture proven onychomycosis
due to a dermatophyte, the sensitivity of Onychodiag was 75,
83 and 100% for lab A, B and C respectively (mean 82%; 87%
including grey zone). The speciﬁcity was 98% when considering
healthy subjects as true negative controls. In pts with suspected
onychomycosis but with negative culture for dermatophyte,
Onychodiag was positive in 52% of pts with positive DE and
18% of pts with negative DE. Based on the results of
Onychodiag on mycological proven onychomycosis and
healthy controls, these results were considered as true
positive. The low performance of mycology on these samples
was related to non-proper conditions of sampling. For DS,
mycology results on properly collected samples (same nail) were
used as reference. Onychodiag on these samples was positive
in 49/53 (92%) cases of proven dermatophytic onychomycosis.
Conclusion: Onychodiag provides diagnosis of onychomy-
cosis due to dermatophytes (without species identiﬁcation)
within 24–48 hours after sampling. Its sensitivity on properly
collected samples and on DS was close to that of mycological
techniques performed on properly collected samples.
P943
Validation of PCR-RFLP analysis of the gap gene
as a useful tool for the species-level identiﬁcation
of staphylococcal isolates
S. Grzeszczuk, A. Sabat, M. Bartoszewicz,
A. Przondo-Mordarska, W. Hryniewicz (Warsaw, Wroclaw, PL)
Objective: An increase in the number of infections due to
coagulate negative Staphylococcus (CoNS) has been documented.
Therefore, rapid and accurate identiﬁcation of CoNS species
may provide important diagnostic information, which would
allow the selection of an appropriate course of treatment in a
timely and effective manner. The gap gene encoding glyceral-
dehyde-3-phosphate dehydrogenase has been proposed as a
target for the polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) analysis for identiﬁcation of
24 Staphylococcus species. The goal of this study was to evaluate
the reliability of the PCR-RFLP system in the identiﬁcation of
staphylococci at the species level.
Methods: A collection of 202 mostly clinical as well as
laboratory strains comprising 30 staphylococcal species was
selected. Isolates were identiﬁed to the species level by partial
sequence analysis of the 16S rRNA, sodA and rpoB genes;
PCR-based ampliﬁcation of the gap gene followed by RFLP
analysis with restriction enzyme AluI; and biochemical tests
based on ID 32 STAPH (bioMerieux) and the presence of
clumping factor and coagulase.
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Results: Using the PCR-RFLP method, we examined the
polymorphism of gap gene. During this study we determined
the gap genotypes by AluI PCR-RFLP for further six
staphylococcal species, therefore we were able to increase the
list of species from24 to30.PCR-RFLPresultswere consistentwith
the results of partial sequencing of 16S rRNA, sodA and rpoB.
Biochemical tests agreed in only 86% with other methods tested.
Conclusion: These results suggest that the PCR-RFLP assay
provides rapid, accurate, and reliable species-level identiﬁcation
of staphylococci. By using a series of control strains in each
experiment the assay will be easy to standardise and interpret.
P944
Clonal complexity in coagulase negative
Staphylococcus catheter-related bloodstream
infection
C. Aldea-Mansilla, D. Garcı´a de Viedma, E. Cercenado,
E. Bouza, M. Ma rı´n (Madrid, ES)
Objective: To determine the clonal features of catheter-related
bloodstream infections (CR-BSI) by Coagulase-Negative Staphy-
lococcus (CNS) and to evaluate the application of molecular tools
in the CR-BSI diagnosis.
Methods: We studied 61 CNS CR-BSI episodes from 55
patients with CNS cultured from peripheral blood and
catheter tip cultures. All different CNS morphotypes (colonies
with different morphology) were picked from each culture,
and biotype, antibiotype and genotype (PFGE type) were
obtained.
Results: Morphological differences were correlated with
differences in the PFGE type in 71% of the cases. Among
these, 98% correlated with differences in antibiogram, 61% in
biotype and 14% at species level. Simultaneous presence of more
than one CNS clone (polyclonality) was found in 17% of
catheters and in 44% of bloodstream infections. Only 77% of
the CNS CR-BSI suspected cases were conﬁrmed by molecular
methods and 44% of true CNS CR-BSI episodes had not been
diagnosed if only a single colony had been randomly selected
from blood and catheter tip cultures. In 5% of the molecularly
conﬁrmed CR-BSI, two different CNS clones were tracked in
catheter tip and blood cultures and they were the cause of
polyclonal CR-BIS. In half of the true CR-BSI episodes, the CNS
clone involved in CR-BSI was accompanied by other CNS
clones, and in 24% CNS CR-BSI this clone was minority found in
blood cultures (less than 50% of the isolates involved).
Epidemiological study revealed 105 clones, grouped in 35
mayor clusters of isolates (from 1 to 8 clusters) with > 80%
homology. There was no greater presence of any clone in any of
the hospital services or during any particular month.
Conclusion: Molecular tools allowed revealing the microbiolo-
gical complexity of CR-BSI by CNS. A precise analysis and
diagnostic of CNS CR-BSI requires to consider this ﬁnding and
to consequently redeﬁne the microbiological procedures and
tools to efﬁcient management of this entity.
P945
Effect of treatment on Toxoplasma-speciﬁc IgG
antibodies and IgG avidity maturation
V. Meroni, F. Genco, G. Ferraris, L. Bollani, L. Piccoli, C. Bodini,
P. Lanzarini (Pavia, Milan, IT)
Objective: Aim of the study was to evaluate the inﬂuence of
treatment with spiramycin on the increase of IgG titre and IgG
avidity index in pregnant women with seroconversion or very
recent Toxoplasma gondii infection (twofold or greater IgG
antibody increase, IgM positive, low avidity index), from
beginning of therapy until delivery, in comparison with adult
patients with recently acquired, but not pharmacologically
treated, toxoplasmosis.
Methods: Eighteen pregnant women with seroconversion for
toxoplasmosis and/or very low IgG avidity index were
followed, from beginning of therapy with spiramycin, until
delivery. Fifteen out of 18 pregnant women were also tested a
few months after delivery and interruption of therapy. IgG
antibody response and IgG avidity index were also evaluated in
a control group of 11 adult patients with seroconversion or very
recent infection. All serum samples were tested with
commercially available kits: VIDAS TOXO IgG II, VIDAS
TOXO IgG AVIDITY, Toxo-ISAGA (bioMerieux, Marcy
l’Etoile, France), LIAISON Toxo IgG II and LIAISON Toxo IgG
Avidity II (DiaSorin, Saluggia, Italy).
Results: Maturation of Toxoplasma-speciﬁc IgG antibodies and
IgG avidity are delayed after therapy administration in pregnant
women. When we compared the time curves obtained with
untreated patients, we observed faster maturation of IgG and IgG
avidity index in the latter ones. In addition, an antibody rebound
was observed in the treated pregnant population with IgG
avidity maturation after delivery and interruption of therapy.
Conclusion: As previously described, therapy with spiramycin
may modify IgG antibody response and IgG avidity maturation
in pregnant women. The reason for the delay in serological
response may be reduction of parasitic load in early treated
infections due to the effect of spiramycin on trophozoite stage.
The antibody rebound observed after delivery and therapy
interruption may thus also be explained.
P946
Evaluation of rapid molecular methods in
diagnosis of B streptococci under delivery
B. Ko¨nig, B. Ghebremedhin, W. Ko¨nig (Magdeburg, DE)
Objectives: Group B streptococcal infections are a leading cause
of neonatal mortality. To prevent the severe diseases, especially
the "early onset disease", either a risk-based or a screening-based
approach is used to identify candidates for intrapartum
antibiotics. In the latter case all women are screened for
carriage of group B streptococci between 35 and 37 weeks of
gestation by culture, and intrapartum chemoprophylaxis is
offered to carriers. However, the culture strategy may not
accurately predict genital tract colonization at time of labour and
potential over treatment as well as under treatment is an issue of
debate. There our study looked at a new rapid polymerase chain
reaction (PCR) assay as an alternative-screening tool.
Methods: We evaluated a fast polymerase chain reaction test,
the IDI-GBS (Cepheid), for rapid identiﬁcation of B streptococci
colonized women ad admission for delivery. In this rapid PCR
technique, a sample (genital/anal swab) is analysed using
ﬂuorescent hybridization probes and ﬂuorescence detection
and results are available in less than 1 hour.
Results: During a two months period we analysed 94 swabs
(vaginal/anal) from women under delivery for the presence of
B streptococci by culture and PCR (IDI-GBS) in parallel. The
results from both methods were 100% congruent. B streptococci
were detected in 13 cases (13.8%). All B-streptococci were
penicillin susceptible.
Conclusion: One of the potential advantages of using this test
for screening is that it could be used at time of admission for
labour, therefore offering better sensitivity and speciﬁcity for
predicting colonization in women at the time of labour.
Furthermore, mothers who did not receive prenatal care could
be screened with the PCR technique at time of admission to the
hospital and rapid processing makes it possible to admister
chemoprophylaxis promptly to women before delivery.
Abstracts
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Screening with the convential culture, which takes 2 or 3 days,
would not be possible for such women.
P947
Diagnosis of human brucellosis usingAMOSPCR
W. Yu, K. Nielsen, T. Grushina, T. Meka-Mechenko (Nepean,
CA; Almaty, KZ)
Objectives: Numerous PCR-based assays have been developed
for the identiﬁcation of Brucella to improve diagnostic
capabilities. For some purposes, the simple identiﬁcation of
Brucella is adequate. However, PCR with IPS1 and IPS2 primers
is a reliable tool for rapid identiﬁcation of Brucella species and its
differentiation from closely related organisms. A fundamental
question that arises during epidemiological investigations of
outbreaks is whether the outbreak strain is genetically related to
a proposed strain. Highly discriminating genetic markers
for characterizing bacterial strains can help in clarifying the
genetic relationships among strains. The Brucella AMOS
(AbortusMelitensisOvisSuis)-PCR assay was previously devel-
oped to identify and differentiate speciﬁc Brucella species.
Material and methods: Twenty strains of B. melitensis isolated
from humans and animals using traditional techniques during
four ﬁeld trips to rural areas in two regions of Kazakhstan. Total
360 people were examined. B. melitensis biovars 1, 2 and 3 were
isolated in 18 cases out 130 individuals presumed to be infected
with Brucella sp. Two B. melitensis biovar 2 were isolated from
sheep milk. Twenty isolates were identiﬁed and tested by the
conventional biochemical tests, PCR-based and Brucella AMOS
PCR
Results: Twenty isolates were identiﬁed and tested by the
conventional biochemical tests, PCR-based and Brucella AMOS
PCR. This included 6 isolates identiﬁed as B. melitensis biovar 1;
10-identiﬁed as B. melitensis biovar 2; 4-identiﬁed as B. melitensis
biovar 3. The results of classical typing for 20 B. melitensis
cultures isolated from humans and animals were conﬁrmed at
genetic level by PCR. The high speciﬁcity of this PCR-based
assay was demonstrated by testing all of the biovars of twenty
strains of B. melitensis. The Brucella AMOS PCR correctly
identiﬁed each isolate as a B. melitensis. However due to
AMOS, but not biological typing, genetic features of 2 strains
of B. melitensis biovar1 and 2 have been found. Two B. melitensis
biovar 1 and 2 have been isolated from the people with
serological positive acute brucellosis (SAT: 1: 1600).
Conclusion: The PCR-based test and AMOS-PCR could be used
as a complementary test to identify genus Brucella and
differentiate speciﬁc Brucella species. However, to explain
further genetic distinctions, ﬁngerprinting is required.
P948
Evaluation and comparison of molecular tests for
identiﬁcation of methicillin-resistant
Staphylococcus aureus
A. Kerttula, A. Vainio, S. Mero, T. Pasanen, J. Vuopio-Varkila,
A. Virolainen (Helsinki, FI)
Objective: The aim was to compare different in-house and
commercial molecular methods to detect methillicillin-resistant
S. aureus (MRSA).
Methods: A total of 208 bacterial isolates were tested: 122
consecutive, clinical S. aureus strains [108 MRSA, 7 borderline
methicillin-resistant S.aureus (BORSA) and 7 methicillin-
sensitive S.aureus (MSSA)] sent to National Public Health
Institute for conﬁrmation and genotyping during a two month
period, 19 Finnish epidemic MRSA (EMRSA) strains, 2 BORSA,
1 MSSA, 3 ATCC S. aureus reference strains, 41 S. epidermidis
strains, 18 other ATCC staphylococcal reference strains, 1
Enterococcus faecalis, and 1 E. faecium isolate. We compared
Geno Type MRSA test (detection of mecA, universal bacterial
control, S. aureus and S. epidermidis speciﬁc DNA), EVIGENETM
test (mecA, nuc, 16SrRNA present in all staphylococci),
LightCycler MRSA Detection Kit (mecA) and in-house real-
time-PCR method (RT-PCR) (mecA, nuc) to conventional
in-house PCR of mecA and nuc test.
Results: All 144 S. aureus isolates tested positive for the nuc-
and 127 for the mecA-genes in our in-house PCR-tests. The
results obtained with Geno TypeMRSA, i.e. detection of mecA
and amplicons speciﬁc to S. aureus species, corresponded with
the conventional PCR results. The Geno Type MRSA also
correctly detected all 41 S. epidermidis strains, of which 39
possessed the mecA-gene. Both Enterococcus isolates and all
other coagulase-negative staphylococcal isolates remained
negative, except for one strain possessing the mecA gene.
EVIGENETM, in-house RT- PCR and LightCycler MRSA
Detection Kit test results corresponded with the conventional
PCR results with all 127 mecA-positive MRSA strains. MSSA
and BORSA strains were detected correctly also by using
EVIGENETM but the real-time PCR methods gave some false
positive or uncertain results.
Conclusion: A good variety of reliable commercial molecular
tests for rapid MRSA identiﬁcation and conﬁrmation were
available for clinical microbiological laboratories.
P949
Comparison of ﬂuorescent in situ hybridization
and histological method for diagnosis of
Helicobacter pylori in gastric biopsy samples
S. Tajbakhsh, A.R. Samarbaf-Zadeh, S.M. Moosavian (Bushehr,
Ahwaz, IR)
Objective: The objective of this study was to compare
ﬂuorescent in situ hybridization (FISH) with histology for
detection of H. pylori in gastric biopsy specimens.
Methods: Fluorescent–labelled oligonucleotide probes that
target ribosomal RNA, were utilized in FISH procedure. In
this project, FISH tested 91 specimens and histological method
using the haematoxylin-eosin (H-E) and Geimsa stains.
Furthermore, clarithromycin resistance in 39 samples of above
91 specimens were examined by FISH
Results: The sensitivity and speciﬁcity of FISH for detection of
H. pylori were 97.9% and 97.7%, respectively. Of those 39
samples that were tested for clarithromycin resistance, 19 were
FISH positive for H. pylori, which 15 and 4 specimens were
infected with clarithromycin susceptible and clarithromycin
resistant strain, respectively.
Conclusion: FISH is a highly sensitive and speciﬁc technique
for diagnosis of H. pylori in gastric biopsies. The ability of FISH
for detection clarithromycin resistant and susceptible strains is
the essential advantage of this technique on histology.
P950
Comparison of a real-time PCR assay and a
chromogenic MRSA selective medium for the
detection of methicillin-resistant Staphylococcus
aureus directly from nasal and rectal swabs
R. Reyes, B. Catanzariti, E. Isaac, M. John, L. Stoakes,
J. Vandierendonck, Z. Hussain (London/Ontario, CA)
Objective: IDI-MRSA assay (Genome, California), a real-time
PCR and in vitro diagnostic test amplify a highly conserved
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MRSA-speciﬁc gene sequence within SCCmec and orfX.
SCCmec is the mobile genetic element, which harbours the
mecA gene. We evaluated the assay for the detection of MRSA
from nasal and rectal swabs obtained from hospitalised patients
and compared it with a chromogenic MRSA selective medium.
Methods: Copan swabs with liquid Stuart media were used to
collect nasal and rectal specimens. For the IDI-MRSA assay,
nasal swabs were processed as described by Warren et al.
(J. Clin. Microbiol. 2004, 42: 5578). Rectal swabs were vortexed
with 1 ml of sample buffer, 50 ml of which was added to lysis
tubes. After brief vortexing of tubes, tubes were heated at 95C
for 2 minutes. Subsequently, 2.8 ml of cooled sample buffer was
added to the PCR master mix. MRSASelect (Marnes la Coquette,
France) plates were either inoculated directly with the nasal
swabs or with 100 ml of the sample buffer prepared with rectal
swabs.
Results: In total 259 pairs of nasal and rectal swabs were tested.
Results of culture and IDI MRSA assay are shown below. Of 17
culture positive and PCR-negative results, 6 could be considered
being true positive because MRSA was isolated from a
subsequent nasal or rectal specimen. The positive predicative
value increased to 78%, when 6 results were regarded as true
positive. Thirty-one rectal and 21 nasal specimens could not be
evaluated or to be repeated because of inhibition of
ampliﬁcation reaction.
Conclusion: IDI-MRSA assay is rapid and sensitive MRSA
detection method from nasal and rectal specimens. The assay
has advantage over other real-time PCR and conventional PCR
methods that it can be performed directly on patient specimens
and allows same day result. Disadvantage of IDI-MRSA include
the high initial investment for equipment, and high cost of
testing. We also observed a higher rate of inhibition than
previously reported.
P951
Evaluation of SeptiFast – a new commercially
available broad-range real-time PCR assay for
detection of bacteria and fungi in blood
G. Lisby, H. Westh (Hvidovre, DK)
Introduction: Blood culture (BC) is the gold standard for
detection of bacteraemia and fungaemia but has several
limitations. False positive results due to contamination and
false negative results due to e.g. antibiotic treatment at the time
of sampling are well known problems. Nucleic acid target
ampliﬁcation (PCR) could potentially supplement traditional
BC.
Objective: To compare a new commercially available broad-
range real-time PCR assay (SeptiFast) with BC for detection of
bacteria and fungi in blood from patients with suspected sepsis
or SIRS. SeptiFast detects a total of 23 pathogen species.
Methods: A BC sample (32–40 ml) was obtained using sterile
technique. Immediately after, a 5 ml blood sample was obtained
for PCR. At the Department of Clinical Microbiology, Hvidovre
Hospital, BC (BactAlert, BioMerioux) was performed according
to standard operating procedures. PCR (SeptiFast, Roche
Diagnostics) was performed according to the manufacturers’
description using a MagNA Lyser and LightCycler 2.0 (Roche
Diagnostics).
Results: A total of 114 episodes (combined BC samples and PCR
samples) were collected from 114 patients. 83 episodes were
negative in both BC and PCR and 21 episodes were positive in
one or both assays. 13 episodes were BC positive, yielding 13 BC
isolates (positive rate for non contaminant BC: 7.9%). Two
isolates were not included in the PCR panel and three isolates
were considered as contamination. Of the remaining seven
isolates available for direct comparison, PCR detected ﬁve. 15
episodes were PCR positive (positive rate for non contaminant
PCR: 11.4%), detecting a total of 19 microorganisms. Two of the
detected microorganisms were considered as contamination, six
were also detected by BC, but 11 were not detected by BC. Of
these 11 PCR ± BC- isolates, six were conﬁrmed by culture of the
same micororganism from a clinical relevant anatomical site and
ﬁve could not be conﬁrmed by culture. The combined tests had a
positive rate for non-contaminants of 15.8%. In the six episodes
positive by both PCR and BC, PCR would reveal species
identiﬁcation in approx 18 hours if performed on a daily basis.
BC had an average delay of 2 days until Gram stain, and 3–4 days
until species identiﬁcation.
Conclusion: This study shows SeptiFast PCR to be a valuable
add-on to conventional BC for detection of bacteria and fungi in
blood.
P952
Multiple aetiology of urethritis and cervicitis in
sexually transmitted disease clinics caused by
Chlamydia trachomatis, Neisseria gonorrhoeae,
Mycoplasma genitalium, and Trichomonas
vaginalis
C.A. Gaydos, N.E. Maldeis, A. Hardick, J. Hardick, M. Barnes,
B.J. Wood (Baltimore, US)
Objective: To determine the prevalence and multiple
aetiologies of male urethritis and female cervicitis of Chlamydia
trachomatis (CT), Neisseria gonorrhoeae (GC), Mycoplasma
genitalium (MG), and Trichomonas vaginalis (TV) in patients
from STD clinics using Gen-Probe APTIMA TMA and PCRs.
Methods: Urines from 290 men and self-administered vaginal
swabs from 325 women were collected. Demographics, beha-
vioural risk factors, signs and symptoms were recorded. CT and
GC were detected by APTIMA Combo 2 (Gen-Probe Incorpor-
ated). MG and TV were detected by real time research PCR
(MLRT-PCR for MG and B-TUB FRET for TV) and by prototype
Gen-Probe TMA-based assays for MG and TV (TMA-MG and
TMA-TV). ). A patient considered to be infected with MG and/
or TV if both research PCR assay and prototype Gen-Probe assay
were positive.
Results: Prevalence: males (N = 153) with urethritis: CT 32.7%,
GC 24.2%, TV 5.2%, MG 21.7%; males (N = 137) without
urethritis: CT 6.6%, GC 0%, TV 1.5%, MG 8.0%. Prevalence:
females (N = 77) with cervicitis: CT 18.2%, GC 7.8%, TV 18.2%,
MG 26.0%; females (N = 248) without cervicitis: CT 9.3%, GC
3.2%, TV 13.8%, MG 17.5%. Kappa statistics for comparison
between research PCRs for MG and TV and TMA-MG and
TMA-TV were excellent (0.941 and 0.858, respectively).
Co-infections of > 2 organisms occurred in 10.6% of males.
Co-infections with > 2 organisms occurred in 11.4% of females.
Conclusion: Prevalence of all organisms was higher in men
with urethritis and in women with cervicitis in this population.
Co-infections were common. MG and TV were associated with
urethritis and cervicitis. Prototype TMA-based assays for MG
and TV performed very well compared to research PCR assays.
Abstracts
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P953
Advances in diagnostic testing of Chlamydia
trachomatis
M. Eickhoff, S. Cramer, T. Grewing (Hamburg, DE)
Objective: The genome of the obligate intracellular bacterium
C. trachomatis consists of a circular chromosome of 1.045 MB and
a conserved cryptic plasmid, which is approximately 7.5 KB in
size and is present in multiple copies (5–10) in the organism. The
plasmid has great practical importance as favoured target for
nucleic acid ampliﬁcation technologies (NAATs). However, a
few isolates of C. trachomatis have been described, which do not
contain the plasmid. We evaluated the performance of the
artusTM C. trachomatis Plus RG PCR Kit (QIAGEN Diagnostics
GmbH, Germany) which combines highly sensitive detection of
chlamydial DNA from swab, urine and sperm samples and high
speciﬁcity by using a combined ompA- and cryptic plasmid-
based PCR.
Methods: The artusTM C. trachomatis Plus RG PCR Kit consti-
tutes a ready to use system for the detection of C. trachomatis
DNA by real-time polymerase chain reaction (PCR) using the
Rotor-GeneTM instrument (Corbett Research, Australia). The C.
trachomatis Plus RG Master contains reagents and enzymes for
the speciﬁc ampliﬁcation and the direct detection of a 106 bp
region of the C. trachomatis genome and of a 111 bp region of
the chlamydial cryptical plasmid. In addition, it contains a
second ampliﬁcation system (internal control) to identify
possible PCR inhibition and to control the isolation procedure.
Swab and sperm specimens were puriﬁed using the QIAamp
DNA Mini Kit, urine specimens using the QIAamp Viral
RNA Mini Kit (QIAGEN, Germany). The evaluation of the
assay was performed with 142 retrospective swab samples (50
urethral, 48 cervical and 44 vaginal swabs), 94 retrospective
urine samples (49 male, 45 female) as well as 65 prospective
sperm samples.
Results: Diagnostic sensitivity and speciﬁcity for sperm sample
have shown to be 100%. For swab and urine samples the artusTM
C. trachomatis Plus RG PCR Kit showed a diagnostic sensitivity
of 98% and a speciﬁcity of 99%.
Conclusion: Our results show that the new real-time PCR assay
provides a sensitive and speciﬁc way to detect C. trachomatis in
various sample materials. With the artusTM C. trachomatis Plus
RG PCR Kit laboratory physicians no longer need to implement
conﬁrmation-PCRs that are necessary if commercial test systems
are used, which are based on the cryptic plasmid only.
P954
LCR method for detection of Chlamydia
trachomatis in patients with chronic nonbacterial
prostatitis
N. Draskovic (Belgrade, CS)
Objective: Chronic prostatitis is frequent in men of all ages.
Almost 95% of all prostatitis cases consist of chronic non-bac-
terial prostatitis (CNBP), which has unclear aetiology. In
recent years role of Chlamydia trachomatis (CT) in etiopatho-
genesis of CNBP came into focus. Genital chlamydia infection
is widespread and frequently asymptomatic and chronic,
therefore some forms of prostatitis can be considered to be
complication of genital CT infection. Aim of our study was to
determine whether CT infection could be correlated to some
CNBP forms.
Method: Samples of 72 patients (32 in CNBP group and 41
with prostatodynia as a control group) were analysed. Samp-
ling was performed according to standard Starney and Mears
method (urethral swab, VB1- ﬁrst urine ﬂash, VB2-middle
urine ﬂash, EPS - expressed prostatic secretions, VB3-urine
after prostate massage). This kind of sampling enables seg-
mental localization of infection. Samples were analysed for
bacteria, CT determination was done by nucleic acid ampliﬁ-
cation performed by ligase chain reaction (LCR). Direct
microscopy of Gram-stained prostate experiment was per-
formed. Infection criterion was ﬁnding of more than 10 white
blood cells (WBCs) per high-power ﬁeld (HPF).
Results: In CNBP group, there was no CT in urethral swab and
VB1. In VB2 samples CT was found in 1 (3.13%), in EPS samples
in 7 (21.88%) and in VB3 samples in 5 (15.63%). In control group
with prostatodynia, CT was found only in one EPS sample
(2,44%). In all other samples CT was not present.
Conclusion: In CNBP group, CT was determined in samples
by LCR in 40.64% and in control group in 2.44%. Difference is
statistically signiﬁcant. In CNBP patients who were CT positive
(13), EPS sample was positive in 7 (53.08%). CT can be
correlated with some forms of CNBP, but for valid assessment
sampling must be done according to Stamey and Mears
method.
P955
Improvement of an existing magnetic particle
based NAAT sample preparation system for
C. trachomatis in urine by signiﬁcantly reducing
processing time while maintaining sensitivity
M. Angle´s d’Auriac, T. Engen, U.H. Refseth (Oslo, NO)
Objective: Chlamydia trachomatis is the leading cause of
sexually transmitted disease worldwide and is still on the
rise. To obtain control over this pandemic, health authorities
have been promoting the use of non-invasive sample collection,
such as urine, to increase testing among target population.
However, with the available technology, this represents a
challenge with respect to cost control and logistics in
diagnostic laboratories. A major bottleneck associated with
NAAT based analysis for C. trachomatis diagnostics using urine
specimens, is the cumbersome manual procedure to obtain
DNA of sufﬁciently high quality. Automation of the sample
preparation is a necessity to reduce both hands-on time and
cross contaminations. A method based on magnetic particles
for sample preparation, BUGS’n BEADSTM, (Genpoint,
Norway), has previously been shown to be well suited for
isolation of C. trachomatis from urine. This automated system
currently uses a customized Tecan Miniprep 75 instrument,
using about 2.5 hours to process 48 samples. However,
laboratories may require even higher throughput, which
could be achieved by trying to further reduce the sample
preparation time.
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Methods: In this study, a simpliﬁed magnetic particle based
protocol, completing the entire sample processing in only
1.5 hour on the Tecan Miniprep 75 robotic platform, was
compared with the original BUGS’n BEADS procedure. A total
of 24 urine samples, previously determined positive for C. tra-
chomatis using the original BUGS’n BEADSTM method, were
analysed using the new preparation protocols in combination
with the BDProbeTec detection system for C. trachomatis. The
ampliﬁcation control (AC) in the BDProbeTec kit was included
for the new method to reveal any potential inhibition.
Results: All 24 samples were positive with the new sample
preparation protocol indicating that sensitivity is not reduced in
comparison with the original BUGS’n BEADSTM procedure.
Moreover, no inhibition was encountered for any of the urine
samples as demonstrated by the AC MOTA values, which were
all above the cut-off value as deﬁned for the BDProbeTec
detection kit.
Conclusion: This new and faster DNA preparation method
allows for signiﬁcant increase in throughput compared to the
original BUGS’n BEADS solution. Finally, as a consequence to a
reduction in processing time, this new method will allow more
laboratories to access full NAAT automation by the introduction
of smaller and cheaper robotic systems.
P956
A comparative study of three different PCR
assays for detection of Mycoplasma genitalium in
genital specimens from men and women
A. Edberg, E. Johansson, E. Wikander, A. Ho¨o¨g, T. Ahlqvist,
M. Jurstrand, L. Falk, J.S. Jensen, H. Fredlund (Karlstad, O¨rebro,
SE; Copenhagen, DK)
Objective: The aims of this study was to compare conventional
16S rRNA PCR, real-time 16S rRNA PCR and real time MgPa
PCR as detection methods for Mycoplasma genitalium infection.
We also wanted to determine the prevalence of M. genitalium in
patients, both men and women, visiting a STI clinic in a rural
area in the west of Sweden.
Methods: First void urine (FVU) and/or urethral swab were
collected from 381 men and from 298 women, FVU and/or
cervical swab and/or urethral swab were collected. Two
hundred and ﬁfteen specimens were used in the PCR
comparative study, 100 consecutive specimens, and 36
consecutive specimens from patients with symptoms of
urethritis and 79 specimens from patients positive for M.
genitalium by real time MgPa PCR in the prevalence study.
True-positive samples were deﬁned as a specimen positive in
any two PCR assays.
Results: The prevalence of M. genitalium infection in men and
women were 27/381 (7.1%) and 23/298 (7.7%), respectively. In
the PCR comparative study, M. genitalium DNA were detected
in 59/62 (95.2 %) by conventional 16S rRNA PCR, 52/62 (83.9 %)
by real time 16S rRNA PCR and in 62/62 (100 %) by real time
MgPa PCR of true-positive specimens. M. genitalium DNA were
detected in an additional 12 specimens with real time MgPa
PCR. Four of these specimens were from women with another
true-positive sample. An additional 2 specimens, also from
women with another true-positive sample, were detected with
conventional 16S rRNA PCR.
Conclusion: Real time MgPa PCR indicates slightly higher
sensitivity compared to conventional 16S rRNA PCR and
increased sensitivity compared to real time 16S rRNA PCR for
detection of M. genitalium DNA. The prevalence of 7.1 % in men
and 7.7 % in women attending a STI clinic is in concordance
with other Swedish studies.
P957
A new real-time quantitative TaqMan PCR to
detect Chlamydia trachomatis DNA in urine and
in urogenital swabs
K. Jaton, J. Bille, C. Andre´, G. Greub (Lausanne, CH)
Objective: Chlamydia trachomatis infection is the most frequent
bacterial sexually transmitted disease. Urogenital infections are
often asymptomatic and, when remaining untreated, they may
lead to severe late complications in women, including infertility
and extra-uterine pregnancy. Screening for Chlamydia trachomatis
infections may be performed on urines and urogenital swabs
using molecular detection techniques. However, commercially
available methods remain expensive and are associated with
large laboratory workload. To reduce costs and increase
throughput, we developed a C. trachomatis speciﬁc real-time
quantitative TaqMan PCR (q-PCR).
Material and methods: A q-PCR that may be used on ABI
Prism 7900R Sequence System (Applied Biosystem) was
developed. This system was coupled to a liquid handling unit
(TecanR), allowing automatic pipetting and use of 384 wells
micro plates. DNA was extracted with the Magna-PureR
(Roche), and q-PCR was performed using 5 ll DNA and 15 ll
PCR mixture. Primers and probe were selected from highly
conserved sequence of the cryptic plasmid. This new q-PCR was
compared to the commercial Cobas AmplicorR (C-PCR) on a
total of 646 specimens taken from 564 patients (297 urogenital
swabs and 349 urine samples).
Results: The q-PCR exhibited the same analytical sensitivity as
C-PCR. The analytical speciﬁcity of q-PCR was excellent with no
signal detected in presence of bacterial DNA of 7 others
Chlamydia species and of 15 other bacterial species potentially
present in urogenital samples. No inhibition of PCR reaction
was observed with q-PCR whereas 19 out of 646 samples (2.9%)
were inhibited with the C-PCR. Comparison of the remaining
627 specimens showed an overall agreement of 99.7% between
C-PCR and q-PCR (95 +/+, 530 -/-, 2 ±, 0 ±). Considering the
C-PCR as gold standard, the speciﬁcity was 100% (530/530) and
the sensitivity of 98% (95/97). The 2 discrepant results were
re-investigated in a second run of C-PCR and q-PCR. One was
found strongly positive with the 2 methods. The other was
found negative in a second run of Cobas and once positive by
q-PCR when 5 additional replicates were done, suggesting that
there is a very low amount of DNA in this sample.
Conclusion: The q-PCR is a speciﬁc method that exhibits a
similar sensitivity than C-PCR for the detection of C. trachomatis.
Given its high throughput potential and the low costs of q-PCR
reagents (about 2 $ per sample), it may contribute to future
large-screening program.
P958
First void urine can be used as transport medium
for cervical swab specimen for detection of
Mycoplasma genitalium by polymerase chain
reaction
T. Ahlqvist, A. Edberg, E. Johansson, H. Fredlund,
F. Aronsson (Karlstad, O¨rebro, SE)
Objective: The objective of this study was to determine if the
patients’ ﬁrst void urine (FVU) could be used as transport
medium for cervical swab specimen for detection of Mycoplasma
genitalium infection.
Methods: Cervical swabs and FVUs were collected from 329
women attending a STI clinic during the period of August 2004
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to June 2005. Three types of samples were collected from each
patient, FVU, cervical swab transported in 2SP medium and
cervical swab transported in FVU. All samples were analysed
forM. genitalium DNA by real time MgPa PCR on SmartCyclerII
(Cepheid, Sunnyvale, USA).
Results: M. genitalium DNA was detected in 19 of 20 (95%)
samples was the cervical swab was transported in the patients
FVU. Whereas, M. genitalium DNA was detected in 17 of 20
(85%) in FVU samples and 12 of 20 (60%) in cervical swab
transported in 2SP medium. When comparing two different
DNA extraction methods, manually extraction using Chelex
slurry (BioRad, Richmond, USA) and automated biorobot M48
extraction (Qiagen, Hilden, Germany), M. genitalium DNA was
detected in additional 5 samples (total 25) using the M48
extraction compared to 20 M. genitalium positive samples
detected using Chelex extraction. Further, inhibition was
detected in 6% of the Chelex extracted samples whereas no
inhibition was detected using M48 extraction. In a small subset
of samples we were able to detect M. genitalium DNA after
4 weeks of storage in room temperature.
Conclusion: This study shows that cervical swabs can be
transported in the patients FVU were M. genitalium DNA is
detected by real time PCR. These results indicate that 2SP
medium can be excluded from the M. genitalium analysis
procedure and lead to a reduction of sample numbers from two
to one per patient, which will reduce the costs for the analysis.
P959
Automation for generic nucleic acid sample prep
in a routine diagnostic laboratory
T.E. Schutzbank, N. Kahmann, C. Jarvis, M. Weimer, A. Yount,
K. Lopez (Dayton, US)
Objectives: To validate and integrate automated magnetic-
particle sample puriﬁcation systems into the routine workﬂow
of a commercial diagnostic laboratory and to increase the
standardization of nucleic acid puriﬁcation using mid-to-low
throughput robotic workstations.
Methods: Nucleic acids were puriﬁed using the QIAGEN
BioRobot EZ1 and M48 workstations using protocols from the
EZ1 DNA Bacteria Card and EZ1 Virus Card, and protocols on
Infectious Disease Application Package for the BioRobot M48.
Bacterial DNA was extracted using the BioRobot EZ1
workstation together with the EZ1 DNA Tissue Kit. BioRobot
M48 workstations were used to purify bacterial DNA in
combination with the MagAttract DNA Mini M48 Kit and
protocols on the Infectious Disease Application Package CD.
Viral DNA and/or RNA was puriﬁed using the EZ1 Virus Mini
Kit on the EZ1 and the MagAttract Virus Mini M48 Kit.
Pathogen nucleic acids were extracted from a range of clinical
specimen types, including plasma, respiratory samples, swabs,
and whole blood. Both artusTM assays and a range of in-house
designed downstream assays were used to compare extraction
efﬁciency.
Results: Automated extraction, followed by detection of
bacterial DNA from group A and B Streptococci, S. aureus, and
B. pertussis showed high sensitivity and speciﬁcity while
signiﬁcantly reducing both the mean time-to-result and
workﬂow efﬁciency compared to manual extraction methods.
Cytomegalovirus (CMV) DNA nucleic acids performed well,
showing a large dynamic range and allowing accurate
quantiﬁcation using both an in-house designed and a
commercially available, artusTM, assay. Human Papilloma
virus (HPV) DNA and Hepatitis C virus RNA performed well
in other commercial assays.
Conclusions: The BioRobot M48 and EZ1 provide standardized
and easy-to-use protocols for nucleic acid puriﬁcation from a
wide range of clinical sample types. The BioRobot M48 provides
processing capacity (6–48 samples/run) to enable routine
applications for mid to high throughput clinical laboratories.
The low-throughput of the BioRobot EZ1 (1–6 samples/run)
ensures that priority samples can be handled safely and quickly
without decreasing laboratory efﬁciency. Performance of
puriﬁed nucleic acids in artusTM assays was excellent,
illustrating the combined efﬁcacy of BioRobot sample
preparation and the artus assays used for diagnostic analyses.
P960
Multiplex real-time PCR for detection of Candida
infections in blood
A˚. Innings, M. Ullberg, A. Johansson, C.J. Rubin, N. Nore´us,
M. Isaksson, B. Herrmann (Uppsala, SE)
Objectives: To develop a multiplex real-time PCR method for
detection of the seven most common Candida species-causing
septicemia: C. albicans, C. dubliniensis, C. glabrata,
C. guilliermondii, C. krusei, C. parapsilosis and C. tropicalis. To
evaluate a DNA extraction method and detection limits of the
PCR for direct detection of Candida infections from human
venous blood.
Method: A multiplex four channel real-time PCR assay was
developed with the target gene RPR1, coding for the RNA
subunit of ribonuclease P. The RPR1 sequences of the seven
Candida species were determined. The multiplex PCR contained
four primers and four TaqMan probes labelled with
ﬂuorophores of different wavelengths. Three of the probes
enabled speciﬁc detection of C. albicans, C. glabrata and C. krusei
and the fourth allowed general detection of the remaining
species. Candida DNA was extracted from 3 ml human blood
using lyticase and the QIAamp tissue kit.
Results: The multiplex PCR was able to detect 1–10 genome
copies when the detection limit was tested repeatedly for the
four species C. albicans, C. glabrata, C. krusei and C. guillermondi.
No signiﬁcant difference in detection limit was seen when
the multiplex format was compared with single species PCR,
i.e. two primers and one probe. When the Candida DNA was
extracted from spiked human blood a detection limit
of < 10 cells per ml was reached. The multiplex system has an
inbuilt speciﬁcity control as only one channel should be positive
for a speciﬁc species and this was achieved in all runs
performed. The sequence data from the seven Candida species
showed surprisingly large sequence variation. With broad-range
primers C. glabrata produced an about ﬁve times longer
amplicon compared to the other species and the nucleotide
sequence similarity between C. krusei and C. albicanswere as low
as 55%. General primers for satisfactory real-time PCR could not
be designed for the species C. glabrata and C. krusei resulting in
the multiplex four-primer system.
Conclusions: A sensitive and speciﬁc multiplex real-time PCR
was developed for the detection of seven Candida species and
the identiﬁcation of C. albicans, C. glabrata and C. krusei. It can be
used for detection of Candida spp in blood samples.
P961
The application of MALDI-TOF mass
spectrometry for the quality control of NCTC
strains
L. Molenaar, D. Dare, H. Sutton, J. Russell, H. Shah, M. Roberts,
M. Lunt (London, Manchester, UK)
Objectives: Type and reference strains from the National
Collection of Type Cultures (NCTC) are used for quality
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assessment in both national and international laboratories. The
Centre of Infections currently supplies these preserved strains as
freeze-dried cultures. The preservation and provision of such
cultures in LENTICULE format rather than the freeze-dried
cultures is however preferred, since it facilitates easier
processing of cultures, increases the distribution rate, provides
a more cost effective format and facilitates postage worldwide.
To assess the effect of this change in format and thereby ensure
that the quality of the NCTC strains remains unchanged,
MALDI-TOF mass spectrometry is used for direct comparison
of the respective NCTC preserved strains.
Method: Ten NCTC type and reference strains, representing 6
genera and 9 species, were simultaneously revived from freeze-
dried and from the equivalent LENTICULE discs that were
preserved between 1996 and 2004. The intact microbial cells
from equivalent samples were inoculated onto the same MALDI
target plate and co-crystallised with the same batch of MALDI
matrix. Laser interrogation of the surface associated molecules
from the paired type and reference strains provided the
comparative MALDI-TOF mass spectral proﬁles used for
assessing the differences associated with each preservation
format.
Results: Mathematical interrogation of the mass spectral
proﬁles demonstrated there is negligible difference between
each of the organisms recovered from the two preservation
methods. Surface associated molecules of intact microbial cells
therefore remain unaltered after preservation by lenticulation.
Conclusion: The application of MALDI-TOF mass spectrometry
for the quality control of NCTC strains suggests that
LENTICULE production has not resulted in altered
morphotype and ensures the quality of the NCTC strains is
maintained.
P962
LightCycler SeptiFast Test: rapid detection of
nosocomial pathogens by real-time PCR
T. Emrich, M. Moczko, S. Lohmann, J. Mayr, H. Stockinger,
G. Haberhausen (Penzberg, DE)
Objective: At present, one of the main medical problems in
hospitals is the increasing number of nosocomial (hospital-
acquired) infections. Epidemiological data show that a limited
number of microorganisms are responsible for the majority of
bloodstream infections. Twenty-ﬁve species account for more
than 90% of all nosocomial pathogens. A rapid diagnosis of
Sepsis and the correct identiﬁcation of the causative pathogen
followed by immediate and appropriate antimicrobial therapy is
the key of success in the management of bacteraemia and
fungaemia in septic patients, but not limited to these.
Methods: The LightCycler SeptiFast Test was developed to
detect and differentiate up to 25 pathogenic microbial DNA(s) in
human whole blood. Specimen preparation is based on a semi
automated procedure using the MagNa Lyser followed by a
manual spin column based nucleic acid preparation.
Ampliﬁcation and detection are automated using the
LightCycler 2.0 Instrument.
Results: Compared to classical methods (blood culture
followed by gram staining and species identiﬁcation based on
culture methods), the LightCycler SeptiFast Test offers an
improved sensitivity and a much better time to result. In most
cases, the result will be available in about 4.5 hours instead of
two to three days. In case of a positive PCR result, therapy can
be adjusted about two days earlier, which might lead to
signiﬁcant savings for the hospital as well as to improved
outcome for the patient. In case of negative PCR results, blood
culture remains the basis for medical decisions.
Conclusion: The LightCycler SeptiFast Test is the ﬁrst IVD
assay using PCR for the rapid detection and identiﬁcation of
bacterial and fungal pathogens involved in nosocomial
infections directly from whole blood. Here we present non-
clinical performance data as well as selected data from several
external clinical studies to illustrate the ability and power of the
assay.
P963
Comparison of real-time and conventional PCR
assays for diagnosis of Cat Scratch Disease in
patients with lymph node enlargement
C. Le Brun, S.J. De Martino, Y. Hansmann, J. Debs, C. Walter,
Y. Piemont, B. Jaulhac (Strasbourg, FR)
Objectives: Real-time polymerase chain reaction (PCR) is a
novel rapid method for the detection and identiﬁcation of
fastidious growing bacteria like Bartonella. The aims of this
study were (i) to develop a real-time PCR based method able to
differentiate the main Bartonella species involved in human
endocarditis and in Cat Scratch Disease (CSD) (ii) to compare
real-time PCR with conventional PCR for diagnosis of CSD.
Methods: A real-time PCR assay, using a double hybridization
probe format (Light Cycler) was developed. Identiﬁcation and
differentiation of Bartonella species was based on the
ampliﬁcation by real time PCR of a 205-bp fragment of the
gltA gene followed by Tm determination. Conventional PCR
targeted a 414-bp fragment of the htrA gene of B. henselae (i). We
evaluated 113 samples (lymph node biopsy or cytopunctures)
over a ten-year period. The patients were divided into three
groups according to the number of positive diagnostic criteria
for CSD: 23 patients with deﬁnite CSD (two or more classical
criteria), 69 with possible CSD and 21 for whom another
diagnosis was retained used as a control group.
Results: Conventional PCR detected B. henselae only, whereas
the real-time PCR method could detect and differentiate
B. henselae, B. quintana, B. koehlerae, B. vinsonii, B. alsatica and
B. berkhofﬁi. Speciﬁcity was 100% for the both assays. Sensitivity
was 78% by both conventional and real-time PCR assays on
samples from patients with deﬁnite CSD. Real-time PCR
coupled to automate DNA extraction on the MagNA Pure
robot (Roche) was less susceptible to inhibitors than manual
extraction (6 vs.0 by MagNA Pure).
Conclusion: This Light Cycler PCR assay was sensitive,
speciﬁc, and less time consuming than conventional PCR.
Therefore, real-time PCR analysis could be used for CSD
diagnosis in combination with epidemiological, serological and
histological criteria. (1) Hansmann Y, De Martino S, Pie´mont Y,
Meyer N, Mariet P, Heller R, Christmann D, Jaulhac B.
Diagnosis of Cat Scratch Disease with detection of Bartonella
henselae by PCR: a study of patients with lymph node
enlargement. J Clin Microbiol 2005; 43: 3800–3806.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Fast detection of respiratory microbes
P964
Advances in PCR detection of Pneumocystis
jiroveci in immunocompromised patients: count
seems to be important
J. Lochmanova, Z. Racil, M. Lengerova, D. Minarikova,
P. Volfova, D. Dvorakova, J. Mayer (Brno, CZ)
Objectives: Pneumocystis jiroveci remains one of the important
causes of pneumonia in immunocompromised patients.
Detection of this fungus in bronchoalveolar lavage (BAL) ﬂuid
using nested PCR has great sensitivity and speciﬁcity for
diagnostics of Pneumocystis pneumonia (PCP). Because this
two-step method is rather time consuming we decided to
replace it by TaqMan real-time quantitative PCR targeting the
neighbouring region of the same gene (mtLSU rRNA gene).
Methods: Between VI/99 and X/2005, a total number of 266
BAL specimens of immunocompromised patients were tested
using nested PCR assay. Forty-nine specimens (18,4%) were
P. jiroveci positive. Twenty-nine P. jiroveci positive and 10
negative specimens were retested using novel real-time PCR
assay. Results of both methods were compared and detected
copy numbers were correlated to clinical ﬁndings.
Results: There was absolute concordance between positive and
negative results obtained by both methods. The real-time PCR
assay is able to detect< 10 copies of a plasmid standard per tube
and it has the same sensitivity as the nested PCR. The copy
numbers of the target gene in positive samples varied between 6
and 139534 copies per tube; median was 121 copies per tube.
The 29 positive patients that were retrospectively clinically
evaluated could be divided into 3 groups: (i) 15 (51.7%) patients
with PCP had median copy number of 4766 (range 12 – 139534)
copies per tube, (ii) 6 (20.7%) patients with polymicrobial
pneumonia (P. jiroveci + another pathogen) had median copy
number of 334 (range 13 – 11237) copies per tube and iii) 8
(27.6%) patients without PCP had median copy number of 70
(range 6 – 138) copies per tube.
Conclusions: We developed a rapid and sensitive real-time
PCR assay for detection of P. jiroveci. Using this assay, we are
able to obtain results in about 4 hours from sample delivery,
contrary to 6 hours that are necessary for nested PCR. Moreover
this assay seems to discriminate patients with PCP and P. jiroveci
carriers. Certainly, more samples must be tested to determine
the cut-off values more precisely. This work was supported by
Ministry of Health of the Czech Republic (grant no. NR/8452-3).
P965
Evaluation of a new assay for the detection and
differentiation of B. pertussis, B. parapertussis
and B. bronchiseptica based on real-time PCR
technology
A. Burmeister, T. Grewing, H. Petersen, N. Kahmann,
T.E. Schutzbank, M. Hess (Hamburg, DE; Moraine, US)
Objective: Laboratory diagnosis of whooping cough, is not well
standardized. Different PCR systems have been developed for
the detection of Bordetella pertussis, mainly based on insertion
sequences (IS) as target region. IS show copy numbers of up to
250 per cell, which makes these systems highly sensitive?
However, IS are transposable DNA elements, capable of
horizontal transfer across species and of spontaneous
elimination. These are characteristics that tend to compromise
speciﬁcity of PCR based diagnostic systems. The goal of this
work was to develop and to evaluate a highly sensitive, absolute
speciﬁc and reliable IVD assay, based on Real-Time PCR
technology for the detection and differentiation of the human
pathogenic Bordetella species B. pertussis, B. parapertussis and
B. bronchiseptica.
Methods: We developed an IS-independent PCR system for the
simultaneous detection of B. pertussis, B. paraperussis and
B. bronchiseptica and the differentiation of these species by
melting curve analysis using the LightCycler Instrument (Roche
Diagnostics). We combined this system with an IS-dependent
(IS481/IS1001) PCR system and an Internal Control (IC) PCR.
Testing type strains of all known Bordetella species, different
clinical isolates of human pathogenic Bordetella species and
about 50 different bacterial, viral and fungal isolates validated
speciﬁcity. The analytical and clinical sensitivity of the assay
was evaluated by Probit analysis and by testing over 200 clinical
specimens by different laboratories.
Results: We were able to develop a one tube Real-Time PCR
assay for the detection and differentiation of B. pertussis,
B. parapertussis and B. bronchiseptica. An Internal Control was
also implemented into the system. Testing DNA preparations of
all known Bordetella species and of viral, bacterial and fungal
isolates, either closely related to Bordetella or causing similar
symptoms observed no cross-reactivity. The analytical
sensitivity of the assay for B. pertussis determined by Probit
analysis is 1.3 copies/ll (p £ 0.05). Clinical sensitivity and
speciﬁcity was demonstrated by testing over 200 clinical
specimens.
Conclusion: We could demonstrate that our new Real-Time
PCR assay for the detection and differentiation of human
pathogenic Bordetella species combines the high sensitivity of
Insertion Sequence based PCR systems with the reliable
speciﬁcity of a IS independent PCR system and the security of
an Internal Control in a single reaction.
P966
Molecular diagnosis of Mycoplasma pneumoniae
and Chlamydia pneumoniae infections by
real-time NASBA
P. van Aarle, P. van Deursen, K. Loens, P. Sillekens, M. Overdijk,
M. Ieven, H. Goossens (Boxtel, NL; Edegem, BE)
Objectives: Evaluation of a nucleic acid ampliﬁcation proce-
dure for the detection of Mycoplasma pneumonia and Chlamydia
pneumoniae in respiratory tract specimens.
Methods: Using RNA as the principal target, ampliﬁcation was
performed with NASBA reagents from the NucliSens Basic Kit
and in-house produced primers and molecular beacon probes.
Internal Control (IC) RNAs were developed to monitor the
procedures at the individual sample level. For nucleic acid
extraction from respiratory samples, the NucliSens miniMAG
method based on magnetic silica was used. Methods were
evaluated on sputa, bronchus aspirates, bronchoalveolar lavages
and throat swab samples from patients with CAP.
Results: For respiratory samples, optimal IC RNA input levels
were established as a compromise between reliable detection of
the IC RNA and minimal effect on the sensitivity for the
detection of pathogen RNA. Both IC RNAs were spiked into the
samples and nucleic acid extraction was followed by
ampliﬁcation in duplicate with either of the primer/beacon
combinations. Sensitivity, deﬁned as the 90% hit rate, was found
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to be 60 copies of RNA per extraction for Chlamydia pneumoniae
and 130 copies for Mycoplasma pneumoniae. Successful nucleic
acid extraction was reﬂected by efﬁcient IC RNA ampliﬁcation.
Only incidentally, invalid results were obtained, most of which
could be resolved by a second ampliﬁcation analysis of the
nucleic acid extract. A total of 15 samples was found positive (9
for Mycoplasma pneumoniae and 6 for Chlamydia pneumoniae), 14
of which could be conﬁrmed by a second molecular method.
Conclusions: Real-time NASBA ampliﬁcation in potential is a
valuable tool for the molecular diagnosis of Mycoplasma
pneumoniae and Chlamydia pneumoniae. Multiple ampliﬁcation
analyses, each with its own IC RNA, can be performed on a
single nucleic acid extract. Further evaluation is needed to
conﬁrm the clinical value of these methods.
P967
Development of a real-time PCR using SYBR
Green and melting curve analysis to identify
Bordetella pertussis and Bordetella parapertussis
in clinical specimens, and evaluation of its
effectiveness in current practice
P. Lehours, A. Menard, J. Sarlangue, C. Laguente, C.H. Bebear,
F. Megraud, B. De Barbeyrac (Bordeaux, FR)
Objective: Whooping cough affects now young adults and
teenagers, thus being able to contaminate infants unvaccinated
or incompletely vaccinated. In this population, it evolves readily
into atypical or severe forms difﬁcult to diagnose and a
biological conﬁrmation is necessary. Thus molecular techniques
represent invaluable tools. Here, we describe a real-time PCR
assay for the identiﬁcation of B. pertussis and B. parapertussis in
clinical specimens
Methods: The available IS481 sequences of B. pertussis were
aligned to identify conserved regions for the primer design.
Primers for the detection of B. parapertussiswere designed on the
IS1001 sequence. A universal PCR targeting the 16S rDNA gene
was also developed to be used as a control for extraction and for
absence of PCR inhibitors. The PCR primers sets were tested on
DNA extracted from the Bordetella species, and from diverse
bacterial species commonly found in humans. The SYBR
Green real-time PCR ampliﬁcation and melting curve (Tm)
analysis were carried out in an ABI PRISM 7000 thermocycler
(Applied Biosystems), and followed by a melting program. A
retrospective study was performed on positive (n = 19) and
negative (n = 13) nasopharyngeal aspirates (NPA). We tested
prospectively 131 NPA received between April 2004 and
November 2005.
Results: When using the control strains, only DNA extracted
from B. pertussis and B. parapertussis led to ampliﬁcation,
demonstrating the speciﬁcity of these two PCRs. Melting curve
analysis of the amplicons from B. pertussis and B. parapertussis
control strains exhibited Tm of approximately 79C and 86C,
respectively. Serial dilutions of the extracted DNA from
bacterial suspensions were tested using this assay and the
regression curve was linear from 105 to 1 bacterial genome with
slopes closed to that of the maximum efﬁciency. For the
retrospective analysis, the 19 positive samples were all
positive for B. pertussis, and no peak appeared for the 13
negative samples. Prospectively, this assay allowed the
detection of 21 positive clinical samples (18 B. pertussis, 3
B. parapertussis), among these 14 could not have been isolated by
culture.
Conclusion: We have developed a new real-time PCR for the
identiﬁcation of B. pertussis and B. parapertussis targeting the IS
sequences. This method, which uses the SYBR green chemistry
and analysis of the melting point, is rapid, sensitive and speciﬁc,
and can be easily implemented in a setting where a real time
PCR apparatus is available.
P968
Diagnosis of pertussis by real-time LightCycler
PCR
M. Alves, G. Rocha, A. Magalha˜es-Sant’Ana,
C. Nogueira (Coimbra, PT)
Objectives: Pertussis (whooping cough) is a well-known
childhood respiratory disease and is caused primarily by
Bordetella pertussis infection. Although immunization programs
brought the disease under control for decades, studies
conducted in recent years indicate that is re-emerging as a
potential threat even among those who are vaccinated. The
disease is now quite prevalent among adults and adolescents in
whom the disease symptoms are often atypical. They are a
source of B. pertussis, and this is a major reason why this disease
is being transmitted to children. Deﬁnitive diagnosis of pertussis
has traditionally been made by culture. However it is insensitive
and slow. Serological tests are more sensitive than culture, but
provide late or retrospective diagnosis. Other commercial
immunoassays do not distinguish between B. pertussis and
B. parapertussis infection. Our aim was to perform a rapid highly
speciﬁc and sensitive detection of B. pertussis and B. parapertussis
that is essential for providing appropriate therapeutic
intervention and controlling transmission of the disease.
Methods: Between December 2004 and November 2005 a total
of 126 nasopharyngeal aspirates (NPA) were analysed for
B. pertussis detection and 15 of those were also analysed for
B. parapertussis. In 115 the patients were aged 1 day to 18 month
(59 female and 56 male) with a mean of 3.34 months. 3 NPA
were obtained from 3 older children (3 female), median age
11.33 years and 7 NPA from household contacts.Nucleic acid
was extracted from NPA with the QIAamp DNA Mini Kit
according to manufacturer’s instructions. Extracted DNA was
directly analysed by LightCycler  PCR without storage.
Primers and probes from IS481 and IS1001 for B. pertussis and
B. parapertussis, respectively, were adopted from the work of
Ko¨sters K. et al., 2002, J Clin Microbiol: 1719-1722.
Results: From the 126 NPA analysed, 52 (49 children and 3
adults; 28 female and 24 male) were positive for B. pertussis. For
B. parapertussis, all samples tested were negative.
Conclusions: The standard LightCycler protocol used can
complete an analysis of up to 30 samples plus negative and
positive controls within a total assay time of 55 minutes. It
achieves high speciﬁcity and sensitivity by adding speciﬁc
probes. In sum, real-time LightCycler PCR is suitable for
diagnosis of B. pertussis and B. parapertussis infections in a
routine diagnostic laboratory.
P969
Bordetella pertussis real-time PCR: sample
preparation by different kits from one
manufacturer
M. Riffelmann, C. Wirsing von Koenig, J. Schmetz,
S. Bock (Krefeld, DE)
Background and aims: Pertussis is a re-emerging disease, and
its diagnosis is increasingly done by real-time PCR. Commercial
kits for preparing DNA from respiratory material are not CE
marked for this purpose.
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Methods: More than 100 nasopharyngeal swabs, tracheal
secretions and other respiratory materials were spiked with
various amounts of B. pertussis cells. Commercially available
ion-exchange chromatography column kits from one company
(QIAGEN) were compared: (i) the QIAamp DNA mini kit,
which is validated for DNA extraction from various materials,
(ii) the QIAamp Min Elute Virus Vacuum kit, (iii) the QIAamp
Virus BioRobot MDx kit, and (iv) the QIAamp DSP Virus kit,
which is CE marked. All kits are validated only for preparation
of viral RNA and DNA from cell-free material and from blood.
PCR was performed by two real-time PCR’s based on a
hybridization probes format (LightCycler, Roche) and on a
TaqMan format (SDS 7700, Applied Biosystems). Both PCRs
ampliﬁed different parts of the insertion sequence IS 481 from
B.pertussis.
Results: All four kits tested could be used for the preparation of
B. pertussis DNA from respiratory materials. The reproducibility
of all kits was comparable. All procedures showed linearity of
extraction over a broad range of bacterial DNA (5–500 000
organisms/PCR). The MinElute Virus Vacuum kit and the DSP
Virus kit did not effectively remove inhibitory substances from
respiratory samples.
Conclusions: Commercial nucleic acid preparation systems
were effective in preparing DNA for B.pertussis real-time PCR.
The DNA Mini Kit could be used for the extraction of single
samples, and the Virus BioRobot MDx Kit could be used for
preparation of 32–96 samples with the BioRobot MDx
instrument. Our ﬁndings underline the necessity of validating
nucleic acid preparation kits for different clinical materials and
applications.
P970
Comparison of speciﬁcity and sensitivity of
various diagnostic methods of ureaplasma
respiratory tract infections in newborns
M. Biernat-Sudolska, D. Rojek-Zakrzewska,
B. Zawilinska (Cracow, PL)
Objective: Ureaplasmas can cause respiratory insufﬁciency in
newborns. Detection of ureaplasma infections by culturing is
difﬁcult and time-consuming. In newborns an additional prob-
lem is the necessity of antibiotic administration before the
diagnostic procedures are started. Antibiotics inhibit the growth
of ureaplasmas limiting reliability of the culture method. The
purpose of our study was to estimate various diagnostic
methods of urea plasma infections in newborns with respiratory
disorders.
Methods: Five hundred newborns were examined. Specimens
were cultivated in PPLO medium according to Hayﬂick (CH)
and parallelly examined with a BioMerieux test (BM). The
polymerase chain reaction (PCR) assay was also applied to test
speciﬁc regions of 2 ureaplasma species occurring in man:
Ureaplasma urealyticum (Uu) and Ureaplasma parvum
(Up).Endotracheal aspirates were collected from each infant
and placed in transport medium BM. Next they were sub
cultured in liquid and solid PPLO media and in BM medium.
DNA was isolated from the transport-culture medium BM after
18–24 hours of incubation. Specimens were centrifuged at
14 000 g and the DNA was denaturated at 950 C for
5 minutes. Two pairs of primers speciﬁc for Uu and Up were
used. DNA from reference strains was used as a positive control.
The PCR products were separated electrophoretically in 2%
agarose gel and visualized with ethidium bromide under UV.
Results: Ureaplasmas were detected in respiratory tracts of 79
(16%) newborns examined. CH showed positive results in 68
cases, BM in 77 cases and PCR in 75 cases. Correlation of results
of CH with BM, CH with PCR and BM with PCR was 97%, 89%
and 90%, respectively. Sensitivity and speciﬁcity of PCR in
comparison with CH was 86% and 98%, respectively and BM -
96% and 98 %. In 40 cases the other bacteria made it impossible
to recognise the results of ureaplasmas in culture. PCR results
were then deﬁnitive. In 4 cases the positive result of BM test
could not be conﬁrmed by other methods. Only in 1 case the
positive result of PCR was not conﬁrmed by culture result.
Conclusion: PCR, as a highly sensitive and speciﬁc method, can
be recommended in rapid diagnostics for respiratory infections
in newborns suffering from respiratory disorders. It allows
detecting ureaplasmas in case of concomitant infections and
identifying their species.
P971
Evaluation of real-time nucleic acid sequence-
based ampliﬁcation and dipstick-based detection
with conventional NASBA and PCR for rapid
detection of Mycoplasma pneumoniae in
respiratory specimens
K. Ohkusu, M. Komatsu, N. Ishiwada, T. Hoshino, N. Takeda,
H. Sakata, T. Takeshima, T. Ezaki (Gifu, Nara, Chiba, Hokkaido,
Shizuoka, JP)
Objectives: Mycoplasma pneumoniae is an important etiologic
agent of respiratory tract infections and is responsible for 10 to
20% of community-acquired pneumonia in adolescents and
adults. M. pneumoniae is not sensitive to b-lactam antibiotics,
which are often used for the empiric treatment of lower
respiratory tract infections (LRTI). Therefore, rapid and
accurate diagnostic methods are likely to improve the
management of patients with M. pneumoniae infections. In this
study, we evaluated a real-time NASBA assay forM. pneumoniae
RNA in clinical specimens and compared it with real-time PCR.
In addition, we developed a nylon membrane strip method for
the rapid visual detection of nucleic acid hybridization.
Methods: Respiratory specimens from 140 paediatric and adult
patients with acute LRTI at ﬁve hospitals in Japan were included
in this study. Nucleic acids were extracted using NucliSens
magnetic extraction kit (bioMe´rieux). Real-time NASBA assays
were performed using NucliSens basic kit and EasyQ analyser
(bioMe´rieux) with primers OT2156NBK, OT2157 and a
molecular beacon probe (Loens et al., J Clin Micobiol 2003,
41:4448–50). For a reference method, real-time PCR using SYBR
green I was performed on an iCycler iQ system (Bio-Rad) as
described by Morozumi et al. (J Infect Chemother 2004, 10:274–
9). Detection of NASBA ampliﬁed products on a nylon
membrane strip was achieved by sandwich nucleic
hybridization with two target-speciﬁc oligonucleotide probes,
one for capture and the other for detection. The formation of
sandwich complex, within 15 minutes, on the membrane strip
resulted in a visually apparent aggregation of nucleic acid target
and latex conjugated probes at the capture zone.
Results: For both NASBA and PCR assays, 12 of the 140
specimens tested were positive and none of 128 PCR-negative
clinical specimens were positive by real-time NASBA. The
analytic sensitivity of the strip detection was 200–1000 copies of
wild type in vitro-synthesized RNA generated by a 60 minutes
NASBA ampliﬁcation assay. All 12 positive specimens were
positive by the visual strip detection in combination with
NASBA.
Conclusions: The sensitivity and speciﬁcity of the real-time
NASBA were 100% using a real-time PCR assay as the standard.
Furthermore, a combination of the NASBA assay and strip
detection could facilitate the use of NASBA in resource-limited
settings and in point-of-care testing.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P972
Identiﬁcation of Legionella species using DNA
sequence analysis and online tools
N.K. Fry, B. Afshar, W. Bellamy, A. Underwood, R.M. Ratcliff,
T.G. Harrison (London, UK; Adelaide, AU)
Objectives: Fifty species of Legionella have now been described,
and the identiﬁcation of the majority of these by classical
phenotypic methods is increasingly difﬁcult. The aim of this
study was to investigate the feasibility of providing a dedicated
database allowing the on-line identiﬁcation of putative Legionella
spp. following standard PCR ampliﬁcation and sequencing
using a previously published identiﬁcation scheme for
Legionella. The Legionella mip gene sequence database is
created by the Health Protection Agency, Centre for Infections
(http://www.hpa.org.uk/infections/default.htm) and can also
be reached via the EWGLI website (www.ewgli.org).
Methods: DNA sequence can be entered as text or by uploading
sequencing chromatogram ﬁles. The database provides the
following functions: (i) an alignment of all the sequences from
the reference alignment, top ﬁve database matches and the user
sequence, (ii) a neighbour-joining tree of the alignment,
including the reference species, ﬁve closest matches from the
database and the user sequence, and (iii) an alignment of the
eight sequences from the combined alignment that are most
similar to the user sequence.
Results: The ability of centres to correctly identify Legionella
species was assessed following the distribution of two
proﬁciency panels each comprising 10 coded isolates. Most
centres, 7 of 10, and 11 of 13 correctly identiﬁed all isolates
tested. Furthermore training needs were highlighted and
addressed resulting in improvement in sequence quality.
Conclusions: Genotypic identiﬁcation of Legionella species is
essential for reference laboratories. Standard protocols,
dedicated identiﬁcation libraries, and online tools provide a
valuable resource to help achieve this goal. It is anticipated that
additional genes including those coding for: 16S rRNA, RpoB,
RnpB, and GroEL, will be added to the current identiﬁcation
system to aid in the characterization and identiﬁcation of known
and potential novel members of this genus.
P973
A real-time PCR for Mycoplasma pneumoniae
V.J. Chalker, D. Pitcher, T.G. Harrison (London, UK)
Objectives: To create an improved real-time PCR for
Mycoplasma pneumoniae detection.
Methods: Using primers directed to the P1 adhesion gene a
real-time PCR was developed with FRET probes to simulta-
neously detectMycoplasma pneumoniae and an inhibition control.
Sensitivity was ascertained using samples previously conﬁrmed
by culture and/or serology and speciﬁcity using a panel of
respiratory bacteria and Mollicute species. Since introduction
into routine practice 45 clinical samples have been screened by
this method.
Results: The assay was used on a panel of 175 respiratory
samples from patients with pneumonia for which data
regarding other respiratory pathogens was available. The
speciﬁcity was excellent, 96.6%, with no cross-reactions with
other Mollicutes or respiratory bacteria. The sensitivity was
calculated as 60% when compared to serology and the LDL of
the assay was 5 x 102 organisms m/l, 10 fold lower than
previously described methods. Inhibition was detected in 24%
of neat sample extracts and reduced to 4% in samples diluted by
a factor of 10. Since introduction a total of 4/45 (8.9%) clinical
samples tested were positive, 1 lung biopsy, 1/4 sputa (25%)
and 2/4 (50%) NPA.
Discussion: A highly speciﬁc rapid method of real-time PCR
for Mycoplasma pneumoniae detection is described with greater
sensitivity than previous assays.
P974
Detection of Legionella DNA in clinical samples
using real-time PCR
L. Franzin, D. Cabodi, N. Bonfrate, F. Tortorelli (Turin, IT)
Objectives: Culture is the gold standard for the diagnosis of
Legionella infection. However several days are required to obtain
a positive result. DNA techniques are promising for rapid
detection. In this study a real time (RT)-PCR system was
evaluated for the direct detection of Legionella from clinical
samples and compared to culture.
Methods: Culture and RT-PCR was performed on 78
respiratory samples (10 sputum, 44 bronchoalveolar lavage
ﬂuid, 19 bronchial aspirate, 5 lung tissue) from 76 patients with
pneumonia. Legionella infection (LD) was conﬁrmed in 23
patients by positivity to at least one of these tests: urine
antigen detection (ELISA), serology (fourfold rise in antibody
titres by indirect immunoﬂuorescence and/or micro
agglutination test) and culture. Aliquots of the untreated, heat-
treated and acid-washed samples were plated on BCYE, BMPA
and MWY. The plates were incubated at 37C for 15 days. Blood
samples from 11 symptomatic old patients involved in an LD
outbreak were also examined. RT-PCR for L.pneumophila (Lp)
and Legionella spp (L.spp) was performed after DNA extraction
with iCycler and BIO-RAD reagents, according to a modiﬁed
protocol.
Results: Culture from respiratory samples was positive from 17
patients. Lp serogroup 1 was isolated from 15 subjects, Lp 3 from
one and L.bozemanii from another. RT-PCR was positive in a
total of 25 (32%) samples. 24/25 (96%) samples from LD patients
were positive by RT-PCR, while 52/53 (98%) samples from
patients without LD were negative. Discrepancy was observed
in only one case (1.3%) for category of patients with and without
LD. Three patients with proven LD was positive by RT-PCR for
L. spp and negative for Lp, but one of these was culture positive
for L.bozemanii. All culture positive respiratory samples were
RT-PCR positive, except one where Lp3 was isolated.
Concordance for respiratory samples was 97.4%. All blood
culture samples were negative, while RT-PCR was positive from
4/6 outbreak patients with laboratory conﬁrmed LD and from
5/5 patients with clinical, but not laboratory conﬁrmed, LD.
Conclusion: Laboratory diagnosis LD is better achieved by
combined urine antigen detection, serology and culture. Results
of this study showed good concordance between the criterion
based on traditional methods and RT-PCR. This new sensitive
technique, that needs to be further evaluated, offers the
advantage of a rapid diagnosis.
P975
Rapid diagnosis of Mycobacterium tuberculosis
by a triplex real-time PCR assay
W. Sougakoff, C. Truffot-Pernot, G. Millot, V. Jarlier (Paris, FR)
Objectives: Sensitive and rapid techniques to detect and
identify Mycobacterium tuberculosis directly in clinical
specimens are important for the diagnosis and management of
patients with tuberculosis. In this study, we report the
evaluation of a real-time PCR assay targeting the IS6110
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element and the RD9 speciﬁc region as a tool to rapidly diagnose
and differentiate M. tuberculosis and M. canetti (IS6110 positive
or negative – RD9 positive) from the other mycobacterial species
included in the M. tuberculosis complex (IS6110 positive – RD9
negative) such as M. bovis, M. bovis BCG, M. africanum,
M. microti, M. caprae and M. pinnipedii.
Methods: The performances of the assay were assessed from
166 clinical samples collected from patients over a two months
period. DNA preparations and ampliﬁcations were carried out
with a new kit developed by BioRad (Bio-Rad Real Time TB
Assay), following the manufacturer’s instructions. An internal
control was added before DNA extraction in order to measure
the efﬁciency of DNA recovery and check for the absence of
inhibitors.
Results: The BioRad Real Time TB assay correctly identiﬁed 17
specimens that were proven by culture to containM.tuberculosis,
of which 16 were positive for IS6110 and RD9 and 1 was positive
for RD9 but negative for IS6110. Seven samples IS6110-positive
but RD9-negative was shown by culture to contain M. bovis
(n = 6) or M. africanum (n = 1). Eight samples that remained
culture-negative were found to be positive to either IS6110-based
ampliﬁcation (n = 2) or RD9-based ampliﬁcation (n = 3) or both
(n = 3). Finally, 131 of the 134 samples negative for both IS6110
and RD9-based ampliﬁcations remained negative on culture, the
three culture-positive ampliﬁcation-negative samples yielding
only a few colonies of M. tuberculosis on culture.
Conclusions: The assay, based on the real-time ampliﬁcation of
three distinct targets (IS6110, RD9 and Internal Control) was
found to be robust, sensitive and speciﬁc, and is characterised by
a complementary pattern of identiﬁcation: broad for the IS6110-
based ampliﬁcation and speciﬁc of M.tuberculosis and M.canetti
for the RD9-based ampliﬁcation.
Diagnostic and laboratory methods for bacteria - I
P976
The antimicrobial susceptibility and API
CORYNE proﬁle code for 34 strains of the newly
reported Corynebacterium resistens
Y. Otsuka, Y. Kawamura, Y. Yamaguti, H. Takahashi,
K. Ohkusu, H. Hanaki, T. Ezaki (Tokyo, Gifu, JP)
Objectives: In 2005, Corynebacterium resistens was reported as a
new species of Corynebacterium demonstrating multi-resistance
to antimicrobics (J. Clin. Microbiol. 43:3713–3717). Multi-resist-
ant corynebacteria such as C. jeikeium and C. urealyticum are well
known for contributing to mortality in immunocompromised
patients with haematological malignancies. We report on API
CORYNE (bioMe´rieux, France) and minimum inhibitory con-
centration (MIC) proﬁles observed for C. resistens.
Methods: During a period of 7 years (March 1998 through
September 2005), 34 isolates of an unknown Gram positive
bacilli were recovered from blood, sputum, operative wound,
pus, otorrhea, and CV line specimens. Based on 16S rRNA
sequencing of a 1400-bp segment, the organism was identiﬁed
as a new species of Corynebacterium and named C. resistens.
API CORYNE (bioMe´rieux, France) examined it according to
a designated method. Microdilution antimicrobial
susceptibility studies were performed using 1% Tween 80
as a supplement to Mueller-Hinton broth to stimulate the
lipiphilic C. resistens.
Results: Four API CORYNE patterns were observed: 0100004
(14 strains), 4100004 (13 strains), 6100004 (6 strains), and
2100004 (1 strain). While alkaline phosphatase was positive in
all strains, pyrrolidonyl arylamidase and pyrazinamidase
varied depending on the strain. While corynebacteria are
deﬁned as oxidizing glucose and ribose, this characteristic is
dependent on inoculum density; glucose and ribose reactions
were negative in API CORYNE. MIC results for b-lactams,
aminoglycosides, clindamycin, ﬂuoroquinolones, and
tetracycline demonstrated resistance, whereas, results for
vancomycin were susceptible. With respect to vancomycin,
the MIC 90 was 2.0 lg/ml while linezoloid showed the most
activity at 0.5 lg/ml.
Conclusions: C. resistenss is capable of causing serious
infections comparable to C. jeikeium. It is important to assess
the clinical signiﬁcance of each isolate recovered from clinical
specimens. Furthermore, there is a need to update the API
CORYNE date base to reﬂect C. resistens. Linezoloid or
vancomycin should be given consideration as ﬁrst-line drugs.
P977
Rapid phenotypic detection of pneumococci and
beta-haemolytic streptococci directly from blood
cultures
J. Montgomery, B. Mayall (Melbourne, AU)
Objectives: Lance ﬁeld groups A, B, C and G are the major beta-
haemolytic streptococci (BHS) causing human infections. Life
threatening toxic shock-like syndromes and bacteraemia are not
restricted solely to Group A Streptococci and the incidence has
recently increased. The aim of this study was to determine the
accuracy of pneumococcal antigen test (PN) for detection of
S. pneumoniae (SPN) and a modiﬁed streptococcal grouping
(MSG) test, directly from blood culture broth (BCB) on the day
of detection of a bacteraemia (Becton Dickinson, USA).
Methods: If Gram-positive cocci resembling Streptococci were
seen on Gram, 10 ml BCB was centrifuged in a gel tube.
Pneumococcal antigen (PN) test was done from the supernatant
using Wellcogena¨ S. pneumoniae kit as instructed by the
manufacturer (Remel Inc. USA). PN negative BCB were then
grouped by the MSG test using the Streptococcal Grouping Kit
(Oxoid Ltd, England). The supernatant was discarded; the
bacterial pellet resuspended in 0.4ml of extraction enzyme and
grouping was performed as instructed by the manufacturer.
Results were compared with standard culture methods.
Results: PN was performed on 203 bottles with Gram stain
resembling Streptococci. A total of 80 were SP. Two false
negatives but no false positive reactions occurred. Sensitivity
(SN) was 98%; Speciﬁcity (SP) and Positive Predictive Value
(PPV) were 100% and Negative Predictive Values (NPV) 98%.
MSG was then performed on 115 PN negative bottles from 110
patients. Five Enterococci auto-agglutinated and were excluded;
77 were groups A- D, F or G and 36 non-groupable Streptococci.
There were three false positive and twelve that did not group by
this method. Group D was problematic with six negative
Enterococci and four negative S. bovis. Overall SN, SP, PPV and
NPV were 87, 90, 95 and 75% respectively. Of 36 BHS: Group A
(13), B (8), C (7) and G (8) 34 grouped correctly with SN 95%, SP
99%, PPV 97% and NPV 98%.
Conclusion: Direct grouping of blood culture with a Gram
resembling Streptococci but PN negative, was unreliable for
Enterococci, but gave accurate and rapid phenotypic detection of
Groups A, B, C and G. This has signiﬁcant impact on the
laboratory turnaround time, may impact on therapy and the
clinical relevance of results especially in severe invasive disease.
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Perioperative monitoring of the endotoxin
chemical markers and procalcitonin blood plasma
concentrations in cardiosurgical patients
N.V. Beloborodova, D.A. Popov, A.Y. Olenin, A.S. Archipova,
E.A. Chernevskaya (Moscow, RU)
Objectives: 3-hydroxy fatty acids (3-OH FAs) of 10–18-carbon
chain lengths are constituents of the lipopolysaccharide of
Gram-negative bacteria. Thus, these acids can be used as
chemical markers for determining endotoxin. The aim was to
study the perioperative blood plasma levels of 3-OH FAs and
marker of systemic inﬂammation of bacterial origin -
procalcitonin (PCT) - in cardio surgical patients (pts.).
Methods: Blood plasma samples from 22 consecutive adult pts.
with acquired heart diseases (mean age 49 (42–56) years) were
taken before and on the 1st day after surgery. PCT
concentrations were measured by immunoluminometric
method (PCT LIA, B.R.A.H.M.S Aktiengesellschaft GmbH,
Germany). The levels of 3-hydroxytetradecanoic acid (3h14)
were detected by gas chromatography-mass spectrometry (GC-
MS) (HP-5973, Agilent technologies, USA). Postoperatively all
pts. were divided into two groups: with less than 2 ng/ml
(Group A, n = 12) and more than 2 ng/ml (Group B, n = 10)
PCT levels. The data were compared by Mann-Whitney U-test
and Wilcoxon matched pairs test, p-value of < 0.05 was
considered statistically signiﬁcant. The data are expressed as
median and 25th and 75th percentiles.
Results: None of the patients had exhibited any signs of infection
before surgery. Initial PCT concentrations didn’t exceed the
normal values (< 0.5 ng/ml). The levels of 3h14 were
signiﬁcantly higher post-op compared to the baseline (6.1
(5–8.9) ng/ml vs. 5.6 (3.3–7.1) ng/ml, p = 0.006). Post-op 3h14
levels were 5.1 (4.9–7.6) ng/ml in Group A and 7.9 (5.6–9.6) ng/
ml in Group B, p = 0.038. The rate of systemic inﬂammatory
response syndrome (SIRS) on the 1st day post-op was also
signiﬁcantly higher in Group B (70% vs. 33% in Group A,
p =0.04).
Conclusions: GC-MSmethodmaybe a suitable tool for detection
of endotoxin chemical markers in blood plasma samples.
Elevated levels of 3h14 are associated with the development of
SIRS of bacterial origin, as conﬁrmed by PCT-test.
P979
Are blood cultures necessary in the management
of women with complicated pyelonephritis?
Y. Chen, O. Nitzan, W. Saliba, B. Chazan, R. Colodner,
R. Raz (Afula, Haifa, IL)
Objectives: Data from previous studies suggest that blood
cultures in women with uncomplicated acute pyelonephritis
(APN) are of limited value. Our objective was to assess the role
of blood cultures in the management of complicated APN in
women, and to examine the demographic and clinical
characteristics, and the outcome as related to the bacteraemic
status of these patients.
Methods: Data from medical records of 158 women
hospitalised with complicated APN over a 2-year period was
analysed retrospectively. It included demographic, clinical and
laboratory data, empiric antimicrobial therapy, urine and blood
culture results, complications and clinical outcome.
Results: Out of 158 women with complicated APN, in 155 (98%)
the urine culture grew pathogens, and 33 (20.9%) of them had
bacteraemia. In the great majority of patients (98.7%), the blood
cultures were sterile, or contained the same phenotypically
proﬁled pathogen that was isolated from the urine. Only in 2
patients (1.3%), the blood cultures grew pathogens different
from those found in the urine. The initial empiric antimicrobial
therapy was not changed in any of the patients. No signiﬁcant
difference existed between the bacteraemia and non-
bacteraemia patients in the demographic and clinical
characteristics, the severity of disease or the outcome.
Conclusion: In the management of complicated APN, routine
cultures of blood are often unnecessary.
P980
Procalcitonin marker for sepsis diagnosis
A. Emami Naeini, S. Montazerolghaem (Isfahan, IR)
Objective: Sepsis is a life-threatening syndrome and a common
problem in all acute care hospitals. Routine laboratory tests lack
both sensitivity and speciﬁcity in correctly identifying sepsis
from other non-infectious systemic inﬂammatory response
syndrome (SIRS). Most conﬁrmatory microbiological test
results are time consuming. The aim of this study is
determining value of Procalcitonin (PCT) detection by a rapid,
no instrument dependent test for differentiation patients with
non-infectious SIRS and patients with sepsis, sepsis syndrome
and septic shock.
Method: We conducted this prospective, cross-sectional, case
control survey on patients with SIRS criteria with and without
infection. The subjects were comprised 50 patients [32(64%)
males and 18(36%) females] aged 18 to 94 years (mean: 56 ± 38).
25 in sepsis group with positive blood culture, [19(76%) male,
6(24%) female]. 25 SIRS group without infection [13(25%) male
and 12(48%) female]. Patients admitted in St -Zahra hospital,
Isfahan (centre of Iran) during February 2004 to February 2005.
After taking 2 ml of venous blood sample from each patient at
admission ward, we separated the serum, and stored the
samples frozen at -20C. Samples with severely haemoglobin
values > 5 g/dl (haemolytic) were excluded. The PCT level was
measured using a semi-quantitative immunochromatographic
rapid test (B•R•A•H•S• PCT -Q B•R•A•H Diagnostica,
Germany). All samples were examined after bringing to room
temperature; a new individual test was used for each
determination. Data were analysed by t student –test, and one-
way analysis of variance using SSPS software version 11.
Results: 22 (88%) of those patients with sepsis had positive
test (slightly elevated PCT = 0.5 ng/ml [3(12%)], moderately
elevated PCT > 0.5 ng/ml [5(20%)], markedly elevated
PCT ‡ 2 ng/ml [11(44%)], severely elevated PCT ‡ 10ng/ml
[3(12%)] and 1 (4%) out of those with no sepsis SIRS had
moderately elevated level of PCT.
Conclusion: In this survey PCT shows 88% sensitivity,
96%speciﬁcity and clearly discriminates sepsis from non-sepsis
SIRS.PCT titre raises with progression toward sepsis syndrome
and septic shock. PCT titre can aid in diagnosing, monitoring
and outcome prediction in septic patients and can be considered
as a routine and useful test in the initial workup of sepsis.
P981
Brain natriuretic peptide as diagnostic and
prognostic marker in patients with bacterial
infection and sepsis
A. Charalampopoulos, A. Stavrianou, C. Kotsovassilis,
P. Tsiodra, C. Keramidas (Athens, GR)
Objectives: Brain natriuretic peptide (BNP) is a well-known
index of left ventricular systolic dysfunction and a prognostic
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marker in congestive cardiac failure and myocardial infarction.
In critically ill patients such as those in sepsis and septic shock
left ventricular dysfunction and subsequently high serum levels
of BNP have been reported. Some studies suggest the potential
prognostic value of BNP in patients with sepsis. The purpose of
our study was to determine (a) if BNP serum levels increase in
sepsis and (b) if BNP can predict outcome and be a valuable
prognostic marker.
Methods: We examined retrospectively 70 patients with febrile
bacterial infections admitted to our department over a period of
one year. No one had a history of established cardiac failure. The
diagnosis of the infection was based on clinical and laboratory
data. Among the 70 patients 39 were in sepsis on admission. We
measured BNP in blood samples taken the ﬁrst two days of the
hospitalization. The outcome was determined as survivors and
non-survivors. Statistical tests applied were Student’s t-test and
Chi-Square test.
Results: We had 32 male and 38 female patients. In patients
with sepsis the mean BNP value was 268.7 (SD: 271.3) and in
patients without sepsis was 152.3 (SD: 198.3). There was a
signiﬁcant increase of BNP levels in patients with sepsis
(p < 0.05). Among the 70 patients 55 were survivors (78.6 %)
and 15 non-survivors (21.4 %). All the non-survivors were in
severe sepsis. The percentage of death among the septic patients
was 38.4 %. The mean BNP in survivors was 161.8 (SD: 197.87)
and in non-survivors 420.2 (SD: 642.1) but that difference was
not statistically signiﬁcant (p > 0.05).
Conclusions: In our study BNP, measured soon after
admission, (a) increases signiﬁcantly in patients with sepsis
and (b) does not seem to be a valuable prognostic marker in
patients who suffer from febrile bacterial infections and sepsis.
Further studies with more participants are needed to conﬁrm
that hypothesis.
P982
The value of the automatised blood culture
systems in the diagnosis of CAPD peritonitis
O¨.K. Azap, F. Timurkaynak, S. Sezer, U¨. Cagir, G. Yapar,
H. Arslan, N. O¨zdemir (Ankara, TR)
Objectives: Peritonitis is a common clinical problem that occurs
in patients with end-stage renal disease treated by peritoneal
dialysis (PD). Therapy should be guided by culture results and
antimicrobial sensitivities. The aim of this study is to evaluate
the value of the blood culture systems in the diagnosis of CAPD
(continuous ambulatory peritoneal dialysis) peritonitis.
Methods: Twenty-six samples of peritoneal ﬂuid obtained from
patients with the suspicion of CAPD peritonitis were included.
Leukocyte count, Gram and Wright stains of the samples were
performed. All samples were both inoculated onto solid agar
media and into the blood culture broth (BACTEC 9050). Agar
plates were incubated for 48 hours and the blood culture bottles
were incubated for 5 days unless a positive signal was obtained.
Results: Leukocyte count was < 100/mm3 in 9 of the 26
samples and the cultures of these samples grew no bacteria.
Of the 17 samples, which have leukocyte counts > 100/mm3 14
samples grew in solid agar and/or blood culture media.
Etiologic agent was detected in both blood culture broth and
on the agar plates in 4 samples; on the other hand in 8 samples
bacteria grew only in blood culture broth and in two samples
only on solid agar media in 2 samples. The two growths on only
solid agar media were interpreted as contamination. As a result
signiﬁcant growth was detected in 12 (70.5%) of 17 samples. The
most striking ﬁnding is that 8 (66.6%) of these 12 results were
obtained only from blood culture bottles. The identiﬁed
pathogens are methicillin-sensitive coagulase-negative
staphylococci (in 5 of the samples), alpha-haemolytic streptococci
(in 2 of the samples), Corynebacterium spp. (in 2 of the samples),
Escherichia coli (in 2 of the samples), Enterococcus faecalis (in 1 of
the samples).
Conclusion: Infectious complications account for
approximately two thirds of all PD catheter losses. Treatment
should be based on antimicrobial susceptibility results. This
mandates the proper management of the samples obtained from
CAPD patients. The use of blood culture bottles inoculated with
peritoneal ﬂuid at the bedside, rather than submitting the
specimen to the laboratory for later processing is advocated.
P983
No beneﬁcial impact of shortened
microbiological procedures for either
hospitalized patients overall or for patients with
bacteraemia
M.J. Bruins, H.C.A. Oord, P. Bloembergen, M.J.H.M. Wolfhagen,
A.F. Casparie, J.E. Degener, G.J.H.M. Ruijs (Zwolle, Rotterdam,
Groningen, NL)
Objectives: Shortening the turnaround time of microbiological
procedures by using an automated system for bacterial
identiﬁcation and susceptibility testing is associated with an
improved clinical outcome and a reduction of hospital cost,
according to two American studies. We investigated whether
the same beneﬁcial effects could be reported for patients in a
hospital in the Netherlands by conducting a single blind,
randomized controlled trial.
Methods: Patients hospitalized in the Isala klinieken in Zwolle,
the Netherlands, with a bacterial infection conﬁrmed by culture
were randomly assigned to a control or to an intervention
(rapid) group. As is customary practice, the clinical
microbiologists orally reported clinically relevant information
to the clinician for all patients. For all patients complete culture
results were reported on paper. For identiﬁcation and
susceptibility testing overnight methods were used in the
control group. In the rapid group the Vitek 2 system
(bioMe´rieux, Marcy l’Etoile, France) was used. In each of the
three consecutive study periods accelerating factors were added
in a step-up manner to the laboratory workﬂow of the rapid
group, such as increasing oral reporting, extending the working
day and adding an extra hard-copy report delivery. The
workﬂow for the control group remained identical throughout
the study. We analysed whether the turnaround time to
reporting was shortened by using the Vitek 2 system and
additional factors, and assessed the effects of a shortened
turnaround time in terms of mortality, morbidity and cost for (i)
the overall patient group and (ii) a subgroup of patients with
bacteraemia
Results: For the overall patient group (n = 1870), the time
interval to oral reporting of ﬁnal susceptibility results was
signiﬁcantly shorter for the rapid groups in all three-study
periods, the time to reporting on paper was signiﬁcantly shorter
in the third period. For the subgroup of patients with
bacteraemia (n = 183) a similar shortening of turnaround times
was found. For neither the overall patient group nor the
subgroup a signiﬁcant difference in any of the clinical impact
variables or a cost reduction was found.
Conclusion: Although the turnaround time to reporting of
microbiology results was shortened signiﬁcantly for both the
overall patient group and the subgroup of bacteraemic patients,
in our hospital setting no clinical impact or cost reduction could
be reported as a result.
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P984
Routine use of the BacT/ALERT FAN anaerobic
bottle: indicated or not?
B. Van Meensel, J. Verhaegen, J. Frans, H. Castryck,
N. Blanckaert (Leuven, BE)
Objectives: Traditionally, routine blood cultures for adult
patients consist of paired aerobic and anaerobic blood culture
bottles. However, expert opinions differ on the routine use of
the anaerobic blood culture bottle, debating substitution of the
anaerobic bottle by an additional aerobic bottle. In this way, the
optimal volume of 20 ml of blood per culture for detecting
bacteraemia would be collected. The aim of our study was to
evaluate the beneﬁt of routinely using the combination of the
BacT/ALERT FAN aerobic and anaerobic bottle in a tertiary care
medical centre.
Methods: We performed a retrospective study of 11 740 blood
culture bottles (5855 paired and 30 unpaired) obtained from
3611 adult patients admitted to the emergency room between
January 2005 and August 2005. Statistical analysis using the
sign-test was limited to those isolates classiﬁed as clinically
signiﬁcant and was only performed when at least 10 isolates per
category were recovered.
Results: A total of 325 signiﬁcant microbial strains were
isolated from 312 patients. Analysis of these isolates revealed
no signiﬁcant difference between the yield of the FAN aerobic
and FAN anaerobic bottles. However, signiﬁcantly more
Pseudomonas aeruginosa (p < 0.0001) and Streptococcus
pneumoniae (p = 0.0156) were recovered from the aerobic bottle,
while signiﬁcantly more strictly anaerobic bacteria (p < 0.0001)
and Enterobacteriaceae other than Escherichia coli (p = 0.0156) were
recovered from the anaerobic bottle. Twenty-two patients (7.1
%) had a positive blood culture with strictly anaerobic bacteria,
which were only recovered from the anaerobic bottles. These
were mainly elderly patients, 15 with an abdominal pathology, 3
with neutropenic fever, and 3 with a decubitus ulcer and 1 with
a tooth abscess. In two of these 22 patients, the result of the
blood culture led to a change in diagnosis and an adjustment of
the antibiotic therapy.
Conclusion: Our data suggest that the routine use of the BacT/
ALERT FAN anaerobic bottle is still recommended in our
institution because we have a relative high proportion of strictly
anaerobic bacteraemia and because some facultative organisms
apparently grew preferentially in the anaerobic bottle.
Furthermore, although infrequently, the knowledge of an
anaerobic bacteraemia did inﬂuence the management of
patients.
P985
Developing clinical rules and a urinary dipstick
rule to predict urinary tract infection in primary
care settings
P. Little, S. Turner, K. Rumsby, G. Warner, M. Moore, H. Smith,
C. Hawkes, M. Mullee (Southampton, Hastings, UK)
Background: Suspected UTI is one of the commonest acute
infections. Systematic reviews have documented no adequately
powered studies in primary care to assess independent
predictors of rigorous laboratory diagnosis, nor robustly
estimated the performance of urinary dipsticks in a typical
primary care population. Our aim was to estimate independent
clinical and dipstick predictors of infection and develop clinical
decision rules.
Methods: 427 women presenting with suspected UTI in
primary care had laboratory diagnosis assessed using the
European Urinalysis guidelines standard. Independent clinical
and dipstick predictors of diagnosis were estimated.
Results: 62.5% of women had conﬁrmed UTI. Only nitrite,
leukocyte esterase (+ or greater), and blood (haemolyzed trace
or greater) independently predicted diagnosis (multivariate
odds ratios respectively 6.36,4.52,2,23). A dipstick rule – based
on having nitrite, or both leukocytes and blood was moderately
sensitive (77%) and speciﬁc (70%) (positive predictive value
(PPV) 81%, negative predictive value (NPV) 65%). Predictive
values were improved by varying the cut point: the NPV was
73% for all three-dipstick results being negative; the PPV 92%
for having nitrate and either blood or leukocyte esterase. A
‘clinical rule’ based on having 2 of urine cloudiness, offensive
smell, reported moderately severe dysuria, moderately severe
nocturia - was less sensitive (65%) (Speciﬁcity 69%, PPV 77%,
NPV 54%). The NPV was 71% for none of the four clinical
features, and the PPV 84% for 3 or more features.
Conclusion: Simple decision rules could improve targeting of
investigation or treatment. Strategies to use such rules will need
to take account of their limited sensitivity, which is lower than
expected from previous research.
P986
Quantitative sputum culture versus direct
sputum culture
O. Akan, E. Ozyilmaz, K. Ahmed, S. Uysal, M. Gulha (Ankara,
TR)
Objectives: Gram stain is preferred for the diagnosis of lower
respiratory tract infections (LTRI) at microbiology practice, but
sputum culture is still needed to isolate the pathogens for
antibiotic susceptibility tests. This study is performed to
evaluate the quantitative sputum culture (QSC) compared to
direct sputum culture (DC) for isolation of the common bacteria
causing LTRI.
Methods: 100 sputum obtained from adults with or without
chronic obstructive lung disease having clinically and/or
radiologically diagnosed LRTI were included in the study. All
of the samples contained ‡ 25 polymorphonuclear leucocytes
(PNL), and < 10 epithelial cells per low-power ﬁeld (LPF) under
light microscopy and all of them revealed at least one
microorganism as a causative agent by Gram stain. After
direct inoculation of culture plates, the sputum samples were
mixed with Sputasol (Oxoid) at a ratio of 1:1 and after serial
dilutions, quantitative cultures were performed. Blood and
chocolate agar plates were used for culture and standard
microbiological methods were used for bacterial identiﬁcation.
24 and 48 hours later both direct plates and quantitative cultures
were observed. Cut off point ‡ 1000 000 cfu/ml was
determined to be positive for the QSC.
Results: 16 % of sputum samples were negative by both culture
techniques. Ten cultures displayed mixed growths with two
organisms and 94 bacteria from 84 positive sputum cultures
were observed. Haemophilus inﬂuenzae (48%) was the most
common isolate followed by Streptococcus pneumoniae (32%)
and Branhamella catarrhalis (14%). QSC detected 97.9% and DC
detected 60.6% of the pathogens. 39.4% of bacteria (16
H.inﬂuenzae, 18 S.pneumoniae, 3 B.catarrhalis) were detected by
QSC only and this rate was 2.1% (1 Branhamella catharralis, 1
S.pneumoniae) for DC. QSC detected more agents than DC
(p < 0.0001).
Conclusion: To obtain pathogenic bacteria from sputum
samples, which are available for culture, QSC can be used
instead of DC. For routine use of QSC at clinical microbiology
laboratories, cost effective analysis should be performed
according to the individual needs of the health care facilities.
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P987
Quantitative urine microscopy as a quick, reliable
examination for bacteriuria
S. Mhalla, A. Ferjani, N. Hannechi, J. Boukadida (Sousse, TN)
Objectives: The diagnosis and treatment of urinary infection
are often delayed, causing renal damage, largely because of the
unavailability of quick, accurate, diagnostic examination. The
aim of this study is to compare the accuracy in diagnosing
signiﬁcant bacteriuria between quantitative urine microscopy
and the Gram-stain method.
Methods: Urine samples were obtained from fresh urine
specimens, which were sent to our laboratory during the
month of October 2005.These urine samples, were examined
for signiﬁcant bacteriuria using the standard culture, than
examined using the Gram-stain method and quantitative urine
microscopy by Mallassez cell. When particles could not be
distinguished deﬁnitely as bacilli by quantitative microscopy,
the urine was examined using oil immersion microscopy at
· 1000 magniﬁcation.
Results: Signiﬁcant bacteriuria was detected by bacterial
culture in 70 of 325 urine samples. Using quantitative
microscopy, rods were found in 52, cocci in a cluster in 2, cocci
in a chain in one, and indeﬁnite particles in 19 samples. In the 19
indeﬁnite samples, oil-immersion microscopy was able to
distinguish rods in 9, cocci in a cluster in one, and negative in
9, which were conﬁrmed by culture as rods, staphylococci and
negative, respectively. The quantitative microscopy method was
more reliable (93% sensitivity, 98% speciﬁcity) for diagnosing of
signiﬁcant bacteriuria when compared with the Gram-stain
method (70% sensitivity, 93% speciﬁcity).
Conclusion: Quantitative urine microscopy, conﬁrmed by oil-
immersion, is a quick, reliable method for diagnosis of
signiﬁcant bacteriuria, and is considered to be useful for early
diagnosis of urinary infection.
P988
Detection of extended-spectrum beta-lactamases
among Enterobacteriaceae using automated
microbiology systems and manual detection
procedures
H. Seifert, H.K. Geiss, D. Mack, E. Stu¨renburg, I. Wiegand
(Cologne, Heidelberg, Hamburg, Bonn, DE; Swansea, UK)
Objectives: The reliability of automated antibiotic susceptibility
testing systems for the detection of extended-spectrum beta-
lactamases (ESBLs) among Enterobacteriaceae is crucial for
optimal patient therapy and outbreak management.
Methods: A total of 150 strains, including Escherichia coli (62),
Klebsiella spp. (45), Enterobacter spp. (24), Citrobacter spp. (6),
Morganella morganii (4), Proteus spp. (7), and Serratia marcescens
(1) were tested. Three automated microbiology systems were
compared: The PhoenixTM Automated Microbiology System (BD
Diagnostic Systems, Sparks, MD), the VITEK 2 system
(bioMe´rieux, Marcy l’Etoile, France), and the Microscan
WalkAway-96 SI (Dade Behring, Inc.). Conventional
phenotypic conﬁrmatory test such as the NCCLS double disk
synergy test (DDS), the disk approximation method (DAM), and
the Etest ESBL (AB biodisk, Solna, Sweden) were also evaluated.
Combined uses of isoelectric focusing, PCR procedures for the
detection of TEM and SHV genes, and/or DNA sequencing
were used as the reference method.
Results: Of the total 150 isolates, 95 were ESBL producers as
determined by the reference methods, 2 isolates were excluded
due to indeterminate results, and the remaining 53 isolates were
identiﬁed as non-ESBL producers. The sensitivity, speciﬁcity,
negative (NPV) and positive (PPV) predictive values were
determined:
Conclusions: These results indicate that the Phoenix System
offers the highest sensitivity and acceptable speciﬁcity among
the automated susceptibility testing systems for the detection of
ESBL production in clinically important Enterobacteriaceae. The
most reliable overall performance was achieved with the ESBL
ETest.
P989
Assessment of the delay in reporting blood
culture results – development of a method to
identify defects in quality
U. Saarela, P. Ka¨rpa¨noja, H. Sarkkinen (Lahti, FI)
Objectives: It is a well-known fact that early reporting of
positive blood cultures results in a more rational treatment of
patients with sepsis. One might expect that early reporting of a
negative blood culture as well as impact on the clinical
assessment and treatment of patients with symptoms of
infection. We have previously analysed that 93 % of all
positive blood cultures are ﬂagged as positive in our
automated blood culture system within two days of
incubation. Based on that, we have deﬁned the maximal delay
time of two days for the ﬁrst report of a blood culture, whether
positive or negative. To verify that our laboratory practice
complies with this guideline, we audited our blood culture
reports.
Methods: 10 001 blood culture reports were included in the
analysis. The blood culture bottles were incubated in the BacT/
Alert (Bio-Merieux) automated blood culture system. 813 (8.1
%) of these were positive. According to our documented
procedure positive results are reported by phone and the
laboratory information system (Efﬁca Microbiology System,
TietoEnator) immediately after gram-staining and preliminary
identiﬁcation directly from the blood culture bottle. Negative
results are reported for the ﬁrst time after two days of incubation
and ﬁnally after ﬁve days. The implementation of the reporting
system (expected reporting delay) was analysed using a
developed report generator, now included in the Efﬁca
Microbiology System software. To exclude the various
variations due to the workﬂow in the laboratory, the
acceptable delay was set to three days instead of two.
Results: The mean delay time in reporting the ﬁrst result
(whether positive or negative) was 1.45 days with a standard
deviation of 0.737. The median was 1.00 days (minimum 0 days,
maximum 25 days). 9913 (99.1 %) of all results were reported
within the three days. We found 88 (0.9 %) cases where
reporting delays exceeded the pre-deﬁned time. Seven of these
reports were not considered errors on different grounds. For the
81 cases no acceptable reason for the delay was found. They
were regarded as human errors.
Conclusions: The reporting delay is an important quality
indicator in a microbiological laboratory. The number of
results reported falsely later than three days after the
beginning of the incubation, was very small (n = 81, 0.81 %).
With the developed reporting generator described we are able to
detect the ‘‘outliers’’ thus improving the quality of our
reporting.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P990
Validation of commercial kits for detection of
antibodies to Legionella
P. Elverdal, S.A. Uldum (Copenhagen, DK)
Objectives: Validation of four commercial kits for detection of
antibodies to Legionella (L.) pneumophila by comparison with an
in-house Legionella IFA assay. Three-kits were indirect Enzyme-
Linked Immunosorbent Assays (ELISA) and one kit was an
indirect immunoﬂuorescent antibody assay (IFA). For this
study, the kits were tested with sera, which had been tested
positive for other bacteria than Legionella, and with in-house IFA
assay positive sera from patients with L. pneumophila infection.
Methods: Seventy-ﬁve sera, which had been tested positive for
other bacteria (Campylobacter, Helicobacter, Riskettsia, Mycoplasma
pneumonia, Chlamydia group, Pseudomonas aeruginosa and
Coxiella) than Legionella. One hundred in-house IFA assay
positive sera (titre ‡ 256) from patients with L. pneumophila
infection conﬁrmed by one of the following methods: PCR,
culture or Legionella urinary antigen test. In the in-house IFA
assay heat inactivated L. pneumophila serogroup 16, L. micdadei
and L. bozemanii were used as antigens. The kits, which were
validated, were:
(i) Focus Diagnostics IFA kit for L. pneumophila serogroup 1–6
and 8,
(ii) SERION ELISA classic for L. pneumophila 1–7 IgM kit,
(iii) SERION ELISA classic for L. pneumophila 1–7 IgG kit, and
(iv) Zeus Scientiﬁc, Inc. L. pneumophila serogroup 1–6 ELISA kit
Results: In Table 1, it can be seen that the sensitivity was
highest for the Focus Diagnostics kit (77%), but this kit also had
the next highest false positive rate properly caused by cross-
reaction (16%). To compare the SERION ELISA classic kits with
the other kits, the IgM and IgG results were combined because
the other kits all detect IgG/IgM/IgA. The SERION ELISA
classic kits had a sensitivity of 73.9% and a false positive rate of
5.6%, when the two kits (IgM + IgG) results were combined.
Table 1: Numerical percent of sensitivity and cross-reaction in
kits and LAT.
Conclusion: The Focus Diagnostics, SERION ELISA classic and
Zeus Scientiﬁc, Inc. ELISA kits are all relatively sensitive. But
both Focus Diagnostics and Zeus Scientiﬁc, Inc. ELISA kits have
high false positive rates. The best kit, compared to the in-house
assay, is the SERION ELISA classic kit when the IgM and IgG
results are combined, because it has the best combination of a
relative high sensitivity and a low false positive rate.
P991
Intrathecal synthesis of anti-borrelia antibodies
in multiple sclerosis
J. Bednarova, P. Stourac (Brno, CZ)
Objectives: Multiple sclerosis (MS) is a chronic inﬂammatory
demyelinating disease of autoimmune origin. It is the most
common cause of neurologic disability in young adults. The
intrathecal synthesis of speciﬁc IgG antibodies against measles,
rubella and varicella zoster viruses, called MRZ reaction, is
reported in 84–94% MS patients. As a part of oligoclonal,
polyspeciﬁc immune response in MS, intrathecal synthesis of
speciﬁc IgG antibodies against herpes simplex virus and
toxoplasma is also reported. The aim of our study was to
investigate the frequency of intrathecal synthesis of speciﬁc IgG
antibodies against Borrelia burgdorferi in MS.
Methods: We investigated a cohort of 101 patients: 56 patients
were diagnosed as multiple sclerosis, 30 patients were
diagnosed as neuroborreliosis (NB), 15 patients had other
neurologic diseases (OND). Serum and CSF samples were
analysed at each patient. The diagnostic kit of Test-Line
Company, Clinical Diagnostics, Czech Republic (EIA Borrelia
garinii IgG) was used for the detection of speciﬁc antibodies.
Absolute values of absorbances were converted to arbitrary
units (AU) and the intrathecal synthesis was evaluated as
speciﬁc antibody index (AI) according to Reibers method.
Values of AI > 1.4 indicated positive intrathecal synthesis.
Statistical signiﬁcance was conﬁrmed by Spearman rank
coefﬁcient and Wilcoxon test.
Results: Intrathecal synthesis of speciﬁc IgG antibodies against
B.burgdorferi was detected in 25% MS patients with AI in the
range 1.8–9.3. The CSF arbitrary units of antibodies against
B.burgdorferi were in the range 0.5–65.0 with AU median 1.8 and
AU mean 7.2. Intrathecal synthesis of speciﬁc IgG antibodies
against B. burgdorferiwas detected in 90% NB patients with AI in
the range 1.5–33.0. The CSF arbitrary units of antibodies against
B.burgdorferi were in the range 4.0–100.0 with AU median 100.0
and AU mean 75.2. One-OND patient had positive intrathecal
synthesis against B.burgdorferi with AI = 2.5. Low anti-borrelia
AU in MS patients reﬂect polyspeciﬁc immune response in MS
compared to high anti-borrelia AU in NB patients that indicate
immune response against B.burgdorferi as the causative agent in
NB.
Conclusion: We detected positive intrathecal synthesis of
speciﬁc IgG antibodies against B.burgdorferi in 25% MS
patients. Speciﬁc intrathecal synthesis against infectious agents
in MS is a part of polyspeciﬁc immune response in chronic
autoimmune disease of the nervous system.
P992
Antimicrobial susceptibility as a complementary
diagnostic tool for the identiﬁcation of rarely
encountered non-fermenting Gram-negative
bacteria
Y. Glupczynski, G. Detry, C. Berhin, M. Janssens,
G. Wauters (Yvoir, Brussels, BE)
Objectives: Gram-negative non-fermenters (GNNF) other than
Pseudomonas aeruginosa and Acinetobacter spp. are increasingly
implicated in various different types of nosocomial infections.
Commercially available identiﬁcation methods have limited
performances and conventional methods despite improved
accuracy are difﬁcult to implement in routine diagnostic
laboratories. Because of the occurrence of the wide variations
in the natural antimicrobial resistance patterns among the
different genus and/or species of rarely encountered GNNFs,
we aimed to assess the antibiogram as an auxillary aid in their
identiﬁcation.
Methods: 218 clinical strains and 34 reference strains belonging
to 31 different genera and species of rarely encountered GNNFs
identiﬁed to the species level by conventional methods and/or
by sequencing or 16S rRNA gene were tested by disk diffusion
against 30 to 32 agents representing most classes of antibiotics.
Susceptibility categorization was made according to CLSI
interpretative criteria for non-fermenters except for colistin
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which was interpreted as resistant on the basis of the absence of
any zone size.
Results: S. maltophilia, C. meningosepticum and O. anthropi
displayed the most multi-resistant proﬁle. Besides colistin
and fosfomycin, the susceptibility or resistance pattern to
speciﬁc beta-lactam agents (see table) was found as a useful
complementary tool for identiﬁcation: Susceptibility to aztreo-
nam and to temocillin was only found in Burkholderia, Deftia
and Comamonas species. Resistance to carbapenems sometimes
dissociated between imipenem and meropenem was encoun-
tered in Stenotrophomonas, Chryseobacterium, Burkholderia and
Ralstonia. Synergy between beta-lactamases inhibitors and beta-
lactams was only seen with Stenotrophomonas, Chryseobacterium/
Myroides spp. and Rhizobium spp. Images of cephalosporinases
induction by cephamycins, carbapenems or beta-lactam/beta-
lactamases inhibitors was typically seen in Ochrobactrum
anthropi.
Conclusion: Overall the natural antibiotic resistance patterns of
several GNNF genus/species group appears may appear as a
valuable useful complementary for identiﬁcation of these
organisms.
P993
An improved protocol for the serological
diagnosis of atypical pneumonia
C. Jenkins, I. Balakrishnan (London, UK)
Objectives: The Royal Free Hospital Microbiology Department
receives approximately 500 requests for atypical pneumonia
serology tests each year. Prior to April 2005, sera from all
atypical pneumonia serology requests were analysed for
antibodies to Mycoplasma pneumoniae, Chlamydia pneumoniae
and Coxiella burnetti. (Legionella pneumophila is detected using a
urinary antigen test and not included in this study.) However,
tests on acute-stage sera can neither exclude a speciﬁc aetiology
by a negative result nor ﬁrmly establish it by detecting antibody
in an early sample. Tests on paired sera are more useful but the
inherent delay reduces the value of a result for case
management.
Methods: From April 2005, clinicians were requested to provide
details on the date of onset of patients’ symptoms. Samples
taken less than seven days from the onset of symptoms or those
with no date of onset were not tested but saved at -20oC for
seven days and a report issued stating ’Serum saved. Please
phone Microbiology if specimen was taken more than 7 days
into illness or send follow-up specimen in 7–10 days for parallel
testing if indicated. The requests for atypical pneumonia
serology from 01.04.04 to 30.09.04 were compared to those sent
between 01.04.05 to 30.09.05 to determine whether the new
protocol had reduced the number of tests performed and
improved the service provided.
Results: During the review period, 159 requests for atypical
pneumonia serology were sent in 2004 compared to 309 in 2005.
Sixty-six of the requests received in 2005 were not tested
immediately as they did not fulﬁl the testing criteria. Of these, 27
were tested after the clinician provided the required
information. No feedback was received from the requesting
clinician in 39 of these samples and they were not tested. The
Infectious Diseases ward responded with further information
most often whereas Accident and Emergency were least likely to
respond.
Conclusion: From April to September 2005, tests were not
performed on 39 samples due to the change in protocol,
resulting in a reduction in both expenditure and workload.
There was no signiﬁcant reduction in the number of requests
sent without the date of onset of patients’ symptoms, despite our
proactive approach. However, there was an increase in the
number of clinicians responding to our request for more
information. In addition, the new protocol has improved the
quality of the service by rationalizing the diagnosis of atypical
pneumonia.
P994
Potential antigenic determinants of Chlamydia
trachomatis major outer membrane protein
modeled by overlapped recombinant proteins
N. Savel’eva, J. Zagriadskaya, S. Klimashevskaya, V. Puzyrev,
A. Obriadina, A. Burkov, T. Ulanova (Nizhnyi Novgorod, RU)
Background: Major outer membrane protein (MOMP) is a
primary target of speciﬁc anti-Chlamydia trachomatis antibodies.
This protein performs important structural and immunity-
related roles and contains 4 variable segments (VS I, II, III, IV).
Previously it has been shown that immunoreactive antigenic
epitopes are located within VS I, II and IV.
Objective: The purpose of this study was determination of
potential antigenic epitopes encoded by open reading frame for
major outer membrane protein of Chlamydia trachomatis and
modelling them by using overlapped recombinant proteins
about 100 amino acids (aa).
Methods: Several antigenic determinants of Chlamydia
trachomatis MOMP have been predicted by bioinformatics
analysis. Six pairs of primers were designed to produce six
overlapping DNA fragments from genomic DNA Chlamydia
trachomatis by using PCR reaction. Recombinant genes encoding
selected amino acid sequences about 100 aa with overlapping 30
aa have been synthesized. Proteins were expressed in Escherichia
coli as hybrid proteins with Glutathione S-transferase and
6-Histidine tag. To study antigenic properties of new proteins
64 well deﬁned positive (n = 39) and negative (n = 25) serum
samples were tested. All serum samples were previously
characterised by three commercially available assays for the
detection of IgG anti-Chlamydia trachomatis.
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Results: Six clusters of potential antigenic determinants have
been predicted within major outer membrane protein of
Chlamydia trachomatis. Recombinant genes encoding predicted
amino acid sequences of MOMP at positions 1–116 aa, 66–165 aa,
128–216 aa, 191–286 aa, 252–354 aa and 317–398 aa were
synthesised. The pure samples of 6 proteins were obtained by
afﬁnity chromatography. All proteins were immunoreactive and
demonstrated different speciﬁc activity with anti-Chlamydia
trachomatis antibodies in serum samples. The 191–286 aa
protein showed the highest level of immunoreactivity. This
antigenic epitope(s) comprise VS III.
Conclusion: The predicted antigenic epitope(s) located within
191–286 aa demonstrated a signiﬁcant diagnostic potential as
candidates for the development of diagnostic assays for the
detection of anti-Chlamydia trachomatis IgG activity in serum
specimens.
P995
Evaluation of the Giardia-strip: an in vitro
immunochromatographic test for the detection of
Giardia lamblia cysts in faecal specimens
D. Van Kerkhoven, M. Lontie, J. Verhaegen, K. Lagrou (Leuven,
BE)
Objectives: Giardiasis is a diarrhoeal illness caused by Giardia
lamblia, a one-celled parasite that lives in the intestine of humans
and animals. The disease is diagnosed by microscopical iden-
tiﬁcation of cysts or trophozoites in faeces, using direct mounts
as well as concentration procedures. Since these analyses are
labour-intensive and require a skilled microscopist, antigen
detection tests (direct ﬂuorescent antibody (DFA), enzyme
immunoassay (EIA) and rapid, dipstick-like tests) have been
developed as alternatives. We have evaluated the performance
of a commercially available one-step immunochromatographic
membrane test using speciﬁc monoclonal antibodies against
the cyst membrane antigens of G. lamblia, the Giardia-strip
(CorisBioconcept).
Methods: The test performance was evaluated with known
positive (n = 18) and negative (n = 55) stool specimens for
G. lamblia, tested by the standard ova and parasite (O&P)
examination as the golden standard. Faeces with other parasites
(8 Endolimax nana, 8 Entamoeba coli, 4 Entamoeba histolytica and 1
Ancylostoma) and Staphylococcus aureus (3) were included to
evaluate the speciﬁcity of the test. These fresh and unpreserved
samples, obtained from the laboratory of UZ Gasthuisberg and
Medisch Centrum voor Huisartsen Leuven, were frozen and
maintained at -20C prior to testing. The Giardia-strip was used
according to the manufacturer’s instructions.
Results: By the Giardia-strip, 17 of the 18 known positive
specimens were positive and 54 of the 55 Giardia-negative
samples were negative (94.4% sensitivity, 98.2% speciﬁcity,
94.4% positive predictive value and 98.2% negative predictive
value), compared to (O&P) which is considered as the reference
method. The Giardia false-positive discrepant sample came
from a patient who was on holiday in Tunisia. Microscopy on a
control sample of the same patient remained negative. The
missed positive specimen by the Giardia-strip contained many
cysts. No cross-reactions with other parasites or S. aureus were
observed in this study.
Conclusion: The Giardia-strip has an excellent sensitivity and
speciﬁcity for the detection of G. lamblia in stool. The test is easy
to perform (no concentration prior to testing), suitable for single
sample analysis and has a short turn-around-time (15 minutes).
This diagnostic kit may be very beneﬁcial in the absence of
trained microscopists. However, it cannot substitute the routine
O&Ps as only G. lamblia is detected.
P996
Use of the T tube test in the setting of a paediatric
tuberculosis clinic
J. Paton, C. Lucas, C. Williams (Glasgow, UK)
Objective: To assess the feasibility of use and performance of
the T Spot TB test within a paediatric TB clinic by monitoring the
level of agreement between tuberculin skin testing (TST) and T
Spot TB test.
Methods: T-SPOT (Oxford Immunotec) directly detects
individual activated effector T-cells, via their secretion of the
cytokine a˜-Interferon using an ELISPOT (Enzyme Linked
Immunosorbent Spot) assay. The assay is based upon the
principle that T cells of individuals sensitized with tuberculosis
antigens produce a˜-interferon when they re-encounter
mycobacterial antigens. Antigens speciﬁc to M. Tuberculosis
such as early secretory antigenic target 6 (ESAT6); culture ﬁltrate
protein 10 (CFP10) are used to stimulate cells removed from the
patients blood. These are more speciﬁc to M. tuberculosis than
PPD, as they are not shared with any BCG sub-strains or most
Non Tuberculous Mycobacterium (NTM) species with the
exception of M. kansasii, M. marinum, and M. szulgai. We have
performed 147 Elispot tests and have results comparing
ELISPOT and TST in 65 cases.
Results: There was a technical failure of the test in 11 cases the
commonest cause (8 tests) being insufﬁcient cells to proceed
with the assay. There was generally good agreement between
negative ELISPOT and TST in patients with no history of BCG
vaccination with agreement in 95% of cases, however in patients
with positive TST only 54% were ELISPOT positive. In 13
patients with a history of BCG vaccination and positive TST only
1 was positive by ELISPOT.
Conclusions: The use of the T SPOT test is practical in a
paediatric TB clinic. The assay has a high degree of concordance
in negative tests in the absence of BCG vaccination and is also
useful when previous BCG vaccination has been given however
ongoing evaluation of this methodology in the paediatric
outpatient setting is needed.
P997
Do hyaluran levels determine the outcome of
bacterial infections?
H. Lydatakis, I. Hager, I. Binikos, P. Afentra, H. Chrisanthidou,
T. Peppas, S. Pappas, I. Diamantis (Piraeus, Athens, GR)
Objectives: Bacterial infections remain a major cause of
morbidity and mortality, despite the continuous development
of antibiotics. The prognosis of these infections is variable and
depends on host and bacterial speciﬁc factors. The role of CRP
and WBC count as prognostic factors is controvercial. In this
study, we measured the Hyaluran (HA) levels in an effort to ﬁnd
new prognostic factors which could deﬁne the clinical outcome
of bacterial infections.
Patients/Methods: From June to October 2005, 54
immunocompetent adults, with conﬁrmed bacterial infection,
including cholecystitis, pneumonia and pyelonephritis, were
admitted to our hospital. These patients were monitored for at
least 9 days and the levels of HA, CRP and WBC count, as well
as the temperature were measured on the 2nd and 8th day of
hospitalization. The levels of HA were measured using an
ELISA. The normal limits were 5–70 ng/ml. On the 2nd day, 32
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patients had HA levels higher than 70 ng/ml (210.25 ± 170.12-
Group 1), while the rest 22 had HA levels within normal range
(48.73 ± 37.98-Group 2). Both groups had similar mean values of
age, admission temperature, and admission serum CRP and
WBC count.
Results: By the 8th day of hospitalization 28 patients of group 1
had complete remission of their infection, 2 developed septic
syndrome and 2 died (6.2% mortality), while only 4 patients of
group 2 improved, 11 developed septic syndrome and 7 died
(31.8% mortality). The WBC levels of group 1 were signiﬁcantly
lower than that of the second group (15 300 ± 2137
vs.7850 ± 2116 p = 0.001). Likewise there was a signiﬁcant
reduction of serum CRP in the ﬁrst group compared to the
second one (33.30 ± 25.22 vs.180.83 ± 56.64 p=0.01). The
temperature of patients of group 1 returned to normal limits
(36.72 ± 0.23) while in group 2 remained high (38.21 ± 1.12)
(p = 0.003). The mean HA levels remained high in patients of
group 1 (135.89 ± ±33.12) while in patients of group 2 remained
within normal limits (52.47 ± 28.12) (p = 0.001).
Conclusions: These data indicate that HA could be used as
prognostic factor in determining the outcome of bacterial
infections. More studies are needed to conﬁrm these ﬁndings
and to establish the mechanism by which the HA might
inﬂuence the evolution of the bacterial infections. Finding the
exact mechanism could help in designing new therapeutic
strategies.
P998
Evaluation of the new chromogenic medium:
CHROMagar Salmonella Plus for the detection of
all Salmonella species including Salmonella typhi
and Salmonella lactose plus
A. Rambach, Q. Tran, A.C. Le Dantec (Paris, FR)
Infections due to Salmonella continue to be a major problem
throughout the world. Culture media have several advantages
in comparison to PCR and immunological methods: culture
media allow antibiotic susceptibility studies, epidemiological
studies of the detected strains and, in addition, only living
bacteria are detected. Recently several new chromogenic media
improve the detection of Salmonella. We studied with pure
strains the new chromogenic media CHROMagar Salmonella
Plus (CHROMagar, France), which after 24 hours of incubation
at 37C detects Salmonella species including Salmonella Typhi and
Salmonella lactose plus. Our ﬁrst results, in comparison to
Hektoen Enteric Agar (BD) and OSCM (Oxoid), show that
only CHROMagar Salmonella Plus allows detection of Salmonella
spp, Salmonella Typhi and Salmonella lactose plus while HEA and
OSCM fail to detect many lactose positive Salmonella. Prelimin-
ary results show that CHROMagar Salmonella Plus is a conveni-
ent, rapid, sensitive and speciﬁc medium for detection of the
three types of Salmonella species. The next step of the study will





bloodstream infections in adults in Korea
Y.K. Kim, S.Y. Shin, M.S. Kim, Y.S. Park, Y-A. Kim, H.J. Yoon,
J.Y. Choi, Y.G. Song, K.H. Roh, D. Yong, K. Lee, J.M. Kim (Seoul,
KR)
Background: The deﬁnition of community-acquired infection
(CAI) needs to be reformulated with increase in outpatient
management, nursing care facility, etc. The characteristics of
healthcare-associated infection (HCAI) are similar to that of
nosocomial infection (NCI) in several studies. We investigated
the characteristics of HCAI caused by S. aureus and E. coli.
Methods: Four hundreds twenty two adult patients, admitted
from Jan. 2004 to June 2005 at Severance Hospital, Seoul, Korea
with bloodstream infection (BSI) caused by S. aureus or E.coli
were studied. To characterize healthcare-associated bloodstream
infections caused by S. aureus or E.coli, we investigated
comorbid medical condition, predisposing factor, site of
infection, resistance patterns, in-hospital mortality by
epidemiological category such as NCI, HCAI and CAI.
Results: Among 422 patients, 129 patients were S.aureus BSIs
and 293 E.coli BSIs. One hundred sixty ﬁve patients met criteria
of NCI, 109 of HCAI, and 148 of CAI. HCAI was similar to
nosocomial infection in terms of frequency of malignancy,
predisposing factor, source of infections and in-hospital
mortality. MRSA prevalence of HCAI was similar to that of
NCI (43.8% versus 63.8%, p > 0.05) but was not similar to that of
CAI (43.8% versus 7.1%, p = 0.001). But, E.coli resistance
patterns of HCAI were similar to that of CAI (18.2% versus
14.2%, p > 0.05 in ampicillin/sulbactam, 7.8% versus 2.5%,
p > 0.05 in cefotaxime, and 6.5% versus 2.5%, p > 0.05 in ESBL-
producer) but were not similar to that of NCI (18.2% versus
38.5%, p = 0.004 in ampicillin/sulbactam, 7.8% versus 19.8%,
p = 0.026 in cefotaxime, and 6.5% versus 16.7%, p = 0.042 in
ESBL-producer). Prevalence of quinolone resistant E.coli was in
order as follows; NCI (34.4%), HCAI (23.4%), and CAI (14.2%).
Conclusion: HCAI was similar to NCI in clinical characteristics
and MRSA prevalence but not similar in resistance patterns of
E.coli. The further consideration is needed for the deﬁnition of
HCAI with regard to Gram-negative infections.
P1000
Secular trends of antimicrobial resistance of
blood isolates in a newly founded Greek hospital
P. Rafailidis, S. Kasiakou, P. Morfou, G. Georgoulias, D. Nikita,
M. Falagas (Athens, GR)
Objectives: Antimicrobial resistance is one of the most
challenging issues in modern medicine. We sought to evaluate
the secular trends of the relative frequency of blood isolates and
of the pattern of their in vitro antimicrobial susceptibility in our
hospital during the last four and a half years.
Methods: We focused on Gram-negative and Gram-positive
bacterial isolates from cultures of blood specimens.
Susceptibility testing that was performed with the Vitek 2
system, applying the criteria suggested by the Clinical and
Laboratory Standards Institute (CLSI), followed isolation of
bacteria. We compared the antimicrobial resistance of blood
isolates of two periods: the ﬁrst period was 1/1/2002-31/12/
2003 (1200 isolates) and the second period 1/1/2004-30/6/2005
(774 isolates).
Results: Overall, the data regarding the relative frequency of
blood isolates in our newly founded hospital do not differ
signiﬁcantly from those of hospitals that are functioning for a
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much longer period of time. Out of 2156 bacterial isolates
Coagulase negative staphylococci were the commonest blood
isolates (52.5% of total). The relative frequency of other Gram-
positive and Gram-negative microorganisms was the following,
in descending order: Escherichia coli (8.9%), Staphylococcus aureus
(5.9%), Pseudomonas aeruginosa (5.2%), Klebsiella spp. (4.8%),
Acinetobacter baumannii (4.1%), and Enterococcus faecalis (2.2%).
A noteworthy emerging problem is the increasing antimicrobial
resistance of Gram-negative bacteria, mainly Acinetobacter
baumannii and Klebsiella pneumoniae to various classes of
antibiotics. Acinetobacter baumannii isolates showed an increase
of resistance to amikacin (p = 0.019), ciproﬂoxacin (p = 0.001),
imipenem (p < 0.001), and piperacillin/tazobactam (p = 0.01)
between the ﬁrst and second period of the study.
Conclusion: An alarming increase of antimicrobial resistance
was noted during our study for Gram-negative bacteria,
especially Acinetobacter baumannii and Klebsiella pneumoniae.
P1001
Hospital-acquired bacteraemia: occurrence of
pathogens throughout a decade
H. Moraitou, M. Makarona, A. Koundourakis, I. Kousseris,
N. Makrygiannis, V. Tzolos, M. Panagi, S. Kanavaki (Athens,
GR)
Objectives: The isolation frequency and resistance proﬁle of the
commonest bacteraemia-related organisms were retrospectively
studied throughout the periods 1991–1995 and 2001–2005,
covering a decade, in ‘Sotiria’ Chest Diseases Hospital of
Athens.
Methods: All bacteraemias were considered as nosocomial,
since they occurred at least 48 hours after patient’s admission to
hospital. The cases were analysed in relation to responsible
organisms and their antibiotic resistance proﬁles. In our
Hospital, in Period A (1991–1995), 426 patients developed a
nosocomial bacteraemia, while in Period B (2001–2005) 1872.
Results: In periods A and B, the isolation frequency of Gram (+)
organisms was respectively for S. aureus 8.2% and 15.5%,
S. epidermidis 27.5% and 24.0%, CNS 2.1% and 12.3%,
S. pneumoniae 3.5% and 1.8%, E. faecalis 3.5% and 3.2%,
E. faecium 0% and 1.6%, K. pneumoniae 4.9% and 6.5%, E. coli
5.4% and 9.7%, P. aeruginosa 5.2% and 8.1%, A. baumanii 1.9%
and 3.9% and S. maltophilia 0.24% and 6.3%, respectively.The
main characteristics in antibiotic proﬁles in periods A and B,
included: MRSA occurrence 69.0% and 31.1%, oxacillin-resistant
S. pneumoniae 0% and 8.8%, GRE faecalis 0% and 1.6%, and GRE
faecium 0% and 13.3%, ESBL-producing K. pneumoniae 0% and
46.7%, ESBL-producing E. coli 0% and 1.1%, MBL-producing K.
pneumoniae 0% and 23.7%, carbapenem-resistant P. aeruginosa 0%
and 30.2% and carbapenem-resistant A. baumanii 0% and 58.1%
respectively.
Conclusions: It is worthy of remark:
• The excessive rise in bacteraemia cases during period B (2001–
2005), which could be partly attributed to the recent
development of Oncology Unit, as well as University Internal
Medicine Unit in our Hospital
• The decreasing frequency of MRSA isolations, probably due to
control measures taken
• The increased incidence of oxacillin-resistant S. pneumoniae
• The recent occurrence of glycopeptide-resistant enterococci
• The emergence of highly resistant organisms, such as ESBL-
producing Enterobacteriaceae, MBL-producing K. pneumoniae, and
carbapenem-resistant P. aeruginosa and A. baumanii, and,
• The striking incidence of S. maltophilia, which is now
considered as a serious nosocomial pathogen.
P1002
Positive central venous catheter cultures and
bloodstream infections
C. Papadopoulou, Z. Afkou, G. Kythreotou, D. Tokatlidou,
M. Tsivitanidou, D. Soﬁanou (Thessaloniki, GR)
Objectives: The purpose of this study was to determine the
spectrum of microorganisms isolated from positive central
venous catheter (CVC) cultures and to assess the correlation
between bacteremia and positive CVC cultures.
Methods: From January 2002 to July 2005, a total of 1737 CVC
sent for microbiological analysis were studied. Catheter tips
were considered as infected when they yielded equal or more
than 15 colonies using the semi quantitative Maki’s method.
Blood cultures were performed using the BacT/Alert automated
system. Identiﬁcation of microorganisms was performed using
the VITEK 2 automated system (bioMerieux).
Results: Among the 1737 CVC cultures, only 287 (16.5%)were
considered as positive. The microbial agents isolated from the
positive CVC cultures were: Staphylococcus epidermidis 85 (29.5%),
Acinetobacter baumannii 62 (21.5%), Pseudomonas aeruginosa 34
(11.85%), Klebsiella pneumoniae 21 (7.3%), coagulase-negative
staphylococci 40 (13.9%), Enterococcus faecalis 14 (4.9%),
Staphylococcus aureus 10 (3.5%) and other gram negative
bacteria of the genus of Enterobacteriaceae 21 (7.55%).
Furthermore, 97 positive blood cultures drawn from peripheral
vein in patients with positive CVC cultures were studied, in
order to evaluate if the CVC was the source of bloodstream
infection. In 45 cases (46.4%)the same microorganisms were
isolated in both CVC and blood cultures demonstrating that
catheter, previous colonized by microorganisms of skin ﬂora as
well as nosocomial pathogens was the entry site of bacteremia.
The most common microorganisms recovered from blood
cultures were the following: A. baumannii 14 (31.1%),
S. epidermidis 8 (17.7%), P. aeruginosa 7 (15.6%), K.pneumoniae 7
(15.6%), E. faecalis 2 (4.4%) and other Enterobacteriaceae 7 (15.6%).
Conclusions: (i) S.epidermidis were mainly responsible for
catheter-related infections in our hospital.(ii) Catheter-related
bacteremia was considered in only 46.4%.(iii) Aseptic techniques
as well as continuous microbiological surveillance studies
leading to effective empiric treatment of catheter-related
infections are required.
P1003
Laboratory-based epidemiology of nosocomial
candidaemia in a tertiary teaching hospital
L.G.O. Cardoso, P. Trabasso (Campinas, BR)
Objectives: To describe the epidemiology of nosocomial
candidemia in a 400-bed teaching hospital.
Methods: Prospective follow of all patients with positive blood
cultures for Candida species was done between August-2003 and
October-2004. Searching for underlying diseases, presence of
central venous lines, use of antibiotics and antifungal drugs
prior to candidemia, and treatment were performed. Outcomes
were survival thirty days after candidemia or death.
Results: Seventy-three patients with candidemia were followed
(65.8% male), mean of age was 47.3 years (range 0 to 87).
Previous episodes of bacteremia occurred in 31.5%. Isolation of
Candida in other sites before candidemia was present in 15.1% of
patients. The most frequent underlying disease was cancer,
diagnosed in 35.6%. Diabetes mellitus, cardiopathy,
nephropathy, pulmonary or neurological diseases were
presents in less than 20% of cases. Almost half of patients
(49.3%) were submitted to surgery in the last three months.
Antifungal prophylaxis with ﬂuconazol was received by 13.7%.
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Antibiotics for more than 24 hours were previously used in
97.2% of cases. At the moment of candidemia, mechanical
ventilation was present in 30.1% of patients, parenteral nutrition
in 57.5% and central venous lines in 83.6%. Hemodyalisis in the
72 hours before candidemia were performed in 13.7% of cases.
From all Candida isolates, 53.4% were C. albicans and 46.6%
C. non-albicans (23.3% C. tropicalis, 15.1% C. parapsilosis and 8.2%
C. glabrata). None risk factor or underlying disease was
statistically related with any species of Candida. Antifungal
therapy for more than 72 hours was given to 64.4% of patients.
Overall mortality in thirty days was 47.9%. Antifungal treatment
for more than 14 days was the only variable associated with
lower mortality. No difference in the mortality rate was detected
between different Candida species infections.
Conclusion: Candidemia is a frequent and serious nosocomial
infection, with high mortality. Frequency of non-albicans species
of Candida is high, but identiﬁcation of species with lower
susceptibility to ﬂuconazol was not common. Antifungal
treatment for more than 14 days was associated with lower
mortality. Death in the ﬁrst 72 hours of treatment was not rare
and reinforces the importance of suspicion of candidemia in risk
patients and early start of therapy.
P1004
Nosocomial bloodstream infection following
cardiac surgery in children
N. Jashiashvili, A. Nanuashvili, M. Chkhaidze (Tbilisi, GE)
Objectives: Hospital infections continue to be a major problem,
causing high morbidity and mortality in surgical clinics and
signiﬁcantly increasing the length of hospitalization and cost of
treatment. Nosocomial bloodstream infection have repeatedly
identiﬁed as the most frequent type of nosocomial infections in
pediatric patients. Although, it is known that the frequency of
infectious complications, as well as their etiology is rather
different in various geographical regions, sometimes even at the
concrete hospitals.The aim of our study was to determine the
frequency and etiology of hospital bloodstream infection
following cardiac surgery in children and to ﬁnd out whether
the emergency operation increases the frequency of bloodstream
infection or not.
Methods: We studied 421 patients at Paediatric Cardiac
Surgery Clinic, who were operated in the period from January
2001 till December 2004. The age of the patients varied from 1
day to 18 years. In 383 cases the operations were planed and in
38 cases-emergency.
Results: Out of 421 patients hospital infections occurred in 66
(15.7%) patient. The frequencies of infectious complications were
as follows: pneumonia )32 (7.6%), bloodstream infection )14
(3.3%), wound infection )10 (2.4%), urinary tract infection )7
(1.7%), endocarditic )2 (0.5%), pericarditis )1 (0.2%), non
differentiated site infection )12 (2.9%). The most cases of
bloodstream infections occurred in children < 1 year of age.
Bloodstream infection in 6 cases were caused by Gram-negative
bacteria: Klebsiella pneumoniae )3, Serratia marcescens )2,
Acinetobacter baumanni -1 and in 8 cases by Gram-positive
bacteria: Staphilococcus epidermidis -7, Streptococcus salivaris -1.
The rate of bloodstream infections following 383 planed
operations was 3.4% and after the 38 emergency operations-2.6%.
Conclusion: The bloodstream infection was the second most
frequent infectious complication following cardiac surgery in
children. In the etiology of bloodstream infection the most
frequent gram-positive bacterium was Staphilococcus epidermidis
and the most frequent gram-negative bacteria-Enterobacteriaceae.
The frequency of bloodstream infection was not signiﬁcant
different between emergency (2.6%) and planed operations
(3.4%).
P1005
Nosocomial bloodstream infections in the
cardiovascular surgery centre, Iasi, Romania
A. Mereuta, M. Dan, L. Colar, G. Tinica, G.I.M. Georgescu,
D. Buiuc (Iasi, RO)
Objectives: To analyse the aetiology, the origin,
epidemiological features and outcome of nosocomial
bloodstream infections (NBSI) in patients that underwent
cardiovascular surgery.
Methods: A retrospective study of bloodstream infections was
conducted between April 2001 and September 2005 in the
Cardiovascular Surgery Centre of Iasi.
Results: There were 57 episodes of nosocomial bloodstream
infections at 2068 admissions. Bloodstream infections were
secondary to an infectious body site (lower respiratory tract,
wound, urinary tract) in 35.08% of the episodes, catheter-related
in 22.80% and in 42.10% of cases they had an unknown origin.
Cell-wall deﬁcient forms (45.61%) were the most prevalent
microorganisms (26 strains, out of which 12 reverted to the
classical state: 4 gram-positive cocci, 6 gram-positive bacilli, 1
Gram-negative bacilli, 1 anaerobe and 14 were L-stable),
followed by Staphylococcus aureus and coagulase-negative sta-
phylococci 12 strains (21.05%), gram-positive bacilli 11 (19.29%),
fungi 8 (14.03%), HACEK group, gram-negative bacilli, Entero-
coccus spp. 3 strains each (5.26%), Streptococcus pneumoniae 2
(3.50%), anaerobes 1 (1.75%). The proportion of polymicrobial
episodes was 3.5% (Staphylococcus aureus + Haemophilus paraph-
rophilus and H. parainﬂuenzae + Enterococcus faecalis) and fatality
was 26.3%.
Conclusions: We found a high proportion of cell wall deﬁcient
forms, rarely reported before. This may be due to: blood culture
collection under antimicrobial therapy (P = 0.016), especially
beta-lactams; more adequate methods for blood culture
processing: sucrose enriched media (Hemoline Performance
Duo, bioMerieux, France) and acridine orange stain for
microscopy of the blood culture.
P1006
Rifampin and minocycline impregnated central
venous catheters: a meta-analysis of randomised
controlled trials assessing catheter colonisation
and catheter-related bloodstream infection
M. Falagas, K. Fragoulis, I. Bliziotis, I. Chatzinikolaou (Athens,
GR)
Objectives: The use of antimicrobial-impregnated central
venous catheters (CVC) for the prevention of CVC microbial
colonization and of catheter-related bloodstream infection
(CRBSI) is a controversial subject. We performed a meta-
analysis of randomised controlled trials (RCT) of CVCs coated
with rifampin-based antimicrobial combinations in order to
further evaluate this subject.
Methods: The assessed primary outcomes were microbial
colonization of the CVC and CRBSI. The analysed secondary
outcomes were the occurrence of adverse events, emergence of
resistant organisms and all cause mortality. Our main analysis
included RCTs that compared the efﬁcacy of CVCs impregnated
with rifampin and minocycline to that of non-impregnated with
antibiotics CVCs.
Results: 8 RCTs fulﬁlled our inclusion criteria, comparing 1262
CVCs impregnated with rifampin-based antimicrobial
combinations to 1236 non-impregnated with antibiotics CVCs.
Our primary analysis showed that rifampin-minocycline
impregnated CVCs were associated with lesser rates of
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colonization (OR 0.41, 95% CI 0.25–0.68) and CRBSI (OR 0.21,
95% CI 0.10–0.43). Sub analyses of studies comparing rifampin-
minocycline impregnated CVCs to non-tunnelled, non-
antimicrobial-impregnated CVCs (5 studies) demonstrated
superiority of the impregnated catheters in preventing
colonization (OR 0.35, 95% CI 0.24–0.52) and CRBSI (OR 0.21,
95% CI 0.10–0.43). Further analysis, of RCTs comparing CVCs
impregnated with any rifampin-based combination of
antimicrobials to non-impregnated with antibiotics CVCs (all 8
RCTs), demonstrated superiority of the rifampin-based
combinations in reducing colonization (OR 0.33, 95% CI 0.19–
0.58), and CRBSI (OR 0.17, 95% CI 0.09–0.32). None of the RCTs
reported signiﬁcant increase in mortality, toxicity, or emergence
of resistance in any of the studied groups.
Conclusion: Rifampin-minocycline impregnated CVC are safe
and effective in reducing the rate of CVC colonization and
CRBSI. Additional RCTs are needed to provide more
information on cost –analysis, on the possibility of emergence
of microbial resistance, to evaluate more their beneﬁt in long-
term catheterisation and to compare them versus the new
generation of CHSS – coated CVC.
P1007
Infections related with tunelled haemodialysis
catheter
T. Aldabo´, R. Luque, M.J. Marcos, Y. Blanco, J. Ibeas, E. Bouza
for the Red Espan˜ola de Investigacio´n en Patologı´a
Infecciosa (REIPI)
Introduction: In Spain, every year 12000 CVC are inserted in
patients on HD, 40% of them tunnelled (TC). Infection is the
second leading cause of death in this population, and catheter-
related bacteremia (CRB) a major cause of hospitalisation.
Objectives: 1) To asses the incidence, epidemiology and risk
factors for CRB in patients with TC on HD. 2) To know the
length of TC use (catheter survival).
Patients and methods: We prospectively analysed all
consecutive TCs inserted in four Spanish hospitals from Sep/
04 to Oct/05. We used IDSA deﬁnitions for intravascular
catheter-related infections (CID 2001). Characteristics of
patients and TC, and risk factor associated with CRB during
insertion and removal, were analysed. All patients were
followed until CRB, death, removal of TC or time for the end
of the study (one year). Data were colleted by an ‘‘on-line’’
database system. Quantitative variable were expressed as
median (range). Chi-square and T-student tests were used for
statistic analysis.
Results: One hundred and twenty-eight TCs were inserted in
117 patients (57% males). Age: 71 years (20–88). Previous time
on HD before TC insertion: 78.5 days (5–8701). Catheter
survival: 162 days (2–366). Tunnelled catheters were used after
other vascular accesses in 64% of patients. Six episodes of CRB
were observed, with an incidence of 0.29/1000 catheter-days
(total time 20711 catheter-days). The causative bacteria were:
E. faecalis (N = 3), S. aureusMS (N = 2) and S. aureusMR (N = 1).
Three tunnel infections were reported and two of them
developed CRB. Time since catheter insertion to the onset of
CRB: 23 days (5–141). Thirty-two TC were removed (although
only 4 for CRB). Insertion in femoral or subclavian veins (RR 19,
95% CI 3–114; p 0.000), previous hospitalisation (RR 5.7, 95% CI
0.8–39; p 0.057) and surgical procedure (RR 13, 95% CI 0,9–178; p
0.022) 1-month before were associated with CRB. In the outcome
we registered one death, one relapse (who later died) and two
metastatic infections (septic arthritis and vertebral
osteomyelitis). Two deads (33%) were CRB-related and
another 3 deads (2.70%) were observed in the non-CRB group
in one-year follow-up (RR 11.2, 95% CI 2.4–44.7).
Conclusions: The incidence of CRB with TCs was very low,
however its mortality-related is high. Risk factors associated
with CBR were non-jugular vein insertion, previous
hospitalisation and surgical procedure performed until 1-
month before.
P1008
Bacillus spp. bacteraemia in children on
parenteral nutrition
E. Lebessi, G. Antonaki, A. Zaﬁropoulou, K. Malliou,
N. Paleologou, M. Foustoukou (Athens, GR)
Objectives: To study the epidemiologic and clinical data
concerning bacteremia due to Bacillus spp. associated with
total parenteral nutrition (TPN), during a four-year period
(2002–2005).
Methods: Patients, who presented clinical signs of bacteremia
while receiving TPN, with blood and/or TPN solution culture
positive for Bacillus spp. were included. Blood drawn from
peripheral veins and samples of the discontinued TPN solutions
were cultured by the BacT/Alert system (bioMerieux, France).
TPN solutions were also cultured quantitatively. Identiﬁcation
of microorganisms was carried out using Gram stain, colony
morphology, motility test and lecithinase production at egg yolk
agar (Oxoid, England), BBL Crystal Positive ID kit (Becton
Dickinson, USA) and/or API20E/50CHB (bioMerieux, France).
Three epidemiological environment surveys in TPN preparation
room (PPR) were performed, according to the hospital infection
control guidelines, when clusters of episodes occurred (Sept
2003, Jun 2004, Oct 2005).
Results: During the study period, 23 episodes occurred in 20
patients ranged in age from 6 days to 14 years. Bacteremia due to
Bacillus spp. was documented by positive blood culture in 14
cases. TPN was discontinued in 7 cases and TPN solutions were
found to be contaminated with the same organism. Bacillus spp.
was also isolated fromTPN solutions involved in 9 episodes,with
negative (n = 5) or not performed (n = 4) blood culture. B. cereus
(11 strains) and B. megaterium (10 strains) were the most common
species isolated, followed by B. pumilus (1 strain) and Brevibacillus
brevis (1 strain). The implicated organisms were also recovered
from the laminar ﬂow-hood of PPR.Abrupt onset, presentedwith
fever and/or chills, occurred in all patients, accompanied with
vomiting and diarrhoea (one case) and thrombophlebitis (one
case). Dramatic clinical response was observed to discontinuing
the infusion. No deaths were observed.
Conclusions: The isolation of Bacillus spp. from the laminar
ﬂow-hood and the TPN solutions suggested the in-use
contamination during the preparation and compounding of
admixtures. Bacillus spp. due to spores formation can resist to
disinfectants. We emphasize the need for stringent asepsis in the
hospital pharmacy, in order to avoid the contamination of
infusates with potential pathogens, widely distributed in the
environment, such as Bacillus spp.
P1009
Survey of virulence factors of clinical isolates
from neutropenic patients with enterococcal
bacteraemia
S.H. Park, S-M. Choi, D-G. Lee, J-H. Choi, J-H. Yoo,
W-S. Shin (Seoul, KR)
Objective: This study was aimed to survey the prevalence of
virulence factors in enterococci from clinical isolates, relatedness
with vancomycin resistance, and their impact on clinical
outcomes, and furthermore to elucidate their role in
pathogenesis of blood stream infection of enterococci at the
Catholic HSCT center
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Method: A Collection of Enterococcus isolates from blood in
neutropenic patients with hematologic diseases between
January 2000 and December 2004 and vancomycin resistant
enterococci (VRE) isolated from rectum from the same patients
at the time of VRE bacteremia were screened for the presence of
virulence factor genes, such as those for cytolysin (cylA),
gelatinase (gelE), aggregation substance (asa1), enterococcal
surface protein (esp), hyluronidase (hyl) by PCR. PFGE of the
isolates from blood and rectum of the same patients were done
to evaluate their genetic relatedness.
Result: We collected 56 isolates from blood and 13 isolates from
rectum of 11 patients at the time of VRE bateremia. Among the
isolates from blood, E. faecium accounted for 80.4% (n = 45) and
E. faecalis for 19.6% (n = 11). The proportion of vancomycin
resistant isolates was 76.5% (n = 34) in E. faecium and 27.3%
(n = 3) in E. faecalis. The esp gene and hyl gene were detected in
35 (77.8%) and in 12 (26.7%) of isolates of E. faecium and the
genes asa1, gelE, and cylA were not detected among them. Of 11
strains of E. faecalis, 81.8% (n = 9) were positive for esp., 36.4%
(n = 4) positive for gelE, 81.8% (n = 9) for asa1, 54.5 (n = 6) for
cylA and 9.1% (n = 1) for hyl. None of the virulence factors was
associated with vancomycin resistance. None of the virulence
factors directly inﬂuence on clinical outcome. Thirteen rectal
isolates of VR E. faecium were all positive for esp., 69.2% (n = 9)
positive for hyl. PFGE of 10 pairs of isolates from blood and
rectum revealed that 7 pairs were genetically matched.
Conclusion: The virulence factors were not associated with
vancomycin resitance and did not inﬂuence clinical outcomes.
High relatedness between rectal and blood isolates and the
higher prevalence of esp. and hyl in rectal isolates suggested
that the intestinal tract could be an important focus of
bacteremia in neutropenic patients and another factors other
than esp. and hyl might be associated with invasion of
E. faecium into bloodstream. The role of virulence factors in
E. faecium is needed to be elucidated in the future.
P1010
Accuracy of surveillance blood culture to identify
patients with low response to treatment and high
30-days mortality risk in MRSA bacteraemia:
comparison to a standard clinical and biological
follow-up
E. Forestier, Y. Hansmann, V. Remy, M. Mosheni, N. Lefebvre,
O. Lesens, D. Christmann (Strasbourg, Clermont-Ferrand, FR)
Objectives: Surveillance blood culture accuracy to evaluate
treatment efﬁcacy and predict death in patients with
Staphylococcus aureus bacteremia remains unclear. Furthermore,
whether it is more informative than a standard clinical and
biological follow up is not determined. Finally, MSSA and
MRSA bacteremia should be considered separately since
differences in pharmacological properties of beta-lactamines
and glycopeptides may inﬂuence the length of bacteremia.We
evaluated the accuracy of positive surveillance blood culture to
detect treatment failure and predict 30-days mortality in patients
with MRSA bacteremia and compared it to a standard clinical
and biological follow-up (fever, signs of sepsis, leukocytosis,
C Reactive Protein level).
Methods: A prospective case-control study was realised
between 1st October 2003 and 1st May 2005 in the Hoˆpitaux
Universitaires de Strasbourg. A surveillance blood culture was
systematically performed after 72 hours of presumed active
antibiotic treatment and patients were followed for 30 days.
Results: Fifty patients presenting with MRSA bacteremia were
included in the study. Eighteen (36%) patients had a positive
surveillance blood culture. Main factor associated with
breakthrough bacteremia was the presence of a central
vascular device (CVD), particularly if it was considered as the
portal of entry of the bacteremia (p < 0.01). Conversely patients
treated with teicoplanine were less likely to have positive
surveillance blood culture (p < 0.05) compared to those treated
with vancomycin. Mortality rate in case of sustained bacteremia
was 33.3% vs. 6.3% in case of non-sustained bacteremia
(p < 0.02). Positive predictive value (PPV) for death of isolated
breakthrough bacteremia was 33.3%. However, if considering
only bacteremia developed from another portal of entry than a
CVD, PPV increased to 91.7%.Aggravation of standard clinical
and biological data after 72 hours of treatment was strongly
correlated with 30-days mortality (p < 0.01) and its PPV (75%)
and NPV (87.8%) for death were good, independently of any
other factor.
Conclusion: Positive surveillance blood culture is a predictive
factor for 30-days mortality in MRSA bacteremia but justiﬁes
treatment reconsideration only if the portal of entry is not a
CVD. However, in most of cases, it appears not more
informative than a standard clinical and biological follow-up.
P1011
Methicillin resistance as a risk factor for mortality
in Staphylococcus aureus bacteraemia: an analysis
from EARSS Enhanced Bacteraemia Surveillance
in Ireland, 2005
A. Oza, S. Murchan, R. Cunney on behalf of the Irish EARSS
Steering Group
Objectives: There is uncertainty in the literature about the
contribution of methicillin resistance to mortality associated
with Staphylococcus aureus blood-stream infection (BSI). We
examined risk factors for mortality among Irish patients with
S. aureus BSI.
Methods: A set of Irish hospital laboratories provide enhanced
(clinical, demographic and risk factor) data on episodes of BSI
reported to the European Antimicrobial Resistance Surveillance
System (EARSS). Outcome data, including in-hospital mortality,
has also been reported by a subset of laboratories since the
beginning of 2005. We examined in-hospital mortality vs.
survival before the end of each EARSS survey period (90 days)
with logistic regression and survival analysis.
Results: There were 116 episodes of S. aureus BSI reported, with
39 in-hospital deaths, 71 discharged and 6 still in hospital at the
end of the survey period. Of all the factors examined, length of
stay (LOS) prior to BSI, age and meticillin resistance were all
signiﬁcant predictors of in-hospital mortality. Mortality among
patients with MRSA BSI (n = 53, 60%) was signiﬁcantly higher
than among patients with MSSA BSI (n = 63, 11%). Cox
regression, controlling for LOS and age, demonstrated that
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methicillin resistance was the only signiﬁcant contributor to
mortality (HR 3.4, 95%CI 1.2–9.2). The baseline survival curve is
shown.
Conclusion: Methicillin resistance remains a signiﬁcant risk
factor for in-hospital mortality among patients with S. aureus BSI
after controlling for age and LOS.
P1012
Mortality from sepsis in Russia: identifying a gap
in epidemiological data
D. Galkin, I. Gudkov, S. Zouzov, R. Kozlov (Smolensk, RU)
Objectives: Available epidemiological data on sepsis in Russia
contain scarce clinical information and low reported mortality
rates lead to underestimation of real ﬁgures. The study was
designed to investigate incidence and clinical traits of sepsis
according to autopsies’ records in a large city in Central Russia
for comparison with ofﬁcial statistics.
Methods: Autopsy protocols of all population of the city of
Smolensk who deceased and undergone post mortem
examination from the year 2000 to 2004 inclusive were
assessed. Protocols where sepsis (as a post mortem diagnosis)
was a major cause of death or a complication of an underlying
disease were registered and processed using SAS version 8.2
software (SAS Institute, USA). That data were compared with
reports of the Department of Health of the Smolensk Region.
Results: Overall 9346 autopsy protocols were evaluated. There
were 116 autopsy records of patients who died with sepsis of
whom 79 (68.1%) were men and 37 (31.9%) were women. Mean
age was 42.5 ± 22.8 (0–90 years). All 116 (100%) septic patients
died in a hospital setting. Length of hospitalisation until death
was 11.7 ± 3.5 days and 1.9 ± 0.6 days took from death to post
mortem evaluation. Sepsis as a primary diagnosis was recorded
in 94 (81.1%) and as a complication of underlying conditions in
22 (18.9%) patients. Deviations with clinical diagnosis were
noted in 24 (20.7%) of patients. Overall mortality rate by the
autopsy records was 34.5 cases per 100,000 populations in
comparison to 22.9 cases per 100 000 populations by the ofﬁcial
data during the ﬁve-year study period.
Conclusion: Although the demonstrated difference in mortality
rates from sepsis did not reach statistical difference (p = 0.12) it
shows 1.5 superiority in incidence according to autopsy
protocols in comparison with ofﬁcial data. This is possibly
explained by lack of implementation of common deﬁnitions and
inadequate disease registration recommendations in Russia. To
close gap in the epidemiology data actions to reinforce use of
uniﬁed sepsis diagnostic criteria are required at the nationwide
level.
P1013
Cloxacillin sensitivity evolution in
Staphylococcus aureus bacteraemias from 2001 to
2005 and their resistant phenotypes
M.M. Gallardo, M.V. Garcı´a, R. Rodriguez, E. Granados,
F. Ropero, A. Hernandez, A. Pinedo (Ma´laga, ES)
Objectives: To ﬁnd the clinical and epidemiologic features
associated to S. aureus bacteraemias and their resistant
phenotypes.
Material and methods: Retrospective study of S. aureus
bacteraemias that occurred from January 2001 to September
2005 in the Hospital in Ma´laga. S. aureus was isolated from 251
patients. The blood cultures were processed with BATEC-9240
system (Becton Dickinson). Antimicrobial suceptibilities were
carried out by the MicroScan Walkaway automized system;
resistance to cloxacillin was veriﬁed with saline MH with
cloxacillin and E-test. The statistic study was carried out with
SPSS 10.0.
Results: Of the 251 patients studied 68.1%were men and 31.9%
women with an average age of 59.3 years old (14–89). In 40% of
the cases were from the Medical Service, 24.7% from
emergencies, 20.7% from the Intensive Care Unit and 13.9
%from the Surgical services. Average numbers of days in
hospital were 29 days. In 93.6% of the cases it was a
monomicrobian bacteraemia and in 62.2% the infection was of
intrahospitalarian origin. Patient’s progress was in 34.3% of the
cases towards exitus. Average resistance to cloxacillin (CLO)
during this period is 19.5%, even though its increase is clear
during the years, going from 16.7% in 2001 to 22.7% in 2005.
Resistance rates during the study period were 30.3% for
erythromycin (E), 23.9% for ciproﬂoxacin (CI), 13% for
clindamycin (CC), 11.2% for gentamicin (G) and 1.6%for
rifampin (R). When resistance to CLO in relation to age was
studied, an increase is found in the elderly age group
(12.2% < 50 years old, 19.4% from 50–70 years old,
25.7% > 70 years old). An increase in resistance to CLO in
intrahospitalarian strains (21.2%) was found compared to the
extrahospitalarian (16.8%). When resistance to CLO was studied
related to age, sex, hospitalisation days, hospital department, the
authors haven’t found signiﬁcant differences. Resistance
phenotype mostly found is CLO + CC (76.9%), followed by
CLO + CI (73.2%), CLO + E (63.2%). Moreover, 42.9% strains
showed CLO + CC + E and 38.77% CLO + CC + E + CI
phenotype and 100% strains were sensitive to glycopeptides.
Conclusion: S. aureus bacteraemia is more frequent in men with
an average age of 59 years old, who came from the medical
department and of intrahospitalarian origin. Resistance to
cloxacillin has increased in six points since 2001 (16.7%) to
2005 (22.7%). In 38.7% of the cases cloxacillin resistant strains are
also resistant to clindamicin, eritromicin and ciproﬂoxacin.
ICU infections
P1014
Surveillance of hospital-acquired infections in
intensive care units
J.L. Barrios, C. Ezpeleta, R. Blanco, M.J. Unzaga, J.A. Alava,
R. Cisterna (Bilbao, ES)
Objective: The aim of this study is to know the rates of NI
(Nosocomial Infections) in patients admitted into the ICU from
January to June 2005 and to compare our results with those of
the last NNIS report (National Nosocomial Infection
Surveillance-October 2004).
Patients and Methods: The 1689 patients located in the Medical
ICU and the 1385 patients admitted to the Coronary ICU (137 of
them operated on open heart surgery) from January to June 2005
were included. All the patients were prospectively studied since
the day they were admitted until the end of the episode by the
Infection Control team. Variables under surveillance were the
number of invasive devices: oropharingeal tubes, urinary
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catheter and arterial and venous central catheters and site-
speciﬁc infection rates associated to these devices by using as a
denominator the number of patients at risk, patient-days, and
device-days: Ventilator associated pneumonia (VAP), Urinary
tract infections (UTI), Central line bacteremia (CLB), other
secondary bacteremia (OSB) and primary bacteremia (PB),
microorganisms, and antibiotic susceptibility, treatment and
outcome. A computer based surveillance system (ENVIN-UCI)
was used.
Results: 9 VAP, 6 UTI, 1 CLB, and 2 OSB were diagnosed in the
Medical ICU and 9 VAP, 2 UTI, 1 CLB, 1 PB and 3 OSB in the
Coronary ICU. Densities of incidence rates in Medical ICU were:
VAP (11.43&), UTI (3.86&), SVCB (0.65&) and total bacteremia
(1.77&). In Coronary ICU the values were: VAP (22.16&)-6 VAP
arrived in the postoperative period of open-heart surgery-, UTI
(2.12&), CLB (1.92&) and total bacteremia (3.61&).
Microorganisms in Coronary ICU: Bacteremia: 2 Candida spp.,
2 S aureus, 1 S epidermidis; UTI 2 Candida spp.; VAP 1 S aureus, 1 S
marcencens. Microorganisms in Medical ICU: Bacteremia:
1 Candida spp., 1 S aureus, 1 E coli; UTI 2 Candida spp., 1 E coli,
1 M morganii, 1 P aeruginosa, 1 K pneumoniae; VAP 2 S aureus, 1 P
aeruginosa, S maltophilia, K oxytoca, H inﬂuenzae.
Conclusions: Compared to the data of density of incidence for
device-associated infections in the NNIS report, our results are
in concordance except for VAP. In this case our data are higher
than NNIS data, even more in our Coronary ICU. The rate in the
coronary ICU without the post-operated patients is over the
percentile 90 of the NNISS report (12.39&). Even so the target
for preventing VAP in the Coronary ICU of our hospital must be
the group of patients undergoing open-heart surgery.
P1015
Infections in intensive care unit admitted
multiple trauma patients: incidence, risk factors
and mortality rate
Y-H. Choi, S-H. Baik, Y-J. Lee, K-S. Lee, Y-J. Oh, J-H. Park,
S-S. Shin, K-J. Park, S-C. Hwang (Suwon, KR)
Objectives: Improvement in resuscitative managements of
patients who sustained multiple traumas has increased
survival rates but they still suffer from infections during the
course of their recovery in the hospital. The purpose of this
study was to survey the incidence and the site of infection and to
deﬁne risk factors for infection and mortality in ICU admitted-
multiple trauma patients.
Methods: Prospective record for APACHE II score day by day
was conducted for all multiple trauma patients who were
admitted at surgical ICU of Ajou university hospital from June
1. 2002 to May 30. 2004. Patients who were transferred from
other hospitals after operation, or for more than 48 hours care or
under the age of 18 were excluded. We reviewed medical
records and all imaging studies retrospectively.
Results: A total of 108 patients (81 males) with mean age of 41
years (± 14 years) were included and their mean APACHE II
score was 27.5 (± 18.9). Most common cause of trauma was blunt
injuries (83 patients, 76.9 %) like trafﬁc accidents and fall down.
A total of 60 infections had occurred in 44 (40.7%) patients for an
incidence of 12.5/1000 patient-days. The sites of infection were
lower respiratory tract (22%), skin/soft tissue (11%), intra-
abdomen (5.6%), central venous catheter (5.6%), urinary tract
(2.8%), surgical site (2.8%) and others (11%). Mean onset time of
infection was 25 days (± 41 days) and mean onset time
according to infection sites were in order of following; intra-
abdomen (3.8 ± 3.4 days), lower respiratory tract
(15.8 ± 27.7 days), skin/soft tissue (17.3 ± 28.4 days), surgical
site (23 ± 22.5 days), central venous catheter (41.7 ± 42.8 days)
and urinary tract (50.0 ± 27.7 days). Mortality rate was 7.4%.
Death was attributed to infection in four patients. In
multivariated analysis, patients with infections are more likely
to have prolonged hospital care (odds ratio (OR) = 1.042;
p £ 0.001), long-term ventilator care (OR = 1.556, p < 0.001)
and open fractures (OR = 7.113, p = 0.018). APACHE II score
(OR = 1.037, p = 0.044) and duration of mechanical ventilation
(OR = 1.074, p = 0.001) were contributed to death,
independently.
Conclusions: Multiple trauma patients have high risk of
infection. Most common infection was lower respiratory tract
infection. APACH II score was not a risk factor for infection but
a risk factor for death.
P1016
Nosocomial infections in a neonatal intensive
care unit: evaluation of frequency, risk factors
and cost
I. O¨zgu¨nes, H. Naz, N. Tekin, F. Aksit, E.D. Kartal, N. Erben,
S.N. Alpat, G. Usluer (Eskisehir, TR)
Objectives: Nosocomial infections (NI) are important causes of
morbidity and mortality in neonatal intensive care units (NICU).
The objectives of this study were to identify the incidence and
risk factors of NIs and cost of the NICU stay attributed to NIs in
a Turkish NICU.
Methods: A prospective cohort study was conducted from
November 1, 2004 to May 31, 2005, in the NICU of the
Eskisehir Osmangazi University Hospital, 900-bed academic
tertiary care centre with a 17–bed NICU. Exposure variables
from maternal and newborn data were prospectively collected
by daily visits. Diagnoses of NIs were based on the
recommendations of the Centres for the Disease Control.
Statistical analysis was performed with the software program
SPSS (Version 10.0).
Results: Of the 309 patients surveyed, 48 (15.5%) had acquired
NIs. The most common site of NIs was found as urinary tract
(39.4%), eye-ear-nose-throat (18.8%), skin and soft tissue (18.8%)
and blood stream (12.5%). The relationship between NIs and
probable risk factors such as prolonged hospital stay (+ 7 days),
low birth weight, previous antimicrobial usage, corticosteroid
treatment, intubation, mechanical ventilation, CPAP, surgery,
total parenteral nutrition, enteral nutrition and polycytemia
were found statistically signiﬁcant. The relationship between
NIs and sex, gestational age, twin birth, route of delivery, home
birth, low apgar scores were not statistically signiﬁcant. Most
common nosocomial pathogens were Escherichia coli,
Staphylococcus aureus, enterococci and Klebsiella spp. The
additional hospital stay because of NIs was 7.4 days. The
median cost was found as 1061 Euro for newborns without NIs
and 3082 Euro for newborns with NIs.
Conclusion: The risk factors for NIs detected in our NICU were
similar to those deﬁned worldwide. Gram-negative bacteria
were the leading cause of NIs. The increase in the medical cost
due to NIs was remarkable.
P1017
Colonisation surveillance can predict microbial
aetiology of infection in the critically ill
F. Kontopidou, E. Papadomichelakis, A. Antoniadou,
E. Koratzanis, E. Galani, A. Armaganidis,
H. Giamarellou (Athens, GR)
Objectives: Appropriate empiric antimicrobial treatment
directly affects infection mortality in the intensive care unit
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(ICU). Microbial colonization of the respiratory and
gastrointestinal tract (RT and GT) frequently precedes invasive
infection. We retrospectively studied the ability of colonization
surveillance to predict microbial etiology of subsequent
infections.
Methods: The study was performed in a 5-bed medical-surgical
ICU in a new university hospital from November 2003 to
October 2005. Infection control policy included weekly
surveillance cultures of bronchial secretion, urine and stool
samples. We recorded all cases of ventilator-associated
pneumonias (VAP) and bloodstream infections (BSI) based on
data from patient ﬁles and the microbiology laboratory. The
relationship between infectious etiology and most recent
colonization was analysed, based on species, antimicrobial
susceptibility patterns and molecular typing by REP-PCR of
selected isolates.
Results: We recorded 21 VAP and 74 BSI cases (41 catheter-
related). Pathogens isolated from VAP cases correlated with
bronchial or stool colonizers in 83%. Prior RT colonization
seemed most important. Acinetobacter sp. colonization of the RT
predicted VAP etiology with a sensitivity of 69% and a
speciﬁcity of 75%. Primary Gram (-) BSI pathogens were
recent colonizers in 73% of cases, associated with both the GT
and RT. Klebsiella sp. colonization of the GT predicted Gram (-)
BSI etiology with a sensitivity of 67% and a speciﬁcity of 85%. In
catheter-related isolates no relationship was observed between
Gram (+) and prior colonization. However, 81% of Gram (-)
previously colonized bronchial secretions or stool. REP-PCR
techniques conﬁrmed pathogen and colonizer concordance in all
cases tested. Most cases of pathogen-colonizer discordance were
due to either missed surveillance cultures or growth inhibition
of sensitive strains in antimicrobial-containing media used for
stool surveillance. Empiric antibiotic treatment based on
colonization results permitted 90% adequacy in VAP and 80%
in primary bacteremia treatment.
Conclusions: RT and GT colonization is strongly related to
microbial etiology of subsequent infection. Systematic weekly
colonization surveillance of RT and GT specimens could be
helpful in implementing prompt and empiric antimicrobial
therapy, especially for multi-drug resistant Gram (-) pathogens,
in the ICU.
P1018
Administration of antibiotics via the respiratory
tract for the prevention of ICU-acquired
pneumonia: a meta-analysis of comparative trials
M. Falagas, I. Siempos, I. Bliziotis, K. Rellos,
A. Michalopoulos (Athens, GR)
Objectives: The administration of prophylactic antibiotics via
the respiratory tract is one of several strategies for the
prevention of ICU-acquired pneumonia, an infection with
considerable morbidity and mortality. We sought to
systematically examine the available evidence regarding the
effect of prophylactic antibiotics administered via the
respiratory tract on the development of ICU-acquired
pneumonia, mortality, colonization of the respiratory tract,
emergence of antimicrobial resistance, and toxicity.
Methods: Relevant studies were identiﬁed by Pub Med search
(9/1950 to 9/2005) and references from relevant articles. Trials
that were included in the analysis provided comparative data
regarding the above-mentioned outcomes. Two independent
investigators performed the data extraction to calculate the
effect of the studied intervention on clinically relevant
outcomes.
Results: Eight comparative trials studying gentamicin (3
studies) polymyxins (3 studies), tobramycin (1 study), and
ceftazidime (1 study) that studied 1,877 patients were included
in our meta-analysis. ICU-acquired pneumonia (OR = 0.50, 95%
CI 0.33–0.76) and colonization of the respiratory tract by
P. aeruginosa (OR = 0.51, 95% CI 0.30–0.86) was less common
in the group of patients that received the antibiotic prophylaxis.
No difference in mortality was found between the compared
groups (OR = 0.93, 95% CI 0.72–1.22). No serious drug-related
toxicity was noted.
Conclusion: Prophylactic administration of antibiotics via the
respiratory tract in patients in the ICU setting is associated with
reduction of occurrence of ICU-acquired pneumonia. Despite
the valid concerns for the development and dissemination of
bacteria with antimicrobial resistance, the evidence supports the
further investigation and consideration of this preventive
strategy, at least in ICU patients at high risk for development
of ICU-acquired pneumonia.
P1019
Serial evaluation of CPIS and C-reactive protein
for diagnosing ventilator-associated pneumonia
M. Koeman, M.J.M. Bonten (Utrecht, NL)
Background: Diagnosing Ventilator-Associated Pneumonia
(VAP) remains difﬁcult without the existence of a clinically
available gold standard. Generally, VAP is diagnosed upon a
combination of clinical, radiological and bacteriological criteria,
described in the Clinical Pulmonary Infection Score (CPIS) and
many physicians include C-reactive Protein (CRP) in their
clinical judgement. Importantly, temporary trends of these
variables are frequently used in daily practice, though
diagnostic properties of dynamic values of CPIS and CRP
have not been compared to the diagnostic performance of their
static values. We, therefore, aimed to compare diagnostic
performance of static and dynamic values of CPIS and CRP in
diagnosing VAP.
Methods: 385 consecutive patients, previously included in a
randomised VAP-intervention trial, all needing mechanical
ventilation, were studied. CPIS and CRP were obtained daily.
Values determined at the day of diagnosis were considered static
values. Dynamic values were deﬁned as the difference between
the day of diagnosis and 1 (d1) and 2 (d2) days before in patients
developing VAP. In patients not-developing VAP, CPIS and CRP
on any day were considered static and d1 and d2 were calculated
for all possible sequential days. Reference diagnosis of VAP was
based upon clinical judgement of responsible physicians with
independent adjudication by 3 intensivists.
Results: 52 patients developed VAP. Static CPIS scores were
3.24 ± 2.29 on 2226 VAP-free patient days and 6.02 ± 1.50 on
days of VAP diagnosis (Area Under the Curve (AUC) of
Receiver Operating Characteristic (ROC) being 0.826, 95%CI:
0.783–0.870), with an optimal CPIS cut-off of 6 (sens 73%, spec
81%). No temporary trend in CPIS was discernable for patients
developing and not-developing VAP, whereas CPIS scores
clearly increased towards day of VAP diagnosis. Yet, AUC for
d1 and d2 CPIS values were 0.786 (95%CI 0.715–0.857) and 0.766
(95%CI 0.694–0.838), comparable to static CPIS. Although static
CRP was higher for patients with VAP (187 ± 117 versus
134 ± 139 mg/L; p = 0.024), the AUC of static CRP was 0.549
(95%CI 0.46–0.638) and diagnostic properties did not increase
when using dynamic CRP values: AUC 0.484 (95%CI 0.394–
0.574) and 0.486 (95%CI 0.399–0.572) for d1 and d2, resp.
Conclusions: Use of temporal trends in CPIS does not improve
diagnostic performance. Neither static nor dynamic CRP-values
appear to be reliable for VAP diagnosis.
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P1020
Aetiology and timing of bloodstream infections
in a liver intensive care unit
F. Pink, E. Sizer, W. Bernal, G. Auzinger, J. Wendon,
I. Eltringham (London, UK)
Objectives: To determine the aetiology and timing of
bloodstream infections on an adult liver intensive care unit
and compare results with previously published data from the
same Unit.
Methods: Retrospective study of 1074 adult patients admitted
to a liver intensive care unit for more than 24 hours between
January 2003 and July 2005. APACHE II and risk score on
admission, clinical data relating to aetiology of liver failure,
transplantation, mortality were collected in addition to blood
culture organism identiﬁcation and antimicrobial susceptibility.
Standard criteria were adopted for deﬁnition of bacteraemia.
Chi-square and Fisher’s exact tests were used to determine
associations between categorical variables.
Results: 209 patients (19.5%) had at one or more bacteraemia
with a total of 403 isolates including 14 repeat episodes with the
same species. The mean time from admission to the LICU to ﬁrst
signiﬁcant bacteraemia was 10.9 days. 170 isolates were Gram
positive, 206 Gram negative and 27 were yeasts. The median
time from to ﬁrst bacteraemia for different organisms was as
follows; Escherichia coli and meticillin-sensitive Staphylococcus
aureus (8.5 days) Enterococcus faecalis (9 days), Multi-resistant
Acinetobacter baumanii (9.5 days), MRSA, coagulase-negative
staphylococci, yeasts and Enterococcus faecium (11 days),
Klebsiella sp. (12 days), Stenotrophomonas maltophilia (13.5 days),
Enterobacter sp (19 days) and Pseudomonas sp (22.5 days). For a
number of organisms this difference reached statistical
signiﬁcance. Mean APACHE II scores on admission were 21.2
those who developed a bacteraemia compared with 13.8 for
those who did not.
Conclusions: Compared with earlier studies at the same centre
these data suggest signiﬁcant differences in the timing and
sequence of organisms isolated from septic patients on our
LICU. In this study infections with members of the
Enterobacteriaceae and Gram-positive organisms appeared later.
This may reﬂect changes in the prevalence of different species or
strains and/or the impact of early pre-emptive use of antibiotics
on the development of infection in liver failure patients. The
signiﬁcance of this in terms of management of sepsis is
discussed.
P1021
Epidemiology of bloodstream infections in an
Israeli general intensive care unit: a 6-year
analysis
T. Mashiach, H. Sprecher, R. Finkelstein (Haifa, IL)
Objective: To evaluate the epidemiological features of
nosocomial bloodstream infections (BSIs) observed at the
General Intensive Care Unit (UTI) of our medical centre in the
past 6 years.
Methods: Data were collected retrospectively from our
computerized records from 1January 2000 through 31 October
2005. Potentially skin contaminants, including episodes caused
by only one positive blood culture yielding coagulase-negative
staphylococci were excluded. Multiple cultures of the same
species were considered to be a single infection.
Results: During the study period there were 1321 episodes of
BSIs. Aerobic gram-positive organisms accounted for 44% of
cases, aerobic gram-negative organisms accounted for 46%, 4%
were caused by fungi and 6% were caused by a diversity of
other organisms, including anaerobes. The most common
organisms were coagulase-negative staphylococci (26%),
Klebsiella spp. (11.5%), S. aureus (10.2%) and Acinetobacter spp.
(9.5%). Resistance rates for most pathogens increased gradually
and strikingly during this period. From 2000 to 2005 the rate of
MRSA increased from 59% to 77% (an increase of 30.5%), the
rate of resistance of Klebsiella to 3rd generation cephalosporins
increased from 42% to 70% (an increase of 66.6%), and
resistances of Pseudomonas and Acinetobacter to imipenem
increased from 20% to 37% (an increase of 85%) and from 40% to
78% (an increase of 95%), respectively. Multiple drug resistance
among Acinetobacter spp. during the study period ranged from
80% to 100%. Surprisingly, rates of VRE remained low (mean:
2.2%, range 0%–6%)
Conclusions: These data may allow clinicians to better target
empirical therapy for bloodstream infections in the intensive
care unit as well as to understand the dangerous relationship
between antibiotic use and resistance in this setting.
P1022
Pseudomonas aeruginosa infection in ICU
patients: highlighting the silent epidemic
A. Agodi, M. Barchitta, L. Giaquinta, M.A. Romeo,
C. Denaro (Catania, IT)
Objectives: In order to identify, assess and apply relevant
evidence for better health care decision-making, our study was
addressed to evaluate whether Pseudomonas aeruginosa
associated nosocomial infections (NI) in intensive care units
(ICUs) originate mainly from patients’ endogenous ﬂora or from
exogenous cross-transmission, by determining: i) the occurrence
of P. aeruginosa carriage on admission; ii) the ICU-acquired P.
aeruginosa infection and colonisation rates, by site; iii) the impact
of cross-transmission using molecular typing data of the
involved microrganisms.
Methods: A six months active surveillance survey was
performed at the ICU of an Italian Hospital, in accordance
with the HELICS protocol. Carriage and colonization deﬁnitions
were as described by Bertrand et al. (2001). Molecular typing
was performed by macro restriction analysis of the SpeI-
digested genomic DNA. Interpretation of genomic relatedness
was performed using well-established criteria. The presence of
two indistinguishable strains in two patients was considered
one episode of cross-transmission.
Results: During the survey period a total of 123 patients were
admitted to the ICU. The incidence of P. aeruginosa carriage and
colonization/infection on admission was 1.6% and 2.4%
patients, respectively. The ICU-acquired colonization rate was
29.4% patients and the incidence density was 16.1& patient-
days. The ICU-acquired infection rate was 36.1% patients and
the incidence density was 19.8& patient-days. ICU-acquired
pneumonia (VAP) was conﬁrmed to be the ﬁrst P. aeruginosa-
speciﬁc infection type (51.2%), followed by UTI and local CVC
related infections (18.6% each). Nineteen distinct clones were
identiﬁed by macro restriction analysis. The impact of
P. aeruginosa cross-infection was estimated to be at least 47.1%,
but this ﬁgure was higher when cross-colonization was included
(59.5%), thus deﬁning the preventable proportion of all
P. aeruginosa-sustained cross-transmission episodes.
Conclusions: P. aeruginosa infection in ICUs has been suggested
to represent the tip of an iceberg, whereas colonization reﬂects
the submerged part. The epidemiological scenario depicted by
our analysis shows those cross-transmission is an important
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means of P. aeruginosa infection and highlight the occurrence of
a silent epidemic mainly sustained by a multiresistant clone, that
in the absence of epidemiologic screening would have remained
the submerged part of the iceberg.
P1023
Meta-analyses of the impact of inappropriate
antibiotic therapy on mortality in patients with
ventilator-associated pneumonia and
bloodstream infections
E. Gillespie, A. Patel, C. Coleman (Hartford, US)
Objectives: Several studies have found that initial treatment of
ventilator-associated pneumonia (VAP) and blood stream
infections (BSI) with inappropriate antimicrobial therapy is
associated with higher rates of mortality, but additional studies
have failed to conﬁrm these ﬁndings. To provide a stronger
quantitative basis for addressing these postulated associations,
we conducted a series of meta-analyses of existing relevant
studies.
Methods: Three investigators systematically searched
databases from 1966-September 2005 and reviewed citations in
relevant articles to identify studies that met the following
inclusion criteria: (1) randomised or observational trials, (2)
compare patients receiving appropriate antimicrobial therapy
(deﬁned as an antibiotic regimen with demonstrated in vitro
activity against the identiﬁed bacterial species associated with
infection) and inappropriate antimicrobial therapy in the setting
of VAP or BSI and (3) report data on incidence of mortality. We
conducted mortality analyses, both with and without
adjustment for confounding factors. A random-effects model
was utilized in all analyses.
Results: All studies included were observational in nature. A
meta-analysis of VAP studies utilizing unadjusted mortality
data (n = 8 studies) demonstrated inappropriate antimicrobial
therapy signiﬁcantly increased patients’ odds of mortality [odds
ratio (OR); 2.03 (95%CI 1.35–3.06); Q statistic p-value = 0.23].
Similar results were seen upon meta-analysis of adjusted
mortality data (n = 9 studies) [OR; 2.00 (95%CI 1.32–3.05); Q
statistic p-value = 0.06]. A meta-analysis of BSI studies utilizing
unadjusted mortality data (n = 16 studies) demonstrated
inappropriate antimicrobial therapy signiﬁcantly increased
patients’ odds of mortality [OR; 2.29 (95%CI 1.88–2.78); Q
statistic p-value = 0.0003]. Similar results were seen upon meta-
analysis including adjusted mortality data (n = 16 studies) [OR;
2.11 (95%CI 1.53–2.92); Q statistic p-value < 0.0001]. Assessment
of the funnel plots and Egger’s weighted regression statistics
(p-value > 0.34 for all) demonstrated a low probability of
signiﬁcant publication bias in the VAP and BSI analyses.
Conclusions: There appears to be an association between
inappropriate antimicrobial therapy and higher mortality in
patients with VAP and BSI, thus emphasizing the critical
importance of early appropriate antimicrobial therapy.
P1024
Antibiotic resistance and mortality in patients
with severe pneumonia
R. Erbes, M. Raffenberg, H. Mauch, S. Wagner,
M. Schmidt-Ioanas, H. Lode (Berlin, DE)
Background: Nosocomial infections in patients admitted to
intensive care unit (ICU) are frequently caused by potentially
resistant pathogen (RP). The present study aimed 1) to
determine the inﬂuence of antibiotic resistance on the outcome
and 2) to identify the risk factors for developing an ICU-
acquired pneumonia by RP.
Methods: All patients with severe pneumonia admitted to ICU
between 1998 and 2004 were prospectively included in study.
Clinical data, markers of infection (CRP, leukocytes, differential
blood count, purulent secretions) and quantitative culture of the
respiratory samples (bronchoalveolar lavage, protected
specimen brush, endotracheal aspiration) and bacterial
diagnostic by blood culture were recorded and considered for
distinguishing between colonisation and infection. RP was
deﬁned as a pathogen with resistance against at least two
major antibiotic groups.
Results: In 66 patients of a total of 162 patients (48 female, mean
age 62 ± 15 years) with pneumonia a microbial growth in the
respiratory secretions and in 17 (10.4%) patients a RP was noted.
Furthermore in 20 patients (12.3%), a RP could be isolated
during the ICU-stay The mortality rate in patients with evidence
of RP was signiﬁcantly higher in comparison to the patients with
infection by susceptible pathogens (46% versus 21.5%,
p = 0.006). Factors associated with an infection by RP were:
mechanical ventilation (p = 0.01), renal failure (p = 0.01), sepsis
(p = 0.01). The mean duration of treatment was signiﬁcantly
longer in patients with RP in comparison to the group with
susceptible pathogens or with no microbial growth (34.6 ± 64.1
versus 18.1 ± 23.5 and, respectively, 6.5 ± 6.8 days, p < 0.001).
Conclusion: Patients with severe pneumonia by resistant
pathogens have a signiﬁcantly higher mortality rate. The
factors associated with acquiring pneumonia by a resistant
pathogen were mechanical ventilation, renal failure and sepsis.
P1025
Antimicrobial resistance patterns of Gram-
negative bacteria isolated from intensive care unit
in a Greek hospital
P. Sikalidou, S. Karampa, C. Papadopoulou, G. Kythreotou,
D. Soﬁanou (Thessaloniki, GR)
Objectives: The purpose of our study was to determine the
antimicrobial resistance of gram-negative rods causing
infections in patients from intensive care unit (ICU) of a
tertiary care hospital in northern Greece.
Methods: From January 2004 to December 2004 a total of 1803
clinical specimens from ICU patients were admitted to the
laboratory. All specimens were inoculated onto routine culture
media. The blood cultures were performed using the BacT/Alert
30 automated system. The infections were characterized as
nosocomial according to CDC criteria. Identiﬁcation of
microorganisms and susceptibility testing were performed
using the VITEK 2 automated system (bioMerieux France).
Results: From 1803 clinical specimens, 568 (31.4%) were
positive cultures with one or multiple microorganisms.
Respiratory tract infections were most frequent (28.7%),
followed by bloodstream infections (26.4%), urinary tract
infections (23.4%) and surgical site infections (10%). 464
(81.2%) gram-negative bacteria were responsible for the
infections in ICU. Acinetobacter baumannii were the most
frequently isolated Gram negative species (n = 196; 42.2%),
followed by Pseudomonas aeruginosa (n = 177; 38%), Klebsiella
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
spp.(n = 64;13.8%), Escherichia coli (n = 11;2.4%) , Proteus
mirabilis (n = 10;2.2%), Enterobacter cloacae (n = 7;1.5%).The
resistance rates (%)of gram negative microorganisms are
presented in the table. A total of 58 out of 63 of Klebsiella spp.,
2 / 11 of E. coli and 7 / 10 of P. mirabilis were resistance to third
generation cephalosporins demonstrating an extended spectrum
beta lactamase (ESBL) positive phenotype.
Conclusion: Acinetobacter baumannii were the predominated
pathogen followed by P.aeruginosa. High resistance rates were
observed for all investigated drugs. ESBL production appeared
to be a major mechanism of resistance to beta lactams. Imipenem
appeared to be the most active agent against the majority of
isolates.
P1026
Incidence of methicillin-resistant S. aureus in a
prospective study in critical patients (2002–2004)
P. Palacia´n, A. Rezusta, Y. Martin, J. Castillo,
M. Revillo (Zaragoza, ES)
Objective: To determine clinical features, risk factors and
outcome of infection due to S. aureus in critical patients.
Methods: Study prospective for 3 years period (2002–2004) in
Universitary Miguel Servet Hospital, 313 patients with isolation
of S. aureus from the four units of critical care. The
microbiological studies were carried following the standards
protocols. Epidemiological, clinical characteristics and outcome
were analysed in a posterior exhaustive study.
Results: For a three-year period, 313 patients with isolation of S.
aureus were detected in our study, which represents 4.73% from
the total of patients attended in the critical care units, and we
haven’t observed signiﬁcant changes in our study period. The
isolate rates of methicillin-resistant S. aureus and methicillin
susceptible S. aureuswere 35.46% (n = 111) and 64.64% (n = 202)
respectively. Of all patients whose mean age was 56.73%
(slightly superior in-patients with MRSA isolated: 58.85 versus
54.61) 75.08% (n = 235) were male and 24.92% (n = 78) were
female. 234 patients were prospectively included in a more
exhaustive study. Infection was deﬁned as hospital acquired in
87.61% (n = 235) and community acquired in 12.40% (n = 29).
The most frequent underlying disease were heart disease 25.21%
(n = 59), trauma 24.78% (n = 48), infectious disease 14.10%
(n = 33), neurological disease 13.24% (n = 31) and neoplasm
11.53% (n = 27). Risk factors detected were mechanical
ventilation 77.78% (n = 182), venous central catheter 70.51%
(n = 165), thoracic tube 39.31% (n = 92) and surgery 29.06%
(n = 68). Mortality in-patients with MRSA isolated were 44.88%
versus 55.12% in-patients with methicillin-susceptible S. aureus.
Conclusions: S. aureus is a commonly isolated in critical ill
patients and the knowledge of epidemiological and clinical
characteristics may allow to optimise its management, treatment
to reduce morbidity and mortality in critical care units, so as
prevent the increase of methicillin-resistant S. aureus isolates.
P1027
Screening for MRSA on nasal swabs at
admittance at intensive care units
C. Pina-Vaz, R. Carneiro, M. Espinar, M. Machado-Vaz,
A. Rodrigues (Porto, PT)
Objectives: S. aureus is a well documented nosocomial
pathogen being responsible for serious systemic infections. It
is recommended to perform the screening for MRSA at the
admittance in intensive care units. The traditional search for
MRSA involves the detection of S. aureus and then the
evaluation of the susceptibility proﬁle to oxacilin. This
procedure takes at least 48 h, providing a relatively late
answer to clinicians. CHROMagar MRSA, a chromogenic
medium for isolation of specimens allowing direct
differentiation of Methicillin resistant S. aureus by colony
colour. We decided to compare traditional way for searching
MRSA with the use of this cromogenic medium.
Material and methods: 145 nasal swabs were cultured both on
Columbia 5% blood sheep agar (Difco) and on CHROMagar
MRSA medium (BD), incubated for 24 h and 48 h. Colonies
compatible with Staphylococcus on blood agar plate were
submitted to conﬁrmatory tests like catalase and coagulase
test; if positive, a disk diffusion test was performed to evaluate
susceptibility proﬁle to oxaciline. On CHROMagar medium we
looked for mauve colonies that clearly differentiated from other
bacterial species, which result in blue or colourless colonies. The
mauve colonies of methicillin resistant S. aureus were all later
conﬁrmed using classical methodology.
Results: 22 positive cases of nasal carriage of MRSA were
detected using blood agar after 48 h; in a few of them take one
more day was needed to isolate the colonies that were mixed
with gram negative bacilli. Nine additional more positive cases
were detected on CHROMagar MRSA medium (all conﬁrmed
by classic identiﬁcation methods) after 24 h.
Conclusions: Regarding the detection of MRSA, CHROMagar
MRSA culture showed a sensitive method, giving reliable and
faster results, in comparison with conventional medium, thus
allowing tremendous savings of labour and time.
P1028
Genotypic characterisation and epidemiologic
analysis of vancomycin-resistant enterococci
isolated from patients in intensive care unit
A. Lambiase, M. Del Pezzo, F. Rossano (Naples, IT)
In the past decade there has been a rapid rise in the number of
serious nosocomial infections caused by enterococci resistant to
multiple antibiotics. Enterococci with high-level gentamicin
resistance became a major concern beginning in the 1980s.
Subsequently, ampicillin-resistant enterococci, including both
b-lactamase-producing and no-producing strains, have been
isolated in many hospitals. In recent years, glycopeptide-
resistant enterococci have been reported in both European and
North American hospitals. In Italy, the problem of VRE
(vancomycin-resistant-enterococci) is emerging and it presents
therapeutic problems.
Objectives: The present study describes the molecular
characterization of clinical isolates of VR-Enterococcus faecium,
obtained from patients in an Intensive Care Unit (ICU) of
Naples.
Materials and methods: Over 2-years period (January 2003–
December 2004), 26 isolated of VR-E. faecium was examined
(resistance to vancomycin and teicoplanin was determined by a
standard dilution micro method in accordance with NCCLS
guideline). All strains were obtained from several biological
samples, including urine, blood, catheters, respiratory samples
of ICU patients. Van genotypes (Van-A, Van-B, Van-C) were
determined by using PCR. Therefore, isolates were typed by
pulsed ﬁeld gel electrophoresis (PFGE) with SmaI as restriction
enzyme.
Results: Our study demonstrated a prevalence of genotype
Van-A (20/26 strains; 77%); other strains were Van-B genotypes
(23%). Analysis by PFGE and a comparison of SmaI banding
proﬁles showed 25 isolated belonged to unique PFGE groups
(group A; patterns A1–A14, different in two to three band,
accorded with Tenover’s criteria) and one strains belonged to
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
unique PFGE proﬁle (strain B). The unique strain B and group A
ﬁve strains were Van-B genotype.
Conclusions: Presence of VR-E.faecium was related to risk
factors, as immunosuppression, organ recipient status, and
exposure to antibiotics. Results of our study suggest that the
intrahospital spread of VR-E. faecium can occur. Knowledge of
their epidemiology is essential for the control of further spread.
Use of CHEF electrophoresis might be helpful to clinicians to
initiate effective infection control measures to contain the spread
of this organism.
Gastro-intestinal and hepatic infections
P1029
Norovirus as a cause of acute gastroenteritis in
Northern Greece: detection with IDEIA and
RT-PCR
S. Mitka, A. Ifantidou, S. Sotiriadis, D. Karabaxoglou,
A. Kansouzidou (Thessaloniki, GR)
Objectives: Noroviruses (NVs) are identiﬁed as an important
cause of gastroenteritis in humans. These viruses are also the
leading cause of food borne or waterborne outbreaks of
infectious intestinal diseases. Genogroup II (GII) and I (GI) are
associated with human infection. The virus is transmitted
through contaminated food or water, directly from person to
person or by contact with contaminated surfaces. The aim of this
study was the investigation of NVs as cause of acute
nonbacterial gastroenteritis in Northern Greece.
Methods: A total of 141 faecal specimens from patients (111
children and 30 adults, 79 males and 62 females) with acute
gastroenteritis were studied. The major criterion for the choice of
the samples was the initial exclusion of the bacterial nature of
the disease. For the detection of NVs antigen in all faecal
specimens an IDEIATM test (DakoCytomation) was performed.
This test utilizes GI and GII speciﬁc monoclonal antibodies in a
solid-phase sandwich enzyme immunoassay for the detection of
GI and GII NVs. Specimens that were found to be positive with
the IDEIATM test (N = 23) were examined for the presence of
NVs RNA by RT-PCR using three different pairs of primers. The
RNA extraction was performed by Qiagen spin columns
technique (QIA amp RNA kit). The viral RNA from the
specimens was ampliﬁed using two pairs of primers of the
RNA polymerase gene (PCR A, PCR B) and one pair located
near the 3’ end of the genome (PCR C).
Results: Faecal specimens from 23 patients (19/111 children, 4/
30 adults) were found positive with IDEIATM test (13 for GI, 9
for GII and 1 for GI and GII) representing 16.3% of the total
specimens. PCR A showed positive result in 20 out of 23
specimen, PCR B in 17 and PCR C in 11 (9 specimens were
positive with all three PCR’s, 8 specimens were positive with
PCR A and B, 2 specimens were positive with PCR A and C and
1 specimen was positive only with PCR A).
Conclusion: The present ﬁndings showed that NVs are a
frequent cause of acute nonbacterial gastroenteritis in
Northern Greece. To our knowledge, this is the ﬁrst reported
study to have investigated the NVs as a cause of gastroenteritis
in Greece. Results obtained suggest a seasonal distribution of the
disease, whereas there are no signiﬁcant differences among
ages. PCR A was the most sensitive of the three PCR’s applied.
P1030
Epidemiology and molecular analysis of
norovirus outbreaks in Ireland
S. Kelly, B. Foley, S. Coughlan, L. Dunford, H. O’Neill, B. Smyth,
P. McKeown, M. Lynch (Dublin, Belfast, IE)
This study set out to describe the epidemiology of norovirus
outbreaks in the island of Ireland, over a one-year period. The
study commenced on 01/10/04. Epidemiological data from
outbreaks was collected in an electronic database, which was
established for this project. A link for the sharing of epidemi-
ological and virological data was established leading to an
enhanced data set. Samples from outbreaks in the Republic of
Ireland were sent to the National Virus Reference Laboratory in
University College Dublin for conﬁrmation of the diagnosis by
RT-PCR (Reverse Transcription Polymerase Chain Reaction).
Due to enhance surveillance during the study period there was a
high rate of submission of samples. In the North of Ireland,
samples were sent to the Regional Virus Reference Laboratory at
the Royal Victoria Hospital in Belfast where a nested PCR was
used for diagnosis of norovirus. Sequencing was carried out on
the PCR products to determine the circulating strains of
norovirus in Ireland. Over a one-year period, 153 norovirus
outbreaks were reported in the Republic of Ireland. In the North
of Ireland, over the same period, 73 outbreaks of norovirus
infection were reported to the Regional Virus Reference Labor-
atory. Results so far indicate that the majority of reported
outbreaks in the island of Ireland are associated with hospitals
and residential institutions. In the Republic of Ireland the
noroviruses associated with the majority of outbreaks were a
new variant of Genogroup II.4, known as the JAM strain. A
small number of noroviruses associated with outbreaks in the
Republic of Ireland belonged to Genogroup II.2. The database
will be used as a source of data for the Food borne Viruses in
Europe Network. Safefood-the Food Safety Promotion Board
funded this research.
P1031
Emergence of Vibrio cholerae O1 biotype EL Tor,
serotype Inaba during last summer outbreak in
Iran
M. Rahbar, R. Sabourian, M. Saremi, M. Abbasi, H. Masoumi
Asl, M. Soroush (Tehran, IR)
Objectives: Cholera is an endemic disease in Iran. The aim of
this study was to determine epidemiology and antimicrobial
susceptibility patterns of Vibrio cholerae O1 biotype EL Tor
serotype Inabe, which were isolated in recent outbreak in Iran.
Methods: Stool samples were collected from patients suspected
to have cholera admitted to hospitals and clinics. Specimens
examined by conventional bacteriological methods. All isolates
were sent to cholera reference laboratory for conﬁrmation,
stereotyping and susceptibility testing. Antimicrobial
susceptibility testing was performed by disk diffusion
methods as recommended by NCCLS, The antimicrobial drugs
included Ampicillin (AM), Ciproﬂoxacin (CI), Co-trimoxazole
(SXT), Tetracycline (TC), Erythromycin (EM), Nalidixic acid
(NA) and Furazolidone (F). The E-test MIC method used for
detection of minimal inhibitory concentration (MIC) for
co-trimoxazole, nalidixic acid and erythromycin.
Results: In total 1118 patients diagnosed clinically and
laboratory conﬁrmation to have cholera, disease reported from
twenty-six provinces. The majority of cases were from Tehran
Qum andHamadanwith 219, 190 and150 cases respectively. 50%
of patients were between 15–34 years old. 53% of patients were
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male and 47% female, 97.7 % of patients had Iranian nationality,
2.3% from Afghanistan and, 0.3% from Pakistan. 20% of patients
were hospitalised and 80% were outpatients. Case fatality rate
was 1%. 1104 isolates were Inaba serotype and only 14 cases were
ogawa serotype. Our studies revealed that the origin of Vibrio
cholerae was consumption raw vegetable that watered by swage.
We also isolated V. cholerae from swages. All isolates were
resistant to co-trimoxazole, nalidixic acid, furazolidone,
and intermediate to chloramphenicole. All isolates were
susceptible to tetracycline, ciproﬂoxacin, and erythromycin.
MIC for cotrimoxazole and nalidixic acid were 256 lg/ml and
1.5 lg/ml for erythromycin. The antimicrobial results showed
that all isolates had the same susceptibility patterns.
Conclusion: Our study reveals that in recent outbreak caused
by V. cholerae EL Tor serotype Inaba. All isolates were resistant
to co-trimoxazole, nalidix acid and furazolidone
P1032
National surveillance of Campylobacter
infections and resistance in the Netherlands; an
overview 2000–2004
B.C. van Hees, M.J. Veldman-Ariesen, B.M. de Jongh,
M. Tersmette, W. van Pelt (Nieuwegein, Bilthoven, NL)
Objectives: Campylobacter is the most frequent cause of bacterial
gastroenteritis worldwide. We describe epidemiological features
of culture-proven Campylobacter infections in the Netherlands
over the years 2000–2004.
Methods: Data from two ongoing projects for surveillance of
infectious diseases in the Netherlands were used, covering 3-
and 8 million inhabitants respectively. Incidence and resistance
rates were analysed over time, by region, by level of
urbanization, for seasonal variation and for recent travel history.
Results: The incidence of culture-proven Campylobacter
infections showed an incidental decrease in the year 2003, in
time related to an avian ﬂu outbreak in poultry. Patients in age
group 60 + were tested most frequently, but found positive in
only 3%. Age group 15–29 years had the highest percentage of
positive cultures (12%). The incidence of Campylobacter
infections was highest in the southern part of the Netherlands;
55.7 per 100.000 in the south versus an average of
39.1 per 100.000 in the other parts of the Netherlands. The
incidence was much lower in the rural than the urban areas.
High stable rates of resistance were observed for
ﬂuoroquinolones (35%). Resistance to erythromycin was low
but increasing over the years. Highest resistance rates to
erythromycine were found in the south of the Netherlands.
Resistance rates increased with increasing urbanization level.
An inverse relation was observed between the incidence of
infection (high in summer, low in winter) and resistance to both
ﬂuoroquinolones and macrolides (relatively high rates during
winter). Resistance to predominantly ﬂuoroquinolones was
considerably higher in travel- related infections (54%), as
compared to endemic ones (33%).
Conclusion: We found regional differences in incidence and
resistance rates, both being highest in the south of the
Netherlands. Furthermore we found an inverse relationship
between resistance rates to ﬂuoroquinolones and macrolides
and the incidence of campylobacteriosis. An explanation could
be that during winter months poultry is the most important
source for Campylobacter infections, while during summer
isolates from other sources associated with a low rate of
ﬂuoroquinolone resistance become more important. The high
resistance rates to ﬂuoroquinolones warrant reconsideration of
its use as drug of ﬁrst choice in the empiric treatment of
presumed Campylobacter infections.
P1033
The epidemiology and clinical presentation of
hydatid cyst disease in patients in Imam, Sina,
Shariati and paediatric medical centre hospitals
between 1372 and 1382
Z. Abdi Liae, A. Soudbakhsh, M. Solemani, K. Kiyani (Tehran,
IR)
Background: Hydatid disease is a zeonotic disease and the
most serious disease in human. It’s an important hygienic
problem in any area of the world. It’s endemic in Iran, because
it’s possible for parasite to continue its life cycle. So it must be in
the differential diagnosis list of any patient with cystic lesion.
Methods: We reviewed the epidemiology and clinical
presentation of 300 patients that admitted and treated in the
Imam, Sina, Shariati and Paediatric medical centre hospitals
because of hydatic disease.
Results:
• The disease involves person in the 3rd and 4th decade.
• There is not any sex preference.
• Householder women are the most patient group.
• Most patient’s live in the city.
• The most common involved organ is liver and then lung.
• In liver the right lobe is involved more than left lobe.
• In lung the left lower lobe is involved more than the others.
• Kidney, CNS, bone, heart, spleen are other organ that
involved rarely.
• Laboratory changes are not meaningful but in some patients
eosinophilia may be helpful for diagnosis.
• In our patient’s and in this research CT scan was the most
useful modality for diagnosis.
• The other helpful diagnosis options are hydatid serology (IFA)
• Surgery was therapeutic choice for most patients.
• Disease had same seasonal distribution and no time
preference was seen.
• The infection of the cyst was the most common complication.
Conclusion: Hydatidosis has a low mortality rate but because
of the chronicity of the disease it has a high morbidity rate. So
it’s important to diagnose it early and treat it as soon as possible.
For this reason in any patient with symptoms and signs that rise
or suspicion to space occupying lesion, hydatidosis must be one
of the major disease we think about and rule it out or prove it
with appropriate modality.
P1034
Echinococcus granulosus: lethal effect of low
voltage direct electric current on hydatid cyst
protoscoleces
R. Ghasemikhah, H. Ghasemikhah, M. Sharbatkhory (Tehran,
IR)
Objectives: We have studied a small-scale method for killing
hydatid cyst protoscoleces using low voltage direct electric
current.
Methods: After collecting hydatid cysts from infected organs of
slaughtered animals, protoscoleces were cultured in four
different media: hydatid cyst ﬂuid, RPMI, normal saline, and
Tris buffer, respectively. Protoscoleces from each of the above
media were then transferred to an electrolysis device through
which different electric current densities were applied. For
measuring the survival rate of protoscoleces, ﬂame cell
movement and eosin staining was used.
Results: The results show that the survival rate of protoscoleces
in hydatid ﬂuid was dependent on the electric current density
and the time of the applied current. Current densities of
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
62.5 mA/cm2 (11 V), 53.71 mA/cm2 (10 V), and 18.18 mA/cm2
(5 V) after 1, 2, and 3 min, respectively, killed all the parasites in
the hydatid ﬂuid.
Conclusion: However, a current density of 7 mA/cm2 (9 V) in
RPMI medium after 3 min was most effective.
P1035
Single and multiple pyogenic liver abscesses:
aetiology, clinical course and treatment
F. Mateos, I. Terrancle, G. Peralta, L. Fuentes, J. Pe´rez-Arellano,
F. Amoros, R. Serrano, M.P. Geijo, I. Ta´rraga, M. Rguez-Martı´n,
B. Rguez-Martı´n, J. Blanch, E. Martı´nez-Alfaro for the Infectious
Diseases Group of the Spanish Society for Internal
Medicine (SEMI)
Objectives: The aim of the present study was to evaluate the
differences in etiology, in clinical course and treatment of
patients with single and multiple pyogenic liver abscesses (PLA)
Methods: Multicenter and retrospective review of the PLA
diagnosticated in eight Spanish hospitals from January 1997 to
December 2003. Cases were included if the abscess was
conﬁrmed by imaging as well as by either documentation of
an organism recovered from the abscess site or resolution of
symptoms and signs after treatment. Statistical analysis was
performed with the SPSS software package.
Results: A total of 175 patients with PLA were managed: 117 of
them presented a single abscess (SA) and 58 had multiple
abscesses (MA). The median age was 66 ± 1.2 SEM, and males
were the most affected (65%). Hepatomegaly was more frequent
in MA (p < 0.05). Serum levels of alkaline phosphatase
(p = 0.05) and the neutrophils count (p = 0.007) were
signiﬁcantly higher in patients with MA than in those with a
SA. SA was usually larger than 6 cm, and MA were smaller than
6 cm. SA was located on the right side of the liver in 119 (68.4%)
cases and MA were located on the right side in 28 cases (48%).
SA had a cryptogenic origin in 48 cases (41.3%) and MA had a
biliary origin in 27 cases (47%). The responsible microorganism
was identiﬁed in 80 cases (68.3%) of the patients with SA and in
30 cases (52%) of the patients with MA, (OR 1.98; Chi-Square
p = 0.05). Eschericia coli was the most common etiological agent
identiﬁed in cultures of blood and abscess aspirates in PLA.
Percutaneous drenaige and antibiotic therapy were the most
used treatments in both types of abscesses. The abscess related
morbidity rate was higher in MA (28, 48%). The overall
mortality was higher in SA (8; 13.8%) than in MA (10; 8.6%).
Conclusions: These results suggest that MA had a biliary
origin, showing hepatomegaly, neutrophillia and rise of the
alkaline phosphatase as their clinical presentation most
frequently than SA. Microbiological identiﬁcation was higher
in patients with MA than in patients with SA.
P1036
Comparison of pyogenic liver abscess caused by
non-Escherichia coli and E. coli
F. Mateos, I. Terrancle, G. Peralta, L. Fuentes, R. Serrano,
V. Navarro, M. Herna´ndez, B. Roca, F. Marcos, I. Ta´rraga,
A. Herna´ndez-Belmonte, E. Martı´nez-Alfaro for the Infectious
Diseases Group of the Spanish Society for Internal Medicine
(SEMI)
Objectives: The aim of the present study was to compare
pyogenic liver abscess (PLA) caused by non-Escherichia coli and
Escherichia coli.
Methods: Multicenter and retrospective review of the PLA
diagnosed and treated in eight Spanish Hospitals from January
1997 to December 2003. Cases were included if the abscess was
conﬁrmed by imaging as well as by either documentation of an
organism recovered from the abscess site or resolution of
symptoms and signs after treatment. Statistical analysis was
performed with the SPSS software package.
Results: A total of 175 patients with PLA were managed.
Escherichia coli was the species most commonly isolated in
cultures of blood and abscess aspirates: abscesses caused by
Escherichia coli accounted for 26% (43) of the cases in which an
organism was recovered. There was no difference in the
epidemiological characteristics, duration of fever after
admission, initial laboratory value and duration of antibiotic
therapy. Mean age and female gender were higher in Escherichia
coli s PLA (RR 2.45, CI 95% = 1121 to 5384). The most commonly
identiﬁed underlying cause was biliary disease. The recovery of
Escherichia coli guided to biliary origin [(RR 4.331 (CI 95% = 1916
and 9789)]. When comparing the size of Escherichia coli versus
other causes of PLA, Escherichia coli PLA was greater than non-
Escherichia coli abscesses (p = 0.008), and difference of diameter
average of 1858 cm (CI 95% = 0505 and 3212). They were both
most frequently located on the right lobe. There was no
correlation between the microbiological ﬁndings and the
presence of a solitary or multiple abscesses. The therapeutic
modality (percutaneous drenaige and antibiotic therapy) carried
out in two groups was not signiﬁcantly different, neither were
hospital stay, and morbidity and mortality rates.
Conclusion: These results suggest that PLA cause by Escherichia
coli comprise a disease of biliary origin, higher age, female
gender. Escherichia coli PLA was greater than non-Escherichia coli
abscesses
P1037
Diabetes mellitus as a risk and prognostic factor
for pyogenic liver abscess in Denmark
R.W. Thomsen, P. Jepsen, H.T. Sørensen (Aalborg, Aarhus, DK)
Objectives: Pyogenic liver abscess (PLA) is a rare but life-
threatening disease with rising incidence rates reported from the
United States and Europe. In Taiwan, diabetes mellitus has
emerged as an overwhelming risk factor for PLA, whereas
epidemiologic studies on diabetes as a risk factor for PLA in
Western populations are sparse.
Methods: We examined diabetes as a risk factor and prognostic
factor for PLA in Denmark during a 26-year period, using a
large nationwide data set based on administrative registries. We
identiﬁed all patients with a diagnosis of PLA in the National
Registry of Patients, and randomly selected ﬁfty gender- and
age-matched population controls for each case. We used
conditional logistic regression to estimate odds ratios (ORs) for
PLA according to diabetes, adjusted for medical and surgical
risk factors. Among patients with PLA, we compared adjusted
mortality odds ratios in diabetic and other patients.
Results: The study included 1448 patients with a ﬁrst
hospitalisation with PLA between 1977 and 2003. The median
age (range) was 65 (0–97) years, and 54% were men. A total of
11.1% of the patients with PLA had diabetes recorded before or
on the matching date, compared with 2.5% of control subjects.
After adjustment for potential confounding factors, the OR for
PLA in persons with diabetes was 4.0 (95% CI: 3.3–4.8). At
30 days after discharge, the mortality was 24.8% for diabetic
patients and 18.0% for non-diabetic patients with PLA. The
adjusted mortality odds ratio in diabetic patients was 1.3 (95%
CI: 1.0–1.9).
Conclusion: In this nationwide study, we found a fourfold
increased risk and a poorer outcome of PLA associated with
diabetes mellitus.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
P1038
Bacteraemia is a poor prognostic factor in
spontaneous bacterial peritonitis
J.H. Cho, W.B. Park, H.B. Kim, N.J. Kim, M-D. Oh,
K.W. Choe (Seoul, KR)
Objective: Spontaneous bacterial peritonitis (SBP) is a major
complication of liver cirrhosis. There are few data about
prognostic signiﬁcance of bacteremia in patients with SBP. So
we performed a retrospective study to determine the inﬂuence
of bacteremia on the mortality of patients with SBP.
Methods: All patients with SBP, in whom the microorganism
was isolated from ascites and/or blood, were identiﬁed by
retrospective review of clinical and laboratory records in Seoul
National University Hospital in Korea from January 2002 to
December 2004. They were classiﬁed into the bacteremic group
and non-bacteremic group. The underlying liver function was
determined by MELD (Model for End-stage Liver disease) score.
Microbiologic response rate, ascites polymorphonuclear
leukocyte count reduction rate, and SBP-related mortality were
compared between the two groups. To identify the independent
risk factors of mortality, a multiple logistic regression model
was used to control for the effects of confounding variables.
Results: A total of 203 patients were enrolled in this study.
Among 203 patients, 116 (57.1%) were bacteremic, and 87
(42.9%) non-bacteremic. Escherichia coli was the most common
etiologic organism, followed by Klebsiella pneumoniae. The
distribution of etiologic organisms was not different between
the two groups. Stratiﬁed MELD scores showed no signiﬁcant
difference between the two groups. Microbiologic response rate
(64.7% versus 74.7%, p > 0.05), and ascites polymorphonuclear
leukocyte count reduction rate (34.3% versus 43.3%, p > 0.05)
were not different between bacteremic and non-bacteremic
group. But SBP-related mortality of bacteremic groups was
signiﬁcantly higher than that of non-bacteremic group (31%
versus 8%, p < 0.001).Bacteremia (OR, 5.8; 95% CI. 1.9–16.9;
p < 0.01) and MELD score (OR, 2.4; 95% CI. 1.1–5.1; p = 0.017)
were independent risk factors in multiple logistic regression
analyses of SBP related mortality.




Aetiology of lower respiratory tract infections
among primary care patients of family physicians
in Silesian province in the 2000–2005 period
I. Szymczyk, W. Lukas, J. Skorupka, J. Jo´zwiak (Zabrze, PL)
Objective: Etiological analysis of sputum culture regarding
seasonal ﬂuctuations in family practitioners’ patients.
Methods: The study group included both primary care (207)
and clinically diagnosed patients (50) who had their sputum
examination ordered and then performed in Silesian Analytic
Laboratories in the2000–05 period. All subjects were registered
in the family practise or hospitalised in the Silesian area. The
including criteria were active infections of lower respiratory
tract. The intake, transport and ﬁnal identiﬁcation of the
material complied with laboratory standards.
Results: Number of positive cultures of all sputum samples
taken from both primary care and hospitalised patients
accounted for 77% and 68%, respectively. The most common
pathogens of primary care patients were, in order of prevalence
(excluding Streptococcus viridans): Moraxella catarrhalis (57%),
E.coli 21%, Staph.aureus 11%, Klebs.pneumoniae 10%, Pseud.
Aeruginosa 6%, Proteus mirabilis 4%. In clinically diagnosed
patients these were: Moraxella catarrhalis 33%, Klebs. pneum. 22%,
E coli 19%, Pseudomonas aeruginosa 19%, Staph.aureus 11%, Str.
spp. 11%, Str. pneumonicae 7%. As for any seasonal ﬂuctuations
among primary care patients the higher number of positive
samples was noted in April and October (15%), the least in June,
July and August (3%).The results of our detailed analysis of
primary care samples showed the higher percentage ofMoraxella
catarrhalis strains in Dec. (77%) and Jan.(75%) and the least in
May (20%). In the other months it ranged from 50 to 60%. The
higher percentage of E.coli isolates (70%) was observed in May,
while in Mar., Jun. and Dec. they were absent. As for
Staphylococcus aureus the most frequent detection was stated in
Mar. and Dec.27% and 31%, respectively), whereas they did not
emerge in summer months (from June to Sep.). The higher
emergence of Pseudomonas aeruginosa was observed in June
(20%) while Klebs. pneumoniae isolates tested positively mainly
during the spring and summer period (10–20%).
Conclusions: 1. Because of preference of empirical therapy in
the diagnostic procedures, examination of the sputum is seldom
ordered by family physicians. 2. Moraxella catarrhalis isolates
were the most common pathogen isolated from material of
subjects with lower respiratory tract infections and tended to be
more prevalent in winter months. 3. Obtained data may be
useful in family practise when selecting the optimal treatment
for lower respiratory tract infections.
P1040
Chronic exposure to smoking is not a risk factor
for community-acquired pneumonia in the
elderly population
Y.K. Cho, B.J. Park, H. Kim, N-K. Choi, S-M. Lee (Incheon, Seoul,
KR)
Objectives: The relationship between cigarette smoking and the
risk of community-acquired pneumonia (CAP) in elderly people
remains controversial. Age and gender matched case-control
study to analyse the association between cigarette smoking and
the risk of hospitalised CAP in elderly people was performed.
Methods: The eligible cohort (n = 15,049) is derived from
Korean Elderly Pharmacoepidemiology Cohort (n = 46,113) that
is population-based dynamic cohort. The cohort members were
over 65 years of age, living in Busan Metropolitan City between
1993 and 1998, and beneﬁciaries of Korean Medical Insurance
Corporation (KMIC). The information on smoking status, alcohol
consumption, past-medical history, height, weight, performance
status, and other daily life related variables at their age of 65 years
were collected by self-administered mailed questionnaire.
Potential cases (n = 260) of hospitalised CAP, were collected
from the KMIC medical claims database between January 1, 1993
and December 31, 2000. The incident cases of hospitalised CAP
(n = 83) were conﬁrmed through the medical records. Four
controls were matched to each case randomly using age, gender,
and year of questionnaire survey (n = 332). Adjusted odds ratios
(aOR) were calculated from conditional logistic regression
analysis after adjusting for the confounding effect of smoking,
alcohol consumption, body mass index (BMI), performance
status, and underlying lung or cerebrovascular disease.
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Results: The median age of case patients is 76 years and 33 of 83
(40%) patients are male. Underlying lung disease (aOR, 7.17;
95% CI, 2.78–18.50) and alcohol ex-drinker (aOR, 5.83; 95% CI,
1.36–24.95) by the age of 65 years was associated with higher
risk of hospitalised CAP. Smoking, total amount of cigarette
smoking, and duration of smoking by the age of 65 years were
not signiﬁcantly related to the risk of hospitalised CAP. The
other factors, including performance status, BMI, other
underlying diseases, were not associated with the risk of
hospitalised CAP.
Conclusion: Underlying lung disease and alcohol ex-drinker by
the age of 65 years can be the independent risk factors for
hospitalised CAP in elderly people in later period. The chronic
previous exposure to smoking, however, is not a risk factor of
hospitalised CAP in the same people. These suggest chronic
respiratory damage due to cigarette smoking might not
inﬂuence on the occurrence of acute lower respiratory tract
infection in the community environment.
P1041
Antibiotic resistance patterns among respiratory
pathogens isolated during 2003–2005 at a Turkish
tertiary hospital
Z. Gu¨lay, H. O¨zkul (Izmir, TR)
Objective: To evaluate the current epidemiology of resistance
among Streptococcus pneumoniae (Sp), Haemophilus inﬂuenzae (Hi)
and Moraxella catarrhalis (Mc) in Izmir, Turkey.
Methods: Trends in resistance were investigated retrospectively
in a total of 185 Sp, 169 Hi and 58 Mc, which were isolated
between January 2003 and September 2005. Antibiotic
susceptibility tests were performed according to the NCCLS
(CLSI) recommendations.
Results and Conclusion: The overall rate of resistance to
penicillin (P) was 31% among Sp isolates. Intermediate
resistance, which was 29 % in 2003 and 28.3 in 2004, increased
to 37.8% in 2005. A similar trend was also observed for high level
P resistance (7, 6 and 14.3 % in 2003, 2004 and 2005 respectively).
Although it can be as high as 44.4% among pen I/R isolates,
overall resistance to erythromycin was 15.1% with minimal
variation for different periods of time. MLSb tpe resistance was
dominant among ER isolates as shown both by phenotypic tests
andPZR.No resistance to levoﬂoxacinwas detected.All of theMc
isolates were susceptible to amoxy-clav (AMC), ﬂuoroquinolones
and cefaclor. A small increment in b-lactamase positivity was
seen over the years (78% in 2003 to 93% in 2005). Hi isolates were
also universally sensitive to 2nd and 3rd gen cephalosporins and
AMC with b-lactamase production ranging from nil (2003) to 4.3
% (2005). On the other hand, trimetoprim-sulfamethoxazole
(SXT) resistance was high among all species. There is still a low
rate of resistance to commonly used antibiotics among
respiratory pathogens but an increase in resistance to penicillin
was noted in Sp and to SXT in all three species.
P1042
Differences between Bedouin and Jewish
population in clinical characteristics of patients
admitted with community-acquired pneumonia
V. Novack, L. Avnon, K. Riesenberg, F. Schlaeffer (Beer Sheva,
IL)
Objectives: Ethnic groups have different inherent risk factors
for contracting community-acquired pneumonia (CAP). In
Southern Israel (population: 985,000) two ethnic groups live
side by side: predominantly urban Jewish population and a
population of Arab Bedouins (population: 144,000–14.3%) who
are in social transition from being desert nomads to a settled
lifestyle.The objective of the study was to evaluate the
differences in characteristics and outcome of CAP between
these two populations for patients hospitalised during one
winter season.
Methods: We conducted a hospital based prospective
observational study. Soroka University Medical Centre is a
1200 bed tertiary care hospital, which serves as the only regional
hospital for Southern Israel. During a 4-months period we
assessed clinical as well as demographic characteristics of all
patients hospitalised with CAP.
Results: 262 patients were enrolled, of whom 58 (22.1%) were
Bedouins. Bedouin patients were younger than the rest of the
cohort (60.0 ± 20 vs. 66 ± 17 years, p = 0.05) and had lower rates
of cardio-vascular diseases such as ischemic heart disease and
cerebro-vascular disease (20.7% vs. 39.2%, p = 0.02). Bedouins
had higher smoking rates (39.7% vs. 19.1%, p = 0.001), higher
prevalence of COPD (31.0% vs. 9.3%, p = 0.001) and diabetes
(41.4 vs. 25.0%, p = 0.01). There was no difference between
pneumonia patients outcomes research team (PORT) scores of
Bedouin and Jewish population at admission (median 83 points
vs. 85 points, p = 0.61). Bedouin patients had lower rate of pre-
hospitalisation antibiotics therapy compared to the rest (12.1%
vs. 25.5%, p = 0.03). There were no differences in the length of
hospitalisation (median 4 days, p = 0.8) or 30-day mortality rate
between Bedouin and Jewish patients (3.4% vs. 8.8%, p = 0.26).
Conclusions: There were a number of differences in clinical
characteristics between Bedouin and Jewish patients admitted to
the hospital with CAP. Higher smoking and COPD rates in
Bedouin patients may affect the microbiology of the CAP
pathogens and this should be taken into consideration when
therapeutic decisions are made. Despite socio-economic
differences between the two ethnic groups, there was no
difference in severity of CAP and clinical outcomes.
P1043
Prognostic impact of haematological and
non-haematological malignancies on mortality of
hospitalised pneumonia: a Danish
population-based cohort study
M. Nørgaard, A. Riis, R.W. Thomsen, H.C. Schønheyder,
H.T. Sørensen (Aalborg, Aarhus, DK)
Objectives: To examine mortality of hospitalised pneumonia
within 90 days of follow-up among patients with haematological
and non-haematological malignancies.
Methods: We conducted a population-based cohort study in
three Danish counties (population 1.4 million). Through the
regional hospital discharge registries we identiﬁed all adults
(‡ 15 years) with a ﬁrst-time hospital discharge diagnosis of
pneumonia between 1999 and 2003 (n = 41 793). We
furthermore obtained information on previous discharge
diagnoses including haematological and non-haematological
malignancies. The patients were followed for mortality through
the Danish Civil Registration System. We estimated mortality
ratio (MRR) using Cox regression analysis with adjustment for
calendar year, age, gender, and co-morbidity.
Results: Among 41 793 patients hospitalised with pneumonia
423 (1%) had a haematological malignancy and 3138 (8%) had a
non-haematological malignancy diagnosed prior to
hospitalisation with pneumonia. Another 87 patients had both
a haematological and a non-haematological malignancy.
Cumulative 90-day mortality following pneumonia in patients
without any malignancy was 21% vs. 31% in patients with
haematological malignancies and 34% in patients with non-
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haematological malignancies. Compared with patients without
any malignancy the adjusted 90-day MRR was 1.6 (95% CI 1.4–
2.0) for patients with haematological malignancies and 1.5 (95%
CI 1.4–1.6) for patients with non-haematological malignancies.
Conclusion: Among patients with a ﬁrst-time hospitalisation
with pneumonia both haematological and non-haematological
malignancies are associated with substantially increased 90-day
mortality.
P1044
Outbreak of three related cases of psittacosis
detected by real-time PCR
B.M. de Jongh, J.A. Kaan, A.J. Meinders, J.J. Mager,
E.J. van Hannen (Nieuwegein, NL)
Objectives: Psittacosis can be a life threatening zoonosis caused
by an infection with the obligate intracellular microorganism
Chlamydophila psittaci. Although the majority of these patients
presents with typical symptoms like abrupt onset of fever,
rigors, sweats, prominent headache, and couch, about 18 percent
do not show any respiratory symptoms. Culture is difﬁcult and
time consuming. Isolates of C. psittaci are highly infectious and
the isolates should be handled under bio-safety level 3
conditions. Molecular techniques like real time PCR are
therefore ideal alternatives for the detection of C. psittaci to aid
the diagnosis of psittacosis.
Methods: We developed an internally controlled real time PCR
system that targeted the ribosomal intergenic spacer of C.
psittaci. The PCR assay was validated on a set of clinical samples
from serologically conﬁrmed patients with psittacosis and
controls.
Results: Using this PCR system we detected an outbreak of
psittacosis among members of a veterinary unit. One of these
members was admitted to ICU because of multi organ failure.
Conclusion: With a new developed real-time PCR for C. psittaci
we were able to identify three patients with psittacosis related to
a common source. The symptoms of the patients varied from
mild to severe. This real-time PCR for C psittaci enables the
diagnosis of psittacosis in prior clinical undetected cases.
P1045
Audit of sputum samples before and after a
national smoking ban
J. Fennell, B. Cryan, G. Corcoran (Cork, IE)
Objectives: Smoking is associated with increased morbidity
and mortality from cancer and cardiovascular disease. Smoking
is also associated with infections such as TB, exacerbations of
COPD and meningococcal disease. In March 2004, Ireland
became the 1st nation to enforce a universal smoking ban in the
workplace. This provided a unique opportunity to assess
whether the change in population smoking practice affected
the number of respiratory tract infections and the epidemiology
of respiratory pathogens. This would help to show if the
smoking ban provided any shorter-term beneﬁts other than the
predicted long-term beneﬁts in cancer and cardiovascular
disease, and may suggest if a reduction in smoking protects
against any speciﬁc pathogens.
Methods: Cork University Hospital is a tertiary referral centre
serving a population of 500 000. Samples are evenly divided
between inpatient and GP samples. Sputum samples for culture
and sensitivity from June 2002–March 2005 (22 months before
and 12 months after the imposition of the smoking ban) were
examined. Information on smoking patterns was provided by
the Ofﬁce of Tobacco Control. Sputum samples, tracheal
aspirates and bronchial washings were processed using
standard accredited laboratory methods and results logged
into an APEX (iSoft) database, queried using Cognos database
analysis software and analysed using Excel (Microsoft). Results
from children under 18 and further positives from each patient
were discarded. The monthly totals and the number of positive
samples for Streptococci pneumoniae, Staphylococcus aureus,
Haemophilus inﬂuenzae and Moraxella catarrhalis were assessed
and analysed.
Results: 34342 samples were processed of which 19855 (58%)
were positive. The number of positive samples was 5764 (60%)
from June 02–March 03, 7020 (56.4%) from April 03–March 04
and 7071 (57.6%) from April 04–March 05. The monthly means
of the number of selected species before and after the smoking
ban are shown below:
Conclusion: The smoking ban was associated with substantial
changes in the prevalence of certain bacteria, notably
S. pneumoniae for which the changes in the community were
mirrored by an opposing change in the hospital sputa results.
Further work is required to see if these changes were reﬂected in
the mortality and morbidity from respiratory tract infections
during this period and to explain the apparent inverse
relationship between the changes in community and hospital
specimens of S. pneumoniae.
P1046
Prognostic factors in patients with pneumococcal
bacteraemia in a county teaching hospital, Spain
G. Peralta, E. Lopez, J. Pelayo, M.P. Roiz, I. De Benito, C. Farin˜as,
M.B. Sanchez, J.C. Garrido (Torrelavega, ES)
Objectives: Despite medical advances pneumococcal
bacteremia has an important mortality with prognostic factors
that have been addressed in several studies. However most of
these data are provided by studies developed in University
hospitals, with a high incidence of co morbidity, and the
prognostic factors were obtained by a univariate analysis.
Methods: All cases of S. pneumoniae bacteremia detected from
January 1996 to June 2005 were identiﬁed using the
microbiology laboratory database. A standardized data
collection form was used to review the hospital records. In
statistical analyses, Student’s t test was used for the comparison
of mean values and chi square test and Fisher’s exact test for the
comparison of categorical data (two tailed). A stepwise logistic
regression analysis with a progressive conditional incorporation
of variables was performed for multivariable analysis.
Results: Of the 115 cases of bacteremia detected in the study
period, 14 (12.2%) died. All of the pneumococcal bacteremias
were community acquired. In a univariate analysis, factors
associated with mortality were: age (63.3 ± 18.5 yr among
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survival vs. 76.9 ± 11.2 yr among who died), duration of illness
at admission (3.2 ± 3.6 days vs. 2.2 ± 1.4 days), the absence of
fever (6.9% vs. 35.7%), the absence of chills (63.4% vs. 92.9%), the
presence of severe sepsis or shock (7.9% vs. 28.6%) and the
presence of bilateral pneumonia (9.2% vs. 42.9%). In the
multivariable analysis factors associated with mortality were:
the presence of bilateral pneumonia (OR: 12.7, IC95%: 2.4–66.4,
p = 0.003, and the absence of fever (OR: 7.3, IC95%: 1.4–36.9,
p = 0.02). The duration of illness at admission (OR: 1.5; IC95%:
0.99–2.3, p = 0.053) reached statistical borderline signiﬁcance.
Conclusions: Among our patients with pneumococcal
bacteremia, mortality is low. The duration of illness at
admission, the presence of bilateral pneumonia, and the
absence of fever are prognostic factors.
P1047
Ambulatory treatment with telithromycin versus
clarithromycin of community-acquired
pneumonia in Spain
B. Puchades (Valencia, ES)
Objectives: To assess the efﬁcacy and safety of telithromycin
versus clarithromycin in the ambulatory treatment of
community-acquired pneumonia in patients not requiring
hospitalisation.
Patients and Methods: 192 outpatients with Fine I or II
community-acquired pneumonia were randomised to receive
telithromycin 800 mg od for 7 days (95 patients) or
clarithromycin 500 mg bid for 10 days (97 patients). Patients
requiring admission to hospital were not included. Visits were
performed during and post-treatment. Final evaluation was
performed 17–24 days after inclusion in the study. Failure was
considered when one of the following conditions was present:
persistence or progression of CAP sign/symptoms or X-ray,
death, severe adverse events precluding treatment compliance
or the need of a different antimicrobial agent.
Results: Patients were in a range of 18–73 years of age, with 101
male and 91 female patients. A signiﬁcant difference (p < 0.05)
in success rate of 9.1% (95%CI 0.1, 18.2) between treatments was
found in the ﬁnal clinical assessment (92.6% with telithromycin
versus 83.5% with clarithromycin). Failure rates were 6.3% with
telithromycin and 12.4% with clarithromycin. Distribution of the
12 failures with clarithromycin was asymmetric, 50% of them in
the ﬁrst 48 h. Of the 6 telithromycin failures, only 2 occurred in
the ﬁrst 48 h. No differences were found with respect to
frequency or severity of adverse events between both study
drugs.
Conclusions: Telithromycin for 7 days showed higher efﬁcacy
than clarithromycin for 10 days in the empirical ambulatory
treatment of Fine I and II community-acquired pneumonia in
Spain, where there is a need to cover atypical pneumonia in
addition to penicillin/macrolide resistant pneumococci. Both
drugs were equally well tolerated.
P1048
Comparative assessment of levoﬂoxacin and
macrolides in acute exacerbation of chronic
bronchitis: clinical efﬁcacy and symptom-free
intervals
L. Dvoretsky, N. Dubrovskaya, S. Yakovlev, S.A. Grudinina,
O.Y. Filimonova, S. Sidorenko (Moscow, RU)
Objectives: Comparative clinical studies usually show similar
clinical effectiveness of different antibiotics in acute
exacerbation of chronic bronchitis (AECB). At the same time
the most important outcome of AECB therapy is the length and
full value of the disease remission. In connection with this it
seems useful to estimate the inﬂuence of antibiotics on the long-
term prognosis for patients with AECB, i.e. the length of
symptom-free period after disease exacerbation.
Methods: It was the open randomised comparative study.
Patients with AECB who had at least three exacerbations per
year were included into the study. One group of patients with
AECB were treated by levoﬂoxacin (LFX) 500 mg per day
during 5 days and the other group-by macrolide antibiotic
(azithromycin or clarithromycin) during 5 to 7 days. After the
treatment the patients were followed up for 12 months.
Results: A total of 49 patients with AECB were included into
the study, 29 of which were treated by LFX, and 20-by macrolide
antibiotic. The average age of the patients was correspondingly
58.7 and 57.2 years, length of chronic bronchitis-15.4 and
11.1 years. Number of AECB in previous year was similar in
both groups. Clinical cure rate estimated at 30 days after the end
of treatment was 96.6% for LFX and 90.0% for macrolides. The
eradication rate of causative microorganisms (Haemophilus
inﬂuenzae was the main pathogen) was correspondingly 100
and 30%. The regression rate of main symptoms of exacerbation
(cough, dyspnoea, sputum volume) was higher during LFX
therapy. During the follow-up period of 12 months the
incidence of AECB (requiring prescription of antibiotics) was
53.6% in the group of patients who were prescribed LFX, and
88.9% in the group of patients who were treated by macrolide
antibiotics (P < 0.05). Average length of symptom-free period
after LFX and macrolide treatment was correspondingly
289 ± 90 and 165 ± 112 days (P < 0.01).
Conclusion: LFX was superior to macrolides in long-term
prognosis in AECB and prolongs the symptom-free period.
P1049
Lower respiratory tract infections caused by
Haemophilus inﬂuenzae
D. Kofteridis, D. Alegakis, G. Chrysofakis, T. Anastasopoulos,
A. Repa, S. Maraki , G. Samonis (Heraklion Crete, GR)
Purpose: The description of the clinical features of lower
respiratory tract infection (LRTI) caused by Haemophilus
inﬂuenzae among hospitalised patients.
Materials and Methods: The medical records of hospitalised
adults patients with H. inﬂuenzae LRTI during a 7 year period
(1996 to 2002) were retrospectively reviewed using a
standardized questionnaire.
Results: Thirty-four men (76%) and 11 women (24%) were
identiﬁed suffering of H. inﬂuenzae LRTI. Their median age was
68 (range 28–86 years). The majority of patients had smoking
history (38; 84%) as well as an underlying condition. Chronic
obstructive pulmonary disease in 26 (58%) was the most
frequent. In 34 patients (76%) the infection manifestated as
pneumonia. Among them 9 (26%) had lobar, and 22 (49%)
segmental opaciﬁcation in the chest x-ray. Pleural effusion
accompanying parenchymal lesions was observed in 7 patients
(15.6%). All patients were treated empirically with antibiotics.
Based on the results of the sputum cultures the regimens were
proven appropriate in 40 patients (89%). Thirty-six H. inﬂuenzae
isolates (84%) were resistant to amoxycillin, 15 (34%) to
co-amoxiclav and 3 (7%) to ciproﬂoxacin. In forty out of the 45
patients (89%) the infection had a favourable outcome. All ﬁve
patients who died had pneumonia with respiratory failure and a
severe underlying condition.
Conclusions: LRTIs due to H. inﬂuenzae occurs in populations
with underlying disease. A high rate of amoxycillin resistance
and an alarming increase of resistance to other antibiotics used
were observed.
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P1050
Outcomes and diagnostic workups for patients
with community-acquired pneumonia according
to Pneumonia Severity Index categories: results of
a large single-year series
E. Pe´rez-Trallero, A.M. Martı´n-Sa´nchez, R. Dal-Re´,
J.E. Martı´n-Herrero, J. Garau, F. Baquero on behalf of the NACER
Group
Objectives: To assess variations in outcomes in patients
hospitalised with community-acquired pneumonia (CAP)
according to Pneumonia Severity Index (PSI) categories.
Methods: Retrospective review of the charts of patients
admitted to the hospital with the diagnosis of CAP over a 1-
year period (1Nov01 to 31Oct01) in 10 geographically scattered
hospitals in Spain. To our knowledge this is the largest single-
year series in Spain, and one of the largest in the world (if not
the largest) when adjusted by population.
Results: Overall 3233 patients with CAP were initially included
in the study. PSI score were properly recorded in only 1722
(53.3%) patients. The proportion of pre-treatment blood cultures
was higher among patients in low-risk classes (I–III) than it was
for those patients in high-risk classes (IV–V) (52.4% vs. 45.2%;
P < 0.01), whereas the proportion of blood cultures with a
positive result was lower in the former group (9.4% vs. 14.1%;
P = 0.03). Signiﬁcant differences between both classes were also
observed in the proportion of other diagnostic techniques
applied, such as sputum cultures (52.4% vs. 38.7%; P < 0.01),
Legionella urinary antigen assay (49.0% vs. 32.0%; P < 0.01) and
pneumococcal urinary antigen assay (38.5% vs. 26.3%; P < 0.01).
Outcomes according to PSI categories are shown in the Table.
Conclusions: - All diagnostic workups were performed more
frequently in low-risk patients than in high-risk patients.- In
spite of ATS and IDSA guidelines recommending to carry out a
Legionella urinary antigen in severe CAP, in our study this test
was performed more frequently in low-risk patients (32.0% vs.
49.0%; P < 0.0001).- These results suggest that in severe cases
antibacterial therapy was prioritised to microbiology and/or
that the wider bacterial spectrum covered by empirical therapy
provided the physician with a lower need to obtain etiological
diagnoses.
P1051
Factors inﬂuencing length of hospital stay in a
large, single-year series of community-acquired
pneumonia
E. Pe´rez-Trallero, F. Baquero, C. Garcı´a-Rey, J.E. Martı´n-Herrero,
A.M. Martı´n-Sa´nchez, J. Garau on behalf of the NACER Group
Objectives: To identify variables associated with length of
hospital stay (LOS) in patients with community-acquired
pneumonia (CAP) who were discharged from hospital
Methods: Retrospective review of the charts of patients
admitted to the hospital with the diagnosis of CAP over a
1-year period (1Nov01 to 31Oct01) in 10 geographically scattered
hospitals in Spain. Data were available from 3233 patients.
Patients who died were removed from the analysis. Multivariate
Cox regression analysis was performed to assess factors
independently associated with more prolonged LOS.
Results: Overall mean LOS was 11.5 days (95%CI: 11.2 to 11.8),
with a median 9 days (Q25: 7 days; Q75: 14 days). Range 1 to
111 days. Ninety-six point two patients stayed £ 28 days. The
site-speciﬁc mean LOS ranged from 7.7 to 16.0 days. The Table
shows the results obtained for the different variables assessed.
Conclusions: - Admission to ICU, positive blood cultures,
hypoxia, multilobar X-ray involvement, age ‡ 65, absence of
fever, comorbidities and alcohol abuse (all of them know criteria
of severity) increased signiﬁcantly LOS.
- Neither empirical antibiotic choice as by IDSA/ATS guide-
lines, etiological diagnosis, nursing-home stay nor active smoker
had an insigniﬁcant inﬂuence in LOS of those who survived.-
Likewise, hospital centre was an independent factor associated
to LOS. Variations among centres suggest an increase in medical
care costs in hospitals with the largest LOS.
- The identiﬁcation of factors that increase LOS in patients with
CAP and especially those that are not attributable to differences
in patient’s characteristics, if opportunely modiﬁed could mean
an important saving
P1052
Physicians’ attitude towards guidelines and on
choice of regimen for respiratory infections
T.A. Peppas, O. Kosmopoulou, I. Binikos, I. Skoura, I.F. Hager,
S.I. Pappas, N. Galanakis (Piraeus, GR)
Objective: To assess physicians beliefs on respiratory tract
infections guidelines (G) and whether they affect their choice of
regimen.
Methods: At four different staff meetings of hospital based
physicians (HBP) and two educational meetings of community
practicing physicians (CPP) a question regarding their attitude
towards G and their choice of regimen on scenario of pneumonia
(HBP) and pharyngitis and of non-admission warranted
pneumonia (CPP) was collected. Anonymity was achieved by
ballot voting (HBP) and interactive reply system (CPP). Regimen
choices were checked for concordance with major (IDSA, BTS,
Hellenic IDS) G applicable on data collection date.
Results: Atotal of 57HBPand127CPP replieswere collected and
analyzed. An overall favourable attitude towards G was stated
withHBP declaring always (12%) and frequently (76%) following
G. The respective rates for CPP were 15 and 64%. The analysis of
selected regimens, however, displayed some discrepancy to the
statement as only 49% of HBP choice for pneumonia were
concordant with current G. Penicillin for a scenario of
streptococcal pharyngitis was chosen by 39% of CPP, while
their choice for pneumoniawas concordant to G at 59% of replies.
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Conclusions: Physicians tend to express an overall favourable
attitude towards guidelines, but their choice of regimen reﬂects
either a superﬁcial G knowledge, or limited acceptance
according to their own beliefs or preferences.
P1053
Inﬂuence of aetiologic diagnosis on mortality in
hospitalised patients with community-acquired
pneumonia: results of a large single-year series
J. Garau, F. Baquero, E. Pe´rez-Trallero, J.L. Pe´rez,
A.M. Martı´n-Sa´nchez, C. Garcı´a-Rey on behalf of the NACER
Group
Objectives: To identify variables inﬂuencing early and late mor-
tality in patients with community-acquired pneumonia (CAP).
Methods: Retrospective review of the charts of patients
admitted to the hospital with the diagnosis of CAP over a 1-
year period (1 Nov 01 to 31 Oct 01) in 10 geographically
scattered hospitals in Spain. Data were available from 3233
patients. Multivariate logistic regression analysis was performed
to assess factors independently associated with early (within
2 days) and late (> 2 days) mortality.
Results: Overall 280 (8.7% mortality) subjects admitted to
hospital for CAP died. By day 28 there were 269 deceased
subjects, what represented 96.1% of the total mortality of the
series. The site-speciﬁc mortality rate ranged from 1.1 to 19.7%.
Results are shown in Table.
Conclusions: Admission to ICU, multilobar X-ray involvement
and age ‡ 65 y were independently associated with both early
and late mortality. In contrast, empirical treatment choice as by
IDSA/ATS guidelines, fever, etiologic diagnosis and active
smoking were associated with lower late mortality whereas a
positive blood culture and the presence of comorbidities were
associated with increased late mortality. Hypoxia and residence
in a nursing home were associated with early mortality. In our
series, setting the etiologic diagnosis was an independent
protector factor of late mortality, but not of early mortality.
P1054
Echo-guided management of complicated
parapneumonic effusion in children
C.Y. Chiu, K.S. Wong, Y.C. Huang, T.Y. Lin (Taoyuan, TW)
Objective: The optimal management of parapneumonic
effusions (PPE) and empyema in children remains
controversial; currently there is insufﬁcient evidence to give
clear guidance on therapy. The aims of this study were to
delineate the biochemical characteristics and to examine the
effect of different therapeutic strategies on ultrasound staging of
PPE.
Methods: A retrospective chart reviewed at a tertiary pediatric
referred center from July 2000 to July 2004. Patients with
pneumococcal pneumonia who had complicated
parapneumonic effusion or empyema underwent real-time
chest sonography and thoracentesis for biochemical analysis
were included. The ultrasonic appearances were classiﬁed
according to the deposition of ﬁbrin or formation of ﬁbrin
septations. The staging of ultrasonic appearances of PPE was
used to correlate with the hematologic and biochemical
variables of pleural effusion. Clinical outcomes of the
respective therapeutic strategies on various stage of PPE were
also analysed.
Results: A total of eighty-one patients were enrolled in the
present study. Chest ultrasound was performed and results
were stratiﬁed into anechoic ﬂuid (stage 1, n = 23), with ﬂoating
ﬁbrin strands (stage 2, n = 30) and with septated ﬁbrin (stage 3,
n = 28). The mean days of fever elapsed before detection of
these stages appeared to be higher with advanced stages
(p = 0.03). Univariate analysis revealed that WBC, platelet
count in hemogram and pH, glucose, LDH, protein in pleural
effusion were signiﬁcantly associated with the stage of PPE.
Further multivariate analysis revealed that pH (£ 7.2) and
protein (‡ 4.1 mg/dL) in pleural ﬂuid were two independent
predicting factors for the progression of PPE. Trends in rate of
successful tube drainage decreased as the advancement of stages
of PPE, especially in patients who had initial chest tube drainage
(p = 0.001). Total duration of fever and hospital stay was
signiﬁcantly shorter for those children who had initial video-
assisted thoracic surgery (VATS) compared to those who had
initial chest tube drainage (p < 0.001).
Conclusions: Chest sonography can well discriminate the
progressive stages of bacterial PPE. In children with a
progressive PPE with ﬁbrin formation, early aggressive tube
drainage may avoid a subsequent surgical intervention. In
children with a ﬁbrin septated PPE, an initial VATS is
recommended to shorten the duration of fever and hospital
stay.
P1055
Real-life treatment of acute exacerbation of
chronic bronchitis-moxiﬂoxacin compared to
macrolides
T. Schaberg, M. Mo¨ller, T. File, K. Stauch, H. Landen (Rotenburg,
Hanau, DE; Akron, US; Leverkusen, DE)
Objectives: To compare real-life treatment of acute
exacerbation of chronic bronchitis (AECB) using moxiﬂoxacin
(MXF) tablets or different p.o. macrolides (MCLs) in terms of
symptom relief, time until improvement/cure and overall
efﬁcacy and tolerability.
Methods: This prospective, non-interventional multicentre
study included outpatients with a diagnosis of AECB and a
MCL therapy of their last AECB. The current AECB was either
treated with MFX tablets or a MCL p.o. The decision about the
drug prescribed as well as the dose and duration of therapy was
up to the attending physician. Documentation comprised
patient characteristics, disease and treatment history, the
course of the current AECB treated with MFX or MCL as well
as a ﬁnal assessment of efﬁcacy and tolerability.
Results: In total 1750 patients were included in the analysis, 904
patients were treated with MXF and 846 with a MCL [42.6%
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clarithromycin (CCR), 31.2% roxithromycin (ROX), 26.2%
azithromycin (AZM)]. Patient characteristics did not differ
markedly between the two treatment groups (MXF: mean age
of 57.4 years, mean BMI of 26.6 kg/m2, 27.7% current smokers;
MCL: mean age 56.4 years, mean BMI 26.7 kg/m2, 29.8% current
smokers). About 70% of patients had at least one concomitant
disease, mostly cardiovascular (MXF group 50.9%, MCL group
45.4%). About 40% of patients in both groups suffered from
chronic bronchitis for 1 to 5 years, about 27% for > 5 to 10 years.
The mean number of AECBs in the last 12 months was 2.7 and
2.6, respectively. In most MXF patients treatment was applied
for 5 (43.8%) or 7 days (42.4%). Main therapy regimens in MCL
patients: CCR 500 mg for 4–7 days, ROX 300 mg for 6–7 days,
AZM 500 mg for 3 days. Symptom relief in both groups at last
follow-up is shown in the ﬁgure. Mean duration until overall
improvement and cure of AECB was 3.2 days (SD 1.5) and
6.2 days (SD 2.6) in MXF patients compared to 4.4 days (SD 1.8)
and 7.5 days (SD 3.0) in MCL patients. 8 MXF patients (0.9%)
showed no improvement at all vs. 37 MCL patients (4.4%). 19
MXF patients (2.1%) vs. 86 MCL patients (10.2%) had no
recovery. Physicians assessed overall efﬁcacy/tolerability as
very good or good in 96.1%/98.1% of MXF patients and 67.5%/
91.7% of MCL patients. Both treatment groups showed a similar
good safety.
Conclusions: These results of AECB therapy under real-life
treatment conditions conﬁrm the superiority of moxiﬂoxacin
versus macrolides with a faster symptom relief and higher
recovery rates.
P1056
Bulgarian Surveillance Tracking Antimicrobial
Resistance – BulSTAR: community-acquired
pneumonia: 2004
T. Velinov, M. Petrov, A. Bachvarova, T. Kantardjiev (Soﬁa, BG)
BulSTAR is a National longitudinal surveillance system monit-
oring the isolation and antimicrobial susceptibility of more
important clinically signiﬁcant microorganisms from blood
cultures, cerebrospinal ﬂuid, upper and lower respiratory
tract, urine and wound samples in the participating microbio-
logy laboratories. One hundred and three microbiology labor-
atories – 23 public, 53 hospital and 27 private laboratories from
all 28 counties of the Republic of Bulgaria participated in
BulSTAR 2004. Data on community-acquired pneumonia are
based on 3305 outpatients’ lower respiratory tract samples.
Participating laboratories used the Clinical and Laboratory
Standards Institute (CLSI) methodology. The number of clinic-
ally signiﬁcant isolates is 700. Among them the leading patho-
gen is Streptococcus pneumoniae – 39.1%, followed by
Staphylococcus aureus – 20.9%, Klebsiella pneumoniae – 13.3%,
Moraxella catarrhalis – 3.9% and Haemophilus inﬂuenzae – 1.7%. In
2004 the prevalence of penicillin non-susceptible Streptococcus
pneumoniae was 31.5%, the resistance to erythromycin – 23.8%
and to levoﬂoxacin – 0%. The number of methicillin-resistant
Staphylococcus aureus was 11.6%. Among gram-negative bacteria
the sensitivity to most frequently used antibiotics is moderate.
P1057
Clinical manifestations of complicated
pneumococcal pneumonia
M.H. Tsai, T.Y. Lin, Y.C. Huang, C.H. Chiu (Keelung, Taoyuan,
TW)
Streptococcus pneumoniae is the most common cause of bacterial
pneumonia in children. During the past several years, the
frequency of children with pneumococcal pneumonia compli-
cated by necrosis or empyema is increasing. This study was
undertaken to evaluate the clinical characteristics of children
with pneumococcal pneumonia, especially those with compli-
cated pneumonitis. Hospitalized children with the diagnosis of
pneumococcal pneumonia from January 2002 to October 2004
were enrolled. Patients fulﬁlled at least one of the evidences of
S.pneumoniae infection: culture (blood or pleural ﬂuid) yielded
S.pneumoniae or a positive result of the detection of antigens in
the pleural ﬂuid. Complicated pneumonia was deﬁned by the
presence of pleural ﬂuid parameters consistent with empyema,
and/or CT images compatible with necrotizing pneumonitis.
Fifty-two patients were eligible in this study. 53.8% were female
and the mean age was 46.0 months. Fever and cough were the
most common symptoms. Signiﬁcantly high CRP (‡100 mg/L)
was found in 88.5% of patients. Of the 52 cases, 40 suffered from
complicated pneumonia. In the analysis of clinical characteris-
tics, the occurrence of complicated pneumonia was associated
with longer duration of fever, length of hospitalization, and
longer time to defervescence after antibiotics treatment. No
signiﬁcant difference was noted except CRP in laboratory
ﬁndings between patients with and without complications.
MIC test showed that there was no signiﬁcant difference
regarding the rate of penicillin non-susceptibility between the
2 groups of isolates. Most patients (92.3%) with complicated
pneumonia were empirically treated with third-generation
cephalosporins or high-dose penicillin and then the regimens
were adjusted according to the patients’clinical response.
Besides, in cases with complicated pneumonia, managements
including decortication. endotracheal tube intubation, and
intensive care in PICU were performed in 32.5%,10% and
27.5% of them, respectively. No fatal cases were noted in our
series. In conclusion, children with complicated pneumococcal
pneumonia may have prolonged course of hospitalization,
febrile duration, or longer time to defeverence after antibiotics
treatment. Antibiotics-resistant S.pneumoniae were not more
commonly isolates in patients with complicated diseases. The
clinical outcome appears to correlate with the patient’s clinical
presentation than the susceptibility of the pneumococcus.
P1058
Elderly patients hospitalised with community-
acquired pneumonia. Validation and comparative
evaluation of a prognostic rule
F. Alcazar, A. Plata, A. Villalobos, I. Perez de Pedro,
S. Santamaria, B. Sobrino, L. Valiente,
M.A. Garcia-Ordon˜ez (Malaga, ES)
Objectives: To identify prognostic factors of CAP in elderly
patients, to generate a discriminating rule to predict hospital
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mortality, to validate and evaluate comparative with widely
used prognostic index for CAP in general population.
Methods: 809 elderly patients admitted with CAP were
selected. Multivariable analyses of derivation cohort (n = 343)
identiﬁed factors associated with hospital mortality. A
predictive model of mortality was established and tested in a
validation cohort (n = 476). Our predictive rule was compared
with others prognostic indicators for CAP (American Thoracic
Society, British Thoracic Society and Pneumonia Patient
Outcomes Research Team).
Results: Hospital mortality rates in the derivation and
validation cohorts were similar (14.3% vs. 15.5%). The
identiﬁed prognostic factors were (odds ratio; 95% conﬁdence
interval): bilateral radiographic inﬁltrate (5.2; 2–13.2), a blood
urea nitrogen of more than 7 mmol/l (4.3; 1.9–9.4), absence of
fever (4.2; 1.9–9.2), a respiratory rate of 30/min or more (4.1; 1.9–
9.1), confusion (3.7; 1.6–8.5) and shock (2.8; 1.1–7.2). The
discriminating rule to predict hospital mortality comprising
three or more of these factors was 94.5% speciﬁc, with negative
predictive value of 92.2% and had a greater overall accuracy
(88.7%) than others general prognostic index (ATS: 44.1%; BTS:
83.2%; PORT: 71.8%; p < 0.05) in the validation cohort.
Conclusions: This simple discriminating rule incorporating the
prognostic factors identiﬁed is powerful predictor of hospital
mortality. Widely accepted prognostic indicators for CAP could
be not adequate in elderly patients.
P1059
Heart failure and mortality within 90 days after
hospitalised pneumonia: a population-based
cohort study
R.W. Thomsen, N. Kasatpibal, A. Riis, M. Nørgaard,
H.T. Sørensen (Aalborg, DK; Chiang Mai, TH; Aarhus, DK)
Objectives: To examine the prognostic impact of heart failure
on 90 day mortality in hospitalized pneumonia.
Methods: During 1994–2003 we conducted a population-based
cohort study in the three Danish counties of North Jutland,
Aarhus and Viborg. All adults hospitalized with a ﬁrst-time
diagnosis of pneumonia were identiﬁed in hospital discharge
registries and categorized according to whether or not they had
a previous discharge diagnosis of heart failure. Through the
Danish Civil Registration System we retrieved information
about mortality. Information about potential confounders was
obtained from the hospital discharge registries and population-
based prescription databases. We used Cox regression analysis
to compare 90-day mortality rates in patients with and without
heart failure, adjusted for calendar year, gender, age,
comorbidity, alcohol-related disorders, preadmission antibiotic
and immunosuppressive drug use.
Results: The study included 41,793 adults with a ﬁrst-time
hospitalization with pneumonia. Of these, 3824 (9.2%) had a
diagnosis of heart failure. The overall 90 day mortality was
21.9%, increasing to 34.2% in patients with heart failure. The
adjusted 90-day mortality rate ratio (MRR) from pneumonia in
heart failure patients compared with non-heart failure patients
was 1.24 (95% CI: 1.17–1.32). The adjusted MMR increased from
1.07 (95% CI: 0.82–1.38) among heart failure patients receiving
thiazide-based regimens to 1.49 (95% CI: 1.32–1.68) among heart
failure patients receiving loop-diuretic-based regimens
including spironolactone treatment. Adjusted MRRs from
pneumonia were furthermore higher for heart failure patients
with a diagnosis of heart valve disease (1.64, 95% CI: 1.28–2.11)
than for heart failure patients with atrial ﬁbrillation (1.34, 95%
CI: 1.19–1.51) or previous myocardial infarction (1.06, 95%: CI
0.93–1.22).
Conclusion: Among patients hospitalized with pneumonia,
heart failure appears to be associated with increased 90-day
mortality. Elevated severity of heart failure may be associated
with worse pneumonia outcome.
P1060
Rising incidence and persistently high mortality
of hospitalised pneumonia: a 10-year population-
based study in Denmark
R.W. Thomsen, A. Riis, M. Nørgaard, J. Jacobsen, S. Christensen,
C.J. McDonald, H.T. Sørensen (Aalborg, Aarhus, DK; Indianapolis,
US)
Objectives: Little is known about temporal trends in the
incidence and mortality of pneumonia in the general
population. We conducted a population-based cohort study in
three Danish counties (population 1.4 million) to examine
changes in the incidence and 30- and 90-day mortality
associated with hospitalized pneumonia between 1994 and 2004.
Methods: All adults hospitalized with a ﬁrst-time diagnosis of
pneumonia (n = 41,793) were identiﬁed in hospital discharge
registries and followed for mortality through the Danish Civil
Registry System. We determined age-standardized incidence
rates and adjusted mortality rates associated with calendar year,
gender, age, and comorbidity.
Results: Between 1994 and 2003, the incidence of hospitalized
pneumonia among adults increased from 288 per 100,000
person-years to 442 per 100,000 person-years, equivalent to an
age-standardized incidence rate ratio of 1.50. The cumulative
mortality within 30 and 90 days of admission was 15.2% and
21.9%, respectively, ranging from a 90-day mortality of 2.5% in
patients aged 15–39 years to 34.7% in those aged 80 and over.
Advanced age was the most important poor prognostic factor,
followed by a high comorbidity score and male gender. The
adjusted mortality rate ratios among patients with hospitalized
pneumonia in 1999–2004, as compared with 1994–1998, were
0.89 (95% CI 0.85–0.94) after 30 days and 0.91 (95% CI 0.88–0.95)
after 90 days.
Conclusion: The incidence of hospitalized pneumonia in
Denmark has increased considerably during the last 10 years
and, combined with persistently high mortality rates, is of
clinical and public health concern.
P1061
Once daily sequential intravenous/oral (IV/PO)
moxiﬂoxacin is equivalent to IV ceftriaxone plus
twice daily IV/PO levoﬂoxacin in the treatment of
severe community-acquired pneumonia requiring
hospitalisation: the MOTIV study
A. Torres, R. Read, H. Lode, J. Carlet, J.H. Winter, J. Garau,
T. Welte, P. Arvis, M.-A. Le Berre, S.H. Choudhri (Barcelona, ES;
Shefﬁeld, UK; Berlin, DE; Paris, FR; Dundee, UK; Hannover, DE;
Puteaux, FR; West Haven, US)
Objectives: To determine the efﬁcacy and safety of once daily
400 mg sequential IV/PO moxiﬂoxacin (MXF) vs high dose
ceftriaxone (CTX) plus high dose levoﬂoxacin (LFX) in the
treatment of patients with severe community-acquired
pneumonia (CAP) requiring hospitalization and parenteral
treatment.
Patients and methods: This prospective, randomized,
multicentre, multinational, third-party blind, double-dummy
trial compared the efﬁcacy and safety of IV/PO MXF 400 mg
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OD for 7–14 days, to IV CTX 2 g OD plus IV LFX 500 mg BID,
followed by oral LFX 500 mg BID for 7–14 days (LFX dose
adjusted for renal function). Patients were stratiﬁed to either
Pneumonia Severity Index (PSI) Class III (£ 50% of population)
or Classes IV-V. The primary endpoint was clinical cure at test of
cure (4–14 days after ﬁnal dose).
Results: 748 subjects were enrolled, and 738 were randomized
(MXF: 372, CTX/LFX: 366). The primary efﬁcacy per-protocol
(PP) population was 571 (MXF: 293, CTX/LFX: 278) of which 250
(43.8%) had a microbiologically documented infection at
baseline and 337 (59.0%) were PSI Classes IV or V. The
demographic characteristics were similar between PP
treatment groups. Mean age = MXF: 66.1 16.2, CTX/LFX: 64.9
16.7 years; ventilated subjects = MXF: 4.4%, CTX/LFX: 5.4%.
Results are shown in the table. MXF was equivalent to high-dose
CTX/LFX even in patients in PSI classes IV-V. In the safety
population (MXF: 369, CTX/LFX: 364) treatment emergent
adverse events were MXF: 56.4%, CTX/LFX: 53.0%. During IV
treatment these were MXF: 40.1% and CTX/LFX: 42.9%. During
the study 6.8% of MXF and 4.1% of CTX/LFX subjects died
(P = 0.11, NS); no death was considered drug-related by the
investigators.
n, number of subjects with clinical cure or bacteriological suc-
cess; N, total number of subjects.
Conclusions: Once daily 400 mg sequential IV/PO MXF was
shown to be equivalent to high-dose CTX/LFX in the treatment
of severe CAP, even in the most severe PSI IV-V group.
P1062
Antibiotic therapy of acute lower respiratory tract
infections within Slovakia
K. Banasova, H. Hupkova, V. Foltan (Bratislava, SK)
Backgrounds: Acute lower respiratory tract infections (LRTI)
are common condition managed in primary care. Although the
beneﬁt of an antibiotic therapy is questionable, their prescription
is very often.
Objectives: To assess the antibiotic prescription, the assumed
aetiology and antibiotic groups prescribed at LRTIs (acute
bronchitis, super-infection at acute bronchitis, bronchopneumo-
nia, atypical pneumonia).
Methods: Multicentric prescription study at the acute
respiratory tract infections, four weeks in November 2003 in 5
Slovak cities; the same protocols and methodology were
applied. The 66 paediatricians registered patient characteristics
(gender, age, weight), diagnosis, assumed aetiology, antibiotic
therapy, who prescribed antibiotic, risk factors of patients
(allergy to penicillin, dysimmunity, chronic respiratory tract
disease, etc.).
Results: During four weeks in November 2003, 2056 patients
suffered from LRTI. The most common were acute bronchitis
(1700 patients; 82.7%), second were super-infection at acute
bronchitis (224 patients; 10.9%), third bronchopneumonia (113
patients; 5.5%) and the less frequent pneumonia (19 patients;
0.9%). The incidence of LRTI varied in age groups. The most risk
age group were patients in pre-school age (480 patients; 23.3%).
Antibiotic treatment was indicated to 1706 patients (83%), the
most for pneumonia and super-infection at ac. bronchitis. At the
therapy of acute bronchitis and at ac. bronchitis super-infection
the co-aminopenicillins were the most indicated antibiotic group
(34.9%; 43.7% respectively). Macrolides were used to treat
bronchopneumonia and pneumonia (42.7%; 83.3%
respectively). GPs conceived mainly bacterial aetiology of
infections. The viral aetiology was assumed at acute bronchitis
in 9.9% case, at pneumonia 5.3%. At bronchopneumonia, they
estimated either viral and bacterial in 40.7% cases.
Conclusions: Although lower respiratory tract infections are
caused mainly by viruses, antibiotic therapy is dominant part of
treatment (82.7%). Cut-down of antibiotic prescription is
possible to accomplish by using in time laboratory
examination to settle speciﬁc etiological agents of infection.
Sexually transmitted diseases
P1063
Sexually transmitted infections in Kosovo
L. Gashi, N. Ramadani, I. Dedushaj, A. Kalaveshi,
I. Humolli (Pristina, CS)
Introduction: Control and prevention of reproductive tract
infections (RTI) and sexually transmitted infections (STI), are a
public health priority all over the world. WHO estimates that
340 million new cases of sexually transmitted infections (STIs)
occur worldwide each year. The epidemiological situation
concerning STIs, HIV, and AIDS in Kosova is uncertain,
characterized by a lack of reliable information on HIV/AIDS/
STI and lack of prevention programs and an increased number
of possible threats including changes in social and economic
situation.
Results: Epidemiological occurrence of RTI/STI in Kosova
during the period 1990–2004 did not present the reality of the
epidemiological situation because of lack of reporting of RTI/
STI cases. It was reported in total 1095 cases. Reporting through
this surveillance system identiﬁed 21 syndromic diagnoses and
9 cases of Neisseria gonorrhea in 2001. As laboratory diagnostics
are extremely limited, it is not possible to state the etiologic
proﬁle or prevalence of STIs. Since 1986 until December 2002, 41
conﬁrmed AIDS cases with 22 deaths were registered in the
Institute of Public Health (IPH) in Pristina, Kosovo. In 2001, 11
AIDS cases were reported; in 2000, six AIDS cases, 4 in 1999 and
between 0 and 3 cases during the previous 12 year period. Two-
thirds of reported cases were males.
Conclusion: A speciﬁc RTI/STI Programme is being
established on March 2003. Gaps were identiﬁed in various
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components of STI prevention and care gnostics are not at
uniform current standards. Providers perceive a lack of privacy
and conﬁdentiality in STI care themselves. Due to limited
supplies and reagents, STI diagnostics is limited. A long-term
plan of data needs is essential to direct program work.
P1064
Determinants of human papilloma virus
infections in HIV-infected women
S. Ribeiro-Ayeh, D. Labeith, U. Frank (Mannheim, Freiburg i.Br.,
DE)
Objective: To investigate the correlation between cervical dys-
plasia and socio-demographic and immunologic determinants
in HIV positive women.
Methods: Women admitted to a University Hospital as in-
patients during the 5-year study period were included in the
study. Data were abstracted from clinical charts. Individuals
were divided into two groups, those with normal (Pap I-II) and
abnormal (Pap III-IV) cervical cytological screening results.
Statistical methods were used to compare socio-demographic
and clinical variables. Analysis was performed using Statistical
Package for Social Sciences (SPSS).
Results: A cohort of 75 women who had tested positive for
human immunodeﬁciency virus (HIV) was included in the
study. The mean age was 33.9 (range 19–56). Fifty-one
individuals (68.0%) originated from Europe, 16 (21.3%) from
Africa and eight (10.7%) from Asia. The overall prevalence of
abnormal cytological smears was 29.5%. During the study
period, 41 (54.7%) presented with normal and 34 (45.3%) with
abnormal smears. Of these 34 women, 27 (79.4%) had cytological
evidence of human papilloma virus infection (HPV). Herpes
simplex virus infection was detected in seven (9.3%) women,
Trichomonas vaginalis and Chlamydia in ﬁve (6.7%) and seven
(9.3%), respectively. When comparing both groups, no
signiﬁcant association was found between socio-demographic
determinants and the presence of dysplasia. However, a
signiﬁcant determinant for HPV infection was
immunosuppression (CD 4 cell count 291 vs 488/ll; viral load
134.679 vs 16.102 RNA copies/ll). Numbers of cytological
changes due to HPV infections occurred more frequently in this
group (cytological evidence of infection 79.4 vs 24.4%;
Condylomata acuminata 29.4 vs 7.3%).
Conclusions: Cervical dysplasia due HPV infections appears to
be highly correlated with the immunosupression in HIV positive
women.
P1065
Infection with HSV in HIV/AIDS patients
L. Manolescu, P. Marinescu, C. Sultana, S. Ruta (Bucharest,
Giurgiu, RO)
Introduction: Reactivation of latent infection remain one of the
main causes of HIV morbidity.
Objective: Prevalence study of herpes virus infection in HIV
positive patients monitored in Giurgiu county.
Methods: We evaluated clinical, virusological and
immunological 370 adolescents HIV positives with mean age
18 ± 5 years during 1996–2004. The HSV diagnostic was made
by immunoﬂuorescence in the Institute of Virology ‘‘St. S.
Nicolau’’. Each episode of herpes infection was treated with
acyclovir, no suppressive therapy was.
Results: The prevalence of herpes virus infection is 56.75%.
98.6% of the patient are HSV-1 infected (facial localisation
87.85% and other localisation 33.2%) and the rest with HSV-2.
50.46% of the patients are treated with different antiretroviral
combinations. During monitorisation 67.5% of the treated
patients and 61.3% of the untreated presented herpes
recurrences (mean 4.2 ± 2.9 vs 3.9 ± 2.7). The recurrences were
more frequent in severe immunosuprest patients (CD4<200),
76.4% vs 57.4%, p = 0.005. Recurrent ratio wasn’t modiﬁed in
patients with a good immune response to therapy. The
recurrences were less frequent in patients with undetectable
viral load, 58.6% vs detectable, 80%, (p = 0.02).
Conclusions: Antiretroviral therapy and immune restoration
do not inﬂuence the rate of herpetic reactivation.
P1066
Prevalence of HIV, hepatitis B and C and syphilis
and risk behaviour among drug users inside and
outside prison
C.J.P.A. Hoebe, H.L.G. Ter Waarbeek, C.W. Rademaker,
A. Smismans (Heerlen, Maastricht, NL)
Objective: The purpose of this study was to evaluate the
potential risk for transmission of bloodborne and sexually
transmitted infections in Dutch prisons. A high proportion of
prisoners in many countries use drugs. Among injecting drug
users (IUD) infections like HIV, hepatitis B virus (HBV),
hepatitis C virus (HCV) are prevalent.
Methods: Drug users were recruited at different assembly
points, such as streetwalkers district, methadon providing
points and homeless shelters. Injecting and non-injecting drug
users were eligible if they used at least one day a week.
Participants were given a face-to-face questionnaire about
sociodemographics, prison history, drug using behaviour and
sexual practice. Serum samples were tested for the following
infection markers: antiHIV, HbsAg, antiHBc, antiHCV and
TPPA. HIV antibodies were conﬁrmed by Westernblot. The
characteristics of the source population were representive for
the regional drug using population: 78% were male, mean age
was 36 years (sd. 7; range 19 to 57), 79% was of Dutch origin,
71% had ever used drugs intravenously, 85% used heroin, 59%
used cocaine, 65% used methadone, 55% used benzodiazepines,
35% recently injected heroin (in the last 6 months) en 20%
recently injected cocain.
Results: We compared two groups: A) 153 participants who
were never imprisoned or only once and B.) 165 drug users who
were imprisoned at least two times (but often many times more).
In group B 10% ever injected drugs while in prison (17/165) and
67% (54/165) recently had sex. Group B differed signiﬁcantly
with higher prevalence of HIV (AntiHIV; 14% vs 4%), hepatitis B
(HbsAg; 7% vs 1%; AntiHBc; 64% vs 43%) and hepatitis C
(AntiHCV; 72% vs 57%) are found. Syphilis (TPPA) does not
signiﬁcantly differ between the two groups, although
prevalences are suggestive in the same direction (3% vs 1%).
In our study population 68% (215/318) recently had sex in the
last 6 months (usually unprotected) and 37% had sex for money
(often without condoms).
Discussion: The high observed in-prison prevalence of viral
infections have consequences for in prison transmission
potential. Transmission of these infections could be prevented
by hepatitis B vaccination among prison populations and prison
staff, needle exchange and condom use. Because of the shortage
of cells in Dutch prisons, the national policy is changed to put
not one prisoner in a cell but two. This policy might create an
additional risk for transmission.
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P1067
Antimicrobial resistance in Neisseria gonorrhoeae
in the northeast Romania
A. Badescu, A. Enache, Z. Petrescu, D. Buiuc (Iasi, RO)
Objectives: The emergence of gonococcal isolates with reduced
susceptibility or resistance to antimicrobial agents is a signiﬁcant
concern in the whole world. This study is aimed to characterize
the current antimicrobial susceptibility/resistance patterns of
N. gonorrhoeae isolates from North-East of Romania.
Methods: From September 2004 to October 2005, a total of 40
isolates of N. gonorrhoeae were collected from 37 male patients
with urethritis and 3 female patients with cervico-vaginitis
attending the Sexually Transmitted Diseases Clinic in Iasi.
Specimens from each patient were inoculated directly onto
Thayer-Martin selective agar and incubated for 24 to 48 h at
35C in a 5% CO2 atmosphere. Identiﬁcation of suspected
colonies was based upon the presence of gram-negative,
oxidase-positive, superoxol-positive diplococci with typical
enzyme patterns. The isolates were also tested for
betalactamase production. The antimicrobial agents tested
were penicillin, tetracycline, ciproﬂoxacin, ceﬁxime, ceftriaxone
and spectinomycin. Susceptibility testing were performed by
agar diffusion method with a GC agar base containing1% Vitox,
according to CLSI recommendations.
Results: Of the 40 tested isolates 31(77.5%) were resistant to
penicillin by betalactamase production, all the betalactamase
negative strains demonstrated intermediate resistance.
Tetracycline resistance was observed in 32 (80%) of isolates
and 5 (12.5%) were intermediate resistant. 52.5% of the strains
were resistant to ciproﬂoxacin with a further 27.5% showing
intermediate resistance. In our study 13 strains (32.5%)
demonstrated triple resistance (penicillin, tetracycline,
ciproﬂoxacin). No isolate was found to be resistant to
ceftriaxone, ceﬁxime or spectinomycin.
Conclusions: Penicillin, tetracycline, and ciproﬂoxacin can no
longer be recommended for the treatment of gonorrhea in our
area; ceftriaxone, ceﬁxime and spectinomycin should be
considered the antimicrobial of choice. Since 32.5% of tested
gonococcal isolates were resistant to three antibiotics, the
monitoring of the resistance to antimicrobial agents in N.
gonorrhoeae must be established in Romania on a permanent
basis in order to adjust standardized treatment regimens.
P1068
Use of polymorphic Treponema pallidum repeat
genes to elucidate syphilis transmission networks
in Amsterdam, Netherlands
S.M. Bruisten, M. Dierdorp, M-E. Kolader, J.S.A. Fennema,
R.A. Coutinho (Amsterdam, NL)
Introduction: Syphilis incidence has increased dramatically in
Amsterdam from 5/100.000 in 1998 to 32/100.000 cases in 2003.
This may be due to increased unsafe sexual behaviour of
homosexual men resulting from a diminished perceived threat
of HIV/AIDS. The TP surface proteins encoded by repeat genes
(Tpr) A to L are polymorphic and involved in partial host
immunity.
Objective: To develop a typing technique for TP to track
syphilis transmission.
Methods: From 2002 to 2004 we studied 199 cases of primary
syphilis (96% men). Swabs of genital lesions were used for TP
PCR diagnostics. Positive isolates were thereafter used for
sequencing analysis of the TprK gene spanning the variable
domains V3-V5. Phylogenetic trees of amino acid sequences
allowed cluster analysis. Structured questionnaires were used in
the Amsterdam STI clinic to collect socio-epidemiological
information, and routine contact tracing was performed.
Results: Four patients had two anatomical locations TP-PCR
positive on one visit, and 2 patients visited the clinic twice
(recidivists) during the study period, resulting in 205 nucleic
acid isolates. In 161 (79%) a single TprK sequence type was
obtained. In the other isolates either TprK PCR was negative or
sequencing implied the presence of at least two TprK types. The
isolates of 3 patients with dual positive lesions revealed identical
sequences, however in one other patient two different TprK
types were found. The isolates of both recidivists also showed
two different TprK genes. Despite the fact that none of the TP-
patients were known sexual partners, we identiﬁed 19 clusters
of identical isolates. Cluster size varied from 2 to 4 patients.
These clusters may reveal links which remained unknown by
classical contact tracing.
Conclusion: Typing the V3 to V5 domains of the TprK gene
shows potential to identify transmission routes for syphilis.
Travel medicine, tropical and parasitic diseases
P1069
Animal-associated injuries and related diseases
among travellers
P. Gautret, P. Gazin, G. Soula, J. Delmont, P. Brouqui, P. Parola,
P. Pandey, D. Kraklau, M. Shaw, G. Brown, J. Torresi,
E. Schwartz for the GeoSentinel Surveillance Network
The aim of the study was to retrospectively review the
epidemiological and clinical features of mammal-associated
injuries in travellers reported to the GeoSentinel Surveillance
Network. Characteristics examined included type of animal,
countries of exposure, provision of rabies post-exposure pro-
phylaxis (PEP), and the occurrence of other related infections.
From May 1997 to May 2005, there were 594 animal-associated
injuries reported to GeoSentinel. There was a female predom-
inance amongst injured travellers (M/F ratio 0.84) and the
average age was 32 years. The predominant regions from where
animal-associated injuries had been reported included Asia
(75.1%), Latin America (8.2%) and Africa (6.1%). The animal
species associated with injuries were known in 300 cases. Dogs
were involved in 61.7% of cases, monkeys in 28%, cats in 8.7%,
humans in 1% and bats and mice in 0.6% with no predominance
of a particular species in the different geographical regions.
Rabies PEP was given in 65% of the cases, however information
for the remaining 35% was missing. There were no reports of
either rabies or tularaemia in any traveller. Cat scratch disease
was reported as a complicating infection in 1.2% of all reports.
Animal-associated injuries accounted for 1.4% of the total
reported health problems in travellers seen after travel and
1.6% in patients seen during travel. The proportionate morbidity
for sustaining an animal bite was higher amongst travellers
visiting Asia (2.1%) compared to Africa (0.9%), Latin America
(0.6%), Australia-New Zealand (0.9%), North America (1.2%)
and West Europe (1.3%) (p = 0.00001). Victims of animal injuries
were younger than the other ill travellers (32 vs. 35 years old,
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
p < 0.0001) and more frequently females (p < 0.04). Finally, the
proportionate morbidity for sustaining an animal bite was
higher (2.2%) in children less than 15 years (p = 0.001). This data
shows that animal-associated injuries are not uncommon
complaints among travellers presenting to GeoSentinel sites.
The highest proportion is recorded in travellers to Asia, mostly
in regions which are endemic for rabies, and this led to a
requirement for PEP. Pre-exposure rabies prophylaxis must be
considered for travel to regions of the world where appropriate
PEP is not available. In addition, the pre-travel consultation
should also include advice regarding animal-associated injuries,
risk of rabies and other associated infection and PEP when
travelling to high-risk regions.
P1070
The use of saliva to soothe blood-sucking
arthropod bites and the transmission of human
herpesvirus 8 (HHV-8)
R. Romano, F. Candura, G. Russo, A. Al Hamdani, L. Ceccherini
Nelli, F. Benvegnu’, V. Ascoli, M. Coluzzi (Rome, Pisa, Padua, IT)
Objectives: The transmission of HHV-8, previously considered
a sexually transmitted virus, sometimes appears strictly related
to the child’s hypersensitivity response to the bite of a blood
feeding arthropod and to the mother’s (or caregiver’s) habits of
attempting to relieve itching and reduce scratching,
contaminating the bite site with infected saliva (Coluzzi et al.
2002; 2003). Saliva seems to play a major role in the viral
transmission and appears to be the reservoir body ﬂuid for
HHV-8 (Taylor et al. 2004). In order to conﬁrm the promoter
arthropod hypothesis we carried out surveys with
questionnaires.
Methods: Two anonymous questionnaires for women in
reproductive age and for students were tested on samples
from three different regions of Italy (Veneto, Tuscany, Latium),
from a region of Palestinian Territories (Gaza strip) and from
Africa (Uganda, Cameroon).
Results: The frequencies in the use of saliva among students
(age 5–13) were not signiﬁcantly different in the three Italian
regions: Tuscany 13% (20/150), Latium 14.6% (49/335), Veneto
12.5% (47/377). In the case of Tuscany the mothers were also
interviewed with closely corresponding results 11.3% (17/150).
For the students the mean frequency of 13.4% (116/862) has
been compared with the frequency recorded in Gaza strip, 6.6%
(6/90) and showed no statistically signiﬁcant differences
(p = 0.069). The relatively low rate recorded in Gaza is rather
surprising since the socio-economic status of that population is
notoriously one of the worst in the Mediterranean area.
However it is important to note that among Palestinians there
is a culture which tends to ‘‘avoid the use of saliva as it is
considered impolite!’’ The frequencies recorded in Italy and
Palestine were compared with those of Uganda, 74.8% (119/
159), showing very high statistically signiﬁcant differences
(p << 0.00001). Similar data were also obtained from the
comparison with preliminary results in Cameroon.
Conclusion: The results obtained with questionnaires are in full
agreement with the known HHV-8 seroprevalences in central
Africa (>50%) and in Mediterranean area (10–30%). The present
HIV epidemics increases enormously the risk of Kaposi’s
Sarcoma (KS) in HHV-8 infected people, thus the reduction of
HHV-8 prevalence might constitute the primary prevention of
thousands of KS cases as one of the most serious complications
of AIDS in terms of suffering of the patients and social costs of
their assistance.
P1071
Prolonged viraemia and viral shedding of
hepatitis E virus in a traveller with fulminant
hepatitis
M. Riffelmann, I. Greiffendorf, M. Roggendorf, W. Jilg (Krefeld,
Essen, Regensburg, DE)
Background: Hepatitis E is generally regarded as a self-limiting
and relatively mild disease in non-pregnant travellers. The
disease is thought to be at least in part a zoonosis, because one
source of transmission may be uncooked meat from wild
animals. Fulminant cases have very rarely been reported from
non pregnant patients in non-endemic areas such as Japan.
Case report: A 32-year old paediatrician, who travelled with her
33-year old husband and her 36-year old sister for three weeks to
Cashmere, India, suffered from diarrhoea in the last week before
she returned to Germany. After 4 weeks, she presented with
malaise, headaches and fatigue, and after another two weeks she
was hospitalized with symptoms of an acute hepatitis. Within a
week, she showed all signs of acute liver failure, and a liver
transplantation was being prepared. After a total duration of
four weeks, however, symptoms and signs of the fulminant
acute hepatitis decreased, and after another 4 weeks, the patient
was feeling well again, and she was discharged from the
hospital. Although her husband and her sister shared all meals
with the patients, and travelled together at all times, both stayed
without any clinical symptoms, and tested negative for
antibodies to HEV and were negative for HEV-RNA by RT-
nPCR. Hepatitis E in the patient was diagnosed by detecting
antibodies to HEV by enzyme-immunoassay and immunoblot
assay. Stool specimens and serum samples were repetitively
tested for HEV-RNA by RT-nPCR. It can be assumed that HEV-
viremia lasted as long as 4 weeks and HEV-RNA was detectable
as long as 9 weeks in stool samples.
Conclusion: This patient was remarkable for developing a
fulminant hepatitis E without being pregnant. She shed viral
RNA in stools as long as nine weeks after she ﬁrst presented
with hepatitis symptoms. The duration of HEV-viremia detected
by HEV-RT-nPCR was estimated be at least 5 weeks after her
ﬁrst clinical symptoms of hepatitis. This case indicates that HEV
may be present in patient’s blood and stool samples for a
prolonged period of time.
P1072
Dengue fever associated with severe reactive
thrombocytosis and gangrene of the toes: a case
report
S.K. Surrun, D.A. Kandiah (Singapore, SG)
Introduction: We present a patient with dengue fever
associated with severe reactive thrombocytosis and gangrene
of the toes; a condition that to our knowledge has not been
described before.
Case report: A 45-year-old Chinese lady, without any previous
signiﬁcant medical history, was admitted with fever, chills,
myalgia and skin rashes of a few days’ duration. The clinical
examination was unremarkable except for some petichaeal
rashes on the legs and arms. The blood investigations revealed
a mild thrombocytopaenia, the platelet count dropping from
263 · 109 to 135 · 109/l, and a positive paired dengue serology.
During the hospital stay she developed severe pain and bluish
discoloration of the middle three toes of both feet that
progressed to patches of superﬁcial gangrene. The platelet
count increased to a maximum of 1299 · 109/l. The
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echocardiogram and the CT scan of the aorta were normal. The
duplex scan of arteries of the legs was normal up to the distal
ends of posterior tibialis and dorsalis pedis. The full auto-
immune serology was negative and complement levels were
normal. After clopidogrel and pentoxyphylline were started the
skin lesions and the platelet count improved signiﬁcantly.
Discussion: Progression from thrombocytopaenia to severe
thrombocytosis in dengue fever is an uncommon event.
Though many types of skin lesions are known to occur in
dengue fever, gangrene has not been documented so far. In our
case, the unusual association of thrombocytosis and gangrene of
the toes forced us to exclude other differentials like embolic
phenomena, atherosclerosis and immunological disorders. As
the investigations were negative, the diagnosis of dengue fever
associated with severe reactive thrombocytosis with gangrene of
the toes was one of exclusion. Though the thrombocytosis and
the clinical condition responded to clopidogrel and
pentoxyphylline, spontaneous resolution could still have
occurred.
Conclusion: Severe reactive thrombocytosis and gangrene of
the toes are rare complications of dengue fever. These
complications can occur even in mild cases of dengue fever. A
repeat full blood count after an episode of dengue fever is thus
of paramount importance.
P1073
Localisation of Rift Valley fever virus in different
organs and blood of infected mice using
developed PCR test
A. Belov, N. Potapova (Moscow, RU)
Objectives: Rift Valley fever (RVF) is an important disease of
domestic livestock in Sub-Saharan Africa, causing acute febrile
disease, abortions and death. It is also a human disease, usually
it shows inﬂuenza-like clinical signs. However, during the
epidemics RVF may be complicated by hemorrhagic syndrome,
encephalitis, blindness and death. RVFV belongs to the genus
Phlebovirus, family Bunyaviridae. It has a RNA genome, which
consists of three segments. Two segments – large (L) and
medium (M) are represented with negative strand RNA, and the
small (S) is an ambisense RNA. It is known, that mice are
convenient model for studying the virus in a laboratory. The
purpose of this study was to detect the RVFV in organs and
blood of infected mice using the developed PCR test.
Methods: Vero E6 cells were infected with RVFV (Entebbe
strain). Isolation of RNA from monolayer using Trizol (Life
Technologies, USA) and method of RNA isolation based on non-
organic carrier (SiO2) was conducted. A PCR in nested
modiﬁcation was developed for this research. Primers were
designed based on the sequence of nucleocapsid protein (N)
gene following alignment of different RVFV sequences from
GenBank database with version 1.6 of Clustal W.
Results: For evaluation of speciﬁcity of developed system,
different related phleboviruses were tested, as follows: Arbija,
Corfou, Karimabad, Sandﬂy fever Sicilian (SFS), Sandﬂy fever
Naples (SFN), Salehabad and Toscana. Our results indicated
that there were no cross-reactions with related phleboviruses.
Therefore, the developed PCR test possessed high speciﬁcity.
For determining of virus localization, different organs (spleen,
liver, brain, muscles, lungs) and blood of infected adult mice
were tested by using the developed PCR test. Isolation of the
virus from the organ tissues of infected mouse was conducted
with two different methods. Extraction with non-organic carrier
showed the best results, because the virus was detected in all
types of tissues. As for the other extraction method, using of
Trizol did not allow to detect the virus in lungs and spleen.
Conclusions: It was conﬁrmed that the virus was present in all
tested organs and blood of experimentally infected mice. Also,
high speciﬁcity of the developed PCR test was shown.
P1074
Presentation of a case with pityriasis rosea and
Brucella infection
F. Kaptan, S. Ural, S. El, N. Turker, N.A. Coskun, B. Ormen,
G. Yilmaz, M. Ermete (Izmir, TR)
Introduction: Although brucellosis is a worldwide existing
zoononis, it is more prevalent in the Mediterranean region.
Skin lesions in brucellosis are rare and reported in approxi-
mately 5% of patients. These lesions are nonspeciﬁc and often
transient. Pityriasis rosea is a symmetric, erythemateous and
squamateous disease, most commonly seen in young adults.
Although aetiology is unknown hypersensitivity reaction to
human herpes virus 7 is suspected. Histopathologic ﬁndings in
Pithyriasis rosea are not pathognomonic. The most prominent
feature is microscobic vesicle. Oedema in papillar dermis,
perivascular inﬁltration of lymphocytes and histiocytes and
extravascular erythrocytes in dermal papilla and epidermis are
seen.
Case: Twenty-nine year old, male patient admitted to hospital
with the complaints of annular, erythemateous rash on the
extremities and both of the buttocks for a month and with fever
and knee pain for the last two weeks. During investigations for
vasculitis Brucella standard tube agglutination test was found to
be positive at 1/1280 titre and Brucella spp was isolated from the
blood cultures. Pityriasis rosea was found in the histopathologic
examination of the skin lesions. After starting rifampisin
600 mg/day and doxycycline 200 mg/day, fever returned to
normal at the sixth day and the treatment was completed to
45 days in the outpatient basis. Skin lesions resolved after the
completion of the treatment. No relaps was seen in 6 months of
follow up.
Conclusion: In literature co-existance of brucellosis and
Pityriasis rosea has not been reported earlier. Although this
co-existance may be coincidental, hypersensitivity reaction to
Brucella spp. might have been the cause of pityriasis rosea. As a
result brucellosis must be one of the diseases in the differential
diagnosis of patients presenting with rash and fever, especially
in endemic areas.
P1075
Imported chronic Chagas disease in Valencia,
Spain: epidemiological and clinical features
P. Segarra, M. Garcı´a-Rodrı´guez, V. Abril, C. Parada, E. Ortega,
T. Fraile, J. Ballester, M. Garcı´a-Deltoro (Valencia, ES)
Objectives: To analyze epidemiological and clinical features of
patients with Chagas Disease in Valencia, Spain.
Methods: Prospective study of patients with Chagas Disease
diagnosis between January and October 2005 in Hospital
General de Valencia Tropical Medicine Division. Subjects of
the study: blood donors or people born in Latin America,
children from chagasic mothers, and travellers with
epidemiological risk for Trypanosoma cruzi infection.
Immunological diagnosis was made using commercially
available serological tests: Recombinant ELISA (BioElisa-
Chagas, Biokit S.A.), that was the test used for serological
screening, and IFI (MarDx Diagnostic) used in addition in case
of ELISA positivity.
Case deﬁnition: Any patient with epidemiological risk factors
and two or more different serological test positives. Clinical and
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epidemiological review, physical examination, chest
radiography, and electrocardiography (ECG) were performed
in all cases. Radiographic contrast study of oesophagus and
colon and echocardiography only were performed if patient had
any symptom or ECG abnormalities.
Results: Ten cases of Chagas Disease have been identiﬁed, all of
them Latin American immigrants. Seven of them have been
submitted from blood bank because of a positive ELISA
screening. Mean age 45.5 years (27–66). Gender: 7 females and
3 males. Seven patients had aquired infection in Bolivia, 2 in
Argentina, and 1 in Chile. Serological results: see Table.
Polymerase chain reaction was available only in 2 cases, and
was positive in one. Nine patients were indeterminate chronic
forms, and one had a mixed chronic cardiac and digestive form.
Chest radiography was normal in all patients. Right bundle
branch hemiblock were detected in two patients and left anterior
fascicular hemiblock in one case.
Conclusions: We have identiﬁed ten patients with imported
Chagas Disease between January and October 2005. Only one
has a chronic cardiac and digestive form, and the other nine
have indeterminate form. Chagas Disease is an emergent disease
in Europe because migratory movements. This situation requires
improvement in clinical and diagnostic knowledge, specially in
blood banks, and determine priorities on preventive and
assistencial needs.
P1076
Anti-Acanthamoeba activity of caspofungin
S. Bouyer, C. Imbert, C. Kauffmann-Lacroix, G. Daniault,
M-H. Rodier (Poitiers, FR)
Objectives: Acanthamoeba spp. are causative agents of
granulomatous amoebic encephalitis, and more frequently of
keratitis, in the case of minor corneal surface injury caused by
contact lens or other agents. The effective therapy for these
pathologies has to be improved and new drugs are needed,
particularly when a resistance to classical therapeutics is
encountered. Some azoles or other antifungals have already
been used in different clinical situations. We evaluated here the
effect of caspofungin, a new antifungal belonging to the
echinocandins, on trophozoites and cysts of three strains of
Acanthamoeba.
Methods: Trophozoites and cysts of A. castellani (ATCC 30234),
A. polyphaga (ATCC 30461), and A. culbertsoni (ATCC 30171)
were exposed to solutions of 500 lg/ml to 16 lg/ml of
caspofungin for 1, 4 and 24 h (trophozoites) and 24, 48 and
72 h (cysts). The viability of trophozoites was then determined
by the toluidine blue staining. The cystic forms were
resuspended after contact with caspofungin in a medium
allowing the viable microorganisms to excyst. Replication of
the subsequent trophozoites was observed microscopically
during 7 days. Each experiment was repeated three times.
Results: The activity of caspofungin on the trophozoites’
growth was dependant of the tested concentration. At the
concentration of 16 lg/ml, the viability of trophozoites was
reduced of 5 (A. castellanii) to 60% (A. polyphaga). At the
concentration of 500 lg/ml, we observed no viability of the
trophozoites for the three tested strains. The cysts of A. castellanii
and A. polyphaga were sensitive to the concentration of 500 lg/
ml of caspofungin. As a matter of fact, no trophozoite was
recovered after 7 days of incubation. Then, the percentage of
viable forms increased when the concentration of caspofungin
decreased. Concerning A. culbertsoni, the highest concentration
used in this study did not prevent the excystation of a weak
percentage of the treated cysts forms.
Conclusion: Our results indicated that caspofungin showed in
vitro activity against trophozoites and cysts stages of the tested
Acanthamoeba strains. This new antimicrobial agent could be
promising to treat, alone or in association, Acanthamoeba keratitis.
P1077
Cyclospora cayetenensis infection in ﬁve
immunocompetent patients in a Turkish
university hospital
B. Sancak, Y. Akyon, S. Erguven (Ankara, TR)
Objectives: Cyclospora cayetanensis (C. cayetanensis) is a newly
recognized coccidian parasite, emerged as an important cause of
epidemic and endemic diarrhoeal diseases in humans. We
present, ﬁve immunocompetent patients infected with
C. cayetanensis who sought medical care in Hacettepe
University Hospital.
Methods: Three stool samples collected three days
consecutively were evaluated in the parasitology laboratory
for routine ova and parasite examination. The samples that ova
were found as negative, were stained by modiﬁed acid fast
staining. The ones which revealed pink to reddish stained oval
to round organisms 8 to 10 lm in diameter, were diagnosed as
Cyclospora cayetanensis oocysts. For modiﬁed acid fast staining,
2% sulphuric acid was used for decolourisation.
Results: In microscopic examination of the faecal samples, no
leucocytes and erythrocytes were seen. Bacteriological stool
cultures were found negative. We detected C. cayetensis oocysts
by modiﬁed acid fast staining in ﬁve patients. In none of the
patients was immunodeﬁciency determined. All the patients
were treated with trimethoprim (160 mg)-sulfamethoxazole
(800 mg) bid for 7 days. After treatment, clinical symptoms of
patients disappeared between seven to 15 days.
Conclusion: Cyclospora have been isolated in chronic
diarrhoea of immunocompetent patients, therefore this
infection must be taken into consideration, especially in
patients with prolonged diarrhoea. More coccidial infections
could be detected if modiﬁed acid-fast staining is routinely
performed.
P1078
Malaria: current status in Latvia
J. Keiss, I. Zeltina, A. Jeruma, V. Sondore, N. Ivanova, L. Viksna,
B. Rozentale (Riga, LV)
Malaria is a rare disease in Latvia at present – only 37 malaria
patients are registered in 1997 – October 2005. Increasing
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tourists, travellers, guest workers ﬂow spread the disease across
borders. The aim of study is to characterize the malaria cases,
novel malaria tendencies in Latvia.
Patients and methods: Analysis of 34 case records of malaria
patients treated in the Infectology Center of Latvia in 1997–2005
was performed. Malaria Plasmodia were diagnosed by using of
thin and thick blood smear.
Results: The obtained data show the growing of malaria
patients number in Latvia, particularly Plasmodium falciparum
caused cases. Epidemiological anamneses of 33 out of 34
patients suggested that the patients have been present in
malaria endemic region prior to affection (imported malaria).
One case of non-imported malaria (local malaria) as a result of
P.falciparum transmission from imported case has been
established. The source of infection could be either a contact
person (transmission mechanisms – mosquitoes of the genus
Anopheles inhabiting in Latvia; however, sexual contacts and
the use of intravenous drugs cannot be excluded) or an infected
mosquito that has travelled in from a malaria – endemic area
(patient was worker in the railway station). One case of severe
P.falciparum malaria with broad spectrum of complications
(cerebral malaria, acute renal failure, acute respiratory distress
syndrome, gastroenteritis, hypoglycemia) and fatal outcome due
to late hospitalization (at 7th day of illness) and
hyperparasitemia has to be of particular clinical interest. A
possible resistance against chloroquine received for malaria
prevention has been established in about 60% of the affected.
Conclusions:
1. A continued increasing in malaria throughout the world
hastens malaria spread in Latvia: during last years number of
malaria, particularly P. falciparum caused malaria cases, is rising.
2. The case of local P. falciparum malaria is detected in Latvia.
3. The increase in drug-resistant malaria in the world promotes
the increase of imported drug resistant malaria in Latvia.
4. Taking into account the widespread distribution of malaria in
the world in general and the unconventional transmission
routes emerging in Latvia, primary health care physicians
should be ready to detect malaria in seemingly non-typical
cases.
P1079
Correlation of serum bilirubin level with
mortality in P. falciparum malaria
A.K. Aribandi, M.S. Albur (Shefﬁeld, UK)
According to WHO, severe hepatic dysfunction and encephal-
opathy are unusual in malaria.However literature review as
shown recently some evidence correlating severity of falciparum
malaria with liver dysfunction.
Objectives: 1) To study liver function abnormalities in patients
with falciparum malaria who presented with jaundice. 2) To
assess the prognosis of P. falciparum malaria in relation to liver
function abnormalities.
Methods: It is a prospective study done in a tertiary referral
hospital (teaching) in south-central India over a period of
2 years. All patients with smear positive P. falciparum who
presented with jaundice were included in our study. Their
clinical presentation along with laboratory ﬁndings was noted.
Patients with a history of excessive consumption of alcohol,
hepato-toxic drugs, known liver disease and/or positive viral
hepatitis serology were excluded from our study.
Results: Total number of patients included in this study was 25,
with age ranging from 11–55 yrs (mean age 33) out of which 19
(76%) were males and 6 (24%) females. Clinically all patients
had jaundice and fever with chills/rigor; 21 patients (84%) had
pallor, 20(80%) had hepatomegaly; 13 (52%) had splenomegaly;
10 patients (40%) had hepatosplenomegaly; 16 (64%) had renal
failure and 14 (56%) patients had altered sensorium. Based on
serum bilirubin level(in mg%, normal range 0.8 to 1.5), patients
were categorized into group A (15 patients, serum bilirubin
3–10 mg%), group B (7 patients, serum bilirubin 11–20 mg%),
group C (2 patients, serum bilirubin level 21–30 mg%) and
group D (1 patient, serum bilirubin 31–40 mg%). Majority (80%)
of patients had conjugated hyperbilirubinaemia. Serum ALT
levels (in IU/dl, normal range 40 to 80) ranged between 100–324;
AST 80–354; Alkaline phosphatase (in KA units, normal range
0–5) 6–24; albumin (in grams/dl, normal range 3.5–4.5) 2–4.5.
Overall mortality in our study was 24%. The following table
shows correlation of serum bilirubin level with mortality rate.
Conclusion: Patients with P. falciparum malaria & abnormal
liver functions, also had other features of severe malaria such as
renal failure, ARDS, altered sensorium with high mortality. The
mortality rate in this setting was correlating with serum
bilirubin level.
P1080
Leishmaniasis in travellers in endemic areas
S. Halichidis, S. Rugina, E. Dumea (Constanta, RO)
Objectives: Clinical, epidemiological and therapeutical study
about 4 cases of leishmaniasis in travellers in endemic areas.
Methods: Retrospective study about 4 patients with
leishmaniasis hospitalized in Clinical Infectious Diseases
Hospital of Constana, Romania, during 2005. Diagnosis was
histologically and microbiologically conﬁrmed. Treatment
consisted of: sodium stibogluconate in one case, meglumine
antimonate in 2 cases, and amphotericin B in one case. Clinical
follow-up was conducted daily during treatment and 2 months
afterwards.
Results: Diagnosis: cutaneous leishmaniasis in 3 patients
(2 males and one female) and visceral leismaniasis in one
patient (female); age of the patients: between 30 and 55 years
old. All travelled in endemic areas. Examination showed
nodular lesions and depressed central ulceration all over the
body. All lesions and the clinical manifestations (for visceral
leishmaniasis) were improved at the end of therapy. For the
patient treated with amphotericin B, some brown spots
appeared on the hands and soles, on the end of therapy, like
adverse event, but disappeared after one week.
Conclusions: Romania is not an endemic area for leishmaniasis,
but in the last years cases were related because of the person’s
circulation in touristic, professional and humanitarian purposes.
P1081
Unusual clinical presentation of visceral
leishmaniasis in an immunocompetent patient
T. Kontopoulou, E. Vaidakis, E. Bournakis, N. Alexiou,
I. Porfyridis, E. Sioula (Athens, GR)
Objectives: Classic visceral leishmaniasis presents as fever,
hepatosplenomegaly and pancytopenia. Fever is almost always
present at the time of medical consultation. We will present a
case of leishmaniasis without fever in an immunocompetent
individual.
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Case report:A 67-year-old man was admitted in our department
due to fatigue, splenomegaly and elevated serum IgG. He never
had fever during his illness. In his neighbourhood he had dogs.
From his medical history we noted a mild diabetes mellitus,
gastritis, appendicectomy, surgical extraction of gall bladder,
and thrombocytosis of unknown origin a year before, that
yielded without any treatment. Upon admission he had
temperature 36.5C. Physical examination revealed a slight
paleness, spleen enlargement (~ 8cm below the left costal
margin), small nontender cervical lymphnodes and a maculo-
papular rash of the front thoracic side. Blood analysis revealed
hematocrit 35%, haemoglobin 12g/dl, leucocytes 3470/mm3
(granulocutes 40%), platelets 299000/mm3 (seriously decreased
compared to those of a year before), erythrocyte sedimentation
rate of 90 mm/h, C-reactive protein 0.4 mg/dl and serum IgG
6870 mg/dl, with a small IgG-k band. Chest radiograph and
bone scan were normal. CT scan of chest and abdomen showed
only splenomegaly. Bone marrow biopsy and aspirate revealed
no haematological malignancy. The bone marrow smear
revealed a good deal of Leishmania amastigotes and PCR for
Leishmania from bone marrow was also positive. Leishmania
serum ﬂuorescent antibodies were positive (1/320). The patient
was administered liposomal amphotericin-B 2 mg/kg/day for
5 days and another 2 mg/kg eight days later. After 1 month the
patient is doing well, the spleen and lymphnodes are no more
palpable, the rash has disappeared and the laboratory values are
within normal range.
Conclusion: Mild leishmaniasis –as the one described above- is
becoming more and more frequent in the developed and
developing world. Therefore, unexplained constitutional
symptoms those appear within two years after exposure to an
endemic area might warrant investigation for infection with
Leishmania.
P1082
Efﬁcacy of medical treatment in hydatid disease
I. Dumitru, S. Rugina, E. Dumitru, E. Dumea (Constanta, RO)
Objective: To analyze the efﬁcacy of medical treatment for
hydated disease.
Materials and methods: We performed a study on 320 patients
admitted in our department of parasitology in the last 5 years.
The diagnosis was based on ELISA reaction for Echinococcus
granulosus, chest x-ray, ultrasonography and computed
tomography. Treatment involved Albendazole 800 mg/day for
28 days separated by two weeks intervals, minimum three cures.
In 2 cases with giant liver cysts (11 cm and 12 cm) we performed
a percutaneous ultrasonography-quided puncture of the cyst
with ﬂuid aspiration (PAIR) followed by medical treatment.
Results: Echinococcosis had different locations, involving liver
(251), lung (81), spleen (6), kidney (5), brain (2), pericardial (2),
mediastinal (1), peritoneum (10) and retro peritoneum (3),
muscles (4), bone (2), and parotid glands (1). Secondary
hydatidosis was reported in 71 cases (22.18%) and multiple
cysts were found in 111 cases with liver, pulmonary, muscular,
bone, peritoneal and parotid glands hydatidosis and multiple
locations in 44 cases. At the beginning of therapy the cysts had
less than 7 cm in dimension. After medical treatment we notice
a regress of the cysts dimensions or cysts walls calciﬁcation in
most cases. No signiﬁcant changes were observed in muscular
and bone cysts requiring surgical intervention.
Conclusion: Albendazole is the election therapy in cysts with
dimension less than 7 cm. PAIR is a good choice in solitary giant
liver cysts.
P1083
The in vitro effect of levamisole and praziquantel
combination on Echinococcus granulosus
protoscolices
A. Guvenli, M. Hokelek (Samsun, TR)
Objectives: The larval or metasestodes forms of Echinococcus
granulosus brought into existence a zoonotic infection on
humans is called cystic echinococcosis (CE). CE is widely most
part of the world and it is also important for human health,
animal health and economy. The aim of this study was to
investigate the protoscolicidal activities of Levamisole (LVM),
Praziquantel (PZ) and Metronidazole (MZ) interactions of
E. granulosus protoscolices during in vitro incubation.
Methods: E. granulosus protoscolices were aseptically removed
from liver hydatid cysts obtained from animals slaughtered at
the private abattoir in Samsun, Turkey. Viable protoscolices were
cultured in medium 199 during three days. The three drugs
were added in combination or separately to the medium for
comparison of the results. We used the following ﬁnal
concentrations of the drugs: LVM at alone 1000 and 2000 lg/
ml, PZ at alone 10 and 100 lg/ml, LVM at 1000 lg/ml + PZ at
10 lg/ml, MZ at alone 100, 50 and 20 lg/ml respectively. Their
protoscolicidal activities were assessed after 5, 15, 30, 60 and
120 minutes post-incubation.
Results: A signiﬁcant protoscolicidal effect was obtained with
LVM + PZ combinations after 120 minutes on protoscolices. The
minimal protoscolicidal effect was found for all MZ
concentrations.
Conclusion: Our results showed that LVM + PZ combinations
signiﬁcantly deadly for protoscolices, and that further studies
with regard to use of LVM + PZ combination in animal models
of E. granulosus may be of help for designing new treatment
regimens for CE in humans.
P1084
Multiple hydatid cysts in the left main
pulmonary artery: an extremely rare location
O.K. Aribas, E. Turk-Aribas, F. Kanat, I. Erayman, T.
Yuksek (Konya, TR)
Hydatid cysts may very seldom develop within pulmonary
arteries after ruptured cardiac or hepatic cysts. We report a case
with multiple hydatid cysts within pulmonary arteries that
necessitated left pneumonectomy. We present a 49-year-old
female patient with a symptom of haemoptysis. The patient
described fever and cough attacks controlled with medical
therapy within previous year. Past history revealed hepatic
hydatid cyst operation 5 years ago. Physical examination was
unremarkable except diminished pulmonary sounds and inspir-
atory rates on the left lung. ESR was 68 mm/hour and IHA test
for echinococcosis was highly positive. Chest X-ray revealed
enlargement of the left hilus, linear heterogeneous inﬁltration in
the left lower zone and a paracardiac pulmonary nodule on the
right lower zone. Chest CT scan disclosed 7 · 5 · 3 cm in
diameter cystic septated mass lesion obliterating and lying
downward within the trace of right main pulmonary artery,
widespread tubular dilatation and peribronchial thickening in
the left lower lobe bronchi and two small neighbouring nodules
in the right lower lobe. A probable crescent moon appearance
was seen within the left inferior pulmonary artery. Contrast
enhanced chest magnetic resonance imaging revealed multiple
cystic lesions in the left main and left lower lobe pulmonary
arteries and magnetic resonance angiography showed amputed
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left inferior pulmonary artery. Ventilation-perfusion lung scan
conﬁrmed perfusion defect in the left lower lobe. Echocardiog-
raphy was normal. Abdominal ultrasonography revealed het-
erogenous, hypoechoic calciﬁed area in left liver lobe (operation
sequela). The patient underwent left pneumonectomy for
irreversible pulmonary arterial wall and pulmonary parenchy-
mal destruction via median sternotomy under total circulatory
arrest to prevent contralateral hydatid cyst embolization.
Numerous intact or ruptured hydatid cysts in various sizes
within the pulmonary artery were observed after pulmonary
artery dissection in resected specimen. The intimal destruction
was prominent in the dilated and thinned pulmonary artery
wall. Albendazole treatment was given to the patient since no
procedure was performed on hydatid cysts in the right side. We
believe that if an albendazole prophylaxis were given to the
patient after surgical intervention to the hepatic cysts 5 years
ago such life threatening unusual presentation of hydatid cysts
might not be seen and the patient might be saved from
pulmonary resection.
P1085
An extremely rare location of cardiac hydatid cyst:
interventricular septum
I. Erayman, E. Turk Aribas, S. Avcu, M. Bitirgen (Konya, TR)
Hydatid csyt is zoonosis. In humans, disease may usually,
manifest by lung, liver involvement and cardiac involvement is
rare. Clinical picture depends on localisation of the illness,
diameter of the cyst and complications. Echocardiography and
radiological imaging are the most reliable methods in describing
the anatomical localisation. Serological tests have supportive
role in diagnosis. Surgical resection as well as albendazole
treatment are suggested in treatment. In this presentation we
described a case who did not respond to 6 months of medical
therapy. Case who was diagnosed to have cardiac hydatid cyst
located at the interventricular septum, was re-evaluated using
transoesophageal echocardiography and multislice computed
tomography that was recently introduced in our country.
56 years old male patient was applied to out patient clinics of
cardiology department with complaints of chest pain, palpita-
tion and abdominal pain. Patient had been taking albendazole
800 mg/day for twenty one days. Transoesophageal echocardi-
ography revealed 4.5 · 3.1 cm hydatid cyst located to interven-
tricular septum. Multislice computed tomography demonstrated
4 · 3 cm hydatid cyst located at interventricular septum. Ech-
inoccocus speciﬁc IgE was raised 10 times the normal. Six cycles
of chemotherapy, each consists of Albendazole 15 mg/kg.day
for four weeks followed by 15 day drug free interval, were
prescribed.
P1086
A 5-year study of intestinal parasitosis in a
general hospital, Piraeus, Greece
S. Konstantopoulou, A. Mourikis, P. Karle, M. Dimitriou,
E. Vlachou, F. Vagia, A. Karle (Athens, GR)
Objectives: To determine the incidence of intestinal parasites in
citizens of Piraeus and analyze the difference between natives
and immigrants coming from developing countries. The
majority of natives from our hospital area have a low social-
economic status.
Methods: During a 5 year period (2001–2005) 5061 faecal
samples (4538 from natives and 523 from foreigners) were
examined in our hospital laboratory for intestinal parasitosis. Of
them 594 were inpatients of the hospital and 4467 outpatients.
The 89.12% of the outpatients were workers who were examined
in order to obtain a health clearance certiﬁcate. All specimens
were examined in direct microscopy using wet mount
formaline-ether concentration, trichrome stain and P.C.R.
methods.
Results: Of 5061 examined specimens, 157 (3.1%) were found
positive for pathogen intestinal parasites: Entamoeba hystolytica/
dispar 136, Giardia lamblia 12, Ancylostoma duodenale 4 (all
patients were foreigners), Ascaris lumbricoides 1, Enterobius
vermicularis 3, and Taenia sagginata 1. The incidence of
pathogen parasites was 2.64% for greek citizens and 7.07% for
the foreign citizens.
Conclusion: The frequency of intestinal parasitosis in Greece is
generally low but during the recent years many immigrants
have introduced new parasites. It is necessary for the public
health services to prevent parasites spreading from the carriers
to the healthy population by taking measures of prevention with
the right information.
P1087
Filariasis infection in immigrants in a Spanish
hospital
N. Portocarrero, A. Amor, M. Baquero, M. Subirats (Madrid, ES)
Introduction: In West Africa Filariasis is an endemic chronic
disease where is a priority in public health. Some programs for
control have been carried out in the last 10–12 years in order to
erradicate this disease. The purpose of this study was to
investigate the prevalence of imported microﬁlaries in
immigrants coming from the Africa endemic areas in the last
3 years in our area.
Methods: Blood and skin samples from immigrants subjects
were collected in our hospital from January 2003 to November
2005. Both Knott concentration technique and observation of
skin snips were used for detection of microﬁlariaes in samples.
After them Field’s stain was used to conﬁrm diagnosis.
Results: A total of 3763 blood samples and 1259 skin samples
(643 from buttocks, 607 from scapulas and 9 from thighs) were
analysed. Most of samples are of the subjects coming from
Equatorial Guinea. We found 304 positive samples for ﬁlarias
(6%), 247 in blood (81.25%) and 57 (18.75%) in a skin. The
prevalence of species obtained were: we report in 10% of cases
with coinfection more than one species of ﬁlarias in both blood
and skin samples.
Conclusions: Although a recent review of the impact of control
programs, indicate that are very effective, we observed a
relevant prevalence of ﬁlariasis among patients coming from
African endemic areas. Routine examination must be performed
in people from sub-Saharian Africa.
P1088
Hepatobiliary ascariasis: a case report
A.T. Bastug, A. Erbay, H. Bodur, E. Akinci, M.A. Cevik (Ankara,
TR)
Objective: Hepatobiliary Ascariasis is endemic in third world
countries. Ascariasis in the hepatobiliary tract can cause acute
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cholecystitis, acute cholangitis, obstructive jaundice, acute
pancreatitis and hepatic liver abscess. After gaining entry from
the ampullary oriﬁce the worms can freely move in and out of
the biliary tree and at times the disease can be symptom-less.
Ultrasound is an excellent modality to diagnose and follow up
hepatobiliary Ascariasis. Ultrasound is also useful in conﬁrming
exit of the worms from the biliary tree.
Case: A 52 years old male patient was admitted with jaundice.
His complaints have begun 15 days ago. In physical examination
the skin and scleras were icteric and the abdomen examination
was normal. Laboratory examination was revealed an AST:
1414 U/L (normal range 0–40), ALT 1327 U/L (normal range
0–50), Alkaline phosphatase: 1039 U/L (normal range 40–150),
total bilirubine: 7.33 mg/dl (normal range 0.2–1.2), direct
bilirubine: 5.15 mg/dl (normal range 0–0.4). Viral markers for
acute hepatitis were negative. Abdominal ultrasound showed
two polyps sized as 4mm on the neck of the gall bladder and
wall oedema. At the follow up while the non-infectious reasons
of jaundice were researching, the patient vomited Ascaris
lumbricoides which was measured 18 cm length and then the
liver enzymes and jaundice was regressed. The day after
vomiting A.lumbricoides, the serum transaminases were
obtained as ALT: 63 U/L, AST: 28 U/L and total bilirubine
was 1.41mg/dl. The control abdominal ultrasound and
tomography were completely normal, the polyps which were
interpreted as an ascariasis were disappeared. The patient was
treated with mebendazole 3 · 100 mg for 3 days. At the one
year follow up the patient had no complaints and ALT and AST
levels were normal.
Conclusion: Ascariasis can be a reason of obstructive jaundice
and the clinicians should be aware of this possibility especially
at the endemic regions.
P1089
The pinworm (Enterobius sp.) infection in lung
mimicking tuberculoma – case report
H. Ja¨rv, V. Adamson, P. Naaber (Tartu, EE)
Objective: We report case of human Enterobius infection in lung
initially misdiagnosed as pulmonary tuberculosis by histological
ﬁnding.
Case report: A 39-year-old female, working in food market, was
routinely checked for tuberculosis by X-ray in March 2004. Chest
radiograph showed the presence of a two round opacities in
lower lobe of left lung. Latest chest X-ray from year 2001 was
without any pathological ﬁnding. Patient was seen to
pulmonologist for consulting. X-ray ﬁnding was conﬁrmed by
CT-scan. Diagnostic hypothesis was pulmonary tuberculosis but
diagnosis was not conﬁrmed despite to repeated culturing of
sputum for mycobacteria from March 2004 to March 2005. In
April 2005 patient was hospitalised for diagnostic
videothoracosopy. Material from lesions in left lung was sent
histopathological investigation in cito. Preliminary ﬁnding was
showing chronic granulomatous process with necrosis
characteristic for tuberculoma. Antituberculotic treatment was
initiated. Final histopathological ﬁnding demonstrated two
granulomas including Enterobius vermicularis eggs. Additional
analysis from rectal swab and faeces were negative to Enterobius.
Discussion: Pinworm (Enterobius vermicularis) and tuberculosis
are both common diseases in Estonia. Granuloma formation
around pinworms and their eggs are quite often reported from
appendix, abdominal and pelvic peritoneum, peritoneum of the
small and large intestines. Granulomas can form around
degenerating adult worms, around discreate eggs, around
cluster of eggs and probably around of migrating worms. The
granulomas in our case were 1 cm across, having necrosis in
centre and other way non-speciﬁc, except ﬁnding of eggs in
centre. Accidental Enterobius transmission via oral route into
respiratory tract was suspected. We like to emphasize the need
to characterize pathogenesis of common parasite like Enterobius
is, in organs rarely involved. Only few cases of Enterobius
involvement into lung tissue are characterized in medical
literature so far.
P1090
Malnutrition in children in Nairobi’s slums
A. Kolenova, A. Ondrusova (Trnava, SK)
Even today malnutrition is a major problem in developing
countries. Over a third of the world’s children suffer some
degree of malnutrition. Malnutrition is deﬁned as deﬁciency of
protein, energy or micronutrients, but the commonest nutri-
tional problem is a general deﬁciency of all food. Malnutrition
increases the mortality from common childhood diseases.
Malnutrition is not just problem of nutrition, but social and
family problem as well. Since January 2003 in Nairobi we
recorded 240 children from 0–5 years. After clinical examina-
tion, laboratory tests and according strict indication, we placed
children in supplementary feeding program. We measured
weight, arm circumference at beginning, during (every 2 weeks)
and before ending of the program. We checked vaccination
schemes, social history. We observed clinical status, risk factors,
duration of the program, age of the children, some laboratory
results (especially HIV, TB and stool for parasites), and speciﬁed
the criterions for leaving the program. Mothers were well-
informed about conditions of the program, breastfeeding,
nutrition, treatment, vaccination; they got breast milk substi-
tutes, multivitamins. In the case of illness, children got a
examination and treatment according clinical status. From 240
children, 79% ﬁnished the program. Main indication was
malnutrition according weight and age, second was contraindi-
cation of breastfeeding, because of HIV+ mothers. The most
frequent group was children between 1–3 years. From tested
children 38% were positive for HIV and 18% for TB. The
commonest diseases were respiratory infection, then intestinal
infection, skin changes and others. The main intestinal parasite
was gardia and a main risk factor was low birth weight. 44% of
children leaved the program because of optimal weight and
good clinical status, 39% for inadequate co-operation of mothers,
11% died, 6% moved to countryside. Children were often sick
and had intestinal parasites. We monitored higher morbidity,
complication and mortality especially in children with HIV.
After properly monitoring, treatment and education, we
achieved a nice success, almost a half of the children leaved
with normal weight and good clinical status. But there is still
large number of mothers, who don’t care and don’t understand
the problem of properly nutrition. Because of these matters, the
most important is to know HIV status (start HAART), to get
properly education and to treat all infections.
P1091
Incidence of tropical diseases at university clinic
in Mapuordit, Sudan
S. Seckova, A. Augustinova, J. Bencza, M. Bartkoviak,
A. Doczeova, M. Taziarova, V. Sladeckova, M. Vilimova,
Z. Kniezova, K. Kutna, M. Ocenas (Trnava, SK)
Objectives: This observational study presents incidence of
infectious diseases and their therapy at DOR (Diocese of
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Rumbek) and University of Trnava Clinic in Mapuordit, South
Sudan through the patient ﬁle analysis in the period from the 1st
January 2002 up to 29th June 2003 and monitoring of
antimalarial drugs efﬁciency at the population most vulnerable
group in the stable malaria area.
Methods: Case history, clinical examination and laboratory
diagnosis determined diagnosis. Data were collected from
laboratory registers and hospital clinical records and processed
by median test for veriﬁcation of data level coincidence and test
for comparison of two sizeable independent ﬁles. In above
mentioned period 28 667 patients were examined, from them 22
036 patients (77%) presented infectious disease.
Results: The number of malaria cases or fever of unknown
origin was 7445 (33.7%), 2982 of them were in age category from
6 months up to 5 years. Severe malaria with complications was
recorded in 185 cases (2.5% from all malarial cases), cerebral
malaria was diagnosed in 48 cases, pulmonary oedema in 10
cases, macroscopic haemoglobinuria in 5 cases, generalised
convulsions in 67 cases, partial convulsions in 26 cases, severe
anaemia in 29 cases. Hyperparasitemia was diagnosed in 230
cases, in the category from 6 months to 5 years in 158 cases.
Respiratory tract infections were diagnosed in 3609 patients
(16.3%). Sexually transmitted diseases and urinary tract
infections were diagnosed in 3339 patients (15.1%), intestinal
parasitosis in 3220 patients (14.6%), from which 32% represented
ankylostomiasis, diarrhoeal diseases in 1788 patients (8.1%), skin
infections in 1886 patients (8.6%), onchocercosis in 589 patients,
wuchereriosis in 10 patients, dracunculosis in 8 patients,
meningitis in 14 and tetanus in 12 patients. Number of new
diagnosed cases of leprosy was 97.
Conclusion: The most common disease remains malaria
(caused by Plasmodium falciparum with 76% sensitivity to
chloroquine), in this area in early stages easy treatable, but
with persistent high mortality rate especially among children
under 5 years. The next most common diseases were bacterial
infections, especially respiratory tract infections and diarrhoeal
diseases. Despite of excellent antibiotic sensitivity and
negligible resistance due to low consumption, this group of
diseases represents the main cause of morbidity and mortality




R. Gowda, A. Tunbridge, M. McKendrick (Shefﬁeld, UK)
Introduction: Pyrexia of unknown origin (PUO) is one of the
most challenging problems for a clinician. If the patient has
travelled extensively around the world, the possibilities are
legion. Therefore, a careful and thoroughhistory and examination
with amethodical, systematic approach to investigation is crucial.
We describe an extremely challenging case that highlights the
pitfalls in the investigation and diagnosis of PUO.
Case report: A 79-year-old Caucasian man presented with a
2-year history of cyclical fever of up to 39.5c, myalgia, weight loss
and night sweats. His fever re-occurred with clockwork like
regularity, once a week, every week on Saturdays. During the
episodes, the patient felt extremely unwell and was bed bound.
However, complete resolution occurred within 24 hours.
Inﬂammatory markers were raised with an ESR of 61mm/hr
and C-reactive protein 211 mg/l. A signiﬁcant travel history
around the world working in the navy prompted us to undertake
an extensive PUO screen.Awide range of investigations for PUO,
imported infections, multiple whole body imaging and bone
marrow were undertaken. The only abnormalities were
gallstones in the gallbladder and an increased uptake in the
right upper abdomen on Indium labelled white cell scanning. It
was postulated that this might be the source of fever and the
patient underwent a laparoscopic cholecystectomy but this
unfortunately did not resolve his symptoms. Despite
sequential, empirical therapy with chloroquine, doxycycline
and two trials of colchicine (inﬂammatory familial disorders
were considered) his symptoms persisted. He ﬁnally had a
profound and dramatic response to indomethacin. His
symptoms, pyrexia and inﬂammatorymarkers all settled rapidly.
Discussion: Our case demonstrates the difﬁculties of diagnosis
and management of PUO. The patient had travelled to
numerous exotic locations, which widened the differential
diagnosis and prompted us to pursue unusual tropical
infections. The results of investigations however, should be
carefully evaluated, as subsequent medical/surgical
interventions can be potentially dangerous. Our patient had a
cholecystectomy without any beneﬁt. Although no cause was
found, empirical therapy helped resolve his symptoms and
occasionally this may be the only feasible option. We will use
this case to discuss the approach to the investigation of PUO.
Seroepidemiology
P1093
Epidemiological features of diphtheria in Belarus
I.A. Karpov, A. Kachanka, M. Kozatchenko (Minsk, BY)
Objectives: Diphtheria is an infection, the main clinical
manifestations of which are caused by a diphtheria toxin.
Diphtheria is referred to as a controlled infectious disease. It is
usually detected as a localized form (carrying or the localized
forms of larynx diphtheria) and rarely in the form of extensive
diphtheria or a toxic form.
Methods: All data refer to the period 1994–2004, and were
collected at the Medical State University, Reference Center for
Infectious Diseases of the Belarus Ministry of Public Health.
Results and conclusion: According to a thorough
bacteriological check-up of the infected and the contacted, the
number of carries of toxigenic strains of diphtheria’s bacteria out
number 100-fold the number of the carriers may amount to 10%
and more off those uninfected. Susceptibility to diphtheria
depends on the level of antitoxic immunity. At present, as a
result of the active immunization of children the disease is
characteristic mostly of adults and teenagers who are deprived
of their immunity. European WHO committee sets sights on the
succeeding objectives – to reduce the number of the diseases to
0.1 per 100 thousand populations by 2010 or earlier. In the
period of 1994–1995 Belarus experienced the largest number of
the diphtheria acquired – 230 and 322 cases respectively, which
accounts for 8.0 and 14.7 cases per 100 thousand populations
with 22% of toxic forms. From the year of 1996 till 2001 there was
a radical turn in the development of diphtheria epidemic
process: the number of the contracted fell from 3.8 to 0.2 cases
per 100 thousand populations; in 2000 – 52 cases registered; in
2001 – 25 cases; in 2002 – 7 cases; in 2003 – 6 cases and in 2004 –
15 cases. These data justly the attempts directed to the massive
vaccination of those who are subject to it both initially and
exercising revaccination. All the individuals who contacted the
diseased undergo special chemical prophylactic measures
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before the results of the bacteriological tests are ready. The
purpose of this is to prevent the disease and the spread of it. The
general prescription involves phenoxymethylpenicillin,
erythromycin per os according to the age (10 days when we
have positive strain) or benzatin-penicillin intramuscularly one
time.
P1094
An analysis of the factors effecting the prognose
of tetanus in a university hospital between 1991
and 2005
K. Aydin, G. Yilmaz, F. Aksoy, I. Koksal, R. Caylan (Trabzon, TR)
Background: Tetanus is a life-threatening infection relatively
uncommon in the developed countries but occurs frequently in
developing countries with case fatality rates of 40–60%. Early
diagnosis and management may be life saving. In this study is
made an analysis of the effects of prognosticating factors on the
outcome of the patients with tetanus who were seen in our
hospital between 1991 and 2005.
Methods: All the patients admitted with clinical diagnosis of
tetanus in Karadeniz Technical University Hospital, Trabzon,
Turkey, from 1991 through to 2005 were retrospectively
reviewed and the data were analysed to determine the socio-
demographic features and clinical ﬁndings. Analysis was made
using SPSS package. Chi-square analysis and student t-test were
used for comparison of data.
Results: A total of 44 patients were admitted to our hospital
during the study period. All the patients were diagnosed in
emergency service by clinical examination. Respiratory support
was provided for 24 cases. Only 19(43.2%) patients survived
while 25(56.8%) died. The incubation period of the survivors
was 12.6 ± 4.8 days while that of those who died was 6.6 ± 4.3
days (P = 0.000). Other factors that signiﬁcantly inﬂuenced
survival included severity of spasms (OR = 8.67, 95% CI = 1.83–
44.98; P = 0.001), dysphagia (OR = 52.0, 95% CI = 5.04–1301.49;
P = 0.000) and provision of respiratory support (OR = 28.0, 95%
CI = 4.47–217.6; P = 0.000). When prognostic factors are
investigated by logistic regression, the incubation period
(OR = 1.41, 95% CI = 1.08–1.85; P = 0.000) and the provision of
respiratory support at the time of hospitalization (OR = 0.02,
95% CI = 0.0006–0.39; P = 0.000) were found to be independent
prognostic factors for tetanus.
Conclusion: Tetanus is still a severe problem in developing
countries. It is a potentially fatal disease. The rate of high fatality
in our patients was due to short incubation period and severe
clinical ﬁndings. The necessity of respiratory support increased
mortality to 98%. A one–day extension in incubation period
increased the chance of life to 1.41. The majority of tetanus cases
occurred among persons inadequately vaccinated or with
unknown vaccination history during the acute injury. Primary
immunization and scheduled booster immunization are
important preventive measures that have greatly reduced the
incidence of tetanus.
P1095
Determination of tetanus antibody levels among
emergency department patients presenting with
injuries
K. Caglar, K. Hizel, A. Altuncekic, A. Demircan,
R. Karakus (Ankara, TR)
Objective: This study was undertaken to assess the tetanus
immunity status in patients presenting to an emergency
department of a tertiary care hospital because of accident.
Materials: A total of 155 patients (47 women and 108 men, age
from 16 to 81) were enrolled into the study. All patients had
various injuries. At each patient’s presentation, demographic
data and tetanus immunization history given by the patient
himself or herself were recorded. Tetanus antibody levels in
serum samples of the subjects were measured using a double-
antigen enzyme-linked immunosorbent assay. Seroimmunity to
tetanus was classiﬁed as susceptibility (<0.15 IU/ml), basic
protection (0.15–<1 IU/ml), and full protection (‡1 IU/ml).
Results: In terms of protection against tetanus, we found a
statistically signiﬁcant difference between the patients who had
a history of completing their primary immunization series and
the patients who had not. Among the patients who did not recall
their primary tetanus vaccination history, 64.6% of them had
antibody titres above 0.15 IU/ml. On the contrary,
seroprotection rate (92.2%) was signiﬁcantly higher (P < 0.001)
among the subjects who stated that they had received the
primary immunization series. All of the subjects who received a
tetanus booster vaccination during last 5 years had protective
antibody levels. In overall, 22.6% of the patients were found to
be susceptible to tetanus, 23.2% had basic protection, and 54.2%
were fully protected. Susceptibility to tetanus among females
was found to be signiﬁcantly (P < 0.05) lower than that among
males in emergency department patients. The rate of susceptible
subjects among females showed the highest value (90.9%) in
those aged +50.
Conclusion: In emergency department patients with injuries,
possible risk of tetanus should be taken into account especially
in those who did not receive or recall their primary childhood
immunization series. In women particularly over 50 years of
age with injuries, who are at greatest risk, a booster
vaccination should be given in the emergency department
practice without any delay in order to avoid leaving many of
them unprotected.
P1096
Tetanus immunisation status among women of
child-bearing age in three provinces in Turkey
B. Esen, D. Kurtoglu, N. Coplu, A. Gozalan, K. Miyamura,
S. Ishida, L. Akin (Ankara, TR; Tokyo, JP)
Objective: The goal of the study was to assess tetanus immune
status among childbearing aged women in relation to the
tetanus vaccine doses in three selected provinces in Turkey.
Method: A total of 2094 subjects were randomly selected from
26 health centres’ areas in Diyarbakir, Antalya and Samsun
between February 2000 and October 2001. There were no
statistically signiﬁcant differences between provinces by age
group, gender and residence (P > 0.05). Of these, 404
15–49 years old women were selected for analyses about
tetanus immunity among childbearing aged women. Tetanus
antibody titres were determined by using in-house ELISA and
particle agglutination tests and antibody titres ‡0.1 IU/ml was
accepted as protective level. Statistical analyses were done with
qui-square test, Student’s t-test, one-way ANOVA, and logistic
regression analysis using SPSS 10.0 for windows and the special
software prepared using Visual Basic 6.0 and Access.
Results: The women were divided into three age groups, 15–19,
20–39 and 40–49. Among 20–39 years-old women (n = 205),
tetanus antibody level was higher in women with 1–3 children
than those without children, demonstrating the effectiveness of
the pregnant vaccination. The age speciﬁc fertility rate in Turkey
is typically cumulated among the ages less than 40 years old,
and the median age of ﬁrst marriage in Turkey is 19.5. Based on
these data women aged 20–39 years old are accepted as
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childbearing aged for analysis. The protective antibody level
among 20–39-year-old was 74.7%, and the subjects who received
more than two single-type tetanus vaccine doses were 58.8%.
Among the provinces studied, Antalya had the highest
immunity (P = 0.024). The percentages of the protective
antibody level among women 20–39-year-ages were 86.6% in
Antalya, 54.8% in Diyarbakir and 78.7% in Samsun. There was
an inverse association between the percentage of the immunity
level and age (P = 0.002).
Conclusion: Although pregnant vaccination seemed to be
effective, the tetanus immunity among women of childbearing
age was not enough. There is a need to reinforce the pregnant
vaccination through intensive antenatal care services and
encouraging pregnant women to receive these services.
P1097
Serological evidence of acute/recent pertussis
infection in Turkey: how big is the threat for
infants?
B. Esen, N. Coplu, D. Kurtoglu, A. Gozalan, L. Akin (Ankara,
TR)
Objectives: In Turkey, whole cell pertussis vaccine is
administered to 2, 3, 4 months olds and a booster to
16–24 month-old children with a coverage of 83%. Regarding
the life-span of antibodies which is 5–12 years and vaccine
efﬁcacy that is around 80%, school children, adolescents, and
adults become vulnerable to the infection. The aim of this study
was to determine the magnitude of acute/recent infection in
older individuals and the threat pertussis infection poses for
infants. We also wanted to measure the antibody levels in
chilbearing aged women to estimate the frequency of passively
acquired protective antibodies in newborns.
Methods: Questionnaires and blood specimens were collected
from 2085 healthy individuals in three provinces from diverse
regions of Turkey. The age groups were between 6 months old
and >60 years old. There were no statistically signiﬁcant
differences in numbers of the subjects based on age group,
gender, and residence (p > 0.05). The IgG anti-PT antibody was
measured by in-house ELISA, 50–99 ELISA Unit (EU)/ml and
‡100 EU/ml were evaluated as acute and/or recent infection,
‡10 EU/ml for protective level and ‡30 EU/ml for chilbearing
age women (n = 406) to protect their babies until the ﬁrst dose of
vaccine in 2nd month. Statistical analysis were done by SPSS
10.0 for Windows, Chi-square test and Pearson Correlation.
Results: The anti-PT titres of 50–99 and ‡100EU/ml were
lowest in 0–1 year-olds with 5.7% and 5.2%, respectively. This
high titres percentage increased by age, and the maximum was
25.0% in ‡60 year-olds for 50–99 EU/ml and 18.5% in
50–59 year-olds for ‡100 EU/ml. In total, there were 15.3%
and 12.5% subjects with 50–99 and ‡100 EU/ml, respectively.
For unprotected individuals, the situation was the opposite, the
highest percentages were observed in 0–1 and 2–3 year-olds
group with 59.1% and 45.8%, respectively, and decreased from
4–5 year-olds to ‡60 year-olds between 34,3% and 6.7%. The
unprotected subjects were totally 24.6%. Antibody titre ‡30 EU/
ml were found in 57.1% of 15–49 year-old women.
Conclusion: There were acute/recent infection in every age-
group and lower than 4 year-olds showed high susceptibility
indicating risk for serious pertussis infection. Besides, nearly
half of the childbearing aged women did not have enough
antibodies to protect their newborns. Improvement of primary
vaccination procedures and additional vaccination in the older
age groups need to be considered for the protection of infants.
P1098
Immunity against tetanus and effect of its
vaccination in Turkey
N. Coplu, B. Esen, A. Gozalan, D. Kurtoglu, K. Miyamura,
S. Ishida (Ankara, TR; Tokyo, JP)
Objectives: The immune status against tetanus in relation to the
vaccination was investigated among healthy population in
Turkey.
Methods: Questionnaires and blood specimens were collected
from 2085 healthy individuals in three provinces from diverse
regions of Turkey. The study subjects were between 6 months
old and ‡60 years old. There were no statistically signiﬁcant
differences in numbers of the subjects based on age group,
gender, and residence (p > 0.05). An in-house ELISA and a
particle agglutination test (Chemo-Sero-Therapeutic Research
Institute, Kumamoto, Japan) was performed to detect antibody.
From the questionnaires 1789 subjects with vaccination history
were evaluated. The statistical analysis was done by using
Visual Basic 6.0 and Access, and the Student’s t-test.
Results: There was a characteristic distribution of the tetanus
antibody titres in different age groups. The titres in the groups
of up to 20-year-olds were distributed with a peak frequency
between 2.0–8.0 IU/ml, but scattered in lower levels in 30-year-
olds, and less than 0.01 IU/ml in the groups older than 40s.
Geometric Mean Titre (GMT) increased by number of vaccine
doses in 0–1 year-olds from 0.205 IU/ml(95%CI;0.066–0.956) for
1 dose to 6.223 IU/ml(95%CI;3.069–12.618) for four doses. Mean
vaccine doses for 0–1; 2–6; 7–9 and 10–19 age groups were 2.95;
3.54–3.86; 4.38 and 4.21 respectively, and afterwards the number
of doses reduced by age and became 1.21 in ‡50 age group. GMT
of the antibody was found 2.54 International Unit (IU)/ml
(95%CI;1.63–3.96) for 2 years olds, reduce to be 0.85 IU/
ml(95%CI;0.58–1.37) in 4 years olds and became 2.21 IU/
ml(%95CI;1.61–2.90) after booster dose in 7–9 years olds
(p < 0.01),(p < 0.01). GMT reduced by age and it was
0.019 IU/ml (95%CI; 0.015–0.025) in ‡50 years olds. This
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reduction was investigated by the duration after the last dose of
vaccination as 0–4, 5–10, 11–19, ‡20 years, and the vaccine doses
were evaluated by 1, 2, 3, ‡4 doses. GMT reduced in all of the
groups from 1.033 IU/ml (95%CI;0.736–1.442 IU/ml) in
0–4 years to 0.0475 IU/ml (95%CI;0.026–0.086 IU/ml) in
‡20 years group in total. The interception of regression line of
X-axis at 0.01 IU/ml (minimum protective level) was
31.6 ± 5.0 years after the last vaccination.
Conclusion: There is good correlation in vaccination and
immune status. Besides, although antibodies persist for
around 30 years after last vaccination, there is need for
additional doses for in adults and the elderly.
P1099
Prevalence of pertussis antibody and vaccination
status in three provinces in Turkey
D. Kurtoglu, A. Gozalan, N. Coplu, K. Miyamura, S. Ishida,
M. Morita, L. Akin, B. Esen (Ankara, TR; Tokyo, JP)
Objectives: The study aimed to asses the immune status against
pertussis among healthy population in three geographically
different provinces in Turkey in relation to the vaccination
status with the whole cell pertussis vaccine combined with
diphtheria and tetanus toxoids (DwPT).
Methods: Community-based seroepidemiological survey was
implemented in Antalya, Diyarbakir and Samsun between
February 2000 and October 2001. Totally 2085 subjects aged
6 months old or above in the 26 health centres were selected
using stratiﬁed randomised sampling method. There was no
statistical difference between three provinces by age group,
gender and residence (P > 0.05). After obtaining consent to
participate, questionnaire and blood samples were
collected. Antibodies to pertussis toxin (PT) and ﬁlamentous
haemagglutinin (FHA) were assayed with in-house enzyme-
linked immunosorbent assay (ELISA). Titres ‡10 ELISA Unit/
ml are accepted as antibody positive. Statistical analyses were
done using SPSS 10.0 for windows and a special software
prepared using Visual Basic 6.0 with logistic regression and Chi-
square tests.
Results: DwPT vaccination coverage with 3–4 doses among
children under 15 year-olds was higher than older ages in every
province (p < 0.05). This value was signiﬁcantly lower in
Diyarbakir (62.3%) than other two provinces (93.4% for
Antalya and 97.7% for Samsun) (p < 0.05). However, antibody-
positive rates for anti-PT and anti-PT/anti-FHA were higher in
Diyarbakir and Samsun than Antalya and for anti-FHA it was
higher in Antalya than Samsun (p < 0.05). Positive antibody
levels for anti-PT and anti-FHA were lowest in the 0–1 year-olds
in the three provinces (30.6–46.3%) and increased with age up to
14 year-olds (71.9–94.1%) maintaining among adults. Among ‡
20 years old anti-PT and anti-FHA positive rates were higher in
female than male (p < 0.05).
Conclusion: No connection between vaccination coverage and
antibody prevalence and the presence of high titred PT antibody
among all ages showed wide prevalence of B. pertussis infection,
suggesting a potential of adults to play a reservoir of B. pertussis.
It is important to achieve high vaccination coverage especially
among infants whose mortality due to pertussis is higher than
other age groups. In addition, the immunization of adults such
as health workers or family who are likely to have close contact
with infants should be considered.
P1100
Analysis of the changes in the tetanus course
during the last 40 years – own observations
A. Kalinowska-Nowak, A. Garlicki, M. Bocizga-Jasik, T.
Mach (Cracow, PL)
Introduction: Tetanus is acute toxicosis, caused by tetanospasmin
elaboratedbyvegetative formsofClostridiumtetani. This powerful
toxin inhibits the release of GABA and glycine on alpha
motoneuron of spinal cord and brain stem, resulting in increase
muscle tone and occurrence of generalised spasm.
Material and methods: Retrospective analysis of 953 cases of
tetanus hospitalised in the Department of Gastroenterology and
Hepatology and Infectious Diseases from 1965 to 2004. 40 years
period of observation was divided at 4 intervals lasting 10 years:
I – 1965–1974, II – 1975–1984, III – 1985–1994, IV – 1995–2004.
Results: 953 patients, 442 (46%) women, 511 (54%) men, with
tetanus were hospitalised in the Department of Infectious
Diseases and Hepatology within 40 years. During the
following investigated intervals number of cases of tetanus
decreased: I–327, II –276, III–248, and IV–102 patients. Also
changes of the patients’ age were observed. In the ﬁrst decade 50
(15%) patients were children less then 15 years old, 260 (80%)
were 16 to 70 years old, and only 17 (5%) persons were older
then 70 years. 3 (1%) children, 218 (79%) patients aged
16–70 years and 55 (20%) older then 70 years old were
hospitalised in the second decade. In the third decade only
one child (0.4%) with tetanus were hospitalised. 135 (54.6%) of
patients aged 16–70 years, and 112 (45%) were older then 70.
During the last ten years, there was no case of tetanus among
children, and all patients were older then 30. 41 (40%) among
them were younger then 70, and 61 (60%) were older. The
mortality rates in the analysed decades were respectively: 28%,
29%, 41%, and 33%. An average mortality rate during the
40 years was 32.5%.
Conclusions: 1. During the last years tetanus is mainly observed
among old persons. 2. In spite of modern treatment of tetanus
mortality rate is still high, because of advanced patient age and
coexisting diseases. 3. Because there is no possibility to eradicate
the Clostridium tetani from natural reservoir, the proper
immunisation is essential, also among old people.
P1101
Seroepidemiology of rubella in reproductive age
women in Attica area of Greece during ﬁfteen
years (1990 – 2004)
P. Karabogia-Karaﬁllidis, M. Orfanidou, H. Vagiakou, E. Sideris,
E. Kontekaki, A. Kefalakis, H. Malamou-Lada (Athens, GR)
Introduction: Rubella is usually a mild disease but infection
during the ﬁrst months of pregnancy can have severe
consequences as congenital rubella syndrome. The national
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rubella immunization programme in Greece was introduced in
1989 and changed after 1999 but no active policy to immunize
adults or susceptible women of reproductive age has been
implemented to date.
Objectives: The purpose of the study was to determine the
current status of rubella immunity in women of childbearing age
over a period of 15 years (1990–2004) and to estimate the
changes to the immunity status after rubella outbreaks in 1993
and 1999 in Greece.
Methods: We examined a total of 5182 serum samples from
women 17–40 years old attending the ‘‘National Reference
Center for rubella virus’’. The samples were tested for total
antibodies by the HAI assay (Rubeo Kit, Biorad) and for IgG and
IgM antibodies by an ELISA (Enzygnost, Dade Berhing-dSLabs).
Results: The susceptibility rate for rubella found to be 29.8%
(660/2217) for the period 1990–1993, 14.7% (283/1931) for 1994–
1999 and 18.5% (191/1094) for the period 2000–2004. In 1993 a
large epidemic of rubella and congenital rubella syndrome
occurred and was followed by a smaller one in 1999. Acute
rubella infection was serologically conﬁrmed in 82 and 53
persons for the years 1993 and 1999 respectively.
Conclusions: The high susceptibility rate for rubella which was
observed among women of reproductive age during the period
1990–1993 resulted to the appearance of rubella’s outbreak in
1993. Although the sensitivity declined sharply after 1993 a
smaller outbreak occurred in 1999. Our results indicate that a
comprehensive policy is still needed in order to eliminate
rubella and congenital rubella syndrome in Greece.
Mycobacterial infections
P1102
Diagnosis of tuberculosis in suspects in endemic
area by using enzyme-linked immunospot assay
for gamma-interferon
P.R. Hsueh, J.Y. Wang, C.H. Chou, L.N. Lee, H.L. Hsu, I.S. Jan,
P.C. Yang, K.T. Luh (Taipei, TW)
Objectives: We evaluate the value of the ex vivo enzyme-linked
immunospot assay for gamma interferon (TB-ELISPOT) for
rapid diagnosis of active tuberculosis in clinical suspects in
endemic area.
Methods: From January to June 2005, patients whose clinical
symptoms and radiographic ﬁndings were compatible with
tuberculosis were recruited and a blood sample was obtained
for TB-ELISPOT assay within 7 days after the microbiologic
studies were performed.
Results: Sixty-ﬁve suspects were studied, including 39 (60%)
with active tuberculosis. Thirty-ﬁve (53.8%) patients had
underlying co-morbid conditions. Thirty-seven patients had
positive cultures for M. tuberculosis, whereas nontuberculous
mycobacteria were isolated in 11 patients. The overall sensitivity
and speciﬁcity of the TB-ELISPOT assay were 87.2% and 88.5%,
respectively. The positive and negative predictive values were
91.9% and 82.1%, respectively.
Conclusion: Our results showed that the accuracy of the
TB-ELISPOT assay for active tuberculosis in clinical suspects is
higher than 80%, even in an environment highly contaminated
with nontuberculous mycobacteria.
P1103
Autoantibodies to cytokines in patients with
mycobacterial infections
G.A. Fernandez-Ramirez, M.E. Rosales, I. Avila-Miyazawa,
L. Ceron-Gutierrez, C. Espitia Pinzon, J. Cabiedes, E. Sada,
J.A. Montaraz-Crespo, R. Dofﬁnger, G. Barcenas-Morales
(Mexico City, MX; Cambridge, UK)
Systemic infections due to non-tuberculous mycobacteria (NTM)
or BCG have been described in patients with immunodeﬁciency.
In particular, individuals with defects in the IL12 dependant
IFNg pathway are selectively highly susceptible to mycobacteria
and Salmonella. Recently, cases of aquired susceptibity to
mycobacterial infection due to high afﬁnity auto-antibodies to
IFNg have been described (1).
Objective: Our goal was to further investigate cytokine speciﬁc
auto-immunity in patients with unusual recurrent and/or
disseminated infections by environmental NTM or
Mycobacterium tuberculosis (Mtb).
Methods: Sera samples included in this study belong to the
following groups: NTM or Mtb disseminated infection (n = 62),
pulmonary TB (25), Systemic Lupus Erythematosus (SLE)/
pulmonary TB (54), SLE (10), vasculitis/pulmonary TB (37),
vasculitis (10), salmonelosis (5), recurrent infections due to other
opportunistic microorganisms. (15), non-related autoimmune
diseases (21), patients on anti-TNFa treatment (4), healthy
individuals (60). Cytokine speciﬁc autoantibodies to IFNg,
TNFa, GM-CSF, IL-1b, IL-6, IL-10, IL-12p40 and IL-18 were
screened by Multiple Antigen Fix Immunoassay (MAFI).
Samples from patients on anti TNF treatment (Inﬂiximab)
were included to control our system. Autoantibodies titer in
positive samples were conﬁrmed by direct ELISA.
Results: We detected auto-antibodies to IL-6 (3 cases), IL-10 (8
cases), IL-12p40 (2 cases), IFNg (5 cases), TNFa (2 cases), and
GM-CSF (2 cases). No auto-antibodies to any of these cytokines
could be found in healthy controls.
Conclusion: Auto-antibodies to cytokines may be present in
Patients with unusual recurrent and/or disseminated infections
by environmental NTM or Mtb. A potential disease modulating
role of these auto-antibodies is discussed.
Reference:
(1) Dofﬁnger, R., Patel, S., Kumararatne, D.S. Human
immunodeﬁciencies that predispose to intracellular bacterial
infections. Curr. Opin. Rheumatol. 2005; 17: 440–6.
P1104
Tuberculin skin testing among health care
workers in a country with a high tuberculosis
prevalence: booster and conversion rates
K. Hizel, F. Ozer, I. Maral, F. Aktas (Ankara, TR)
Objective: To determine tuberculin skin test (TST) survey and
conversion rates among health care workers (HCWs) of a
teaching hospital in Turkey. Thus, to assess whether HCWs are
at increased risk for tuberculosis (TB) in a country with a high
prevalence and universal BCG vaccination. The effect of
previous BCG vaccination on the result of TST was also
investigated.
Method: In 2001, two-step TST was administered to consenting
HCWs of the hospital. All participants completed a standard
questionnaire regarding demographic data including age,
gender, workplace, occupation, previous BCG vaccination and
history of exposure to tuberculosis. In 2003, TST was reapplied
to HCWs with negative reaction after the two-step test.
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Results: Of the 513 participants, 364 (70.9%) had a positive TST
reaction on initial testing. A higher prevalence of positive TST
reaction was found among participants working in the surgical
ward (79.9%; OR 2.58; 95% CI 1.50–4.44) than in the medical
ward (69.1%), and nurses (75.5%; OR 2.15; 95% CI 1.14–4.06)
than clerks (71%), receptionist (68.8%), and administrative
personnel (58.9%). Presence of BCG scar was not signiﬁcantly
associated with positive TST response. Among 114 employees
with a negative TST reaction who underwent a second test, the
booster reaction was found in 12 (10.5%). In 2003, conversion
was found in 10 (16.3%) of 61 participants. Conversion was not
signiﬁcantly associated with any of the variables examined.
Conclusion: In high TB prevalence countries, HCWs are
increased risk for the infection. The effect of previous BCG
vaccination on the result of TST was minimal, and positive
response to TST was related to natural infection rather than
previous vaccination. Our study supports the CDC
recommendations, which emphasize that screening of HCWs
with TST is beneﬁcial to evaluate TB exposure and is suitable for
high TB prevalence countries too.
P1105
Clinical evaluation of a real-time PCR kit for the
detection and partial differentiation of the
M. tuberculosis complex
S. Cramer, M. Hess, F.C. Bange (Hamburg, Hannover, DE)
Objective: Tuberculosis can be caused by all members of the
Mycobacterium tuberculosis complex. For a successful treatment
the identiﬁcation of the mycobacterial species being responsible
for an infection is important. Classically this is achieved by
examining culture material with biochemical and molecular
biological methods. We developed a real-time PCR assay
(artusTM M. tuberculosis diff. LC PCR Kit) for the use with the
LightCycler Instrument (Roche Diagnostics) which allows the
detection and partial differentiation of the M. tuberculosis
complex directly from clinical samples. To evaluate the assay in
total 300 patient samples were retrospectively analysed and the
results were compared with standard methods used in
tuberculosis diagnostics.
Methods: The real-time PCR assay ampliﬁes a 131 bp region of
the mycobacterial nitrate reductase promoter. The amplicon is
detected by ﬂuorogenic probes, which allow to differentiate
M. tuberculosis from other members of the M. tuberculosis
complex by melting curve analysis. In addition, the assay
contains an ‘‘Internal Control’’ for the control of the DNA
puriﬁcation efﬁciency as well as of possible PCR inhibitors. For
clinical evaluation 300 samples of respiratory and non-respirat-
ory origin were used, which had been previously analysed by
culture and acid fast smear (AFS). 200 of the sample were
culture negative for the M. tuberculosis complex, 30 were AFS
negative, but culture positive and 70 were culture positive and
AFS positive. Isolates of mycobacteria were identiﬁed by
sequencing. From all 300 samples the DNA was puriﬁed using
the QIAamp DNA Mini Kit (QIAGEN) and analysed for the
presence and differentiation of members of the M. tuberculosis
complex using the artusTM M. tuberculosis diff. LC PCR Kit.
Results: The analytical sensitivity of the assay for the detection
of M. tuberculosis and the other members of the M. tuberculosis
complex is 6.4 and 10.4 genome copies per PCR, respectively.
The examination of the 300 clinical samples displayed a high
sensitivity and speciﬁcity for the detection of the M. tuberculosis
complex and the discrimination of M. tuberculosis from the other
members of the M. tuberculosis complex.
Conclusion: The artusTM M. tuberculosis diff. LC PCR Kit is a
sensitive and speciﬁc tool for the detection of the M. tuberculosis
complex and the ﬁrst assay, that allows the highly speciﬁc
identiﬁcation of M. tuberculosis directly from clinical samples.
P1106
Serodiagnostic potential of mammalian cell entry
proteins encoded by mce3 operon of
Mycobacterium tuberculosis
S. El-Shazly, A.S. Mustafa, S. Ahmad, R. Al-Attiyah (Kuwait,
KW)
Objectives: The mammalian cell entry (mce) proteins Mce3A,
Mce3D and Mce3E encoded by mce3 operon of Mycobacterium
tuberculosis have previously been shown to be expressed during
natural infection in humans and to elicit antibody production in
TB patients as determined by Western blotting. This study was
carried out to determine the serodiagnostic potential of these
proteins by quantitative detection of anti-Mce3A, -Mce3D and
-Mce3E antibodies in serum samples from TB patients.
Methods: The mce3A-F genes of M. tuberculosis were cloned,
expressed as fusion proteins and the recombinant proteins free
of the fusion partner were puriﬁed. The quantitative detection of
anti-Mce3A, -Mce3D and -Mce3E antibodies in serum samples
from TB patients (n = 58) was performed by ELISA. The serum
samples obtained from healthy BCG vaccinated human subjects
(n = 24) were used as controls and the mean absorbance values
plus 3 standard deviation for control serum samples were used
as cut-off for a positive reaction for serum samples from active
TB patients. The serum samples obtained from healthy long
term contacts of TB patients (n = 24) were also tested.
Results: Nearly all serum samples (>90%) from active TB
patients reacted with Mce3A or Mce3E, 57% reacted with
Mce3D alone while 55% reacted with all the three proteins.
None of the control sera reacted with any Mce3 protein. The
combination of Mce3A and Mce3E detected antibodies in nearly
90% serum samples from active TB patients compared to control
human subjects. Although 75%, 42% and 88% of serum samples
from long term healthy contacts of TB patients also reacted with
Mce3A, Mce3D and Mce3E proteins, respectively, the antibody
levels in this group of human subjects were signiﬁcantly lower
(p < 0.015) than their levels in TB patients.
Conclusions: The data presented here show that Mce3A and
Mce3E encoded by mce3 operon of M. tuberculosis elicit strong B
cell responses in majority of active TB patients and moderate
response in long term contacts of TB patients, the latter grouping
likely to be latently infected with this pathogen. The
signiﬁcantly higher antibody levels in TB patients than those
found in latently infected individuals could be useful for
serodiagnosis of active TB disease while lower levels of
antibodies to these proteins in serum samples may be useful
for identifying latently infected individuals. Supported by
Research Administration grants MI 05/00, MI 02/02 and
College of Graduate Studies, Kuwait University.
P1107
Rapid identiﬁcation of mycobacterial species
with test INNO-LiPA mycobacteria v2 isolated
from sputum samples obtained from
HIV-negative patients
J. Paluch-Oles, M. Koziol-Montewka, M. Dzbrowska,
M. Montewka, A. Bogut (Lublin, PL)
The nontuberculous mycobacteria (NTM) are a group of bacteria
that can cause pulmonary and systemic diseases. An increased
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risk of NTB infections is more frequent in patients with acquired
immunodeﬁciency syndrome (AIDS) and HIV–negative patients
suffering from immunosuppression due to previous pulmonary
disease, old age and alcoholism. For the rapid detection and
identiﬁcation of mycobacteria new strategies have been devel-
oped. These novel methods such as HPLC, the BACTEC NAP
test and commercial DNA probes are recommended for iden-
tiﬁcation of NTM species. Recently, a new molecular test based
on the PCR technique and reverse hybridization procedure has
been introduced for simultaneous identiﬁcation of different
mycobacterial species.
Objectives: The aims of the study were to perform the DNA
line probe assay – INNO-LiPA Mycobacteria v2 for
identiﬁcation of mycobacterial species obtained from sputum
samples collected form HIV-negative patients and to evaluate
the risk factors of pulmonary NTM infections.
Methods: We tested 15 NTM strains from patients with
pulmonary tuberculosis symptoms, isolated in our centre
within the last 2 years. All the strains were processed from
subculture on LJ medium, conﬁrmed as NTM using the niacin
test and morphology assessment of the organisms. The LiPA
assay based on the PCR and reverse hybridization procedure
ampliﬁcated the 16S–23S ribosomal rRNA spacer region.
Subsequently, the biotinylated PCR products were hybridized
with speciﬁc 22 parallel DNA probes and 2 control lines. The
clear pattern of lines allows simultaneous identiﬁcation of 16
different mycobacterial species.
Results: Among 15 NTM isolates the LiPA revealed 6 isolates
identiﬁed as M. kansasii group I, 4 isolates as M. xenopi, and 1
showed a MAIS pattern which also produced a positive result
for speciﬁc M. intracellulare probe. These 3 species were
identiﬁed in 11 alcoholic patients. In 4 patients older than
60 years 2 strains as Mycobacterium spp. and 2 as M. avium-M.
intracellulare-M. scrofulaceum (MAIS) were identiﬁed.
Conclusion: This study demonstrated usefulness of the INNO-
LiPA Mycobacteria v2 test for the rapid identiﬁcation of
mycobacterial species and revealed M. kansasii, M. xenopi and
M. avium-complex species considered the most frequent
mycobacteria causing lung disease in immunocompromised
alcoholic and old patients.
P1108
A new automated method for sample preparation
of Mycobacterium tuberculosis respiratory
specimens based on magnetic particles
J. Lyse`n, T. Engen, H.K. Høidal Berthelsen, M. Espelund,
S. Jeansson, U.H. Refseth (Oslo, NO)
Objectives: Mycobacterium tuberculosis is today the single
greatest cause of mortality due to an infectious agent.
Routinely, mycobacterium infections are diagnosed by
microscopic examination for the presence of acid-fast bacilli
(AFB) and by conventional culture techniques. Detection of
mycobacterium by culture takes between from 1 week to
2 months, and AFB testing both lacks sensitivity and
speciﬁcity. Compared to culture, sensitivity using various
available NAAT systems is generally lower. In addition,
NAAT based systems require much hands-on time to obtain
DNA/RNA of sufﬁcient quality. Thus, the requirement for both
a rapid and sensitive diagnostic system for TB diagnostics is still
largely unmet.
Method: A pilot study has been performed applying an
automated sample preparation for mycobacterium DNA from
respiratory samples utilizing magnetic particles. In this system
(BUGS’n BEADSTM, Genpoint, Norway), heat-inactivated
mycobacterium cells are initially adsorbed to paramagnetic
particles and magnetically separated from the sample material.
A rapid lysis at RT releases DNA, which is then adsorbed onto
the same magnetic particles. After washing, puriﬁed DNA is
transferred to micro-wells for real-time PCR analysis. As a
reference all samples were cultivated in conventional liquid and
solid medium up to 8 weeks. A few samples were analysed
using the BUGS’n BEADS followed by Roche Cobas Amplicor
detection system for M. tuberculosis as well.
Results: For smear positive respiratory samples there was full
agreement between the BUGS’n BEADSTM isolation procedure
combined with PCR detection and conventional cultivation.
There was also100% agreement with results obtained using the
BUGS’n BEADSTM combined with Cobas Amplicor detection
and cultivation.
Conclusion: The results indicate that with the BUGS’n BEADS
sample preparation system, sensitivity comparable with
cultivation is obtainable for smear positive samples. The
results from the BUGS’n BEADSTM procedure combined with
RT-PCR or Cobas Amplicor could be obtained within a working
day, whereas several weeks were necessary to identify
M. tuberculosis positive samples by cultivation. Furthermore,
the fact that both PCR and the Cobas Amplicor procedure can be
used as downstream detection systems, demonstrates that
different NAAT may be used in combination with BUGS’n
BEADSTM. To further challenge the system, smear negative
samples and non-respiratory samples will be included in a more
extensive study.
P1109
Gold nanoparticle probe-based diagnostic system
for rapid and sensitive detection of
Mycobacterium tuberculosis
M. Koziol-Montewka, J. Paluch-Oles, P. Baptista (Lublin, PL;
Lisbon, PT)
Tuberculosis has re-emerged as a major infectious disease in
several areas in the world and M. tuberculosis (MTb) infections
continue to increase worldwide with an estimated annual
growing rate of 3%. The application of new methods based on
nanotechnology can simplify the bacterial DNA detection and
improve MTb identiﬁcation making the diagnosis of infections
caused by this pathogen faster and less expensive than conven-
tional methods. Here we describe a rapid and sensitive color-
imetric method based on the use of gold nanoparticles
functionalised with thiolated oligonucleotides for MTb detection
directly from clinical samples without the prior DNA ampliﬁ-
cation.
Objectives: The aim of our work was to screen clinical
specimens for the presence of MTb using approved INNO-
LiPA RifTB kit and a novel gold nanoprobe-based method.
Methods: The used gold nanoprobe-based method consisted on
visual and spectrophotometric comparison of the blank
(containing the gold nanoprobes alone), negative (containing
DNA from samples previously tested and conﬁrmed as negative
for MTb) and positive (containing DNA from samples positive
for MTb) solutions. After the NaCl addition blank and negative
samples turned from the initial pink to a blue–purple colour,
denoting gold nanoprobes aggregation. In case of positive
samples, the solutions maintained their original pink colour
after the NaCl addition. The presence/absence of gold
nanoprobe aggregation was corroborated by UV/visible spectra.
Results: We tested 47 clinical samples from patients with the
suspicion of pulmonary and extra pulmonary tuberculosis. The
gold nanoprobe method proved to give consistent positive or
negative results with validated INNO-LiPA RifTB kit for the
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MTb DNA detection in 42 out of 47 samples. Five out of 47
samples were interpreted as "non-consistent" possibly due to the
DNA content being under the threshold of the method.
Conclusion: The results indicate that DNA-derivatives gold
nanoparticles hybridization is a sensitive and speciﬁc tool for the
identiﬁcation of MTb directly in clinical samples without prior
ampliﬁcation by PCR.
P1110
Development of tools for detection of DNA and
mRNA from mycobacteria in clinical samples
N. Potapova (Moscow, RU)
Objectives: Tuberculosis is one of the leading causes of
mortality among infectious diseases. The conventional
methods for detection of Mycobacteria in clinical samples are
based on the demonstration of the acid-fast organisms following
cultivation. In the last years polymerase chain reaction (PCR)
has been used for detection of M.tuberculosis in different tests
and has been shown to be at least as sensitive as the classical
methods.In this study development of Real-Time PCR-based
tests for identiﬁcation of DNA and mRNA fromM.tuberculosis is
described. Prokaryotic mRNA has a short half-life and can be
found only in viable organisms.
Methods: Clinical samples. A total of 70 samples of sputum
were obtained from patients treated for a period of severel
months. DNA and RNA isolation was conducted with Trizol
reagent (Life Technologies) according to the manufacturer’s
speciﬁcation. Primers. The speciﬁc mRNA target is transcribed
from Mtp-40 gene. One of the primers (37 nucleotides) was used
for reverse transcription. First 20 nucleotides of this primer were
complementary to mRNA. Other 17 nucleotides were chosen
randomly and were identical to one of primers for PCR. Two
other primers (20 and 17 nucleotides) were used for Real-Time
PCR.Reverse Transcription was performed at 42C. Annealing
temperature for PCR ampliﬁcation of cDNA was 70C.
Annealing temperature for PCR ampliﬁcation of DNAwas 60C.
Results: Different methods for detection of M.tuberculosis in
sputum of 70 patients were compared. These were: the
developed Real-Time PCR with previous reverse transcription
and classical methods (bacteriology and microscopy). The
research showed high correlation between the data sets
obtained by the PCR and RT-PCR and classical methods.
Conclusions: The developed tools for identiﬁcation of DNA
and mRNA from M.tuberculosis could be applied for
differentiation of viable and nonviable M.tuberculosis. It is
useful for rapid diagnostics and monitoring of the efﬁcacy of
treatment of tuberculosis.
P1111
Diagnosis of tuberculous pleuritis by nested
polymerase chain reaction: a comparison of four
different volumes of pleural ﬂuid
N. Jaimchariyatam, K. Kawkitinarong, K. Naweewitphadung,
N. Udomsantisuk, S. Tumwasorn, W. Kulwichit (Bangkok, TH)
Objectives: Tuberculous Pleuritis remains a major health
problem worldwide. Laboratory diagnosis usually involves
pleural ﬂuid (PF) analysis and pleural tissue histopathology
plus both specimens for culture and PCR. Diagnostic yields of
PF PCR, however, is variable in different studies. Large volumes
of specimens may give a better microbiologic diagnosis in
certain conditions, as described in PF culture for M.tuberculosis
and in PCR of vaginal discharge for C.trachomatis. Higher PF
volumes may provide a better diagnostic yield of TB pleuritis.
Methods: A prospective observational study was conducted in
patients with lymphocytic exudative pleural effusion at our
university hospital from December 2004 to November 2005.
Diagnosis of TB pleuritis is made by EITHER presence of pleural
granuloma with or without acid fast bacilli plus a response to
antituberculous therapy OR positive mycobacterial cultures of
PF and/or pleural tissue. Patients with other ﬁnal diagnoses
served as a control group. Pleural ﬂuids were divided in the
laboratory into four different volumes of 1, 10, 50, and 150 ml
before processing. The specimens were then centrifuged and the
pellets produced were used for DNA extraction. Nested PCR
using primers targeting IS6110 conserved among organisms in
the TB complex group was performed. All standard PCR
precautions were exercised. Presence of PCR inhibitors was
tested in all specimens.
Results: 29 patients and 24 controls were enrolled (Table). In
the TB group, 6, 8, 12, and 6 of 29 specimens of 1, 10, 50, and
150 ml showed positive PCR results (sensitivity of 20.69%,
27.59%, 41.38%, and 20.69%, respectively). All control samples
revealed negative results in all volumes used. The 150-ml group
with positive PCR also gave positive results in all other volumes.
The 50-ml group with positive PCR covered positive results in
all other groups plus 4 additional cases. Processing of the 150-ml
specimens occasionally produced large, sticky pellets potentially
affecting the DNA quality. PCR inhibitors were detected in three
specimens (from different patients) of 10, 50, and 150 ml each in
the controls.
Conclusion: Higher volumes of pleural ﬂuid increase a
diagnostic sensitivity of tuberculous pleuritis by PCR to a
certain extent. Too-large volumes, however, are unsuitable,
probably due to presence of interfering proteins and other
substances. Appropriate pleural ﬂuid volumes should be
assessed and veriﬁed in each laboratory.
P1112
The value of the QuantiFERON-Gold TB test in
the management of patients with suspected active
tuberculosis
J. Democratis, S. Bailey, M. Barer, N. Pereira, I. Stephenson,
K.G. Nicholson, M.J. Wiselka, J. Democratis (Leicester, UK)
Objectives: The QuantiFERON-Gold TB Test detects interferon
gamma production when whole blood is incubated with
puriﬁed mycobacterial antigens. The test is able to detect
latent and active TB, but has not been fully evaluated in
patients presenting with suspected active TB. This study
investigated the use of the test after its introduction in a large
Regional Teaching Hospital in the UK with a high incidence of
tuberculosis infection.
Methods: The QuantiFERON-Gold TB test was introduced into
routine clinical practise in our centre in early 2005 and patient
details were prospectively entered into a clinical database. This
study reviewed the patient demographics, indications for
testing, turnaround time for results and the additional clinical
value of the test. The QuantiFERON-Gold TB Test was
performed in all patients attending the Department of
Infection with suspected active tuberculosis and results were
compared with conventional tests including tuberculin skin
testing (TST), microscopy, culture, histology and radiology.
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Results: During the study period (Jan-Sept 2005) 270 tests were
requested. The majority of requests were for suspected active
tuberculosis in patients attending the Department of Infection,
including HIV-positive and other immunosuppressed patients.
The number of patients receiving TST’s declined as the
QuantiFERON-Gold TB test was introduced. Over 40% of
patients had conﬁrmed tuberculosis infection and there was
generally good agreement between the clinical ﬁndings and the
QuantiFERON-TB test. However 4 cases of disseminated TB in
immunocompetant patients had negative tests, the possible
reasons for this ﬁnding will be discussed. In 18% of cases the test
was considered to have led to a change in clinical management
with anti-TB therapy either commenced or discontinued as a
direct result of the QuantiFERON-Gold test result.
Conclusions: The QuantiFERON-Gold TB test was of
considerable value in the management of patients with
suspected TB and led to a change in treatment in a signiﬁcant
number of patients. The results must be interpreted in
conjunction with all other available information, but interferon-
gamma tests are likely to play an increasingly important role in
the management of patients with suspected TB and will replace
the use of tuberculin skin testing in our institution.
P1113
Prospective MIRU-VNTR typing of
Mycobacterium tuberculosis isolates: initial
epidemiological analysis of isolates typed in the
Midlands from 2003–2005
J.T. Evans, E.G. Smith, S. Gardiner, J. Mowbray, H. Mossop,
B. Olowokure, P. Monk, P.M. Hawkey (Birmingham, Leicester,
UK)
Objectives: From 2003–2005, all 1,952 M.tuberculosis isolates
received at Midlands Regional Centre for Mycobacteriology
were prospectively typed by MIRU-VNTR. The aim was to
prospectively detect links between patients with active TB
disease in support of conventional methods. The initial analysis
of epidemiological data is presented in this study.
Methods: The 3 ETR and 12 MIRU-VNTR loci were ampliﬁed
for each isolate and 5 lL of each amplicon loaded onto a
WAVE DNA Fragment Analysis System and analysed at
0.9 ml/min for 8.2-min (20–900 bp) at 50 C. Basic epidemio-
logic data was gathered from specimen forms and analysed in
comparison to MIRU-VNTR typing results using BioNumerics
version 4.01.
Results: The clustering rate in ten strategic health regions
ranged from 41–57%, with an average of 53%. Clustered MIRU-
VNTR proﬁles were present in from 1 to 9 regions with any
MIRU-VNTR clustered proﬁle present in a median of 3 different
regions. The median patient age was 35 years old with a range
of 0 – 97. The most prevalent age group was 20–34 years old
with 767 (39 %) patients, with 399 isolates (20%) from patients
over 60 years old. 1,304 (67%) isolates were respiratory
specimens and 636 were non-respiratory (33%) with 12
unknown (1%). The most prevalent MIRU-VNTR Proﬁle was
VNTR 32333 MIRU 224325153314 with 70 isolates (3.6%)
detected in 14 laboratories and 7 health regions across the
Midlands. 30 isolates (1.5%) were rifampicin resistant, 106
isolates (5.4%) were isoniazid resistant, and 23 patients (1.2%)
were infected with MDR-TB. 8 MDR-TB isolates were grouped
into 3 clusters by MIRU-VNTR typing, representing a 4.3%
transmission rate of MDR-TB, thus suggesting that MDR-TB is
not transmitted in the Midlands.
Conclusion: The relatively high transmission rate, proportion
of respiratory cases and relatively low median age of cases,
suggests that the emergence of TB in the Midlands may be due
to newly acquired infections and not to disease reactivation.
P1114
Evaluation of clinical utility on direct detection of
MTBC on clinical samples by BD Protec ET
System
J.S. Lin, Y.Y. Yu, C.Y. Lin (Changhua, TW)
Objectives: The clinical utility and outcome of molecular
diagnosis directly on clinical samples becomes popular and
the performance needs to be monitored periodically. This study
aimed to assess the performance of BD Protec ET system (Protec)
in direct detection of MTBC in pulmonary and non-pulmonary
samples in a tertially care medical centre.
Methods: From 2004 to October 2005, we retrospectively
reviewed laboratory results of pulmonary and non-pulmonary
samples that were referred for direct detection of MTBC by
Protec. d-TB probes (BD) were used to amplify a DNA fragment,
i.e., IS6110, within MTBC gene. The positive rate of MTBC
identiﬁed by Protec were compared with the one which was
determined by a rapid culture system (BD Bactec MGIT 960)
followed by molecular identiﬁcation using in-house multiplex
PCR.
Results: A total of 424 clinical samples consisting of 195
pulmonary (46.0%)and 229 non-pulmonary (54.0%) specimens
were recruited for this study. Non-pulmonary samples were
obtained from ascites (16), blood (51), CSF (59), pleural effusion
(32), gastric juice (12), synovial ﬂuid (3) and urine (48), pus (1)
and others (7). Only 134 (31.6%) of 424 samples were also
requested for MTBC culture simultaneously. The positive rate
for MTBC by Protec was 19.8% (84/424), whereas they were
24.6% (48/195) in pulmonary and 15.7% (36/229) in non-
pulmonary samples, respectively. Among 134 samples
submitted to Protec as well as culture, the positive rate for
MTBC by Protec was 21.6% (29/134) as compared with 10.4%
(14/134) by culture. This pattern was also shown in a subgroup
analysis when Protec was compared with culture, i.e., 22.2% vs.
11.1% in pulmonary samples and 21.1% vs. 9.9% in non-
pulmonary samples. Only 11 (8.2%) of 134 samples showed
positive for MTBC by both Protec and culture (7 in pulmonary
and 4 in non-pulmonary subgroups). Three samples positive for
MTBC by culture (3/14, 21.4%) were negative by Protec,
whereas 18 (18/120, 15.0%) samples positive for MTBC by
Protec was negative by culture. The concordance rate (both
positive and both negative) between Protec ET System and
culture was 84.3%.
Conclusion: A lower submission rate (31.6%) for MTBC culture
along with direct detection was noted in clinical behaviour.
Although the concordance rate of MTBC identiﬁcation between
direct detection and culture seems acceptable, the high false
negative rate of Protec reminds of the importance of
simultaneous culture of MTBC in direct detection on clinical
samples.
P1115
Clonal diversity ofMycobacterium tuberculosis in
sputum specimen from individual patients of
pulmonary tuberculosis
C. Shiohira, Y. Bhusal, N. Yamane (Okinawa, JP)
Objectives: The isolation of Mycobacterium tuberculosis from
sputum specimen is the principal tool to make a deﬁnite
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diagnosis on tuberculosis patients. Each isolate is generally
considered to be monoclonal by nature and is directly employed
for phenotypic and genotypic characterization. However, the
properties of individual colonies from a single specimen largely
remain unknown. In the present study, we determined clonal
diversity of M. tuberculosis isolates from individual patients of
pulmonary tuberculosis by using antimycobacterial
susceptibility testing and IS6110 restriction fragment length
polymorphism (RFLP).
Methods: A total of nine patients were included in the study.
Five were newly diagnosed and four were undergoing
chemotherapy. The sputum specimen was treated with NALC-
NaOH, then plated on Middlebrook 7H11 agar plates. After
incubation, 10 to 15 colonies were selected and subcultured. For
individual colonies, antimycobacterial susceptibilities against
eight agents were determined by broth microdilution test and
DNA ﬁngerprinting patterns were analysed using IS6110 RFLP
as well as spoligotyping.
Results: There were signiﬁcant differences among the
individual colonies from a single isolate on susceptibility
testing. Three isolates, including one newly diagnosed, were
mixtures of susceptible and resistant colonies against
streptomycin, isoniazid and/or ethambutol. Whereas, RFLP
revealed that ﬁve isolates, including three newly diagnosed,
contained heterogeneous colonies on RFLP. However, we found
no signiﬁcant correlation between RFLP patterns and
antimycobacterial susceptibilities.
Conclusions: The study indicates that, in some patients of
pulmonary tuberculosis, clonal diversity on phenotypic and
genotypic characterization is present. The diversity of the
isolates from patients treated with antimycobacterial agents
were likely, because of the induction of drug resistance through
the accumulation of spontaneous mutations. However,
polyclonal infection with M.tuberculosis in patients not
previously treated is often the case. Possible infection with
polyclonal strains of M.tuberculosis and heterogeneity in drug
susceptibilities during the single episode of tuberculosis is an
important consideration from epidemiological and therapeutic
aspects.
P1116
Agreement of QuantiFERON-TB Gold In-Tube
and T Spot-TB in HIV-infected patients from
Sub-Saharan Africa in Switzerland
M. Reichmuth, C. Thurnherr, F. Suter-Riniker, P. Vernazza,
H. Furrer, T. Bodmer for the Swiss HIV Cohort Study
Objectives: HIV co-infection is themost important risk factor for
the progression of latent tuberculosis infection (LTBI) to overt
tuberculosis disease. Diagnosis of LTBI traditionally relies on
tuberculin skin test (TST) results. Speciﬁcity of TST is confounded
by previous BCG vaccination resulting in false-positive TST
results. Sensitivity is reduced in patients with severe
immunosuppression with cutaneous anergy, resulting in false-
negative TST results. Novel interferon-gamma release assays
(IGRA) utilize M.tuberculosis speciﬁc antigens providing results
not confounded byBCG-vaccination. The goal of our studywas to
compare the performance of two commercially available IGRA in
patients of the Swiss HIV Cohort Study (SHCS).
Patients: From November 2004 to March 2005, 34 HIV-positive
immigrants (14 males, 20 females) originating from Sub-Saharan
Africa were prospectively studied for LTBI during their regular
clinical follow-up visits as patients of the SHCS. The respective
CD4+ cell counts were: >500/mm3 in 7 pts; 200–499/mm3 in 23
pts; and <200/mm3 in 2 pts. The median CD4+ cell count was
375/mm3 (range, 91–922/mm3).
Methods: Two IGRA test systems were used according to the
respective kit instructions: QuantiFERON-TB Gold In-Tube
(QFT; Cellestis Ltd., Carnegie, Australia) and T Spot-TB
(Oxford Immunotec Ltd., Oxford, UK). For the latter,
peripheral blood mononuclear cells were separated from 8 ml
citrate-blood (Vacutainer Cell Preparation Tubes, Becton
Dickinson, Franklin Lakes, USA) within two hours after
phlebotomy. For QFT, INF-gamma release into the plasma was
detected by EIA provided by the manufacturer; for T Spot-TB,
INF-gamma spot forming cells were counted by the AID Elispot
Reader System (AID GmbH, Strassberg, Germany).
Results: A total of 6/34 (17.6%) and 7/34 (20.6%) patients had
positive test results with QFT and T Spot-TB, respectively. The
observed agreement between both assays was 97% (kappa =
0.91, 95% conﬁdence limits 0.72–1.00).
Conclusions: The very good agreement between QFT and T
Spot-TB suggests that both assays are equivalent for the
diagnosis of LTBI in HIV patients.
P1117
Role of serologic tests (IgG, IgA, IgM antibodies
against A60 mycobacterial antigen) in diagnosis
of tuberculosis
H. Emadi, M. Rasoolinejad, O. Zarghom, S. Siroos Jafari,
Z. Ahmadinejad, Z. Abdi Liae, S. Davoudi, M. Hassibi,
A. Soodbakhsh (Tehran, IR)
Objectives: The identiﬁcation of acid-fast bacilli (AFB) in
sputum or tissue is the deﬁnite diagnosis of tuberculosis.
However, this method of diagnosis is restricted by certain
limitations. The serologic diagnosis of tuberculosis has been
used for a long time. The aim of this study was to determine the
sensitivity and, speciﬁcity of Antigen 60 (A60) IgG, IgA, IgM
ﬁndings in patients with tuberculous and to assess its
application in the serologic diagnosis of pulmonary
tuberculosis.
Methods: ELISA test based on mycobacterial A60 was used to
measure speciﬁc IgA, IgM and IgG antibodies in the sera of 127
cases of tuberculosis, 13 cases of tuberculous HIV positive
patients and 95 controls (46 were healthy volunteers and 49
other controls were patients with chronic diseases of different
types.) The data of A60 IgG using enzyme-linked immunosorb-
ent assay (ELISA), chest radiography, tuberculosis culture and
pathology were obtained. The cutoff value of A60 IgG, IgA and
IgM were chosen according to a receiver operating characteristic
(ROC) analysis. The sensitivity, speciﬁcity and positive likeli-
hood ratio were determined.
Results: The mean levels of IgG, IgA and IgM was signiﬁcantly
higher in patients of pulmonary tuberculosis when compared
with control groups.Sensitivity of the IgG test was 54.3%, while
the speciﬁcity was 84.2%. The IgA test showed a sensitivity of
670.1% with a speciﬁcity of 80%. Combination of the IgG and
IgA tests showed a sensitivity of 45.7% and a speciﬁcity of 94.7%
and the positive likelihood ratio was 8.62. In this study the
chosen cutoff value of IgG IgA, IgM set at 285,265 and 0.9 ELISA
units.
Conclusions: Our study shows a good speciﬁcity (94.7%) and a
reasonable positive likelihood ratio (8.62) of the test when
combined IgA and IgG with new cutoff points are considered, in
the diagnosis of adult’s tuberculosis. The combined use of both
tests allows an increase in diagnosis of tuberculosis.
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P1118
Implementing DOTS in settings with high
prevalence of drug-resistant tuberculosis
Y. Balabanova, I. Fedorin, S. Zakharova, V. Nikolayevskyy,
R. Atun, R. Coker, F. Drobniewski (London, UK; Samara, RU)
Only a few DOTS programmes have been implemented in the
Russian Federation, one of 22 high burden countries.
Objective: Describe DOTS cohorts recruited in Samara Oblast
(pilot Oblast) and assess the outcomes.
Methods: DOTS cohorts were recruited from April 2002 till
September 2004 across civil and prison sector. Standard
technical documentation and diagnostic/treatment protocols
have been employed. All received cultures underwent
subsequent epidemiological molecular typing using IS6110
insertions detection in the dnaA-dnaN intergenic region.
Results: 2093 patients were recruited. Only 29.3% of new cases
were smear-positive in total and 42.9% of all new cases had
bacteriologically conﬁrmed TB. Drug resistant rates including
multi-drug resistance were substantial with signiﬁcantly higher
rates in prison patients versus civil patients (Table 1).
Approximately half of all isolated strains (51.7%; 371/717)
belonged to the Beijing family with a signiﬁcantly higher
proportion isolated from prisoners compare to civilians (60.9%;
117/192 vs 48.4%; 254/525; RR1.3 (95%CI 1.1–1.5). In total 75.3%
(592/786) of patients successfully completed the course of TB
therapy while 7.3% (57/786) failed or defaulted, the rate being
signiﬁcantly higher among smear-positive patients compared to
smear-negative (RR 3.3; 95%CI 2.0–5.4). The death rate was 3.6 %
(28/786); a signiﬁcantly higher proportion (11.3%) of smear-
positive cases dying versus smear-negative (RR 11.2; 95% CI 4.6–
27.2).
Conclusions: Lower case detection rate can be addressed by
changing the national policy of radiological screening;
prioritarisation of bacteriology in diagnostic, monitoring and
measurement of cure of TB as well as and further improvement
of laboratory services. The rate of successful treatment was
below the 85%WHO threshold but slightly higher than reported
from other DOTS pilot regions in the former Soviet Union. High
prevalence of primary drug resistance (associated with Beijing
strain) proves active transmission. It is vital to improve patients’
adherence to therapy to reduce acquired resistance and improve
institutional infection control measures to prevent transmission.
Introduction of rapid techniques of drug resistance





T. Bregenzer, F. Schmid, C. Ebno¨ther (Aarau, CH)
Background: Guidelines recommend empiric therapy (ET) for
tuberculosis (TB) with four ﬁrst-line drugs. Patients with
multidrug-resistant (MDR) TB are at risk for treatment failure
and acquiring additional resistance. MDR TB has to be
considered if standard regimen fails. MDR is prevalent in up
to 14% in countries of the former Soviet Union.
Case report: We report on a case of a 20-year-old Mongolian
woman who presented with night sweats and abdominal pain in
May 2004. She travelled to Switzerland in March 2004.
Microscopic sputum examination, culture and PCR were
negative. Chest CT-scan showed multiple nodules in both
lungs and the mediastinum. Bronchial biopsies showed
necrotisizing granulomas. ET was started with rifampicin
(RIF), isoniazid (INH), pyrazinamid (PZA), and ethambutol
(EMB). Fever persisted and the patient’s condition deteriorated.
CT-scan showed progressive disease with multiple abscesses
and vertebral osteolytic lesions. Cultures were repeated and ET
was switched to linezolid, moxiﬂoxacin and amikacin in August
2004. Resistance tests (October 2004) showed resistance for INH,
RIF, EMB, SM, PZA and Cycloserin. It was sensitive to
ﬂuorochinolons, linezolid, amikacin, PAS, and capreomycin.
Sequential resistance tests conﬁrmed that PZA resistance was
acquired during the ﬁrst ET. In Dec 2004 a simpliﬁed oral
regimen was started with linezolid and moxiﬂoxacin. The
further course was complicated by severe peripheral axonal
degeneration probably due to linezolid (December 2004) and
catheter related P. aeruginosa sepsis (March 2005) after replacing
linezolid by amikacin. As of May 2005 the patient was in good
general condition. Therapy was discontinued after 12 months,
august 2005.
Conclusions: Standard treatment with four or ﬁve ﬁrst-line
agents may fail in patients who immigrate from regions with a
high prevalence of MDR TB and may induce further resistance.
If ET is necessary in a patient with suspected MDR TB local
resistance data should be taken into consideration. The risk of
treatment failure with ET has to be weighed against the risks
associated with delayed treatment while waiting for resistance
results.
P1120
Rapid drug sensitivity testing of M. tuberculosis
based on culture on a porous ceramic support
C. Ingham, A. Ben Ayad, R. Hummelink, B. Mulder (Den Bosch,
Enschede, NL)
Objective: The growth of M. tuberculosis rate-limiting in many
diagnostic procedures including drug sensitivity testing (DST).
Attempts to speed up DST for this organism have included the
detection of microbial metabolism and the optical imaging of
microcolonies. Currently, there is no molecular method for
determining the full drug resistance pattern required to guide
effective treatment regimes. The objective of this work was to
use a highly porous ceramic (Anopore) as a culture support
to facilitate the rapid detection of M. tuberculosis growth, and to
apply this capability to DST. This is a novel methodology, one
that exploits the high porosity and excellent culture and imaging
properties of Anopore.
Methods: Sterile anopore strips were placed upon Middlebrook
7H10 agar plates and inoculated with M. tuberculosis stains 445
(RIFS, INHS) and 473 (RIFS, INHR). The plates were incubated
in a CO2 incubator at 37 degrees C. Cultures were then killed by
placing on ﬁlter paper disks saturated with methanol or by heat
treatment. This was followed by the transfer of the Anopore to a
microscope slide covered with a ﬁlm of solidiﬁed agarose
containing 20 lM Syto16 dye for 45 min. Staining of cells on the
Anopore surface was accomplished with minimal disruption of
the microcolonies on the surface. Microcolonies were then
imaged directly using an Olympus BX41 epiﬂuorescence
microscope equipped with Fluorotar lenses. Image capture
used an 8-bit Kappa CCD camera and BMP ﬁles of images
were analysed using ImageJ software.
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Results: Colonies of M. tuberculosis were visible with 14 days
incubation on Anopore strips placed on Middlebrook 7H10 agar
plates and were similar in size and morphology to culture
directly on the same agar base. Individual cells and
microcolonies could be detected after Syto 16 staining. After
only 2–3 days culture the increase in microcolony area was
found to be signiﬁcant (P < 0.001, n < 200, 2-tailed Mann
Whitney U-test) indicating growth had occurred. DST testing
against Isoniazid and Rifampin is in progress and the results
will be shown.
Conclusions: Anopore is an effective culture support for
M. tuberculosis. Imaging microcolonies in situ has been used to
detect growth within a few days of inoculation and is now being
applied to DST. The ability to kill, stain and image microcolonies
in situ was facilitated by the porous, inert and rigid nature of
Anopore.
P1121
Identiﬁcation of the Mycobacterium tuberculosis
subtype strongly associated with multidrug
resistance within the Beijing family
V. Nikolayevskyy, T. Brown, Y. Balabanova, Y. Bazhora,
A. Asmolov, F. Drobniewski (London, UK; Odessa, UA)
Background: Investigation of M. tuberculosis drug resistance
rates, prevalence of certain genotypes and their association with
mutations conferring drug resistance in Ukraine may contribute
signiﬁcantly to the development of appropriate interventions to
combat converging TB and HIV epidemics.
Objectives: (i) to determine the degree to which isoniazid,
rifampicin and multiple drug resistance (MDR) was associated
with Beijing family isolates and subgroups within Beijing
family; (ii) to identify molecular genotyping methods suitable
for differentiation of isolates in populations where highly
conserved genotypes dominate; (iii) to conﬁrm our hypothesis
that the prisons are major drivers of drug resistance.
Methods: Non-commercial reverse hybridization assay
(macroarray) was used for detection of key mutations
responsible for the development of resistance to rifampicin
and isoniazid. Genotyping was done using multilocus VNTR
typing using the panel of 12 MIRU and 3 ETR loci. Beijing strains
were identiﬁed using spoligotyping.
Results: Total of 225 M. tuberculosis strains isolated from
patients with radiologically and bacteriologically conﬁrmed TB
in Odessa and Nikolaev regions of the Southern Ukraine were
investigated. MDR rates were signiﬁcantly higher in former
prison inmates compared to those never been in prisons (54.8%
vs 27.3%, RR 2.01, 95% CI 1.35–2.97). Mutations in codons 528–
533 of the rpoB gene and codon 315 of the katG gene dominated
in drug resistant strains. The overall discriminatory ability of
VNTR genotyping for the given group of Ukrainian isolates was
higher than that provided by spoligotyping (HGDI 0.968 versus
0.878) with 68.6% of Beijing strains comprising two large clusters
formed of 35 and 21 strains sharing the MIRU-ETR signatures
223325153533424 and 223325173533424 respectively. Isolates
with the latter MIRU-ETR signature were more common
among previously imprisoned patients. Prevalence of mutations
conferring MDR was signiﬁcantly higher in the subgroup of
Beijing strains sharing VNTR signature 223325173533424 com-
pared to other Beijing strains (71.4% vs 45.7%, RR 1.74, 95% CI
1.17–2.57).
Conclusions: Signiﬁcantly higher prevalence of drug-resistant
Beijing strains in former prison inmates suggests that prisons are
major drivers of drug-resistant TB. Beijing genotype with VNTR
signature 223325173533424 is strongly associated with drug
resistance and may be responsible for rapid transmission of
MDR TB in Ukraine.
P1122
Extrapulmonary tuberculosis in sector III of
Zaragoza, Spain during 2000–2005
M.P. Macipe, A. Vitoria, J.A. Amiguet, A.I. Lo´pez-Calleja,
M.A. Arias, P. Crusells, J. Cuesta, C. Rubio (Zaragoza, ES)
Objectives: To analyze the evolution and the clinico-
epidemiological characteristics of the cases of extrapulmonary
tuberculosis with microbiological conﬁrmation, in population
belonging to the Sector III of Zaragoza, H.C.U."Lozano Blesa"
between 2000–2005. To value by means of RFLP the relationship
between the isolated strains and the different clinical
presentations of the disease.
Material and methods: A retrospective study of all patients
with extrapulmonary TBC was made (cases with positive
culture to M. tuberculosis, in any location different to the
pulmonary one) during the period to study. We revised the
variables: Age, nationality, origin service, type specimen, clinic,
HIV, sensibility to antituberculostatic drugs and evolution of the
disease. We studied the RFLP carried out in the Faculty of
Medicine in Zaragoza in all the isolated strains between June
2001 and June 2005, to establish the relationship between the
found clusters and the different extrapulmonary locations.
Results: We isolated M. tuberculosis, in extrapulmonary
locations, in 58 patients. The biggest number of cases (25%)
was in the year 2004. The most frequent locations were: pleural
TB, lymphnode TB and genitourinary TB. Only in 31% of the
samples, the baciloscopy was positive. 84% of the strains grew in
Lowestein-Jensen medium, and 91% made it in the MB/Bactec
means. Only 5 of them (8%) presented some type of resistance to
antituberculostatic drugs: 3 resistant to isoniazid, 1 to isoniazid/
estreptomicini and another one to isoniazid/etambuhtol. 15% of
the patients were immigrants, most of them coming from Africa,
in which any resistance type was not detected. Most of the
patients were HIV negative or this serologic determination was
ignored. In the 58 isolated strains, 8 of them were part of some
cluster, from those tipiﬁcated among all the cases of pulmonary
and extrapulmonary tuberculosis, diagnosed in the period of the
study. In one of them, coming from pleural biopsy, we found
resistance to isoniazid.
Conclusions: The extrapulmonary locations were the 22% of
the patients’ diagnosed of tuberculosis. These manifestations
depend on factors associated to the host. There are not data to
conclude that identical patterns of RFLP correspond to speciﬁc
locations of the disease. M. tuberculosis tipiﬁcation by using
IS6110 has proved to be a valuable tool in epidemiological TBC
studies. Cases of extrapulmonary TBC appear inside the clusters
determined in the period to study.
P1123
Evaluation of tuberculin skin test and
Quantiferon-TB gold for the identiﬁcation of
LTBI or active TB among irregular immigrants in
Milan, Italy
G. Orlando, S. Merli, A. Valerio, L. Cordier, M. Bergonzi,
A. Villa, A. Cargnel (Milan, IT)
Objective: Tuberculosis infection is increasing worldwide.
Targeted testing to identify persons at high risk for TB who
would beneﬁt from treatment for latent TB infection (LTBI)
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would include recent or irregular immigrants from developing
countries. Tuberculin skin testing (TST), generally accepted for
routine evaluation, does not differentiate betweenM. tuberculosis
infections and BCG vaccination and, needing at least 2 accesses
to health care facilities, has a reduced diagnostic power in
critical settings. Here we report an interim analysis of a clinical
trial in which TST and Quantiferon-TB Gold are evaluated for
the identiﬁcation of TB infections among irregular immigrants.
Methods: Consented immigrants observed in the Opera San
Francesco outpatients department for any health problem
underwent to TST evaluation (time 0 and 72 h) through
injection of 0.1 mL of 5 TU PPD and to a blood puncture. TST
was considered positive for an induration less than 10 mm
(recent immigration) or greater than 15 mm (old immigration).
Whole heparinized venous blood samples were analysed after
16–24 h incubation through Quantiferon-TB assay for cell
mediated immune responses to M. tuberculosis-speciﬁc
antigens (ESAT-6, CFP-10).
Results: Since July 2005, 121 (71 F, 50 M) immigrants have been
enrolled; median age 37 years (IQR 29–45). Countries of origin
were Latina America 53.7%, Eastern Europe 25.6%, Asia 10.7%,
and Africa 9.9%. The patients arrived in Italy <1 year (29.4%),
1–3 years (47.9%), 3–5 years (9.2%) and >5 years (13.4%) before
the test. The overall positivity to at least 1 test was 51.2%. TST
were positive in 43 (35.5%), with 18 patients dropped out.
Quantiferon-TB test resulted positive in 44 (36.36%). 103 coupled
test are available: concordance of results were obtained in 68%.
Discordance was characterized by 14.6% Quantiferon pos/TST
neg results and 17.4% Quantiferon neg/TST pos results. In 4/18
dropped TST patients (22.2%) a positive Quantiferon TB test was
identiﬁed.
Conclusions: This analysis underlines that recent immigration
from developing countries and irregular immigration are factors
related to increased risk of infection and progression to clinically
active disease. TB infection control need targeted screening
programs able to reach all susceptible populations. The very
high prevalence of positive results in at least 1 test and of
discordant data suggest the need for further analysis.
This work is supported by a grant from Provincia di Milano.
P1124
Tuberculosis epidemiology in a health care area
of Santiago de Compostela (Galicia, NW Spain)
from 1996 to 2004
V. Tn˜ez, M.L. Pe´rez del Molino, P.A. Romero, M. Conde,
F. Pardo (Santiago de Compostela, ES)
Objective: A Tuberculosis Control and Prevention Gallego
Programme (PGPCT) has been conducted in Galicia, organized
in Health Care Areas, attended in a Reference General Hospital
by territories. There are seven Health Areas in Galicia, each one
has a Tuberculosis Unit with: medical assistance, surveillance-
control, and recording data of all cases of the area. The aim of
this study is to analyze the Tuberculosis epidemiology changes
during the period 1996–2004 in the Health Care Area of Santiago
de Compostela (459.180 inhabitants).
Methods: An epidemiologic descriptive study of temporary
inclination was conducted, the variables included are:
localization, HIV co-infection and Directly Observed Therapy
(DOT). Microbiological studies considered: auramine stain,
growth in liquid medium (Middelbrook 7H9-ESPII) and solid
Coletsos medium. We identiﬁed the strains with M tuberculosis
complex AccuProbe.
Results: During this period 2197 cases has been diagnosed, 1286
(58.5%) males and 911 (41.5%) females. The incidence rate
descended from 72.79/100.000 in 1996 to 33.58/100.000 in 2004.
The incidence for pulmonary disease decreased from 45.86/
100.000 to 22.92/100.000 meanwhile the bacilliferous cases
decreased from 26.70/100.000 to 16.44/100.000 from 1996 to
2004. The pulmonary location is 65.4%, 25.1% extrapulmonary
and 9.5% pulmonary+extrapulmonary. In 1996 we had 119
bacilliferous patients, 145 positive cultures and 32 clinical
diagnosis (no microbiological conﬁrmation), while in 2004
there was 71 bacilliferous cases, 83 positive cultures and 9
clinical diagnosis. 3.7% of DOT were conducted in 1996 in
comparison with 19.4% in 2004. Maximum incidence was
detected between 15–44 years old. Cases with HIV coinfection
has been reduced from 4.34% in 1996 to 2.1% in 2004.
Conclusions: 1. -Tuberculosis disease incidence in Santiago is
higher than expected for its social and economic level, but it
decreased since this programme has been established, probably
due to the exhaustive follow up of the cases and DOTs
implementation. 2. -A high incidence persists in younger
groups, specially with pulmonary disease, although a decrease
was observed. 3. -The percentage of HIV and tuberculosis
coinfection is not determinant of the epidemiological
characteristics of tuberculosis in Santiago.
P1125
Tuberculosis in paediatric and adult population
in Athens, Greece (1994 – 2004)
S. Kanavaki, S. Karabela, A. Skroubellou, E. Varonou, S.
Anagnostou, A. Raftopoulou, H. Moraitou, N. Spyridis, S.
Nikolaou (Athens, GR)
Objectives: We studied retrospectively the new pediatric and
adult TB cases diagnosed in the National Reference Laboratory
for TB in Athens during the period 1994 – 2004.
Material & Methods: Pediatric TB cases were 77, while adult
TB cases 4278. From children, 32 were <2 years, 21 were 2–
5 years, 14 were 6–10 years and 10 were 11–16 years of age.
Results & Discussion:
• A peak in new TB cases was noticed in 200, for both
populations studied. It is of great concern that the peak of
pediatric and adult TB cases was noted in 2000, when migration
reached the highest peak in Greece.
• In relation to resistance to the main ﬁrst line antituberculus
drugs, 15.5% of the TB isolates in pediatric population were
resistant to Isoniazide (INH), 3.8% to Rifampicin (RIF), while
3.8% were multidrug resistant (INH+RIF). However, it is
interesting that in adult population, resistance to INH was
signiﬁcantly lower 9.1%, resistance to RIF was 4.2% and
multidrug resistance 3.5%. Concerning Streptomycin (SM), it is
also interesting that 14.2% of pediatric TB isolates were resistant,
in contrast to 2.5% of TB isolations in adult population studied.
For having a satisfying explanation of these ﬁndings, it is
necessary to further investigate young patients’ medical ﬁles, in
an attempt to associate contacts of young patients with infected
adults, which is our purpose in the near future.
P1126
Screening of immigrants for tuberculosis in
Greece: implications for health care needs
M. Matsagoura, M. Kompoti, A. Koutsovasili, A. Salta,
A. Papaefstathiou, M. Matsagoura (Thiva, GR)
Immigrants from countries with a high prevalence of tubercu-
losis (TB) may allow a signiﬁcant contribution to the increasing
TB rate in the industrialized world. Screening for tuberculosis
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enables new immigrants to receive important medical evalua-
tion and treatment and provides useful surveillance data.
Objective: The aim of this study was to assess the prevalence of
tuberculin skin testing (TST) positivity among immigrants
newly arrived in Greece.
Materials and methods: To be allowed a residence permit, all
immigrants in Greece are screened for TB. Screening procedure
includes TST, a chest X-ray and thorough physical examination.
All immigrants screened for TB during a two-month period in
2005 were included in our study. Demographical data were
recorded for all subjects. Statistical analysis was performed
using logistic regression and Pearsons chi-square test for
categorical variables, Student’s t-test for normally distributed
and Mann-Whitney U test for skewed numerical variables.
Statistical signiﬁcance level was set at p < 0.05.
Results: A total of 237 immigrants were screened (172 males
and 65 females). Mean age was 31.0 ± 10.6 years and mean time
in Greece 2.8 ± 1.9 years. One-hundred twenty-one immigrants
originated from Europe (51%), 109 (46%) from Asia and 7 (3%)
from Africa. TST was positive in 41 subjects (17.3%), 28 males
(16.2%) and 13 females (20%), p = 0.725. There was no
signiﬁcant difference in the prevalence of TST positivity in
respect to origin. Among 86 subjects who developed a detectable
skin induration, the presence of BCG scar was not associated
with a greater TST reaction size (10.6 ± 6.7 mm vs.
11.6 ± 6.1 mm in subjects with and with no BCG scar,
respectively, p = 0.552).
Conclusions: The prevalence of positive TST among
immigrants to Greece is not negligible. A BCG vaccination in
the early childhood must not substantially alter the
interpretation of TST in adults. Given the low risk of acquiring
TBC after arrival in Greece, preventive therapy should be
considered for all immigrants with positive skin test (TST), a
clear chest X-ray and no recent exposure to a known source case
of tuberculosis, after adjusting for the risk of adverse effects
from chemoprophylactic agents.
P1127
Epidemiology of Mycobacterium bovis disease in
Ferrol, Spain, 1991–2004
J.F. Garcı´a Rodrı´guez, H. lvarez Dı´az, V. Trasancos Buitrago,
M.V. Lorenzo Garcı´a, A. Marin˜o Callejo, P. Sesma Sa´nchez
(Ferrol, ES)
Objectives: To examine the current epidemiology of
Mycobacterium bovis disease and to compare patient
characteristics to those of patients with M. tuberculosis disease
in our community.
Methods: Prospective study of surveillance, epidemiological,
and treatment completion data for cases of tuberculosis in our
Tuberculosis Unit between 1991 and 2004. Variables examined
included sex, age, race, country of birth, main location of
disease, drugs susceptibility, HIV infection status, initial
medications, medical provider type, treatment completion
and course of disease. Differences between M. bovis and
M. tuberculosis patient characteristics and treatment completion
rates were compared using the v2 test or the Fishers exact test.
Medians were compared using the Mann–Whitney test.
Differences were considered statistically signiﬁcant at a level
of p < 0.05.
Results: 787 cases of culture-positive tuberculosis were
identiﬁed, of these 782 were M. tuberculosis and 5 (0,6%) were
identiﬁed as M. bovis, (incidence 0.17 per 100,000 person-years).
All the patients infected withM. boviswere HIV-negative adults,
they were born in Spain, none had travelled outside of Spain
and no links that might allow airborne person-to-person
transmission of M. bovis were discovered among any of the
patients. They were older (51.2 ± 14.3 vs 38.1 ± 19.1 years) and
had more extra-pulmonary disease (80% vs 32.1%, p < 0.05)
compared with M. tuberculosis patients. M. bovis isolates were
resistant to pyrazinamide but there were not differences in
resistence to isoniazid (0/5 vs 12/451) and rifampin (0/5 vs
1/450 ) compared with M. tuberculosis. The median treatment
duration was approximately 3 months greater for M. bovis than
for M. tuberculosis patients. Differences in frequency of Direct
Observed Treatment (1/5 vs 37/781), treatment completion rates
(Default 0/5 vs 42/776), toxic hepatitis (0/4 vs 49/770) and
evolution (Death by TB 1/5 vs 21/782; Relapse 0/4 vs 9/771)
was no signiﬁcant. Mean follow-up was 26.7 ± 25.9 months
(range, 1–174; person-months, 21055).
Conclusion: The predominant clinical presentation was consis-
tent with progression from latent TB infection. No person-to-
person airborne transmission was identiﬁed.M. bovis infection is
frequently of extra-pulmonary localization. Duration of treat-
ment tended to be longer for patients infected with M. bovis and
completion rates and evolution were comparable to those of
patients infected with M. tuberculosis.
P1128
Tuberculosis as re-emerging disease in Italy.
Which correlations with HIV infection and other
risk factors, comparing native residents and
foreign immigrants?
R. Manfredi, S. Sabbatani, G. Legnani, F. Chiodo (Bologna, IT)
Background: Tuberculosis (T) is borne by increasing morbidity
and mortality rates, due to changes of epidemiologic scenario,
and diffusion of resistant strains. The recent, profound
modiﬁcations occurred among predisposing factors (increase
mean patient [p] age, concurrent diseases, jatrogenic
immunosuppression, alcoholism, drug use, migration, and
HIV pandemic), played a key role in this process.
Methods: Among the 128 consecutive p hospitalized due to T
since 1996, we compared the 77 p from Italy with the 51
immigrants from extra-European countries, in relation of a
number of risk factors, including HIV infection.
Results: Compared with immigrants, native Italian p had a
higher frequency of HIV-AIDS (32.4%; p < 0.001), and a
prodominant pleuro-pulmonary involvement versus lymph-
node and/or disseminated T among HIV-infected p versus
non-HIV-infected ones (p < 0.01). Moreover, Italians had a
greater mean age (p < 0.001), and an increased frequency and
a broader spectrum of predisposing conditions (positive history,
chronic lung, heart, liver, kidney disease, diabetes mellitus,
malignancies, and collagen vascular disease; p < 0.03), while
foreigners had a lower frequency of more generic supporting
factors (low income, economic-social problems, cigarette smoke,
and alcohol-drug abuse; p < 0.03 versus Italians). Our decade
experience shed light on two different patterns of T. Local p are
predominatly represented by elderly with frequent concurrent
disorders and speciﬁc T risk factors, a more frequent HIV
infection, and a predominant involvement of sites other
than pulmonary ones, while immigrants are represented by
otherwise healthy younger p, who develop prevalent lung
localizations.
Conclusions: The clinicians awareness of T needs further
attention, in order to obtain a rapid diagnosis and treatment,
and reduce transmission risks. The progressive integration of
immigrants with local population may lead to increased risks of
T dissemination, especially among the local, more vulnerable
and older population.
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A randomised trial of a short course with
isoniazid plus rifampin in front of isoniazid
during six months in latent tuberculosis infection
D. Van˜o´, M.P. Geijo, C. Rosa, A. Molina, M. Pe´rez,
J.F. Dimas (Cuenca, ES)
Objective: To evaluate compliance, side effects and the efﬁcacy
of a short course of chemoprophylaxis for tuberculosis with
isoniazid plus rifampin during 3 months, compared with a
course with isoniazid during 6 months.
Patients and methods: Prospective, comparative, randomized
and open study of patients with the suitable criteria for
chemoprophylaxis, in accordance with the guidelines of the
Centres for Disease Control of 1990. HIV positive patients were
excluded. Patients were divided into 2 groups: group I received
isoniazid (300 mg per day) plus rifampin (600 mg per day) for
3 months, and group II received isoniazid (300 mg per day) for
6 months. We realised clinical and analytical follow-up during
the period of treatment.
Results: 83 patients were included, 36 in the group I and 47 in the
group II. Both groups were comparable at base level. It was
hepatotoxicity in the 52.8 % of patients of group I in front of the
21.3 % in the group II (p < 0.01). There were no signiﬁcative
statistical differences in serious hepatotoxicity (8.3% vs 2.3%),
digestive toxicity (5.6% vs 14.9%) or cutaneous toxicity (2.8% vs
2.1%). Chemoprophylaxis was retired before the end of the
treatment in 5 patients of the group I and in 4 patients of the group
II. The average follow-up of the patients was 52.14 months. No
case of tuberculosis has been detected up to the moment.
Conclusions: A short course with isoniazid plus rifampin during
3 months is equal of effectively that the standard coursewith isoniazid
during 6 months in the latent tuberculosis infection. The toxicity in
short course is lower, probably in the minor time of exposition.
P1130
Mycobacterium sherrisii: a new opportunistic
agent in HIV-infected patients?
P. Loulergue, F. Lamontagne, V. Vincent, A. Rossier,
G. Pialoux (Paris, FR)
Background: Various atypical mycobacteriae have been
described to cause disease in HIV- infected patients. We report
the ﬁrst case of a disseminated infection with Mycobacterium
sherrisii in an advanced immunocompromised patient.
Case report: A 53 year old Causasian male, was referred to our
hospital in May 2005. A fever of unknown origin and a general-
ized weakness have been noticed for several months. The patient
was tested positive forHIV infection in September 2003 during an
hospitalisation for pulmonary tuberculosis. In February 2005, an
antiretroviral therapy was started with nevirapine, lamivudine
and stavudine. A relapse of tuberculosis was suspected and
treated with rifampicin, isoniazid, ethambutol and pyrazin-
amid.On admission, his CD4 cell count was 19.106/ml. Six to
nineteen days later ﬁve sputum samples, one peritoneal effusion
sample and two blood cultures grew positive with atypical
mycobacteria. This bacteria was thought to be M. simiae. Treat-
ment was changed for clarithromycin, rifabutin and ethambutol,
without clinical improvement neither microbiological control
(another blood culture was positive). The ﬁnal identiﬁcation
revealedM. sherrisii after two months. The drugs susceptibilities
were tested by BACTEC method and showed sensibility to
clarithromycin, ethambutol, rifabutin, intermediate sensibility to
amikacin and resistance to ciproﬂoxacin. Eventually, we added
amikacin and moxiﬂoxacin with a relative efﬁcacy (general
improvement, negativation of bacterial samples).
Discussion: M. sherrisii is a recently described mycobacteria,
phylogenetically related toM. simiae. Diagnosis has been conﬁrmed
by gene sequencing of 16S rRNA and hsp65, and DNA-DNA
hybridization. The only clinical case reported before was a HIV-
infected african male with a pulmonary injury. A combination of
clarithromycin, rifabutin, ethambutol, moxiﬂoxacin and amikacin
showed clinical and microbiological efﬁcacy in our case but other
combinations were ineffective despite of in vitro sensitivity.
Conclusion: Infection with M. Sherrisii can be considered as an
emerging pathogen in HIV infected patients with poor
immunologic status. The best treatment is not yet deﬁnite, and
may not be strictly correlated to in vitro data.
P1131
Presence of mycobacteria in colon biopsies from
patients with inﬂammatory bowel disease
I. Szpinda, A.T. Jorde, I. Olsen, B. Djønne, M. Vatn,
T. Tønjum (Oslo, NO)
Objectives: Crohn’s disease is a chronic condition with inﬂam-
mation in the intestines. A strong correlation between the
presence of Mycobacterium avium subspecies paratuberculosis and
Crohn’s disease has previously been inferred, and a far higher
incidence ofM. a. paratuberculosis PCR positivity has been shown
in the gut of Crohn’s patients than in healthy people. It is,
however, not clear if M. a. paratuberculosis has an etiological
impact in the pathogenesis of Crohn’s disease, or if it is just a
coincidence in that Crohn’s patients have an increased predis-
position for colonisation by M. a. paratuberculosis. We extended
this question to ask if there is an increased presence of
mycobacteria in general in colon biopsies from patients with
inﬂammatory bowel disease (IBD; Crohn’s disease and ulcerous
colitis) as compared to healthy people. To facilitate the myco-
bacterial detection we used cultivation in enriched media in
combination with direct detection by PCR.
Methods: Biopsies were prospectively taken from inﬂammatory
lesions from all sections of the colon from 200 patients submitted
to colonoscopy with suspected IBD. One hundred healthy
controls were also included. Patients were later grouped
according to IBD status: Crohn’s disease, ulcerous colitis, other
condition or healthy colon. The biopsies were investigated for
the presence of mycobacteria by M. a. paratuberculosis-speciﬁc
IS900 PCR analysis and cultivation in the BACTEC MGIT 960
continuous culture system. The specimens were cultivated in
mycobactin-enriched BBLTM Middlebrook 7H9 medium.
Mycobacterial strains isolated were identiﬁed by species-
speciﬁc hybridization and PCR, as well as 16S rDNA PCR
sequencing and blast analysis.
Results: Among the samples from 60 out of the 200 patients to be
included, only 1 patient was culture positive and 5 patients were
IS900 PCR positive. These patients all had Crohn’s disease.
Mycobacteriawere so far notdetected inbiopsies from thehealthy
controls. The results from the completed study will be presented.
Conclusion: Taken together the ﬁndings from this study will
generate novel knowledge on the occurrence ofmycobacteria in the
human gut. This will extend the basis for deﬁning mycobacteria
have an etiological role in IBD, with special emphasis on Crohn’s
disease.
P1132
Prevalence of nontuberculous mycobacteria in a
Belgian adult cystic ﬁbrosis population
M. Develter, W. Laffut, L. Dupont, J. Verhaegen (Leuven, BE)
Objective: With the increased survival of cystic ﬁbrosis (CF)
patients, colonisation and infection with new respiratory
pathogens have emerged. Among these are nontuberculous
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
mycobacteria (NTM). NTM are ubiquitous micro-organisms, but
geographic differences in their prevalence exist [1]. The present
study was done to determine the prevalence of NTM in the
adult CF-patients attending the university hospital of Leuven
(Belgium).
Methods: During an 18 month period (February 2004 until June
2005) sputum samples were obtained from 83 adult CF patients
while attending the outpatient clinic. These samples were decon-
taminated using the NALC-NaOH method as described by the
American Society for Microbiology [2]. The Mycobacteria Growth
Indicator Tube (MGIT) (Becton Dickinson, USA) was used as a
culture medium with incubation for 6 weeks in BACTEC MGIT
960 (Becton Dickinson, USA). In the case of overgrowth with
micro-organisms other than mycobacteria, a second decontam-
ination following the method described by Bange et al. [3] was
performed on samples indicated by the clinician.
Results: Of 83 patients, 363 samples were obtained (1–12
samples/patient). For 46 patients, no growth of all samples
(146) was seen. The remaining 37 patients had a mixture of no
growth (128 samples) and overgrowth (89 samples), mostly with
Gram negative organisms (60%), a minority with Gram positive
organisms (30%) and a mixture of both (10%). On 17 (for 15
patients) of the overgrown samples secondary decontamination
was performed with 2 samples remaining contaminated. There
were no grown cultures with NTM.
Conclusion: NTM were not recovered from the airways of
Belgian adult CF-patients despite secondary decontamination
procedures.
References:
1. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina
PL, Tomashefski J, Knowles MR. Nontuberculous mycobacteria
in cystic ﬁbrosis study group. Nontuberculous mycobacteria. I:
multicenter prevalence study in cystic ﬁbrosis. Am J Respir Crit
Care Med 2003; 167(6): 828–834.
2. Pfyffer GE, Brown-Elliott BA, Wallace RJ. Mycobacterium:
general characteristics, isolation and staining procedures. In:
Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds.
Manual of clinical microbiology. 8th edn. Washington: ASM
Press, 2003: 532–559.
3. Bange FC, Bo¨ttger EC. Improved decontamination method for
recovering mycobacteria from patients with cystic ﬁbrosis. Eur J
Clin Microbiol Infect Dis 2002; 21: 546–548.
P1133
Tuberculous empyema necessitatis involving
chest wall and retroperitoneum
O.K. Aribas, E. Turk-Aribas, I. Erayman, F. Kanat,
A. Ozturk (Konya, TR)
Empyema necessitatis (EN) is a rarely seen infection of soft
tissue, which is formed by the spontaneous drainage of
empyema through the parietal pleura. Although the most
common site is subcutaneous tissue of the chest wall, it may
include esophagus, breast, retroperitoneum, pericardium, groin
and vertebral column. We present a patient with ES of chest wall
and retroperitoneal space with psoas abscess complicated by
untreated tuberculous empyema. A 21-year-old male patient
was admitted with two months history of two growing masses
on the left posterolateral chest wall and left lumber area
following a left chest pain. Physical examination revealed
ﬂuctuating, 6 cm diameter, ﬁxed, painful two swellings and
diminished pulmonary sounds on the left hemithorax. Chest x-
ray disclosed disclosure of the left costadiaphragmatic sinus and
narrowing of the left intercostals spaces. Chest CT scan revealed
a subcutaneous, 12·6·8 cm in diameter, loculated collection of
high density ﬂuid on the left lateral chest associated with pleural
space and a multiloculated, 15·12·8 cm in diameter ﬂuid
collection between paraspinal musculature and lying into the
psoas muscle in the retroperitoneum. Thoracenthesis revealed
an empyematous ﬂuid with negative nonspeciﬁc culture and the
culture of aspiration of the thoracic wall mass was also negative
for any nonspeciﬁc bacilli. Laboratory examination was normal
except a mild leucocytosis and an increased ESR of 136 mm/
hour. Left thoracotomy was performed with a diagnosis of ES.
Purulent collections in the pleural space and in the abscess
formations within thoracic wall and retroperitoneum were
aspirated and later the patient underwent resection of the
destructed tissues and left pleural decortication. The procedure
was completed with a placement of the drainage tubes into the
pleural, abdominal wall and retroperitoneal spaces. Histopath-
ological examination of the resected tissues and pleura con-
ﬁrmed granulomatous inﬂammation with caseous necrosis.
INH, RIF, EMB and PZA were given to the patient for two
months and the treatment was continued for additional
7 months with INH and RIF. After 9 months of therapy the
patient was in good health. EN is a well-known, however,
extremely rare complication of the tuberculous empyema.
Although the morbidity and mortality were high It is possible
to treat with appropriate surgical debridement, drainage and
antituberculous treatment without sequelas.
P1134
Increasing incidence of Mycobacterium xenopi in
Zaragoza, Spain: an emerging pathogen or a
product of improved laboratory methods?
S. Terraza, J.A. Amiguet, A. Vitoria, M.A. Lezcano, C. Ramos,
P. Arazo, J. Cuesta (Zaragoza, ES)
Objectives: To investigate the clinical signiﬁcance of M. xenopi
isolation and explore the clinical spectrum of M. xenopi disease
in Zaragoza, Spain.
Methods: A retrospective study was carried out between
January 1990 and December 1999 in Miguel Servet Hospital,
Clı´nico Lozano Blesa Hospital, and Royo Villanova Hospital.
Diagnosis of the disease was performed according to American
Thoracic Society criteria.
Results: Thepatient charts of 96 patients inwhich an isolate ofM.
xenopi had been recorded were reviewed. We recovered 40 M.
xenopi isolates from1990 to 1994, and 56 isolates from1995 to 1999.
We considered 10 patients to be suffering from disease caused by
M. xenopi. The number decreased for the second half of the study
period (7 vs. 3 cases). Pulmonary disease was the most frequent
clinical presentation (90%). One patient had clinical M. xenopi
disseminated disease during this period. Eighty percent of all
patientswith diseaseweremale. Themean agewas 39.5 year. The
most commonrisk factors associatedwithdiseasedue toM.xenopi
were smoking (90%), infectedwith the human immunodeﬁciency
virus (HIV) (40%), and chronic obstructive pulmonary disease
(30%). The mean CD4 cell count of the HIV-infected patients at
diagnosiswas 48x 106/L.Themost frequent clinical featureswere
the respiratory symptoms (100%), followed by fever (60%), and
constitutional symptoms (30%). Chest radiographs revealed
cavitating pulmonary disease in 50% of all patients, and nodular
disease in 30 %. The incidence of unilateral disease was 60%. The
most common treatment regimen was isoniazid, rifampicin, and
ethambutol, and the average duration was 10 months. With
treatment, all cases of non-HIV-associated disease had favourable
outcomes, but those of HIV-associated pulmonary and dissem-
inated disease were poor (50%).
Conclusion: The increase inM. xenopi isolates noted in the three
main hospital in Zaragoza (Spain) was due to changes in culture
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technique, and a more sensitive laboratory isolation technique,
rather than a true increase in clinical disease. Chronic pulmonary
disease is the most common clinical manifestation ofM. xenopi in
the nonimmunocompromised patient, but in HIV-infected
patients causes both disseminated and pulmonary disease.
P1135
Mycobacterium chelonae and continuous
ambulatory peritoneal dialysis associated
peritonitis. An unrecognised entity?
I. Gupta, P. Cockwell, I. Das (Birmingham, UK)
Introduction: Continuous ambulatory peritoneal dialysis
(CAPD) is the initial treatment for 30–40% of patients with
end-stage renal disease (ESRD) in the UK. Peritonitis is the
major complication and is a frequent indication for
discontinuation of CAPD. Mycobacteria are rarely reported
from such peritonitis.
Objective: To describe an unusual case of CAPD peritonitis due
to Mycobacterium chelonae (M. chelonae).
Methods: University Hospital Birmingham is one of the UK’s
leading centres for renal dialysis and transplantation.
Investigation for CAPD peritonitis includes microscopy of
peritoneal dialysis (PD) ﬂuid for white blood cell count and
culture by inoculation into blood culture bottles which is
monitored by an automated system (Bactec 9240, Becton
Dickenson Microbiology system).
Case: A 75-year old man with ESRD was converted to CAPD in
May 2004. After 2 months he developed cloudy PD efﬂuent and
abdominal pain but no fever. He was started on intraperitoneal
(IP) vancomycin andoral (PO) levoﬂoxacin according to the unit’s
protocol. Microscopic examination of the PD ﬂuid revealed 333
neutrophils, 207 mononuclear cells. It signalled positive on day 5
of incubation but no organism could be seen onmicroscopy.After
4 days of incubation of the subculture plates, ﬁne growth became
visible. Microscopy of the growth showed a faint Gram-positive
bacillus which was subsequently found resistant to all routinely
tested antibiotics. Identiﬁcation of the organism proved difﬁcult
by routine laboratory methods and was later identiﬁed as
M.chelonae by the reference laboratory (Health Protection
Agency, London). Antibiotic treatment was changed to PO
clarithromycin and IP amikacin, the latter was subsequently
changed to PO ciproﬂoxacin on the basis of sensitivity result.
Clinical and laboratory signs of peritonitis persisted in spite of
2 weeks of antibiotics. The CAPD catheter was then removed
which resulted in gradual resolution of symptoms. The catheter
tip grewM.chelonae.Antibiotics were continued for 5 months. At
one year of follow up the patient remains well and is free of any
peritonitis related complications.
Conclusions: Atypical mycobacteria including M.chelonae
should be considered in culture negative CAPD peritonitis.
Investigation of CAPD peritonitis should include procedures for
mycobacterial isolation. Removal of peritoneal catheter in
addition to antibioticswas required inmanagement of peritonitis.
P1136
Nontuberculous mycobacterial keratitis after
photorefractive keratectomy for myopia
D. Mylona-Petropoulou, G. Vrioni, G. Ganteris, D. Miltsakakis,
A. Kyratsa, C. Mougnai, A. Kouris, S. Levidiotou,
H. Malamou-Lada (Athens, Ioannina, GR)
Objectives: To report a case of nontuberculous mycobacterial
keratitis after photorefractive keratectomy for myopia.
Methods: A 45-year-old woman in good health developed
increased conjunctival redness, swelling and marked decrease of
vision in the right eye, 6 weeks after unilateral photorefractive
keratectomy for myopia. Initial treatment included topical
steroids, oﬂoxacin ophthalmic drops, and systemic treatment
with ﬂuconazole and vibramycin. After 4 more weeks without
improvement, the patient was referred to our hospital. A
diagnosis of infectious keratitis with corneal ulcer in the right
eye was made. Corneal scrapings were sent for culture and
microscopic examination, and therapy with vancomycin and
tobramycin was initiated.
Results: Acid-fast bacteria were seen on smears. Cultures on
Lowenstein-Jensen medium grew Mycobacterium chelonae
complex (group III, M. abscessus) that was identiﬁed using
two different reverse hybridization line probe assays: GenoType
Mycobacteria CM (Hain Lifescience, Germany) and INNO-LiPA
Mycobacteria v2 (Innogenetics, Belgium). Susceptibility testing
was performed by E test method (Solna, Sweden) and the isolate
was susceptible to amikacin and clarithromycin. Based on
microbiological results, topical therapy using amikacin was
initiated. After 5 weeks of treatment due to no-improvement,
topical imipenem was added to her treatment regimen. All
medications were discontinued 4 weeks later and ﬁnal visual
acuity was 7/10.
Conclusions: This case emphasizes the possibility of
nontuberculous mycobacterial keratitis as a potential sight-
threatening complication after photorefractive keratectomy for
myopia and the possible difﬁculties in treating such infection.
Early and accurate diagnosis can lead to prompt management of
the infection with immediate and aggressive antibiotic therapy.
P1137
Leprosy elimination campaign in the Qazvin
province, Iran, 2004
R. Qassemi Barqi (Qazvin, IR)
Introduction: Leprosy Elimination Campaigns are the whole
innovative actions that, they are accomplished for leprosy cases
ﬁnding particularly Multi Bacillary type of them. To promote
the health staff’s capacity, increasing of people’s knowledge and
participation of them about different activities for leprosy
elimination, leprosy cases ﬁnding and treatment of them by
Multi Drug Therapy are the main aims of the LEC. Most
endemic countries have achieved LEC, from 1995.
Objective: The purpose of this study is leprosy new cases
ﬁnding among house hold contacts of Previous patients with
leprosy and also among natives of the endemic areas in the
Qazvin province.
Materials and Methods: In this intervention and cross-
sectional study, the ﬁrst; names and addresses of the patients
with leprosy that had been recorded & treated during 1958–2003
in the Qazvin province; are listed based on Qazvin Health
Centre of province of documents. Then, household contacts of
these patients were recognized and recorded locally. They were
examined from having leprosy signs point of view by expert
team. Cutaneous smears were prepared from suspected cases.
Smears were studied for leprosy bacteriology by microscope.
Results: During study period 1768 household contacts of 319
previous patients with leprosy and 60 > 8 person from the
endemic areas were examined. Suspect cases of leprosy were
258, that 13 cases of them were conﬁrmed as new patients with
leprosy (Incidence Rate = 1.7 /1000). From typing point of view
7 cases (54%) were Multi Bacillary, and 6 cases (46%) were Puci
Bacillary. No one of the new patients were in < 20 years- old age
group.
Discussion & Conclusion: The performance of LEC in the
Qazvin province indicated action programme for the
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Elimination of Leprosy in this province has achieved its goals in
all districts (< 1/10000 population). Also, there was no one
patient in < 20 years- old age group, that indicates success of the
leprosy treatment by MDT in the past two-decade.
P1138
The ﬁrst reported European case of intravascular
catheter infection with Mycobacterium neoaurum
S. Musaad, N. Young, G. Robinson, D. Gascoyne-Binzi,
A. Rajgopal, A. Barrett, D. Norfolk, T.A. Collyns (Leeds,
Newcastle, UK)
Case Report: An 18 year old, newly diagnosed acute myeloid
leukaemia (AML) patient had a Hickman line inserted prior to
commencement of appropriate chemotherapy. He developed a
pyrexia on day 2 post commencement of his second cycle of
chemotherapy and blood cultures (BCs) through both lumina of
his Hickman line yielded ‘‘diphtheroid-like’’ Gram positive
bacilli (GPB). The organism was susceptible in vitro to
vancomycin and a course of this agent resulted in clinical
resolution. After his second cycle of chemotherapy was
completed, the fever recurred, with no apparent focus except a
tender line exit site. Line and peripheral BCs grew GPB as
previously and further vancomycin therapy produced a good
clinical response. Two days after starting the third cycle of
chemotherapy, he became pyrexial with GPBs again recovered
from Hickman and peripheral BCs. However, on light
microscopy the organism appeared beaded and was acid and
alcohol fast on Ziehl-Neelsen staining. The isolate required
48 hours incubation to produce visible colonies, which were
pigmented yellow. It was identiﬁed deﬁnitively on the basis of
the nucleic acid sequence of its I6SrDNA gene. This
demonstrated 100% similarity with that of Mycobacterium
neoaurum (strain 44074 DSM) as described in the RIDOM
database (http://www.ridom-rdna.de). Interestingly, the
organism was not recovered from mycobacterial BCs (Bactec
9050; Becton Dickinson). The mycobacterium was shown to be
susceptible in vitro to rifampicin, ciproﬂoxacin and
clarithromycin among other agents. The line was removed and
the patient received 6 weeks of oral clarithromycin,
ciproﬂoxacin and rifampicin. Routine and mycobacterial BCs
were negative post line removal. He responded well to this
treatment and remains in remission from his AML.M. neoaurum,
a rapid growing chromogenic mycobacterium ﬁrst described in
1972 from soil in Japan, has been reported from a sparse number
of clinical cases world wide. This is the ﬁrst reported case of
Mycobacterium neoaurum line infection in Europe (Medline/
PubMed). In accordance with previous published experience,
the patient responded well to line removal and appropriate
antimicrobial chemotherapy. This case also highlights the need
for continual vigilance in the detection of emerging
opportunistic pathogens in immunocompromised patients.
P1139
Impact of differents antimycobacterial drugs on
the survival of patients with Mycobacterium
xenopi pulmonary infection: 89 cases
C. Andrejak, F.X. Lescure, Y. Yazdanpanah, Y. Douadi, T. May,
B. Hoen, P. Chavanet, G. Laurans, V. Jounieaux, J.L.
Schmit (Amiens, Tourcoing, Nancy, Besancon, Dijon, FR)
Background: Only small series are available about Mycobacte-
rium xenopi (MX) pulmonary infection (PI) without a real
evaluation of the management. Impact of clarithromycin, rifa-
mycins and ethambutol on the survival are discussed in the
literature.
Methods: We reported a retrospective survival analysis of 89
consecutive patients (pts) with MX PI. The aim was to evaluate
the interest of principal drugs used in the treatment of MX PI.
The type of management and survival were recorded for each
patient. Only ATS criteria pts were reviewed in 12 medical
centres of North-East France between 1985 and 2003.
Results: Sex-ratio M/F was 66/23. Mean age was 49 ± 16. The
mean duration of treatment was 7 ± 5 months with often a triple
anti mycobacterial therapy. In ﬁrst line, rifamycins (RFM) were
used in 41 pts (46%), ethambutol (EMB) 36 pts (40%),
clarithomycin (CLA) in 15 pts (17%). Only 33% of pts were
alive after 36 months. 20 pts (23%) died before the end of
treatment. Death was attributed to MX in 58%. Relapse was
documented in 13 pts. Kaplan Meier survival analysis found
variables signiﬁcantly associated with a best prognosis: absence
of neoplasm (p = 0.002), treatment vs abstention (p = 0.007),
RFM and/or EMB containing regimen (p = 0.02). No
signiﬁcative difference was noted for CLA containing regimen.
Cox multivariate analysis showed that treatment containing
RFM and/or EMB was the only one signiﬁcant independent
positive prognostic factor (p = 0.01). Neoplasm (p = 0.06) was
an independent trend.
Conclusion: The preliminary results of this study, the largest to
our knowledge, showed the crucial role of RFM and/or EMB
containing regimen in the treatment of pts infected with MX and
the lack of impact of CLA on survival.
P1140
BCG infection following BCG therapy for
bladder carcinoma: results of a multicentre study,
about 23 cases
A. Godel, E. Bonnet, L. Porte, F. Busato, M. Alvarez, B. Doudie,
P. Brouqui, H. Laurichesse, P. Massip, B. Marchou and the
InfectioSud Group
Objectives: To describe epidemiological and clinical features of
infections due to Mycobacterium bovis after BCG therapy for
bladder carcinoma. To collect data on treatment options and
evolution (with or without treatment).
Methods: We conducted a retrospective-prospective,
descriptive, multicentre study including patients whose
diagnosis of BCG infection following BCG therapy for
urothelial carcinoma was assessed in Infectious Diseases Units
in various University Hospitals in Southern France from January
2000.
Results: 23 cases were recorded. All patients were male, aged
from 49 to 76 years (average = 63.2). Patients received an
average of 4.5 BCG administrations before ﬁrst clinical signs
occurred. A traumatism during administration was noticed in 6
cases (26%). Twenty patients (83%) had an early disease. All the
patients but one had fever. There was a systemic infection with
general signs or located signs distant to the urinary tract in 22
cases (96%). Eight patients had respiratory signs (35%).
Diagnosis was assessed by clinical history and negative search
for ‘‘usual’’ infections (including common bacterial infections
of the urinary tract or the prostate), and positive cultures for M.
bovis [4 cases: positive blood cultures on speciﬁc media for
mycobacteria (2),urine cultures (2)], and/or histologic ﬁndings
compatible with a mycobacterial infection [liver granulomatosis
(4), bone marrow granulomatosis (3), bladder granulomatosis
(1), brain granulomatosis (1)], and/or abnormal images on
CT-scan compatible with mycobacterial lesions. Among the 4
patients for which a medullogramwas performed, 3 had signs of
macrophagic activation. Inﬂammatory biological parameters
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(ESR and/or CRP) were high in 15 patients (65%). Liver enzymes
were increased in 16 patients (70%). Concerning treatment, three
patients were not treated. Twenty patients (91%) received Rifam-
pin and INH of which 11 (48%) received also Ethambutol. Eleven
patients (48%) were also treated with corticosteroids. The out-
come of the infection was favourable in all cases but one (who
stopped his treatment after the ﬁrst month).
Conclusion: BCG infectionmay occurmanymonths after the end
of the BCG therapy. The spectrum of clinical manifestations is very
wide. Cultures forM. bovis are rarely positive and the diagnosis is
suspected on clinical history, histological and tomodensitometric




T. Turunc, Y.Z. Demiroglu, H. Uncu, S. Colakoglu,
H. Arslan (Ankara, TR)
Objectives: Although tuberculosis usually attacks the lungs,
resulting in the pulmonary tuberculosis form, other organs may
also be affected, leading to extrapulmonary tuberculosis (EPT)
or disseminated tuberculosis. This study retrospectively
analysed the incidence, clinical sites and risk factors for EPT
in 46 patients who admitted to the hospital with EPT between 1
January 2003–1 January 2005 in Turkey where tuberculosis is
still frequently seen.
Methods: A total of 46 patients who were diagnosed as EPT
between January 2003 and January 2005 were enrolled in this
retrospective study.
Results: Forty six cases were diagnosed as EPT during the
2 year period. Twenty two were males (47.8%) and 24 females
(52.2%). The mean age of the patients was 50.6 years (range, 17–
80 years). Of the 46 patients, tuberculous lymphadenitis was
diagnosid in 18 (39.1%), genitourinary system tuberculous in 8
(17.3%), Pott’s disease in 7 (15.2%), miliary tuberculosis in 3
(6.5%), peritonitis tuberculous in 1 (2.1%), skin tuberculosis
in 1 (2.1%), bone tuberculosis in 1 (2.1%), and joint tuberculosis
in 1 (2.1%). Symptoms were usually non-speciﬁc, and related to
the site of infection. The most common symptoms were fever
(20/46, 43.4%), fatigue (15/46, 32.6%). Concurrent disease,
previous history of tuberculosis and a history of contact with
an infected patient were determined to be the major risk factors
for EPT. Of all patients, 11 (23.9%) had a previous history of
pulmonary tuberculosis, 8 had chronic renal failure (17.3%), and
diabetes mellitu¨s 5 (10.8%). EPT was diagnosed by
histopathologic methods in 27 (57.8%) and by microbiologic
methods in 13 (28.2%) of the patients. In six of the cases, and
cultures grew no bacteria EPT was diagnosed by the helps of
clinical, laboratory, imaging, and/or histopathological studies.
Surgery was required in 5 patients; 2 had tuberculous
lymphadenitis, 2 had Pott’s disease, and 1 had tuberculous
osteomyelitis. In our study, 3 of the patients (6.5%) died one had
miliary tuberculosis, and 2 patients had tuberculous meningitis.
Conclusion: Physicians should be aware of unusual
presentations and localizations of tuberculosis and should
consider EPT in the differential diagnosis of any patient with
non-speciﬁc symptoms such as fever, fatigue, headache, night
sweat, low-back pain, and weight loss.
P1142
Cigarette smoking and its association with
pulmonary tuberculosis in adults
M. Rasoolinejad, A. Farazi, M. Haj Ab-dul Baghi, P. Hashemi,
P. Kheirandish (Tehran, IR)
Objectives: Smoking and tuberculosis have been widespread
for many years in the world, and are the two health problems of
developing countries.Smoking and tuberculosis are more
prevalent in men than women. The aim of this hospital based
case-control study is to determine the effect of smoking on
pulmonary TB in male adults.
Methods: The subjects were 77 male (age between 21–50 years)
with pulmonary TB. The controls were 154male patients
matched for age and socio-economic conditions chosen from
non-TB patients admitted to hospital from June 2003 to August
2004.In order to reduce bias, the subjects were selected from
different wards from the patients without HIV or diabetes
mellitus based on inclusion and exclusion criteria. The data were
collected by direct interview using Questionnaires, and were
analysed using odd ratio Chi-square, mantel-haenzell and
conditional Logistic regression.
Results: Based on the univariate analysis, cigarette smoking at
the time of study (OR = 2.281, P = 0.004), the age at which
smoking started (OR=2.951,P = 0.01 to OR = 3.463, P=0.001),
duration of smoking (P = 0.043,OR = 2.32 to OR = 2.361,
P = 0.018) and the number of cigarettes smoked per day
(OR = 0.632, P = 0.003 TO OR = 5.397, P = 0.001) were signiﬁ-
cantly associated with pulmonary tuberculosis. Multivariate
conditional logistic regression analysis showed that smoking as
an independent risk factor increased the risk of pulmonary
tuberculosis (P = 2.172, P = 0.009). In this analysis the age at
which smoking started (OR = 9.296, P = 0.001 to OR=14.32,
P = 0.0001) and the number of cigarettes smoked per day
(OR = 5.15, P = 0.008 to OR = 8.54, P = 0.031) signiﬁcantly
increased the risk of pulmonary tuberculosis.
Conclusion: Based on the results, smoking is an independent
risk factor for pulmonary tuberculosis; there is a deﬁnite
association between these two matters. Therefore an effective
antismoking campaign is expected to have positive repercussion
on TB prevalence, and smoking cessation must be considered
and promoted by all levels of health care providers.
Experimental infections: treatment and pathogenesis
P1143
Does reduced susceptibility to disinfectants
compromise colonisation and persistence of
Salmonella enterica serovar Typhimurium in
chickens?
S.W. Cooles, M.A. Webber, L.P. Randall, N.G. Coldham,
L.J.V. Piddock, M.J. Woodward (Addlestone, Birmingham, UK)
Objectives: Reduced susceptibility to some disinfectants has
been linked with reduced susceptibility to some antibiotics. The
use of disinfectants may select for mutants with reduced
susceptibility to both disinfectants and antibiotics, and it
would be of concern if such mutants persist and accumulate
within the food chain. In this study the ability of mutants
derived from Salmonella Typhimurium following exposure to
disinfectants to colonise and persist in chickens was compared
to that of their isogenic parents in the day-old chick model.
Mutants arising from exposure to a common domestic
chlorophenol disinfectant (Triclosan) and an aldehyde-based
farm disinfectant (Superkill) were studied.
Methods: Minimum Inhibitory Concentrations (MIC) of various
disinfectants and antibiotics were determined by the agar
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dilution method. Mutants of Salmonella Typhimurium were
selected by plating up to 1010 colony forming units (cfu) on
media supplemented with 1 – 2x the MIC of disinfectant. Three
mutants exhibiting low (4 mg/L), medium (32 mg/L) and high
(>128 mg/L) level resistance to triclosan and two exhibiting
increased tolerance to superkill were selected. 1-day-old chicks
were infected by oral gavage (c. 104 cfu per bird, c. 1:1 mix of
mutant and parent strain) in competitive index experiments.
Infection was monitored by twice weekly cloacal swabbing for
‡ 27 days post-infection. Weighed swabs were vortexed in
saline (1 mL), diluted and plated (0.1 mL) onto media with or
without antibiotic to differentiate between strains. Colonies
were counted after overnight incubation at 37C. Infection was
calculated as cfu/g of faecal matter.
Results: All mutants showed reduced susceptibility to some
clinical antibiotics. The mutant strains were signiﬁcantly less
able to persist than their parent strains, but persisted in the
chicken gut and in some cases, even 23 days post-infection, they
amounted to approximately 1% of the total Salmonella
population of 106 cfu/g faecal matter.
Conclusion: Exposure of Salmonella Typhimurium to
disinfectants gave rise to mutants with reduced susceptibility
to disinfectants and/or antibiotics. Compared to their isogenic
parent strains, mutants were still able to persist in the chicken
gut to the end of the experiment.
P1144
A study on rat’s pulmonary inﬂammatory
reaction induced by N-protein of SARS-CoV and
effects of glucocorticoids on it
L. He, D. Hao, J. Qu (Shanghai, CN)
Objective: To study rat’s pulmonary inﬂammatory reaction
induced by N-protein of SARS-CoV and effects of
glucocorticoids.
Methods: Rat’s pulmonary inﬂammatory reaction were
induced by intratracheally installation of N-protein of SARS-
CoV with a dose of 0.2 mg/kg. Rats were randomly divided into
four groups: saline control group (Nc), N-protein group one (P1,
6 h), N-protein group two (P2, 24 h), N-protein+dexamethasone
group (D, 10 mg/kg). Their blood, bronchial alveolar lavage
ﬂuid(BALF) and lung tissue were collected after challenging.
Cytological and histopathologic changes of lung tissue were
observed. The wet/dry ratio (W/D) of lung tissue were
determined. Interleukin-6(IL-6), interleukin-10(IL-10) and
transforming growth factor-B1 (TGF-B1) of serum and BALF
were measured by ELISA.
Results: (1) Compared with Nc group (68.42 ± 13.07)%,
lymphocyte percentage of peripheral blood of P2 group
(50.5 ± 14.36)% decreased signiﬁcantly (P < 0.05); Compared
with Nc group (P < 0.01) and P2 group (P <0.01), lumphocyte
percentage of peripheral blood of D group decreased
signiﬁcantly; Compared with Nc group [(5.86 ± 2.25^) x 109]
and P2 group [(4.83 ± 1.49) x 109], WBC total number of
peripheral blood of D group [(1.96 ± 1.30) x 109] decreased
obviously (P < 0.01). (2) Compared with Nc group [(95 ± 29)
x107], WBC total number of BALF of P2 group [(160 ± 60) x 107]
increased signiﬁcantly (P < 0.05); WBC total number of BALF of
D group [(62 ± 23) x 107] decreased obviously compared with P2
group; Analysis of differential cell counts in BALF indicated that
the majority of inﬁltrating cells were alveolar macrophage in
every group. (3) After N-protein challenging, W/D ratio were
signiﬁcantly high in both P1 group and P2 group than Nc group
[(5.18 ± 0.29), (5.19 ± 0.34) vs (4.77 ± 0.27), P < 0.05], W/D ratio
in D group (4.70 ± 0.18) decreased noticeably compared with P2
group (P < 0.01). (4) Compared with Nc group, IL-6, IL-10, TGF-
B1 levels in both serum and BALF of P1 group increased
signiﬁcantly (P<0.01), these cytokines levels in both serum and
BALF of P2 group were higher than P1 group (P < 0.01); these
cytokines levels in D group decreased noticeably compared with
P2 group (P < 0.01).
Conclusions: N-protein of SARS-CoV can lead to rat’s
pulmonary inﬂammatory reaction / acute lung injury which
related to the rise and unbalance of pro-inﬂammatory and anti-
inﬂammatory cytokines; Glucocorticoids can effectively alleviate
pulmonary inﬂammatory reaction induced by N-protein of
SARS-CoV.
P1145
Brain damage in pneumococcal meningitis:
establishment of an infant mouse model
D. Grandgirard, O. Steiner, S.L. Leib (Bern, CH)
Objective: To establish a model of pneumococcal meningitis in
infant mice, that reproduces the brain injury pattern found in
the human disease.
Background: Brain damage, speciﬁcally neuronal necrosis in
the cerebral cortex and apoptosis in the dentate gyrus of the
hippocampus contribute to the high incidence of neurological
sequelae occurring in up to half of children that survive
pneumococcal meningitis.
Methods: Eleven days old mice from deﬁned strains (C57BL/6
n = 136, CD-1 n = 42, BALB/c n = 14) were infected by
intracisternal injection of 10 microL of saline containing log10
5.2 ± 0.5 colony forming units/ml of a clinical isolate of
Streptococcus pneumoniae serotype 3. At 16 h after infection,
cerebrospinal ﬂuid was sampled to document pneumococcal
meningitis and antibiotic therapy (ceftriaxone; 100 mg/kg; s.c.;
bid) was initiated. Endpoints assessed included mortality within
40 h after infection and the occurrence of cortical and
hippocampal brain damage by histomorphometry.
Results: Mortality was lowest in C57BL/6 mice, but did not
correlate with the size of the inoculum used for infection.
Histological evaluations of brain sections showed occurrence of
neuronal apoptosis in the dentate gyrus in 38% of C57BL/6 and
10% of CD-1 mice. Necrotic damage in the cortex was
exclusively observed in C57BL/6 mice. The ﬁndings are
summarized in the table below:
Conclusions: The newly established infant mouse model of
pneumococcal meningitis is unique, in that it exhibits neuronal
apoptosis in the hippocampus and neuronal necrosis in the
cerebral cortex. This characteristic injury pattern causes this
model to be particularly useful as it mimics the
histomorphological ﬁndings in children suffering from the
disease. Thus, this model will allow the use of transgene
technology as a new tool to investigate how bacterial meningitis
causes brain damage in children.
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P1146
PCR and culture correlate well for measuring cure
rates for short course treatment of infections with
the Lyme disease spirochete
C. Pavia, D. Liveris, S. Bittker (Old Westbury, Valhalla, US)
Objectives: To compare the sensitivity of PCR with standard
culture techniques, using BSK media, for measuring the curative
effects of short course treatment with the antibiotic ceftriaxone
(CTX) against Borrelia burgdorferi (Bb) infection in mice.
Methods: Tissue samples were subjected to analysis by
polymerase chain reaction (PCR), following our previously
published procedures. DNA ampliﬁcation was performed using
FS1 and P19 as probes for the JS1-JS2 primers and the IS1-IS2
amplicons. For the mouse infectivity studies, we used 2 different
North American Bb isolates, known as strain 297 and strain
BL206 which we have used in previously published studies.
Separate groups of C3H mice were infected intradermally with
100,000 culture-grown, low passage Bb of either strain, having
an mbc for CTX ranging from 0.025–0.050 lg/ml. Two weeks
later, the mice were given a single intramuscular dose of saline
or CTX (50 mg/kg). One week after treatment, cultures of the
urinary bladder and the ears were established in BSK media, or
were processed separately for PCR analysis. Aliquots of each
extract culture were examined, at weekly intervals, for the
presence of spirochetes using dark ﬁeld or phase-contrast
microscopy.
Results: In infected but untreated control mice, live Bb were
readily culturable from extracts of the urinary bladders and ears.
In contrast, it was found that the one-day, single-dose regimen
of CTX was 100% effective in sterilizing the 2 selected tissue
samples from mice infected with either strain of Bb. It was also
found that, of the culture-positive specimens, 100% yielded a
positive signal for the presence of Bb. For the culture-negative
tissue samples, 80% were negative by PCR.
Conclusions: These experiments show that short course
treatment with CTX is effective against experimental Bb
infection, based on combined PCR analysis and culture
techniques. Given the complexity and time required for
culture, PCR is a useful technique for verifying the
effectiveness of antibiotic treatment regimens against Lyme
disease in various experimental animal-model systems.
P1147
Efﬁcacy of aminocandin (IP960/HMR3270) in
temporarily and persistently neutropenic murine
models of disseminated aspergillosis
P. Warn, A. Sharp, D.W. Denning (Manchester, UK)
Background: Aminocandin (AC) (IP960) is an echinocandin
antifungal agents with broad spectrum antifungal activity.
Patients with invasive aspergillosis often have compromised
immune systems. Concerns have been raised that due to the
mode of action of the candins an effective immune system is
required to clear damaged hyphae. We compared the activity of
aminocandin (AC), micafungin (MFG) and caspofungin
(CAS) in persistently neutropenic (PN) mice; AC, itraconazole
(ITZ) and amphotericin B (AMB) in temporarily neutropenic
(TN) mouse models of disseminated aspergillosis.
Method: Male CD1 mice were infected with either A. fumigatus
AF293 (TN), AF91 (ITZ resistant) (TN) or CBS144 (PN). Mice
were compromised using either one or multiple doses of
200 mg/kg cyclophosphamide every 3 days starting day -3.
Mice were treated IV 4–24 hours later with either 10, 4 or 2 mg/
kg/day or 4 mg/kg every 2 days AC, MFG or CAS (PN) or 0.25–
5 mg/kg AC, 25 mg/kg ITZ, 5 mg/kg AMB (TN). Pk samples
(0.25–2 mg/kg) were taken from a 2nd set of infected mice 4
days post infection. One set of mice were killed 96 hours post
infection, a 2nd set were treated for 10 days then 4–6 days
observation before assessment of tissue burden.
Results: Mortality in untreated mice was 80–100%. Tissue
burdens 4 days post infection in control mice were high with
the liver (log 3.8 cfu/gm), spleen (log 3.7 cfu/gm) and kidneys
(log 4.2 cfu/gm), the main target organs. Treatment reduced
burdens in all organs in PN mice particularly the kidneys which
had a log 1.5 cfu/gm reduction. Survival was excellent in both
PN and TN models after treatment. In the PN model survival
was AC 96%, MFG 93% and CAS 96%. In the TN models
survival was 5 mg/kg AC 100%, 1 mg/kg AC 90%, 0.25 mg/kg
AC 20%, ITC (AF293 only) 70%, AMB 90%. Mean burdens in the
PN model at the end of the observation period were low at
log0.5, log0.3 and log1.95 cfu/gm in the liver, spleen and
kidneys respectively. Total clearance of Aspergillus in the PN
model was found in 7/28, 4/27 and 8/28 survivors treated with
AC, MFG and CAS respectively. PK of AC demonstrated peak
and AUC increased in a linear fashion by dose, with AUC and
half-life of 16–176 mg-hr*hr/L and 27–45 hrs for 0.25–2 mg/kg/
day.
Conclusions: AC at doses in excess of 1 mg/kg/day were
highly effective both at improving survival and reducing tissue
burdens even in persistently neutropenic mice with
disseminated aspergillosis. Alternate day dosing of AC at
twice the daily dose was also very effective.
P1148
Therapeutic drug monitoring of 5-ﬂucytosine in
children aged under 12 years. An 11-year review
of serum concentrations from a United Kingdom
clinical assay reference laboratory
M. Soltani, C.M. Tobin, K.E. Bowker, A.M. Lovering,
A.P. MacGowan (Bristol, UK)
Objectives: 5-Flucytosine is an antifungal drug, used for the
treatment of serious infections caused by Candida or
Cryptococcus species. In the UK, the pre and post dose
therapeutic ranges are 30–40 mg/L and 70–80 mg/L,
respectively. Drug monitoring is recommended in children,
who have unpredictable pharmacokinetics, and in patients with
an impaired renal function, to prevent bone marrow toxicity,
which may occur due to drug accumulation.
Methods: 5-Flucytosine was assayed by high performance
liquid chromatography (HPLC). Patient data were collected
retrospectively from the hospital laboratory information
management system.
Results: From February 1994 to February 2005, pre and post
dose samples were received from more than 100 neonates and
children, aged up to 12 years, from 90 UK hospitals. For patients
aged between 1–30 days (n = 93), 31–90 days (n = 68), and
91 days –12 years (n = 63), 61.3%, 42.7% and 22.4%
respectively of pre dose samples were above the
recommended range of 40 mg/L. The mean values of pre dose
concentration of each group were 51.7 mg/L, 46.1 mg/L and
31.2 mg/L respectively. For post dose concentrations 35%, 32%
and 19.3% were above the recommended range of 80 mg/L.
Conversely, 20.4%, 36.8% and 56.7% of pre dose samples and
46.3%, 62% and 63.2% respectively of post dose samples were
lower than the recommended range. Only 18.3%, 20.7% and
20.9% of pre dose samples and 18.8%, 10% and 7% respectively,
of post dose samples were within normal ranges for the three
age groups.
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Conclusion: An appreciable number of pre and post dose
5- Flucytosine concentrations in the three groups of children
were outside the recommended ranges. Serum concentrations
were signiﬁcantly higher in the youngest age groups, suggesting
that the standard dose of 200 mg/kg may not be appropriate in
neonates. Nevertheless our results show that it is important to
monitor serum levels during therapy in all children.
P1149
Experimental dermatophytosis in guinea pigs: is
voriconazole an option for treatment?
D.M. Saunte, N. Frimodt-Moller, E.L. Svejgaard, M. Haedersdal,
M.C. Arendrup (Copenhagen, DK)
Objectives: Standard treatment of tinea capitis caused by
Microsporum (M.) species has for many years been oral
griseofulvin which, however, is no longer marketed in all
countries. Voriconazole (VCZ) has been demonstrated to inhibit
M. canis in vitro. The aimof this studywas to investigate the efﬁcacy
of voriconazole in a guinea pig model for dermatophytosis.
Methods: Sixteen female Harlan (HsdSsc:AL) guinea pigs
(n = 8/group) were inoculated with 5 · 105 M. canis cells/ml
on razed skin. The VCZ-group was dosed p.o. 20 mg VCZ/kg/
day in 12 days (day 3–15). The control group was left untreated.
The guinea pigs were evaluated clinically twice a week and
mycologically once a week. The clinical evaluation consisted of a
redness score (0 = normal, 1 = pink, 2 = red, and 3 = violet) and
a lesion score (normal = 0, papule = 1, scales = 2, scales (thin)
and ulcers = 3, and scales (thick) and ulcers = 4). The
mycological examination consisted of direct microscopy and
culture of skin scrapings using Sabouraud-glucose-agar with
chloramphenicol & cycloheximid incubated at 25ordm; C for
four weeks. Species identiﬁcation was performed based on
micro- and macromorphology and the number of colonies was
noted.
Results: All animals hadprovenmycological infection.TheVZC-
treated group had signiﬁcantly lower redness and lesion scores as
compared to the control group (P = 0.03 (Mann–Whitney)). After
12 days of treatment 8/8 in the VCZ-treated group was
microscopy negative and 7/8 culture negative in contrast to the
control group where 8/8 animals were microscopy and culture
positive andwith signiﬁcantly higher colony counts (mean colony
count: <1 versus 28 in the control group, P = 0.0002).
Conclusion: These data show that oral VCZ treatment is
efﬁcacious for dermatophytosis caused by M. canis in an
animal model and therefore may be a future alternative for
tinea capitis in humans especially when griseofulvin is not
available.
P1150
Moxiﬂoxacin is markedly more effective than
levoﬂoxacin, gatiﬂoxacin or azithromycin in the
treatment of pneumococcal pneumonia in mice
caused by a macrolide-resistant isolate
D.J. Bast, L. Dresser, C.L. Duncan, L.A. Mandell, D.E. Low,
J.C.S. de Azavedo (Toronto, CA)
Objective: Macrolides are commonly used in the empiric
treatment of community-acquired pneumonia (CAP). However
the increased worldwide prevalence of macrolide resistance
among Streptococcus pneumoniae (SPN), the most common
cause of CAP, has promoted the use of other antibiotic classes
like the ﬂuoroquinolones (FQ). We tested the efﬁcacy of 3 FQ
(moxiﬂoxacin [MXF], gatiﬂoxacin [GFX], & levoﬂoxacin [LFX])
& azithromycin (AZI) in the treatment of pneumococcal
pneumonia caused by a macrolide-resistant isolate.
Methods: Pneumonia was induced in Swiss Webster mice by
endotracheal inoculation with a macrolide-resistant (AZI MIC
256 lg/ml; ERY MIC 1024 lg/ml) but FQ susceptible (MXF
MIC 0.06 lg/ml; GFXMIC 0.12 lg/ml; LFX 0.5 lg/ml) serotype
3 SPN strain. In a bid to produce levels of drug exposure in mice
approximating that in humans, single-dose pharmacokinetics
were evaluated for each drug (MXF [50 mg/kg]; GFX [50 mg/
kg]; LFX [10 mg/kg]; AZI [40 mg/kg]). Animals received
antibiotics subcutaneously at 8-(MXF, LFX) and 12-h intervals
(GFX), or orally at 24-h intervals (AZI), with antibiotic treatment
beginning at 8-h post-infection and lasting for up to 4 days.
Temperatures of all mice were measured prior to, and during
treatment to assess the severity of infection and determine
clinical improvement or failure. Only mice regarded as
moderately ill (< 32 but > 30 degrees C) were used in this
study. A temperature of < or equal to 30 degrees C was used as
the endpoint since previous studies have shown death to be
imminent at this cut-off. Rates of survival, lung eradication &
resistance selection were determined & compared among all
drugs.
Results: Administration of a FQ, and in particular MXF (at free-
drug AUC [0–24 h]: MIC ratios of greater than 40) produced
superior rates of survival & bacterial clearance compared with
AZI (MXF, 142; LFX, 48.6; GFX, 223). MXF protected all 25 mice
(100%) compared with GFX (19/23 [83%]), LFX (19/24 [79%]) &
AZI (9/34 [27%]) (P < 0.05). Furthermore, all mice treated with
MXF or GFX showed complete eradication (100%) from the
lungs compared with LFX (83%) & AZI (24%). No changes in
susceptibility were observed for any of the isolates recovered.
Conclusions: The FQ, & in particular MXF, are highly effective
in the treatment of pneumococcal pneumonia caused by a
macrolide resistant isolate.
P1151
Moxiﬂoxacin is highly active in a murine
Gelfoam implant model of complicated skin
and skin structure infections
K. Merfort, S. Obertegger, R. Endermann (Wuppertal, DE)
Objectives: MXF has recently been indicated for the treatment
of complicated skin and skin structure infections (cSSSIs), so this
study was designed to evaluate the efﬁcacy of moxiﬂoxacin
(MXF) vs methicillin-susceptible Staphylococcus aureus (MSSA)
in a murine model of cSSSI and to compare MXF with
levoﬂoxacin (LFX), vancomycin (VAN), linezolid (LIN),
amoxicillin-clavulanate (AMOX-CLAV) and ceftriaxone (CEF).
Methods: Gelfoam pieces (1 x 1 cm) were implanted
subcutaneously on the back of mice (5 mice/group). Abscess-
like ﬁbrotic capsules formed round the implants after 3 days. A
suspension (50 ll) of S. aureus DSM 11823 was injected into the
Gelfoam – a technique known to produce implant
colonization. Antibiotics at doses of 2.5 and 10 mg/kg were
administered intravenously b.i.d. for 3 days, starting 2 h after
implant infection. On day 3, implants were removed,
homogenized and the viable bacterial load in the Gelfoam
homogenates determined by plating serial tenfold dilutions on
sheep blood agar plates. Bacterial colony forming units (CFU)
were counted after overnight incubation of the plates at 37C.
Results: The results from studies on two different days with
different inocula are shown in the table. At 10 mg/kg, MXF
showed a more pronounced reduction in colony forming units
(CFU) than LFX and VAN. No reduction in CFU was obtained
for LIN and CEF at the same dose.
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Conclusion: In the Gelfoam implant model of cSSSI,
eradication of MSSA with MXF is comparable to that with
AMOX-CLAV and superior to LFX, VAN, LIN and CEF.
Therefore, MXF is likely to be an effective treatment for
abscesses caused by MSSA.
P1152
Efﬁcacy of continuous or bolus IV ceftazidime
and combination therapy in septic neutropenic
mice
J. Buijs, A.S.M. Dofferhoff, J.W. Mouton,
J.W.M. van der Meer (Heerlen, Nijmegen, NL)
Low dose ceftazidime inhibits Penicillin-Binding Protein (PBP)-3
in Gram-negative bacteria, causing ﬁlament-formation, which is
related to high endotoxin-releases in vitro, and possible high
cytokine responses in vivo. High dose ceftazidime causes PBP-1
binding, inducing bacterial lysis. Earlier studies showed that
continuous infusion of ceftazidime above 40 mg/kg prevents
ﬁlament-formation, and leads to early high cytokine responses by
a rapid lysis of bacteria. We hypothesized that, during ﬁlament-
formation, endotoxin is retained in the bacterial cellwall, inducing
lower initial cytokine releases. A consequencemight be the risk of
a postponed, but potentially more severe inﬂammatory response
once bacteria are killed by further treatment.
Objective: To investigate bacterial killing and cytokine
responses after exposure of bacterial ﬁlaments to a beta-lactam
antibiotic with different PBP-afﬁnity.
Methods: In 3 experiments, 54 neutropenic Swiss mice were
challenged with 1.0 · 107 CFU of E.coli ATCC 25922 in thigh
muscles. After inoculation, 80 mg/kg ceftazidime was given
either as an IV bolus or continuous infusion (T = 0). 4 Hours
after start of ceftazidime, mice were injected with meropenem,
to enhance bacterial killing. On T = 4, 6 and T = 8 hours, mice
were sacriﬁced for measurements of circulating IL-6, TNFalfa,
bacterial counts and morphology.
Results: After 4 hours continuous ceftazidime bacteria showed
rod-shapes and debris. Bolus-treated mice showed ﬁlaments IM.
Higher IL-6 concentrations (p = 0.004) were found after 4 hours
of continuous ceftazidime. After subsequent meropeneminjec-
tion, IL-6 and TNF rose to higher levels in the continuous group
untill t = 6 hours (p = 0.011). On T = 8 hours cytokine concen-
trations are lower, but still above the level of bolus-treated mice
(p = 0.005). CFUcounts were lower in continuous treated mice.
Both results aim at a more effective bacterial lysis.
Conclusion: Continuous infusion of 80 mg/kg ceftazidime
prevents ﬁlament-formation and leads to signiﬁcant higher
concentrations of circulating IL-6 and TNF-alfa in contrast to
IV bolus. After addition of meropenem cytokines rise even
further, reﬂecting more lysis and concomittant release of
endotoxin in the initially continuously treated group. This is
conﬁrmed by bacterial counts. So ﬁlament-formation, as shown
after bolus ceftazidime, is associated with a less efﬁcacious
antibiotic induced bacterial lysis, and might thus be
disadvantageous.
P1153
Amoxicillin early and delayed treatment of
serotype 6 pneumococcal acute otitis media in
previously immunised vs. non-immunised
gerbils
C. Martı´nez-Marı´n, G. del Prado, L. Huelves, M. Gracia,
C. Ponte, C. Cenjor, M.J. Gime´nez, L. Aguilar, F.
Soriano (Madrid, ES)
Objective: To study the effect of previous immunisation in the
outcome of pneumococcal acute otitis media (AOM) treated
with Amoxicillin (AX).
Methods: Two serotype 6B pneumococcal clinical isolates with
AX MIC of 2 (strain A) and 8(strain B) mg/L were used. Animal
were weekly intraperitoneally (i.p.) immunised with whole cell
heat inactivated inoculum of each strain for 5 weeks.
Immunised (IMM) and non-IMM animals (8 per group) were
bilaterally inoculated into the middle ear bulla with 20 microL
of broth containing approximately 106 cfu. Doses of AX (5 mg/
kg) were subcutaneously given in an early (2, 4.5, and 7 h post-
inoculation, p.i.) or delayed (18, 20.5, 23, 25.5, 28, and 30.5 h pi)
schedule to previously IMM and non-IMM animals: Efﬁcacy
was evaluated by middle ear ﬂuid colony counting and body
weight, 48 h p.i.
Results: There were not differences in AX AOM treatment
outcome between previously IMM and non-IMM animals. AX
was not efﬁcacious in AOM caused by the resistant strain (B).
AX treatment was efﬁcacious in AOM caused by the strain with
AX MIC in the upper limit of susceptibility (A) only when the
antibiotic was early administered.
Conclusions: In this model, previous serotype 6 pneumococcal
immunisation did not inﬂuence outcome of AX treatment of
AOM caused by AX sensitive or resistant strains.
P1154
Efﬁcacy of amoxicillin-clavulanate in an
experimental murine pneumonia model caused
by AmpC non-hyperproducing clinical isolates of
E. coli resistant to cefoxitin
F. Docobo-Pe´rez, F. Ferna´ndez-Cuenca, M.E. Pacho´n-Iba´n˜ez,
A. Pascual, C. Pichardo, L. Martı´nez-Martı´nez, J.
Pacho´n (Seville, ES)
Objectives: The aims of the study were determine the in vitro
activity of AMC and its efﬁcacy in an experimental pneumonia
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model caused by a new phenotype of AmpC non-hyproducing
E. coli resistant to FOX.
Methods: In vitro studies: two clonal related strains (Rep-PCR)
resistant to FOX were used. Ec985 (no TEM-1 producer)
susceptible to AMX, AMC, CTX, and Ec571 (TEM-1 producer)
susceptible to AMC and CTX. MIC and bactericidal activity
(time-kill curves) were measured. PK and PD parameters
(Cmax, t1/2, and time above MIC) were determined after a
single dose of each antimicrobial. In vivo studies: 1st Phase.
Characterize an experimental pneumonia model by E. coli in
C57BL/6 mice (16–20 g), with a bacterial inoculum of 8–9
log10 cfu/ml. 2nd Phase. Animals were grouped in controls
(CON) without treatment, AMX (50 mg/Kg) each 2 hours
(5 doses), AMC (50/5 mg/Kg) each 2 hours (5 doses), and
CTX (50 mg/Kg) each 3 hours (4 doses). Analysed variables:
log10 cfu/g lung tissue. Statistical analysis: ANOVA, post-hoc
Tukey, and Dunnett test.
Results: In vitro: MIC (mg/l): Ec985 AMX = 8, AMC = 8,
CTX £ 0.5, FOX = 128; Ec571 AMX = 512, AMC = 8, CTX £ 0.5,
FOX = 128. Bactericidal antibiotics: Ec985 AMX, AMC, and CTX
(1xMIC, 2xMIC, 4xMIC, Cmax). Ec571 AMX, AMC, and CTX
(1xMIC, 2xMIC, 4xMIC,Cmax). In vivo: PK/PD (Cmax [mg/l]; t1/
2 [h]; time aboveMIC [h]): AMX (50 mg/kg) 15.1; 0.28; 0.48. AMC
(50/5 mg/kg) 17.9; 0.4; 0.55. CTX (50 mg/kg) 57.6; 0.27;
1.89.AMX, AMC, and CTX reduced the bacterial lung concentra-
tion of Ec985 compared with CON (p < 0.001), no differences
between the treatments were found. AMC and CTX reduced the
bacterial lung concentration of Ec571 respect to CON (p < 0.001).
No differences between the treatments were found.
Conclusions: AMC is effective in the treatment of the
experimental murine model caused by this new phenotype of
non AmpC hyperproducer E. coli, resistant to FOX.
P1155
Telithromycin is effective against susceptible,
ﬂuoroquinolone-resistant and macrolide-resistant
strains of Streptococcus pneumoniae in a murine
model of pneumonia
J.C.S. de Azavedo, C. Duncan, L. Dresser, L.A. Mandell,
D.E. Low, D.J. Bast (Toronto, Hamilton, CA)
Objective: Resistance to commonly utilized antimicrobials such
as the b-lactams, macrolides and ﬂuoroquinolones (FQ) poses a
challenge with respect to empiric treatment for community
acquired pneumonia. Telithromycin (TEL), a ketolide, has high
activity against resistant strains and has been approved for the
treatment of respiratory tract infections. We undertook to
examine its efﬁcacy in vivo, in comparison with azithromycin
(AZM), against a susceptible strain, a FQ-resistant strain
(ciproﬂoxacin [CIP} MIC 4 mg/L) with a ParC mutation, and a
macrolide resistant strain harbouring an Erm methylase.
Methods: A susceptible serotype 3 strain A66 (levoﬂoxacin
[LVX] MIC 0.5 mg/L; TEL MIC 0.004 mg/L; AZM MIC
0.125 mg/L), its isogenic derivative C98, with a Ser-79-Phe
substitution in ParC (CIP MIC 4 mg/L, LVX MIC 2.0 mg/L,
TEL MIC 0.004 mg/L; AZM MIC 0.125 mg/L) and a macrolide-
resistant serotype 3 strain R326 (LVX MIC 0.5 mg/L; TEL MIC <
0.015 mg/L;AZMMIC>256mg/L),wereused to infect groupsof
34 – 46 SwissWebster mice endotracheally with 10E4 to 10E5 log-
phase CFU. Single-dose pharmacokinetics were tested in mice in
order to determine drug levels approximating human kinetics.
TEL (24 mg/kg q12 h) and AZM (40 mg/kg q24 h) were
administered orally 6 – 12 h post-infection and for up to 4 days.
Surface temperature (ST) was used to assess disease severity & to
stratify mice prior to treatment into moderately ill [MI]: > 32C&
severely ill [SI]: < 32C but > 30C. Mice were euthanized if their
ST dropped to < 28C. Bacterial counts from lungs of all mice
were determined using an automated spiral plating system.
Results: TEL showed complete eradication in all mice infected
with the susceptible and FQ-resistant strains with 95 – 100%
survival rates among MI mice and 88 – 100% survival rates
among SI mice. By comparison, AZM showed no eradication in
9% of mice infected with these strains despite survival rates of
100% among MI mice and 78 – 100% in SI mice. Predictably, in
mice infected with the macrolide-resistant strain, AZM showed
eradication and survival rates of only 22% and 25% respectively,
whereas TEL showed eradication and survival rates of 85% and
88% respectively (p < 0.01).
Conclusions: TEL is highly effective against susceptible,
FQ-resistant and macrolide resistant strains of SPN and provides
a useful drug for empiric treatment if resistance is suspected.
P1156
Efﬁcacy of daptomycin in the treatment of
experimental endocarditis due to susceptible and
multidrug-resistant enterococci
J.M. Entenza, M. Giddey, J. Vouillamoz, P. Moreillon (Lausanne,
CH)
Objective: Antibiotic treatment of enterococcal infections may
be difﬁcult as most strains are multi-drug resistant. The aim of
this study was to investigate the efﬁcacy of daptomycin (DAP), a
novel cyclic lipopeptide with excellent in vitro activity against
resistant Gram-positive pathogens, in the treatment of rats
with experimental endocarditis due to Enterococus faecalis and
E. faecium with multi-drug resistant phenotypes.
Methods: The vancomycin-susceptible (VAN-S) E. faecalis JH2-
2, its VAN-resistant (VAN-R) derivative (vanA phenotype)
E. faecalis JH2-2/pIP819, and the VAN-R (vanB phenotype) and
ampicillin-resistant (AMP-R) E. faecium D366 were used. MICs
and time-kill studies were tested by CLSI (formerly NCCLS)
method in Mueller-Hinton broth supplemented with 50 mg/L
Ca++. Rats with catheter-induced sterile aortic vegetations were
inoculated with 106 (E. faecalis) or 107 (E. faecium) CFU/ml.
Treatment with simulated human kinetics of either DAP (6 mg/
kg every 24 h), VAN (1 g i.v every 12 h) or amoxicillin (AMX;
2 g every 6 h) was started 16 h postinoculation and continued
for two days. Control animals were sacriﬁced at the onset of
therapy and treated rats 8 h after the trough level of the last
antibiotic dose. Treatment outcome was assessed by counting
the residual viable bacteria in vegetations.
Results: MICs for strains JH2-2, JH2-2/pIP819 and D366 were,
respectively: DAP: 1, 1 and 2 mg/L; VAN: 2, > 32 and > 32 mg/
L; AMX: 0.12, 0.12 and 4 mg/L. DAP was rapidly bactericidal in
vitro against all strains at concentrations corresponding to peak
(85 mg/L) and trough (10 mg/L) levels in serum. Killing was
delayed, but not abolished, in the presence of 50% rat serum.
The results of experimental endocarditis are shown in the table:
Conclusions: In rats with experimental endocarditis, DAP, at
doses simulating human kinetics of 6 mg/kg every 24 h, was
signiﬁcantly superior to VAN against VAN-R E. faecalis and
E. faecium, and to AMX against AMP-R E. faecium. These results
suggest that once-daily dosing of DAP may represent a
therapeutic option for infections caused by multi-drug
resistant enterococci.
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P1157
Intracellular killing of Staphylococcus aureus
in vivo: comparison of six antibiotics
S. Sandberg, R.L. Skov, N. Frimodt-Møller (Copenhagen, DK)
Objectives: Intracellular persistence of S. aureus has been
acknowledged for years, but most reports deal with this issue
in various cell-lines in vitro. For S. aureus few have studied the
con-cept in experimental animal models in vivo. The purpose of
this study was to develop an In vivomodel to enable us to easily
screen and diversify the extracellular as well as intracellular
killing of different antibiotics.
Method: S. aureus E19977 (penR and methiS) was used through-
out. Antibiotics tested included di-cloxacillin, cefuroxime, gen-
tamicin, rifampicin, clindamycin and azithromycin. MIC’s were
measured by Etest. Infection was induced by intraperitoneal
injection of 5 · 10)7 CFU/ml in 5 % mucin in female NMRI
mice. Two h later mice were treated with a single dose of anti-
biotic or saline for control. Four h later mice were killed, a
peritoneal wash in 2 ml of saline was performed and the ﬂuid
retracted. The total bacterial count was quantiﬁed in the peri-
toneal wash. The cell fraction was isolated by centrifugation,
and the extracellular bacte-rial count was quantiﬁed in the
supernatant. The remaining extracellular bacteria in the pellet
were killed by resuspension in HBSS containing 100 lg/ml of
lysostaphin. The cells were lysed in cold sterile water, and the
intracellular count quantiﬁed.
Results: The results are shown in the table as a reduction
number which covers the number of re-ductions relative to the
saline treated control
Conclusion: The intracellular results are surprising for the beta-
lactams, since they are known for poor accumulation in cells.
They even showed better results than rifampicin, which is
known to be active both extra- and intracellularly. The poor
reduction number seen for gentamicin intracellularly could be
associated with its poor and slow penetration. Azithromycin
and clindamycin reveal their bacteriostatic behaviour. In
conclusion, the new In vivo model works satisfactorily and in
future perspective, more complex pk/pd studies will be
performed.
P1158
Efﬁcacy of telavancin in the treatment of
experimental endocarditis due to glycopeptide-
intermediately susceptible Staphylococcus aureus
J.M. Miro´, F. Marco, C. Garcia de la Maria, Y. Armero, E. Amat,
D. Soy, A. Moreno, A. del Rio, M. Almela, C.A. Mestres, J. Gatell,
M.T. Jimenez de Anta for the Barcelona Hospital Clinic
Endocarditis Study Group
Background: Telavancin (TLV) is a novel, rapidly bactericidal
lipoglycopeptide antibacterial with multiple mechanisms of
action. Since the appearance of glycopeptide-intermediately
susceptible Staphylococcus aureus (GISA), new alternatives to
vancomycin (VAN) are needed. We evaluated the efﬁcacy of
TLV in experimental endocarditis in rabbits using two GISA
clinical isolates: GISA ATCC 700788 and HIP5836.
Methods: 24 h after establishing catheter-induced aortic valve
vegetations, an inoculum of 7 · 105 cfu/mL was injected IV.
18 h later the animals were treated for two days with either TLV
(10 mg/Kg IV qd) or VAN (1gr iv bid) administered with a
computer-controlled infusion pump system that simulated
human serum kinetics. Control rabbits were sacriﬁced at
16 hours. Treated rabbits were sacriﬁced after completion of
antibacterial therapy. Vegetations were quantitatively cultured.
Results: TLV and VAN MIC/MBCs were 1/4 and 2/2 mg/L
for ATCC strain and 4/8 and 8/128 m/L for the HIP strain
respectively. Peak and trough levels for TLV and VAN
treatments were: 90 and 6 mg/L, and 46 and 6 mg/L,
respectively.Therapy with TLV sterilized more vegetations that
VAN. TLV reduced vegetations titers by 2.0 and 2.3 log greater
than VAN for the ATCC and HIP strains, respectively, but the
differences did not reach statistical signiﬁcance (p = 0.09 and
p = 0.051, respectively; Mann-Whitney rank sum test). All
isolates from vegetations remained susceptible to TLV.
Conclusions: After two days of therapy TLV was at least as




Alteration in virulence characteristics of plank
tonic and bio ﬁlm cells of Pseudomonas
aeruginosa following exposure to macrophage
secretory products
R. Mittal, S. Sharma, S. Chhibber, K. Harjai (Chandigarh, IN)
Objective: The primary line of innate defence against most
bacterial pathogens consists of resident macrophages residing in
tissues and polymorphonuclear neutrophils (PMNs) migrating
from blood to the site of infection. Following stimulation of
macrophages, secretory products are produced. The large array
of bio molecules present in macrophage secretory products
(MSPs) including pro as well as anti-inﬂammatory cytokines can
inﬂuence ultimate outcome of an infection. The present
investigation was planned to study the contribution of MSPs
produced in response to interaction of macrophages with plank
tonic and bio ﬁlm cells of P. aeruginosa to virulence of this
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pathogen in mouse model of ascending urinary tract infection. It
has special relevance since receptor structures in mouse urinary
tract are found to be similar to that of humans.
Method: Planktonic and bio ﬁlm cells of clinical and standard
strains of P. aeruginosa were exposed to murine peritoneal
macrophages and macrophage secretory products were
collected. These macrophage secretory products were
characterized in terms of cytokine level, protein content and
presence of reactive nitrogen intermediates and reactive oxygen
species. Organisms were grown in presence of their respective
MSPs and their pyelonephritic potential was assessed.
Result: Organisms grown in presence of MSPs were more
virulent in vivo as indicated by signiﬁcant increase in renal
bacterial load, tissue pathology, malionaldehyde production and
neutrophil recruitment.
Conclusion: The results of the present study bring out that
pathogens poses mechanisms to exploit host defence
mechanisms for its own survival leading to chronicity and
recurrence of infections. Implications of these ﬁndings in
relation to urinary tract infections (UTIs) caused by P.
aeruginosa have been discussed.
P1160
Genetic analysis of alginate production in 140
cystic ﬁbrosis Pseudomonas aeruginosa isolates
from Scandinavian patients
O. Ciofu, T. Wassermann, U. Johansen, N. Høiby for the
Scandinavian Cystic Fibrosis Study Consortium
P. aeruginosa adapts to the lung environment of patients with
cystic ﬁbrosis leading to chronic lung infection. One of the
typical phenotypic changes is the occurrence of mucoid colony
morphology, which indicates the overproduction of alginate.
One mechanism of conversion to mucoidity is based on
mutations in the algU/T mucABCD cluster, encoding the
stress o´ factor AlgT and its regulators. To investigate what
kind of mutations is responsible for the alginate phenotype in
Scandinavian CF patients, we sequenced algT, mucA, mucB and
mucD genes in 70 pairs of mucoid/nonmucoid P. aeruginosa
isolates with the same PFGE pattern. All patients were chron-
ically infected and attended the CF Centres in Copenhagen and
Aarhus (39 patients), Oslo (19 patients) and Uppsala (12
patients). The mean amount of alginate produced by the
mucoid and nonmucoid P.aeruginosa isolates was 193 and
10.85 mg/L, respectively.
We found mutations in mucA in 93% of the mucoid and in 76%
of the nonmucoid P. aeruginosa isolates. The most common
mutations found were C/T transitions in the region 340–352
leading to premature stop codon (33.6 %), followed by mucA22
mutation (24.2 %), deletions (17.8 %) and insertions (6.4%) of
isolates. The distribution of the C/T transitions in the region
340–352 leading to premature stop codon was 33%, 12% and
47% while the mucA22 mutation was found in 27%, 33.3 % and
13.5% in Denmark, Sweden and Norway, respectively. No
deletions were found in the Swedish isolates and no insertions
in the Norwegian isolates. The pulsed-ﬁeld gel electrophoresis
revealed that 15 Danish patients harboured a DK-1 clone, 8
patients a DK-2 clone and 13 Norwegian CF patients had a NO
clone. The rest of 16 Danish patients, 6 Norwegian and all the 12
Swedish patients had non-clonally related strains. The distribu-
tion of the mucA mutation among the 68 non-clonally related
P. aeruginosa isolates was muc A22 33.3%, C/T transitions
15.15% and deletions 15.15%. Mutations in mucA and algT,
indicating that the nonmucoid isolates were revertants of the
mucoid ones were found in only 37% of the nonmucoid isolates.
Our ﬁndings show that the distribution of mucA mutations in
CF P. aeruginosa isolates varies among the different Scandina-
vian CF centres and that besides the algT locus there are
multiple pathways involved in the conversion from mucoid to
nonmucoid phenotype.
P1161
Effect of different growth phases on surface
properties and adhesion of Pseudomonas
aeruginosa
A.P. Fonseca, C.I. Extremina, A. Freitas da Fonseca,
J.C. Sousa (Porto, PT)
Objectives: Pseudomonas aeruginosa has been emerging as the
primary source of nosocomial infections. Its pathological effects
are attributed to many cell-associated virulence/survival
factors. In clinical situations organisms can occur in different
growth phases, which can alter the surface properties and
adhesion abilities of the bacteria. The objective of this study was
to evaluate the inﬂuence of different growth phases in the
surface properties of Pseudomonas aeruginosa strains as well the
effect in adhesion to polystyrene.
Methods: Six control strains, namely, 3 reference strains (ATCC
27853, PAO1, AK1), 3 deﬁned PAO1 mutants with deviating
surface characteristics (MT1562, PT623, PAO1algC) and 5
P. aeruginosa clinical isolates were used. The strains grown in
LB were sampled during exponential and stationary phases. The
effects of different growth phases on bacterial adhesion (1 h)
were studied using a modiﬁed microtiter-plate assay. The
changes on Microbial Adhesion to Solvents (MATS) were
estimated by using a biphasic method, which calculates the
percentage of cells adhering to hexadecane (a polar solvent),
chlorophorm (acidic solvent and electron acceptor) and ethyl
acetate (strongly basic solvent and electron donor).
Results: There was a signiﬁcant increase in adhesion in the
majority of the strains of P. aeruginosa from the exponential to
the stationary growth phase. In bacterial adhesion to
hexadecane (cell surface hydrophobicity) 6 strains had no
differences between growth phases and 5 strains had the same
results as adherence. Adhesion percentage to chlorophorm and
to ethyl acetate was higher than to hexadecane, but there were
no differences statistically signiﬁcant in almost all the strains
between the two growth phases. These two solvents, which have
similar van der Waals (LW) properties and different acid-base
characteristics, allow us to conﬁrm the bipolar character of the
bacterial strains studied. Our results suggest that the increase in
adhesion values from exponential to stationary growth phase
can be due mainly to changes in LW interactions.
Conclusion: There is an increase in adhesion values from
exponential to stationary phase, partially explained, by the
increase in cell surface hydrophobicity. The values with the two
other solvents were regarded as a measure of the electron
donor/basic and electron acceptor/acidic characteristics of the
bacteria and conﬁrm their bipolar character.
P1162
Effect of subinhibitory concentrations of
ceftazidime and meropenem on the morphology
and adherence ability of Pseudomonas aeruginosa
wild-type strains
J. Vranes, S. Bekic, S. Ljubin-Sternak, B. Bedenic, N. Bauk,
G. Mlinaric-Galinovic, L. Glavas-Obrovac (Zagreb, Osijek, HR)
Objectives: Antibiotics are often present at the site of infection
at subinhibitory concentrations, because in human treated with
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intermittent dosage schedules of antibiotics, suprainhibitory
concentrations will always be followed by sub inhibitory levels.
The aim of this study was to determine the effect of sub minimal
inhibitory concentrations (subMICs) of ceftazidime and
meropenem on the adherence ability of Pseudomonas aeruginosa
strains isolated from a variety of isolation sites.
Methods: A total of 35 P. aeruginosa strains isolated from
different clinical specimens (urine, bronchial secretion, and ear,
throat and wound swabs) were used. The ability of strains to
adhere to three different cell lines (Buffalo green monkey
kidney, HeLa, and human fetal ﬁbroblasts) was detected by
immunoﬂuorescence staining. Bacterial adherence to the cell line
was tested before and after treatment with antibiotics.
Comparison were made between the morphology before and
that after exposure of strains to 1/2, 1/4, 1/8, 1/16 and 1/32
MIC of antibiotics, as well as between the number of bacteria
attached to the cells before and the number after their exposure
to the same concentrations of antibiotics.
Results: Most strains (89%) adhered well to the used cell lines,
and there was no signiﬁcant difference between adherences of
the strains to the three cell lines used. Upon comparison of the
number of attached bacteria before and after exposure to
subMICs of antibiotics, statistically signiﬁcant difference was
determined after exposure of the strains to 1/2, 1/4, 1/8 and 1/
16 MIC of ceftazidime, and after exposure of the strains to all the
concentrations of meropenem used. SubMICs of antibiotics alter
not only bacterial adherence ability but also their morphology.
Morphological changes were most prominent after bacterial
exposure to 1/2, 1/4 and 1/8 MIC of ceftazidime and
meropenem. Higher concentrations of those antibiotics caused
formation of very long ﬁlaments with irregular swellings. A
very high correlation was observed between the changes in the
length of bacteria and their loss of adherence ability.
Conclusion: The alteration in bacterial morphology caused by
subMICs of ceftazidime and meropenem was related to
subsequent loss of bacterial adherence ability.
P1163
In vitro study of the inﬂuence of phenyl lactic
acid produced by lactobacillus probiotic strains
on the pathogenic features of Pseudomonas
aeruginosa strains
V. Lazar, L. Ditu, M.C. Balotescu, C. Bleotu, M. Bucur,
O. Dracea, O. Banu, R. Cernat (Bucharest, RO)
Introduction: Our previous studies concerning the probiotic
activity of some Lactobacillus strains have been shown that they
possess inhibitory activity toward the growth of pathogenic
bacteria and the biochemical analysis of the organic acids proﬁle
showed that the probiotic strains produced phenyl lactic acid
(PLA) in signiﬁcant amounts. The purpose of this study was to
investigate the inﬂuence of PLA on the rate growth, the
expression of enzymatic virulence factors, antiobiotic
resistance markers and adherence capacity to the cellular and
inert substrata of some P. aeruginosa strains recently isolated
from bio ﬁlm-forming infections.
Material and methods: Seven 7 Ps. aeruginosa strains isolated
from central venous catheter pieces and from tracheal and
broncho-pulmonary secretions were cultivated in liquid nutrient
broth in the presence of different concentrations of PLA
(dissolved in methanol: water 1:1). The microbial cultures
were harvested at different times of the bacterial growth curve
(1, 2, 3, 4 and 24 h) and investigated for the expression of
different enzymatic factors (haemolytic activities, caseinase,
gelatinase, amylase, lecithinase, lipase, mucinase), adhesion
and invasion of the cellular substrate represented by HeLa
cells (Cravioto’s adapted method), adhesion to inert substrata
represented by central venous catheter pieces and
antibioresistance markers (disk diffusion method). The
inﬂuence of PLA on bacterial cell viability was assayed by
viable cell counting using the calibrated loop method on agar
and by spectrophotometric assesment of the microbial culture
density.
Results: PLA inﬂuenced the growth rate of the bacterial cells, in
a dose dependent manner. The PLA did generally not affect the
pattern of soluble enzymatic factors secretion at different
incubation times (haemolytic activities, lipase, caseinase) with
one exception, i.e. the activation of DNA-se secretion in
logarithmic phase cultures in the presence of PLA, while the
control culture became positive in the stationary growth phase.
It is to be noticed that PLA induced morphological changes of
the bacterial cells, suggesting its inﬂuence on the expression of
bacterial cell surface-associated molecules. The inﬂuence of PLA
on the adherence capacity to the cellular and inert substrata was
either inhibitory or stimulatory, depending on the tested strain.
The expression of antibiotic resistance mechanisms in the tested
strains was not affected.
P1164
Bloodstream infections due to Pseudomonas
aeruginosa: clinical outcome associated with
pathogenesis-related genes
A. Endimiani, B. Pini, A. Baj, F. Luzzaro, A. Toniolo (Varese, IT)
Objectives: P. aeruginosa (Pa) overcomes host defence
mechanisms using two main protein secretion systems: a) type
II system involved in the production of exotoxin A (exoA),
elastases (lasA and lasB), and phospholipase C (plcH and plcN);
b) type III system implicated in the production of exoenzymes
(exoS and exoT), phospholipase A (exoU), and adenylate cyclase
(exoY). Neuroaminidases (nan1 and nan2) play an important
role in Pa adherence to epithelial cells. This study was planned
to evaluate whether pathogenesis-related genes were linked to
clinical features and outcome of patients with Pa-induced
bloodstream infection (BSI).
Methods: Thirty-eight Pa isolates causing BSI at our institution
were studied. Twenty strains had a multi-drug resistant (MDR)
phenotype. Real time PCR (Applied Biosystems, Foster City,
CA) was used to evaluate the presence of exoS, exoT, exoU,
exoY, lasB, plcH, plcN, exoA, nan1, and nan2. Clinical records of
BSI-patients were examined retrospectively. Age, length of
hospital stay, underlying diseases (McCabe-Jackson
classiﬁcation and Charlson weighted index), severity of sepsis,
primary source of infection, and clinical outcome were
evaluated. Statistical analysis was performed using the
Statistica software (StatSoft, Tulsa, OK).
Results: 38/38 Pa isolates were positive for the following genes:
exoT, exoU, lasB, plcH, plcN, exoA, and nan2. The remaining
exoS, exoY and nan1 genes were detected in 30 (78.9%), 28
(73.7%) and 22 (57.9%) isolates, respectively. Independent
statistical analysis showed that the MDR phenotype was
associated with exoS and nan1 genes (P = 0.02 and P < 0.01,
respectively). Rapidly fatal underlying disease was associated
with the exoS gene (P = 0.04). No signiﬁcant differences were
observed with regard to the exoY gene. Overall, 22/38 (57.9%)
isolates were positive for the entire type III secretion pathway.
Statistical analysis showed that no signiﬁcant clinical and
microbiological differences were observed regarding the type
III system.
Conclusions: Compared to published data, the results show
that genotypes of Pa strains causing BSI are similar to those
determining pneumonia in CF patients. Notably, two central
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pathogenetic genes (exoS and nan1) were frequently associated
with MDR strains. The ﬁnding suggests that Pa isolates showing
MDR traits may be more virulent than susceptible strains.
P1165
MR imaging in experimental meningitis – in vivo
correlates for disease severity
C.T. Brandt, H. Simonsen, J.D. Lundgren, C. Østergaard,
N. Frimodt-Møller, L.V. Søgaard, O.B. Paulsson,
I. Rowland (Copenhagen, DK)
Background: Breakdown of the blood-brain-barrier (BBB),
alterations in cerebral blood supply, oedema of the brain and
ultimately hydrocephalus and nervous tissue damage are factors
believed to be associated with disease severity of pneumococcal
meningitis. The developmental relations between these
deleterious entities of disease remains to be deﬁned.
Materials/Methods: Meningitis was induced by intracisternal
injection of ~1 x 105 CFU/ml S. pneumoniae serotype 3 (n = 29)
or saline (n = 13). Rats were randomised and sacriﬁced (4 infec-
ted 2 saline inoculated at each time) after 6,12,24,30, 36,42 and
48 h post-infection and brains harvested for histopathology.
Prior to imaging rats were subject to a clinical and neurological
score, and cerebrospinal ﬂuid and blood samples obtained. MR
images were acquired using a SISCO 4.7T imaging system. T1W,
T2W, quantitative diffusion, dynamic MRI and post contrast
(0.5 mmol/kg GdDTPA). Brain oedema was measured with
ADC maps calculated from images acquired with b-values of 0,
185, 740 and 1665 s/mm2. Blood-brain barrier integrity and
perfusion delay was investigated by dynamic MRI and gado-
linium enhancement kinetics. Ventricular size was an accurate
measure of the mean ventricle-brain ratio in 3 coronal MR
images.
Results: Meningitis was conﬁrmed by pneumococcal growth in
the CSF and the increasing CSF pleocytosis. Rats with meningitis
expectedly differed highly signiﬁcantly from saline inoculated
controls in all examined parameters: WBC counts, clinical score,
motor score, ventricle-brain (v-b) ratio, brain oedema, BBB-
integrity, cerebral perfusion and ADC (two-way ANOVA,
P < 0.0001). Increasing ventricle-brain ratio was found to be
the closest correlate to clinical disease and motor performance
scores (spearman rank rho = 0.83 and rho = 0.82, P > 0.0001,
respectively). The presence of cerebral damage was associated
with more extreme values of the examined parameters.
Conclusion: The course of disease was predictable with severe
and terminal illness developing within 36 to 48 hours after
infection. Twelve hours after infection BBB integrity was
reduced and associated with increased indices of vasogenic
brain oedema and reduced cerebral perfusion. Severe clinical
deterioration developed from 30 h onwards and was associated
with increased ventricular size, decreased ADC (cytotoxic
oedema or cortical compression) and a further decrease in
perfusion whereas BBB integrity, CSF infection and pleocytosis




infection in household contacts in Taiwan
Y-C.Huang, C-F. Ho, C-J. Chen, L-H. Su (Kweishan, Taoyuan, TW)
Background: Methicillin-resistant Staphylococcus aureus (MRSA)
has emerged as a community-acquired (CA) pathogen recently.
However, its transmission in households and the community
has not been thoroughly investigated.
Methods: Prospective family cohort study was conducted to
investigate children and household members of these patients
who had documented CA-MRSA infections between August
2004 and May 2005. 57 case patients and 121 household
members underwent a survey for nasal carriage of MRSA.
Microbiological characteristics of the infected and colonized
MRSA isolates including pulsed-ﬁeld electrophoresis (PFGE),
staphylococcal chromosomal cassette (SCCmec) type, and
Panton Valentine leukocidin (PVL) genes were determined
and compared. Some strains of representative PFGE patterns
were selected for multilocus sequence typing (MLST).
Results: Of the 57 families with 121 household contacts
sampled, MRSA was detected in 30 contacts (25%) from 23
families (40%). 54 clinical isolates from 48 case children were
available for analysis and showed that genotypes D (34/48, 71%)
and C (7/48, 15%) were the two most common PFGE patterns,
particularly type D-SCCmec VT-PVL (+) (in 32 children) and
type C-SCCmec IV-PVL ()) (in 7). Both the infected and
household colonized isolates were indistinguishable in 64%,
highly related in 18% and distinct in 18% of 28 pairs of isolates
available for comparison. Nasal carriage of MRSA was noted in
18 (32%) of the 57 case patients and both the infected and
colonized isolates were indistinguishable in 94% and highly
related in 6% of 16 pairs. MLST was performed in 14 isolates,
disclosing that ST59 was identiﬁed in 8 isolates of types D (4), C
(3), and AA, ST338 (single locus variant of ST59) in 2 isolates of
type D, and ST89, ST8, ST239 and ST30 in one isolate each.
Conclusion: A predominant clone of MRSA (ST59, SCCmec VT,
PVL (+)) was identiﬁed from the CA-MRSA isolates in
Taiwanese children. For children with CA-MRSA infection in
Taiwan, a substantial proportion of these children and their
household members are colonized with an indistinguishable
strain.
P1167
Characterisation of Panton–Valentine leukocidin-
positive Staphylococcus aureus strains isolated in
the Czech Republic
P. Petras, I. Machova, M. Marejkova, R. Pantucek, V. Ruzickova,
J. Doskar (Prague, Brno, CZ)
Objectives: Here we report the ﬁrst Panton–Valentine
Leukocidin (PVL) positive S. aureus strains isolated in the
Czech Republic after their emergence in many European
countries, USA and Australia.
Methods: Carriage of the lukS – lukF genes for PVL was
detected by previously described PCR primers. The RPLA
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method (Denka Seiken) was used for detection of enterotoxin A,
B, C, and D types, TSST-1, and exfoliative toxin A, and B
production. PCR detection of the tst, eta and etb genes allowed
conﬁrmation of toxigenicity. Resistance to 12 antibiotics was
tested by disk diffusion methods (Oxoid). Phage typing was
performed by the standard method using the International Set of
Phages (PHLS London). The MRSA PVL positive strains were
characterized by SmaI macro restriction analysis resolved by
PFGE, SCCmec typing by a multiplex PCR assay and prophage
typing assay and preliminary characterization of prophage
types concerning to PVL production.
Results: The presence of the lukS–lukF genes was detected in 34
(7.7%) of 443 S. aureus strains isolated mainly from deep-seated
skin infections and referred to the NRL for Staphylococci, NIPH,
Prague, from Czech microbiological laboratories. Production of
enterotoxins A–D was found in 12 (35%) of the 34 PVL positive
strains. Three strains also produced TSST-1; one strain was a
producer of exfoliative toxin A. Only 4 of PVL positive strains
were resistant to oxacilin. Those MRSA strains were hospital
acquired, and were multiresistant. Four MRSA strains were
characterized by molecular methods and correlated with the
known European MRSA types. A sizeable part of PVL positive
MSSA isolates were resistant to erythromycin (60%),
amoxicillin/ clavulanate (52%), and clindamycin (36%).
Resistance to other antibiotics was rare.
Conclusions: Only 4 multiresistant and hospital acquired
strains of 34 (12%) Czech PVL positive isolates showed
resistance to oxacillin. Most PVL positive strains were phage–
typeable and were predominantly classiﬁed into phage group II
(70%).
Acknowledgements: This work was supported by research
programme No. MSM0021622415 of the Ministry of Education,
Youth and Sports of the Czech Republic.
P1168
Increased incidence of higher vancomycin
minimal inhibitory concentration and changing
pattern of antibiotic susceptibility in methicillin-
resistant Staphylococcus aureus isolates: a single
institution study
D. Lu, P. Holtom (Los Angeles, US)
Background: The rate of methicillin-resistant Staphylococcus
aureus (MRSA) infections at our institution is 50–60% of all
Staphylococcus aureus infections, thanks to the recent community-
acquired MRSA (CA-MRSA) epidemic. Yet little is known about
changes in the antibiotic susceptibility pattern of these strains.
Has CA-MRSA replaced the traditional hospital-acquired MRSA
to become the new hospital ﬂora, as manifested by a new pattern
of antibiotic susceptibility? Another growing concern is
glycopeptide heteroresistance. The incidence of MRSA with
higher vancomycin minimal inhibitory concentration (vanc-
MIC) is unknown. We sought to address these two issues in our
epidemiologic study.
Methods: Microbiology data for all MRSA isolates at our
hospital from September 1, 2004 to March 1, 2005 were
analysed. Sample location and isolates’ antibiotic susceptibility
and vanc-MIC were compiled.
Results: Over the 6 months period, 1023 MRSA were isolated.
Nasal cultures were not included and recurrent infections
counted only once. Only 32 (3%) of the 1023 isolates were
found to be resistant to 3 or more antibiotics, in addition to the
beta lactams. 188 isolates (18.4%) were found to have a vanc-
MIC of 2. There were no isolates with vanc-MIC greater than 2.
Of those 188.69 (36.7%) came from patients in the emergency
department or primary care clinics. Only 9 (4.8%) of the 188
isolates were found to be multi-drug resistant.
Conclusions: Our study demonstrates that, at our institution,
MRSA antibiotic susceptibility resemble that of CA-MRSA.
Higher vancomycin MIC among MRSA is seen with increasing
frequency. Follow-up studies are needed to determine the
clinical signiﬁcance of these ﬁndings.
P1169
Prevalence of different virulence factors in
enteroaggregative Escherichia coli isolates
causing diarrhoea in children in Ifakara,
Tanzania
E. Mendez Arancibia, J. Ruiz, M. Vargas, J. Gascon,
J. Vila (Barcelona, ES)
Objectives: The pathogenesis of enteritis caused by
enteroaggregative Escherichia coli (EAEC) remains under
discussion. To date several virulence factors (VF) have been
established in EAEC. The main aim of this study was to
determine the prevalence of 18 VF in 86 EAEC isolates causing
diarrhoea in children under ﬁve years of age from Ifakara,
(Tanzania).
Methods: EAEC strains were detected using a PCR validated
method and by adherence assay. The differentiation between
typical and atypical EAEC was based on the presence of the
aggR gene, also detected by PCR. In both groups of EAEC
strains, the following genes were detected by PCR: lt gene (heat-
labile toxin), east gene (heat-stable enterotoxin), shet gene
(Shigella enterotoxin 1 and 2), aspU gene (plasmid-encoded
cryptic secreted protein), sat gene (autotransported toxin), cdtB
gene (cytolethal distending toxin), pet gene (the plasmid
encoded toxin), aafI and aafII (adherence factors), eaf gene
(enterophatogen adherence factor), bfp gene (bundle-forming
pili), fyuA gene (yersiniobactin), Ag43 (Antigen 43), eae gene
(intimin), ipaH gene (invasion antigen gene of enteroinvasive E.
coli EIEC) and the stx gene (verotoxins VT1 and VT2), being
used. The Fishers exact test and the Chi-squared test were used
to analyse the results obtained.
Results: From these 86 isolates, 50 (58.1%) presented the aggR
gene (being classiﬁed as typical EAEC) while 41.9 % did not.
This difference was not statistically signiﬁcant. Overall, 70% and
66.7% of the typical and atypical EAEC showed at least one of
the studied VF. The median of VF among the analysed strains
was of 1.73. Twenty-six percent of the EAEC isolates did not
show any of the VF tested. Ag 43 (30.6%) and Aspu (29.5%) were
the most frequently found VF, followed by Sat (21.2%), Shet1
(20%), FyuA (18.8%), EAST (16%) and CdtB (11.8%). The
remaining VFs were detected in less than 10% of the strains.
Conclusion: These results suggest the possible presence of
unidentiﬁed factors that may underlie the virulence of these
EAEC strains. Moreover, these results show the high
heterogeneity of EAEC isolates and highlight the potential role
of Ag43 and Sat as VF of EAEC.
P1170
Profound difference in virulence genes carriage
between Pakistani and Swedish Escherichia coli
strains belonging to phylogenetic group B2
F.L. Nowrouzian (Go¨teborg, SE)
Objectives: E. coli strains segregate into four major
phylogenetic groups, termed A, B1, D and B2. Group B2
strains cause most extra-intestinal infections, carry the largest
number of virulence-associated genes and have an increased
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capacity to persist in the colonic micro biota. This has, however,
almost exclusively been demonstrated in bacteria sampled from
Western countries. In this study we examine phylogenetic group
distribution in relation to virulence gene carriage and colonic
persistence of E. coli obtained from Pakistani infants.
Methods: E. coli strains sampled from colonic microbiota of 22
Pakistani infants followed longitudinally over the ﬁrst six
months of life. Individual strains were identiﬁed by multilocus
enzyme electrophoresis. Strains appearing on more than one
occasion were deﬁned as resident, while strains isolated on a
single occasion only were deﬁned as transient. The strains were
characterized with respect to carriage of several virulence-
associated genes and were tested for phylogenetic origin using
triplex PCR (polymerase chain reaction).
Results: Overall 158 E. coli strains were identiﬁed in the
Pakistani infants. Forty seven percent belonged to
phylogenetic group A, 23% to group D, 18% to B1 and 12% to
B2. The strains belonging to phylogenetic group B2 signiﬁcantly
more often carried the genes for ﬁmA (p = 0.003) compared to
other strains. As compared to Swedish group B2 E. coli strains,
Pakistani B2 strains lacked the genes sfaD/E (S, F1C ﬁmbriae),
neuB (K1 antigen) and papG class III and they signiﬁcantly less
often carried genes for papC (p = 0.02) and hylA (p = 0.005).
Further, in contrast to previous ﬁnding in Swedish E. coli B2
strains, group B2 strains from Pakistani infants were no more
likely to persist in the intestinal micro biota than strains from the
other phylogenetic groups.
Conclusion: The results suggest that E. coli group B2 strains
from Pakistani infants differ substantially from Western group
B2 strain. Their lower carriage rate of various virulence factor
genes may explain their inferior capacity to persist in the micro
biota and suggest that the accumulation of virulence genes in B2
strains has occurred after the subdivision of E. coli strains into
four phylogenetic groups.
P1171
Pathogenicity island I of Escherichia coli CFT073
and Yersinia high-pathogenicity island are
signiﬁcantly associated with persistence of E. coli
in the intestine of Swedish infants
A.E. O¨stblom, I. Adlerberth, A.E. Wold,
F.L. Nowrouzian (Go¨teborg, SE)
Objectives: Virulence associated genes are often located on
particular regions on the bacterial chromosome, termed
pathogenicity islands. Uropathogenic Escherichia coli strains
often carry pathogenicity islands, such as the pathogenicity
island I (PAI ICFT073) ﬁrst identiﬁed in the uropathogenic E. coli
strain CFT073 and the high-pathogenicity island (HPI) originally
found in Yersinia species. We have examined whether these
pathogenicity islands may contribute to persistence of E. coli in
its normal niche, the colonic microﬂora.
Methods: E. coli obtained from 70 Swedish infants followed
with regular sampling of the faecal ﬂora over the ﬁrst year of life
were analyzed. The E. coli isolates were been identiﬁed to the
strain level by Random Ampliﬁed Polymorphic DNA (RAPD).
A total of 148 strains were classiﬁed, of these 58 strains were
resident (persisting for ‡ 3 wk in the microﬂora) and 19 could
be classiﬁed as transient (persisting for £ 3 wk in the micro
ﬂora). The strains were assessed for carriage of PAI ICFT073 and
HPI, by the use of a single PCR and a duplex PCR assay,
respectively.
Results: Fifty six and 47% percent of the E. coli strains harboured
HPI and PAI ICFT073 respectively. Resident strains signiﬁcantly
more often than transient strains possessed PAI ICFT073 (66% vs.
21% p = 0.001) and HPI (70% vs. 37% p = 0.01).
Conclusion: Our results indicate that HPI and PAI ICFT073
enhance the colonization capacity of E. coli strains in the
intestine. The virulence associated traits characterizing
resident E. coli strains may contribute to the persistence in the
intestinal micro ﬂora as well as increase their pathogenic
capability in the urinary tract.
P1172
Relationships between phylogenetic groups of
Escherichia coli isolates and clinical
characteristics in 161 patients with bacteraemia
F. Jaureguy, E. Carbonnelle, S. Bonacorsi, E. Bingen, B. Picard,
X. Nassif, O. Lortholary (Bobigny, Paris, FR)
Objectives: The aim of this study was to assess the relationship
between phylogenetic groups of Escherichia coli strains isolated
from bacteraemia and clinical characteristics of the sepsis.
Methods: A prospective study was conducted between Decem-
ber 2002 and December 2003 on 161 patients (including 14
children) with E. coli bacteremia in Necker and Avicenne
University Hospitals, Paris, France. Clinical data included
primary source of bacteremia, underlying diseases including
any immunodeﬁciency, hospital versus community acquired
origin and outcome. Bacteriological data included determination
of phylogenetic groups performed by triplex PCR (chuA, yjaA,
DNA fragment TSPE4) and antibiotic susceptibility to amoxicil-
lin (AMX), oﬂoxacin (OFX) and trimethoprim-sulfamethoxazole
(STX).
Results: Among the 161 case patients, 51 % were older than
65 years, 36% were immunocompromised and their severity
sepsis scoring according to Bone’s criteria was: Stage 2 (81.4 %),
Stage 3 (7.5 %) and Stage 4 (11.5 %). Of the 161 E. coli blood
infections, 38. 5% were of nosocomial origin. The most frequent
source of bacteremia was the urinary tract (41 %) followed by
the digestive tract (10.6%). The 161 strains were distributed into
phylogenetic groups B2 (49.7%), D (22.4 %), A1 (21.7 %) and B1
(6.2 %). Sixty three percent of these isolates were resistant to
AMX, 38 % to STX and 17 % to OFX. A factorial analysis of
correspondence conducted on the data allowed the distinction of
2 groups of strains. The strains belonging to the phylogenetic
group B2 were more frequently associated to the following
characteristics: susceptibility to the 3 tested antibiotics, commu-
nity acquired infection, urinary tract origin, immunocompetent
host and favourable outcome. The strains belonging to the
phylogenetic groups A, B1 and D were more frequently
associated to: resistance to the 3 tested antibiotics, hospital
acquired infection, non urinary tract origin, immunocompro-
mised host, Stage 4 and higher mortality.
Conclusion: Results distinguished: (i) urosepsis due to B2
group susceptible strains infecting immunocompetent patients
with favourable outcome, (ii) bacteraemia of others sources due
to non-B2 group resistant strains infecting older and
immunocompromised patients with severe outcome.
P1173
Burden of Clostridium difﬁcile associated disease
in NHS hospital trusts in England
A.D. Pearson, K. Wagner, A. Talebi, E. Robinson,
L. Saker (London, UK)
Summary statement: Results of the ﬁrst year of mandatory
C. difﬁcile reporting are compared to the results and trends
observed in the national voluntary reporting system during the
period 1990 to 2004.
Methods: Surveillance of Clostridium difﬁcile associated disease
(CDAD) has been included in the mandatory healthcare-
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associated infection surveillance system for NHS acute Trusts in
England since January 20041. Data are collected quarterly from
the 169 acute Trusts in England that treat patients aged 65 years
and over. The ﬁndings from the ﬁrst year of mandatory
surveillance are compared with the results from the national
voluntary system of reporting and used to estimate the current
burden of CDAD and assess the national trend. For the
purposes of the mandatory surveillance scheme, microbiology
laboratories were required to test diarrhoeal specimens for
evidence of CDAD from all patients over 65 years old who have
not been diagnosed with CDAD in the preceding four weeks.
Diarrhoeal stools are deﬁned as those that take the shape of their
container. Non-diarrhoeal stools should not be tested for CDAD.
Laboratories should test specimens for C. difﬁcile toxin using
either an immunoassay detecting both toxin A and toxin B, or a
neutralised cell cytotoxicity assay. The method used should be
subject to appropriate quality assurance. The mandatory
surveillance scheme does not distinguish between hospital and
community-acquired cases. Even cases considered to be
community-acquired should be reported by the Trust in which
they are detected.
Results: During the period January-December 2004, the HPA
received 44,488 reports of CDAD from 166 out of 169 acute NHS
Trusts (two Trusts did not submit any data, and one Trust did
not submit data for three quarters). Four Trusts had no cases to
report. In contrast the national voluntary reporting system
indicated that there were 33,493 cases in patients aged 65 years
and above. The relative ascertainment in the nine regions is
given in the attached ﬁgure. This indicates that the under
ascertainment of the voluntary surveillance for CDAD was 32%
in 2004. These ﬁndings will be applied to the 15 year analysis of
trend.
Conclusion: The total number of CDAD reports for all age
groups was 44,551 in the voluntary scheme. Applying the under
ascertainment factor seen for the selected age group in the
mandatory suggests the total burden of cases for all age groups
in 2004 was 58,807 cases.
P1174
In vitro investigation of pro-inﬂammatory
properties of Helicobacter pylori strains involved
in low-grade gastric mucosa associated lymphoid
tissue lymphoma
P. Lehours, G. Lasne, A. Gallois, A. Menard,
A. Ruskone Fourmestraux, J.C. Delchier, F. Megraud (Bordeaux,
Paris, Creteil, FR)
Objectives: In a previous study, we studied the main H. pylori
virulence factors in strains isolated from patient with low grade
gastric mucosa associated lymphoid tissue (MALT) lymphoma,
and showed that none can be associated to these strains
(Lehours et al., Infec Immun. 2004; 72:880–8). We then
postulated that MALT pathogenesis was not linked with more
pro-inﬂammatory H. pylori strains. Nevertheless, the
assumption that these strains possessed unknown pro-
inﬂammatory factors lacked conﬁrmation. We investigated the
ability of 33 H. pylori MALT strains and the two H. pylori
sequenced strains J99 and 26695 to induce interleukin-8 (IL-8)
secretion by the human gastric adenocarcinoma epithelial AGS
cell line.
Methods: H. pylori strains were harvested from 2 days plate
cultures then resuspended in brucella broth. The broth was
adjusted to an optical density of 0.6 at 600 nM corresponding to
approximately 3 x 107 CFU/ml. The bacterial suspensions
(35 ll) were inoculated in each well in triplicate on AGS cells
cultured to 60–70% conﬂuence in F12K/10% FBS medium. After
18 h of co culture at 37C, the supernatants were recovered in
order to quantify immediately or after freezing the pro-inﬂam-
matory cytokine IL-8 (Quantikine Human IL-8 Immunoassay,
R&D Systems).
Results: IL-8 levels obtained for the reference strains (J99 and
26695) were in line with the values published in the literature for
this in vitro model. Because IL-8 production is dependent on a
functional cag secretion system, we studied 16 cagA positive and
17 cagA negative MALT strains. High IL-8 production was
observed in the cagApositive strains (1379pg/ml+659).All of the
negative cagA strains induced low rates of IL-8 (75.2 pg/
ml + 39.7), which indicates that they do not have a pro-inﬂam-
matory potential nor other important pro-inﬂammatory factors.
Conclusion: Although the involvement of H. pylori strains in
MALT lymphoma is well established, gastric inﬂammation,
especially for cagA negative strains representing 50% of them,
does not seem to be the pathomechanism of this cancer. We are
currently testing more MALT lymphoma strains. We are also
analysing or results according to the presence of the main
H. pylori virulence factors and putative virulence genes
identiﬁed in the laboratory.
P1175
Reduced activation of microglial cells by
Streptococcus pneumoniae after treatment with
nonbacteriolytic antibiotics in comparison to
ceftriaxone
A. Spreer, I.M. Hernekamp, M. Lotz, S. Ebert, H. Eiffert,
R. Nau (Gottingen, DE)
Objective: Neuronal injury in pneumococcal meningitis is a
consequence of the direct toxicity and proinﬂammatory activity
of bacterial components. Antibiotic standard therapy consists of
highly effective bacteriolytic beta-lactam antibiotics. However,
beta-lactam antibiotics act by bacterial lyses resulting in an
increased release of bacterial products.
Methods: Primary cultures of mouse microglial cells and
primary mouse cortex neurons were exposed to culture
supernatants of Streptococcus pneumoniae, grown in tryptic soy
broth without addition of antibiotics or after treatment with
non-bacteriolytic antibiotics (clindamycin, rifampin) or
ceftriaxone.
Results: Primary mouse microglial cells were activated by
culture supernatants of Streptococcus pneumoniae, while no
direct toxic effect of pneumococcal culture supernatants on
primary neurons was detected. Treatment of pneumococcal
cultures with clindamycin or rifampin in comparison to
ceftriaxone signiﬁcantly reduced the proinﬂammatory action
of culture supernatant on microglial cells. This effect was also
present after sequential therapy with nonbacteriolytic and
bacteriolytic antibiotics.
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Conclusion: During bacterial meningitis, the occurring
neuronal damage is in parts ascribed to microglia-mediated
toxicity. In vitro, the extent of microglial activation by
pneumococcal culture supernatants is reduced by the usage of
non-bacteriolytic antibiotics in comparison to beta-lactams.
Therefore antibiotic regimens relying on bactericidal protein
synthesis inhibitors should be evaluated for meningitis therapy.
P1176
Contribution of chemokines CXCL10 and
CXCL11 and their receptor CXCR3 to the
accumulation of memory CD4 + T-cells in the
cerebrospinal ﬂuid of patients with tick-borne
encephalitis and neuroborreliosis
S. Zidovec Lepej, O. Dakovic Rode, L. Misic Majerus, B. Barsic,
A. Vince, T. Jeren (Zagreb, Koprivnica, HR)
Objectives: The recruitment of peripheral blood (PB) cells into
the cerebrospinal ﬂuid (CSF) is mediated by chemokines and
their corresponding receptors. The aim of this study was to
compare the concentrations of CXCL10 and CXCL11 in the CSF
and serum of patients with tick-borne encephalitis (TBE) and
neuroborreliosis and to evaluate the contribution of these
chemokines to the recruitment of CXCR3-expressing CD4 + T-
cells into the CSF.
Results: Levels of CXCL10 in the CSF of neuroborreliosis
(median 733.3 pg/mL) and TBE (median 365.1 pg/mL) were
signiﬁcantly increased compared with serum (median 155.4 pg/
mL and 71.7 pg/mL, respectively, p < 0.001 for both groups).
Contrary to this ﬁnding, CSF of NIND patients contained signi-
ﬁcantly lower concentration of CXCL10 median 9.2 pg/mL)
compared to the serum (median 98.5 pg/mL, p < 0.001).
Concentration of CXCL11 in the CSF of neuroborreliosis patients
(median 17.3 pg/mL) was signiﬁcantly increased compared
with serum (median 6.8 pg/mL, p < 0.001). Detectable levels of
CXCL11 (> 13.9 pg/mL) were found in only 4 CSF and 3 serum
samples of TBE patients. CXCL11 concentration in the CSF of
NIND patients (median 69.8 pg/mL) was signiﬁcantly increased
compared with serum (median 8.9 pg/mL, p < 0.001). Percen-
tages of CXCR3-expressing memory CD4 + T-cells in the CSF
were higher compared to the PB in both patient groups.
Methods: This prospective, cross-sectional study included 20
neuroborreliosis patients with early CNS involvement proven
by intrathecal synthesis of antibodies to B. burgdorferi s.l., 16
patients with TBE and 11 patients with non-inﬂammatory
neurological diseases (NIND). Chemokine receptors on CSF
and PB T-cells were analysed by ﬂow cytometry. CXCL10 and
CXCL11 in the CSF and serum of patients were quantiﬁed by
commercially available enzyme-immunoassays.
Conclusion: Our results suggest that CXCL10 and CXCL11
create a chemokine gradient between the CSF and serum and
are, in part, responsible for the recruitment of CXCR3-
expressing memory CD4 + T-cells into the CSF of patients
with both neuroborreliosis as well as TBE.
P1177
Assessment of monocytic function in patients
with septic syndrome induced by ventilator-
associated pneumonia
T. Tsaganos, M. Raftogiannis, D. Zervakis, D. Plachouras,
C. Skalioti, S. Kollias, E.J. Giamarellos-Bourboulis, C. Roussos,
H. Giamarellou (Athens, GR)
Objectives: The present study aimed to investigate the impact
of VAP-induced sepsis on monocytic function.
Methods: Ninety patients presenting with VAP-induced-sepsis
were enrolled in the study and divided into three groups
according to the severity of the septic syndrome; patients
presenting with sepsis, patients with severe sepsis and patients
with septic shock. Blood was drawn on the day of enrolment
and on the third, ﬁfth and seventh day thereafter. For
comparison, blood was also collected from ﬁve healthy
volunteers. The collected blood was layered over Ficoll and
centrifuged. Isolated mononuclear cells were incubated in RPMI
for one hour; non-adherent cells were removed and monocytes
harvested after trypsinization. They were then distributed in
two wells of a 12-well plate and incubated for 18 hours with and
without endotoxin (LPS). Supernatants were collected, aliquoted
and refrigerated pending assay. TNFa and IL-6 concentrations
were estimated by an enzyme immunoassay. The function of
monocytes was determined by difference of estimated
concentrations of cytokines between monocytes incubated with
endotoxin and monocytes incubated without endotoxin.
Results: Mean concentration of TNFa produced by monocytes
of controls incubated without LPS was 38.31 pg/10000cells and
of IL-6 was 7.90 pg/10000cells. Respective concentration of
TNFa by LPS-induced monocytes of controls was 545.59 pg/
10000cells and of IL-6 was 90.88 pg/10000cells. Mean
concentration of TNFa and IL-6 produced by LPS-induced
monocytes of patients with ventilator-associated pneumonia is
shown in the table.On days one, ﬁve and seven, TNFa
production by LPS-stimulated monocytes is statistically
reduced in all three groups compared to controls, whereas on
day three, only patients with sepsis and septic shock present
with reduced TNFa production. Production of IL-6 by LPS-
stimulated monocytes differs statistically among groups on the
ﬁrst day and between controls and patients with severe sepsis
and septic shock on the ﬁfth day.
Conclusion: TNFa production by LPS-stimulated monocytes is
reduced in all patients presenting with septic syndrome induced
by VAP on all days; impaired monocytic function results in
reduced IL-6 production on ﬁrst and ﬁfth days. Monocytic
function in patients with sepsis by ventilator-associated
pneumonia is impaired upon start of septic syndrome and
improves slightly over the course of time.
P1178
Monocytes in systematic inﬂammatory response
syndrome: differences between sepsis and acute
pancreatitis
F. Baziaka, T. Tsaganos, V. Kousoulas, V. Karagianni,
A. Pelekanou, A. Antonopoulou, E.J. Giamarellos-Bourboulis,
(Athens, GR)
Objectives: Monocytes release pro-inﬂammatory cytokines
leading to inﬂammatory response syndrome (SIRS). The
present study aimed to unravel the differences of monocyte
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triggering between SIRS of patients with acute pancreatitis
compared to SIRS of patients with sepsis.
Methods: Peripheral blood monocytes were isolated from 25
patients by density gradient centrifugation of whole blood,
incubation in RPMI and removal of non-adherent cells. Twelve
patients had sepsis and 13 patients acute pancreatitis; in all
symptoms presented within 12 hours before admission. After
diagnosis 20 ml blood was sampled. Half were assayed for
isolation of monocytes and 10 ml were centrifuged for serum
estimation of tumour necrosis alpha (TNF-a) and interleukin-6
(IL-6). Half of monocytes were incubated in the presence of 4%
of patients’ serum and supernatants were collected. The other
half was lyzed; caspase-3 was estimate in the lysate by an
enzymatic chromogenic assay. TNF-a and IL-6 were estimated
in serum and cell supernatants by an enzyme immunoassay.
Results: Median ± SE of TNF-a of serum in septic patients and
in patients with acute pancreatitis was 11.61 ± 7.57 and
17.01 ± 8.64 pg/ml, respectively. Respective values of IL-6 in
septic patients and those with acute pancreatitis were
192.30 ± 35.40 and 21.00 ± 16.05 pg/ml (p = 0.001). Respective
values of intracellular activity of caspase-3 were 0.94 ± 0.17 and
0.34 ± 0.09 pmol/min.104 cells, (p = 0.049). TNF-a of monocyte
supernatants did not differ between patients with acute
pancreatitis and sepsis, a result that remain unaltered in the
presence of patients’ serum. IL-6 of monocyte supernatants of
patients with sepsis was considerably increased after addition of
patients’ serum compared to patients with pancreatitis (see
Figure).
Conclusion The data have shown that monocyte activity was
different between acute pancreatitis and sepsis. The different
kinetics of the release of IL-6 might speculate for the existence of
a probable anti-inﬂammatory mechanism active in acute
pancreatitis but not in sepsis.
P1179
Recombinant Escherichia coli as a model to study
a potential pathogenic agent of Burkholderia
pseudomallei-phospholipase C
B. Sadowska, M. Wieckowska-Szakiel, W. Rudnicka,
S. Korbsrisate, B. Rozalska (Lodz, PL; Bangkok, TH)
Objectives: Burkholderia pseudomallei is the etiological agent of
melioidosis – endemic disease, whose acute form is manifested
as pulmonary or septicemic infection with abscesses formation.
The pathogenic factors of these Gram-negative bacilli are not
known well enough. However, it is worth noting, that they
produce many enzymes including phospholipase C (PLC). We
hypothesised that PLC can be important for B. pseudomallei
interaction with host immune cells.
Methods: A parental E. coli DH5alpha strain (PLC-) and
recombinant mutant E. coli pSN-1a producing phospholipase
C from B. pseudomallei (PLC +) were used for the study. The
mouse peritoneal macrophages were infected with FITC-
labelled and ‘‘normal’’ bacteria to determine their adherence
to the cells by a ﬂuorimetric assay and ingestion / intracellular
killing by a colony forming units-assay. The supernatants were
collected to estimate the production of IL-12 and TNF-alpha by
infected phagocytes using DuoSet ELISA (RandD).
Results: The adherence of E. coli DH5alpha to the macrophages
was stronger that of E. coli pSN-1a mutant, which also
corresponded with better ingestion and intracellular killing of
this PLC- strain by used phagocytes. Interestingly, the
phagocytic activity of the cells infected with the mixed
population of both E. coli (PLC + and PLC )) strains was
diminished as compared with their activity against the
homogenous populations of these bacteria. Two hours
incubation of the macrophages with those E. coli strains led to
the production of TNF-alpha (the level of IL-12 was below
detection limit). However, the stimulatory effects of parental
and mutant strain as well as their homo- and heterogeneous
cultures were similar.
Conclusions: The production of phospholipase C seems to
disturb phagocytic but not secretory activity of the
macrophages. Thus, our data suggest that this enzyme can
play an important role in the survival of B. pseudomallei inside
professional phagocytes. Some investigators even suggest that
phospholipase C of B. pseudomallei can play a similar role in the
pathogenesis of melioidosis as phospholipase for Listeria
monocytogenes, which takes place during the ‘‘escape’’ of
these bacteria from the phagolisosomes.Supported by Grant No.
3 PO4C 081 24 from State Committee for Scientiﬁc Research.
P1180
Fusobacterium necrophorum in young patients
with tonsillitis and healthy controls examined by
real-time PCR. Concomitant Group C streptococci
may aggravate tonsillitis
A. Jensen, L.H. Kristensen, J. Prag (Viborg, DK)
Objectives: Fusobacterium necrophorum (Fn) is presumably a part
of the normal human throat ﬂora. Fusobacterium necrophorum
subsp. funduliforme can cause tonsillitis, peritonsillar abscesses
and Lemierre’s syndrome. We studied the prevalence of Fn in
healthy controls and patients with acute and chronic tonsillitis
by a novel real-time PCR assay and analysed the association of
Group C streptococci with Fn in tonsillitis patients.
Methods: Throat swabs from 93 healthy controls (age 18–32,
median 21 years) and 60 swabs from tonsillitis patients (age 18–
32, median 23 years) were examined quantitatively for Fn by a
novel Fn subspecies speciﬁc real-time PCR assay. Swabs from
both groups were simultaneously inoculated aerobically on 5%
Columbia blood agar to detect haemolytic streptococci and
anaerobic in order to ﬁnd Fn.
Results: PCR detected that 20% of 93 controls had Fn, and they
were all subsp. funduliforme in the throat in quantities ranging
form approx 1.6 · 104 to 3.5 · 105 CFU/swab, mean: 8 · 104
CFU/swab. No Fn was found in 80%. There were none positive
culture with neither Fn nor hemolytic streptococci on the agar
plates. Fifty percent of the swabs from 60 tonsillitis patients
revealed Fn, again all were subsp. funduliforme by PCR in
quantities raging from 7 · 102 to 4.2 · 106 CFU/swab, mean:
1.2 · 106 CFU/swab. Only 3 positive PCR samples, (3 · 105 to
2.5 · 106 CFU/swab) were positive for Fn when cultured. Both
the number of positive samples and the amount of CFU/swab
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were signiﬁcantly greater in swabs from tonsillitis patients,
p < 0.05. Patients with Group C streptococci had signiﬁcantly
higher CFU/swab values than those without Group C
streptococci, (CFU/swab: 2.5 · 105 to 3.7 · 106 mean:
2.2 · 106 CFU/swab). Results are summarized in table 1.
Conclusion: Fn subsp. funduliforme is part of the normal throat
ﬂora in small quantities in 20% of healthy controls and in higher
quantities in 50% of patients with acute or chronic tonsillitis in
young people, indicating that Fn may cause tonsillitis. In
addition this study indicates that concomitant Group C
streptococci may aggravate tonsillitis.
P1181
Expression, immunogenicity and apoptotic
potential of Salmonella enterica serovar Typhi
69 kDa phenotype under oxidative stress, iron
limitation and anaerobic conditions
V. Chanana, S. Majumdar, P. Rishi (Chandigarh, IN)
Objectives: Invasive Salmonella has been reported to induce
apoptosis of macrophages as a part of its infection process,
which may allow it to avoid detection by the innate immune
system. However, the induction of apoptosis remains to be
looked into under the different host environments experienced
by pathogen. Successful pathogens overcome the host
environmental stresses by the coordinated expression of
various genes and eventually proteins. Since, the surface of the
microbe is likely to come in contact with the host initially an
attempt was made to identify the Salmonella outer membrane
proteins (OMPs) which may get expressed under more than one
environmental conditions simulating the in vivo ones and to
assess their apoptotic potential.
Methods: S. Typhi was grown under iron-depleted, oxidative
stress as well as anaerobic conditions and their OMP proﬁles
were compared. The phenotypic similarity among the stresses-
induced proteins was assessed on the basis of their similar
molecular weight, cross reactivity and HPLC. For apoptosis,
assessment of nucleosomal DNA, nuclear staining with acridine
orange-ethidium bromide and Hoechst33342-PI co-staining as
well as by ﬂow cytometry was done. Estimations of cytokines
(TNF-a, Il-6, IL-1a), reactive nitrogen intermediates, lipid per
oxidation, levels of antioxidants; superoxide dismutase and
catalyse were done.
Results: A 69 kDa OMP was found to express with enhanced
intensity under the selected stress conditions in comparison to
normal conditions. The protein expressed under anaerobic and
oxidative stress reacted with the antibodies raised against iron-
regulated OMP, indicating the sharing of at least some of the
epitopes. A single peak observed after subjecting the pooled
69 kDa protein sample to HPLC conﬁrmed the purity and
phenotypic similarity of this protein. Reactivity of pooled
69 kDa protein with 85% of widal positive sera from typhoid
patients revealed its in vivo expression. Stress-induced 69 kDa
OMP caused apoptotic cell death in 49% of macrophages. A
signiﬁcantly enhanced expression of cytokines (TNF-a, IL-1a
and IL-6) was detected when macrophages were interacted with
stressed OMP. A signiﬁcant increase in the levels of oxidants
and decrease in antioxidants was also observed.
Conclusion: The ﬁndings of the study may be relevant in better
understanding of pathophysiology of the disease during the
host-pathogen interactions and for future development of
diagnostic as well as preventive strategies.
P1182
Gram-positive and Gram-negative bacteria
induce different cytokines from human
peripheral blood mononuclear cells irrespective
of taxonomic relatedness
S. Johansson, A. Bigsten, C. Hessle, A. Wold (Goteborg, SE)
Objectives: Upon bacterial stimulation tissue macrophages
produce a variety of cytokines that orchestrate the immune
response necessary to clear the infection. Earlier studies have
shown that Gram-positive bacteria induce higher levels of IL-12,
IFN-gamma and TNF from human peripheral blood
mononuclear cells (PBMC) than Gram-negative bacteria,
whereas Gram-negatives induce much more IL-6, IL-8 and IL-
10 than Gram-positives. The aim of this study was to examine if
this dichotomy is true for Gram-positive and Gram-negative
bacteria irrespective of their position in the taxonomical system,
and to relate cytokine production to phagocytosis.
Methods: PBMCs from healthy blood donors were incubated
with 37 species of UV-inactivated Gram-positive and Gram-
negative bacteria well spread in the taxonomical system. IL-12,
TNF, IL-1beta, IL-6 IL-8 and IL-10 were measured in the
supernatants after 24 h and IFN-gamma after 5 d with ELISA.
Phagocytosis was studied in cytospin preparations after 30 min
incubation.
Results: Irrespective of their position in the phylogenetic tree,
Gram-positive bacteria induced more IL-12, IFN-gamma and
TNF than Gram-negatives, while Gram-negative bacteria were
more potent stimulators of IL-6, IL-8 and IL-10 than Gram-
positives. IL-1beta was induced in equal amounts from Gram-
positive and Gram-negative bacteria. Production of IFN-gamma
and TNF were strongly correlated, as were IL-6 and IL-8, and IL-
6 and IL-10. There was no difference between Gram-positive and
Gram-negative bacteria in the degree of phagocytosis. Nor were
there any correlations between cytokine production and bacteria
phagocytosed.
Conclusion: The results conﬁrm that Gram-positive and Gram-
negative bacteria trigger different cytokine patterns in human
monocytes, irrespective of their genetic relatedness. Differences
in composition of the bacterial wall are likely to account for
these differences.
P1183
Invasiveness of Providencia alcalifaciens to
HEp-2 cells
A. Maszewska, A. Torzewska, A. Rozalski (Lodz, PL)
Objectives: Providencia alcalifaciens is a Gram-negative
bacterium from the family Enterobacteriaceae and is thought to
be a cause of diarrhoea in travellers and children. Cells invasion
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has been proposed as the main virulence mechanism of this
bacterium. The purpose of this study was to determine invasive
ability and other virulence-associated characteristics in
P. alcalifaciens strains.
Methods: Twenty two P. alcalifaciens strains isolated from
patients with diarrhoea were studied. Invasiveness of
P. alcalifaciens strains was preliminarily screened in the
quantitative HEp-2 invasion assays. The bacterial strains were
tested for actin condensation with HEp-2 cells in the ﬂuorescent
actin staining test. The roles of bacterial and host factors in
invasion were investigated using selective inhibitors that
inﬂuence speciﬁc bacterial or host cell functions. Plasmid
proﬁles were determined by Kado-Liu method followed by
horizontal electrophoresis on 0.8% agarose gels. Electrophoretic
whole-cell protein patterns of P. alcalifaciens isolates were
examined.
Results: Of the 22 strains of P. alcalifaciens studied, 21 were
invasive for HEp-2 cells. All the invasive strains caused actin
condensation in infected cells. Inhibition of bacterial protein
synthesis decreased dramatically invasion of HEp-2 cells.
Tyrosine kinases play an important role in P. alcalifaciens
uptake into HEp-2 cells. The ability of P. alcalifaciens to invade
HEp-2 was inhibited by depolymerization of microﬁlaments and
microtubules. Monodansylcadaverine that inhibit receptor-
mediated endocytosis, surprisingly enhanced entry of some
strains of P. alcalifaciens into HEp-2 cells. Endosome acidiﬁcation
did not seem to have any appreciable effect on invasion
P. alcalifaciens. Plasmid DNA analysis showed the presence of
plasmids of 5–172 kb in 13 strains regardless of their invasive
ability, suggesting that invasiveness in P. alcalifaciens is not
plasmid related. Numerical analysis of protein patterns of 22
P. alcalifaciens strains based on UPGAMA method, formed two
distinct group deﬁned as A and B. Interestingly, more of
invasive strains belonged to group A.
Conclusion: These ﬁndings deﬁne some requirements for the
P. alcalifaciens entry mechanism. Further studies are needed to
precise events that occur during bacterial entry and identify the
gene(s) responsible for invasion of these bacteria.
P1184
The exchange of virulence-related and
drug-resistance genes among clinical isolates of
enterococci
N. Amirmozafari, M. Alebouyeh, H. Forohesh (Tehran, IR)
Objectives: Enterococci comprise an important and diverse
group of bacteria that cause disease in human and animals. They
reside in the gastrointestinal tract of human and animal, soil,
water, foods, and can persist in elevated salt contents and
various pH values. They can readily acquire antibiotic resistance
and various other virulence factors. In this study, the prevalence
of various virulence factors among different clinical isolates of
enterococci versus those isolated from healthy individuals was
compared.
Methods: Enterococcal strains isolated from clinical and
healthy cases were tested for various virulence related
properties such as haemolysin, gelatinase, hemoglutinin,
DNase, and phremone (aggregative substance) production.
Their antibiotic resistance patterns were also determined. The
ability to exchange resident plasmids via conjugation was tested
by two different mating protocols.
Results: The frequency of gelatinase, aggregation substance,
and hemolysin production was higher in E. faecalis relative to
those in E. faecium. However, no statistically signiﬁcant
differences were detected in the other traits. Phremone-
responsive plasmids were common in most isolates and had
the ability to transfer between strains with high frequency. Most
isolates contained one or more plasmids in the 3–98 MDa range.
Two isolates showed total resistance to all of the antibiotics
tested. Antibiotic resistance genes had the ability for
conjugational inter-strain transfer. The prevalence of
aggregative substance in the strains isolated from clinical cases
was much higher than those obtained from the control group.
Conclusion: Since no known exotoxin molecule was identiﬁed
in enterococci, their pathogenic potential may be attributed to a
variety of extra cellular enzymes, antibiotic resistance,
aggregative substance, and other factors. Their importance in
medicine is related to their ability to acquire antibiotic resistance
and cause nosocomial infections in hospitalized and debilitated
patients. The statistically signiﬁcant higher proportion of
aggregative substance in enterococci isolated from sick people
relative to those obtained from healthy cases, points to the
pivotal role conjugational gene transfer may play in the
acquisition of pathogenic potential.
P1185
Modulation of GRO-alpha and TNF-alpha
production by peripheral blood mononuclear
cells treated with killed Helicobacter pylori
G. Stassi, A. Arena, A. Cascio, C. Iaria, M. Calapai, D. Gazzara,
D. Iannello (Messina, IT)
Objectives: To evaluate the in vitro production of GRO-a and
TNF-a by human peripheral blood mononuclear cells (PBMC)
after stimulation with a suspension of Helicobacter pylori (Hp)
(live, gentamicin-killed or a combination of killed and live).
Gastric colonization by Hp is the major cause of chronic active
gastritis and is often associated with duodenal and gastric
ulceration, gastric carcinoma and mucosa-associated lymphoid
tissue lymphoma. GRO-a seems to play an important role in
recruiting and activating neutrophils in the gastric mucosa.
TNF-a has been demonstrated to up regulate GRO-a production
and, at high concentrations, to injure the gastric mucosa.
Materials and methods: PBMC obtained from 5 healthy
Hp-seronegative donors were cultured, and, after the stimula-
tion with Hp, supernatants were analysed for the presence of
TNF-a and GRO-a by immunoenzymatic methods. Hp isolated
from a man with duodenal ulcer was cultured and suspended in
PBS to a concentration of 109 bacteria/ml. The combined
treatment was performed by adding to PBMC a suspension of
gentamicin-killed hp (1.2 x 109 killed bacteria/ml) for 20 hours
and after this period adding 1.2 x 109 lives Hp for further 24 h.
After 44 h supernatants were harvested, centrifuged and stored
at 80C until cytokine assays. To verify a possible correlation
between TNF-a and GRO-a monoclonal antibodies (MAb) anti-
TNF-a or anti-GRO-a were added to PBMC in all experimental
conditions.Data were analysed by one-way analysis of variance
and by Student-Newman-Keuls test.
Results: The amounts of TNF-a and GRO-a produced by PBMC
after stimulation with live Hp were higher than those produced
after stimulation with a combination of killed and live Hp and
the latter were higher than those produced after stimulation
with killed Hp. The addition of MAb anti-TNF-a to PBMC
respectively treated with live, killed, or killed + live Hp,
determined lower levels of GRO-a. These results demonstrate
that the strong increase in GRO-a expression in PBMC infected
with live Hp was, at least in part, dependent on the presence in
supernatants of TNF-a. On the contrary, the addition of MAb
anti-GRO-a did not inﬂuence the TNF-a release.
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Conclusions: Our data show that pre-treatment with killed Hp
can decrease inﬂammatory response during Hp infection. The
hypothesis that killed Hp could inﬂuence the outcome of Hp
infection requires further investigation.
P1186
Elevated sialidase and prolidase combined with
vaginal pH > 5 are biomarker for low birth
weight and early preterm birth
S. Cauci, J. McGregor, P. Thorsen, J. Grove, D. De Santo,
F. De Seta, P. Lanzafame, S. Guaschino (Udine, IT; Los Angeles,
US; Aarhus, DK; Trieste, IT)
Introduction: Preterm birth is a multifactorial condition.
Infections are responsible for about 50% of early preterm birth.
Vaginal infections especially bacterial vaginosis have been
associated with adverse pregnancy outcomes.
Objective: Assess if easy to measure vaginal ﬂuid biomarkers
are predictive for low birth weight (LBW, < 2500 g), very LBW
(VLBW, < 1500 g), spontaneous preterm at < 37 weeks gesta-
tion, and total preterm deliveries (at < 37, < 35, < 32 weeks
gestation).
Methods: Low and high cut-offs for vaginal ﬂuid pH, sialidase
and prolidase activities were examined in a nested case-control
study of 579 Danish women (from a study population of 2,846
women) with samples collected at mean 17 weeks gestation. 116
LBW (17 VLBW), 117 preterm deliveries (85 spontaneous), and
418 normal term deliveries were analysed.
Results: Vaginal pH ‡ 4.7 or pH ‡ 5 by itself was not associated
with LBW or prematurity. Conversely, combination of pH ‡ 5
and high sialidase activity demonstrated OR 17 (CI 1.8–150) for
LBW; OR 31 (CI 1.8–516) for VLBW; along with OR 18 (CI 1.6–
204) for preterm at <35 weeks and OR 31 (CI 1.9–542) for
preterm at < 32 weeks gestation. The combination of pH ‡5 and
high prolidase activity demonstrated OR 13 (CI 1.3–122) for
LBW; OR 33 (CI 2.0–553) for VLBW; as well as OR 9.2 (CI 0.6–
150) for preterm at < 35 weeks and OR 35 (CI 2.0–586) for
preterm at < 32 weeks gestation. In this population, no woman
having high sialidase and high prolidase activity had a term
birth, or a baby weighting ‡2500 g at birth.
Conclusion: In this Danish population, mid gestation ﬁndings
of vaginal ﬂuid elevated pH with sialidase and/or prolidase
were associated with LBW, VLBW, and early preterm at < 35, or
< 32 weeks gestation.
P1187
Levels of IgA against Gardnerella vaginalis
hemolysin (anti-Gvh IgA) before and after
therapy of bacterial vaginosis
S. Cauci, S. Driussi, G. Casabellata, M. Di Santolo, P. Lanzafame,
D. De Santo, F. De Seta, S. Guaschino (Udine, IT)
Objectives: Bacterial vaginosis (BV) is a complex change of the
vaginal ecology, its pathogenesis is still elusive. Gardnerella
vaginalis is virtually always present in the abnormal ﬂora milieu
of women with BV.So far, the only characterized vaginal speciﬁc
IgA response in women with BV, is the IgA against the
hemolysin produced by G. vaginalis (anti-Gvh IgA).The anti-
Gvh IgA appears to be a critical host response in vaginal ﬂuid of
women with BV. Interestingly, a study performed in Caucasian
pregnant women showed that high anti-Gvh IgA levels were
protective for preterm birth and low birth weight. On the
contrary, low anti-Gvh IgA values associated with high
microbial hydrolytic enzymes (sialidase and prolidase activity)
were correlated with increased risk of adverse pregnancy
outcomes including early preterm birth (< 32 weeks gestation)
and very low birth weight. To our knowledge, no study has
evaluated the anti-Gvh IgA response before and after therapy of
BV.The aim of the study was to assess changes of anti-Gvh IgA
in vaginal ﬂuid before and after antibiotic treatment of women
with BV.
Methods: Enrolled women were aged 18–50 years. A 7 days
oral metronidazole therapy was administered in accordance
with CDC protocols for fertile women with BV (4 Amsel’s
criteria positive and Nugent score 7–10). Patients were re-eval-
uated 1 month after starting of the antibiotic treatment. Anti-G.
vaginalis hemolysin IgA were evaluated in the vaginal ﬂuid by
ELISA according to a procedure previously described, values
were obtained as absorbance in millioptical density units (mOD)
at 405 nm.All measurements were performed in duplicate.The
Mann-Whitney U-test was used to compare anti-Gvh IgA levels
between groups. Any P value < 0.05 was considered statistically
signiﬁcant. The software package SPSS (Statistical Package for
Social Sciences) was used for data analyses.
Results: Anti-Gvh IgA values were largely increased (3-fold,
P = 0.001) after therapy in women cured by the antibiotics.On
the opposite, levels of vaginal anti-Gvh IgA were unaffected by
the antibiotic treatment in women not cured (still having BV) .
Conclusions: It is presently not known why the currently
adopted antibiotic treatments for BV give a low cure rate
(around 60–80%). A major problem for clinicians is to evaluate if
the woman is cured after therapy as vaginal ﬂora is altered by
antibiotics. Rise of vaginal anti-Gvh IgA is a reliable objective
marker to assess cure of BV after antibiotic treatment.
P1188
Q fever in Northern Greece: epidemiologic and
clinical data from 58 acute and chronic cases
M. Pape (Thessaloniki, GR)
Objective: The clinical presentation of Coxiella burnetii is very
pleomorﬁc and non-speciﬁc. The incidence of Q fever among
humans is probably underestimated, and diagnosis relies upon
the physician’s awareness of the symptoms of Q fever and the
presence of a reliable diagnostic laboratory. The aim of this
study was to investigate the epidemiologic and clinical aspects
of acute and chronic Q fever in northern Greece.
Methods: Over a period of 2 years (2004–2005), 980 patients
(520 men, 460 women, mean age 45 ± 5 yr) were examined and
58 cases of Q fever (6%) were identiﬁed. The diagnosis was
based on clinical manifestations (ﬂu-like syndrome, pneumonia,
hepatitis, pericarditis, lympathenopathy, Guillain-Barre,
endocarditis) along with serological conﬁrmation (ELISA/IFA
methods). Acute Q fever was diagnosed on the basis of phase II
IgG and IgM titers > 1:256 and 1:40 respectively. Chronic Q
fever was suspected on the basis of prolonged disease and the
presence of phase I IgG titer ‡ 800.
Results: 65% of the patients were men (38/58) and 35% were
women (20/58). We classiﬁed patients according to the different
clinical forms of acute and chronic Q fever: pneumonia (28-
cases), ﬂu-like syndrome (15-cases), hepatitis (7-cases),
lymphathenopathy (2-cases), pericarditis (2-cases), Guillain-
Barre (1-case), osteomyelitis (1-case), optic neuritis (1-case).
Hepatitis occurred in younger people and pneumonia in older
and more immunocompromised patients. Contact with animals
was found to be a major risk factor for acquisition of Q fever,
since 40 patients (68%) had a history of contact, mainly with
sheep (30 patients: 51%). Only one chronic case, an endocarditis
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fulﬁlling the Duke criteria (IgG class anti-phase I titre > 800)
was detected. Most patients were treated with doxycycline and
recovered. Only two patients who were signiﬁcantly older and
more immunocompromised than the others died eventually.
Conclusion: Q fever was rarely notiﬁable disease in Northern
Greece. Our data indicate, however, that Q fever should be
considered a public health problem with several clinical
manifestations.
P1189
Gram-negative commensal gut bacteria aggravate
small intestinal inﬂammation via toll-like
receptor 4
M.M. Heimesaat, A. Fischer, H.-K. Jahn, J. Niebergall,
O. Liesenfeld, R.R. Schumann, S. Bereswill, U.B. Go¨bel (Berlin,
DE)
Gram-negative commensal gut bacteria such as Escherichia coli
and Bacteroides sp. are suspected to contribute profoundly to
inﬂammatory bowel diseases such as Crohn’s disease and
ulcerative colitis. It has been recently shown that both bacterial
groups accumulate at very high levels in the inﬂamed ileum and
trigger severe Th1-type immunopathology of acute pan-ileitis in
susceptible mice infected perorally with 100 cysts of Toxoplasma
gondii. Thus, this model is excellently suited for the study of
host-bacterial-relationships in small intestinal inﬂammation. To
unravel the mechanisms by which bacteria aggravate ileal
inﬂammation, we investigated the severity of small intestinal
inﬂammation in mice lacking Toll-like receptors (TLRs) 2 and 4,
which constitute important components of the bacteria-related
innate immune system. Escherichia coli and Bacteroides sp.
accumulated to comparable levels during ileitis and their
concentrations did not differ signiﬁcantly in inﬂamed ilea of
wild type mice and of mice lacking TLR2 or TLR4. However, the
severity of ileitis was clearly diminished in mice lacking TLR4-/-
, as indicated by reduced histological scores and letality. Because
TLR4 is highly speciﬁc for bacterial lipopolysaccharide (LPS),
these ﬁndings provide evidence that commensal gut bacteria
aggravate the immunopathology of intestinal inﬂammation via
TLR4-mediated sensing of bacterial LPS, which might play a key
role in inﬂammatory process.
P1190
The condition of a mucous stomach membrane of
region blood-groove after shigellosis
M. Chemich, A. Snitsar (Sumy, UA)
Objectives: To study a mucous stomach membrane of region
blood-groove (MSMRB) in the course of late reconvalescation of
shigellosis (Sh), to investigate these changes’ dependence on the
therapy of the sharp period.
Methods: In the course of late reconvalescation 29 persons have
been examined. All of them have suffered middle-severe Sh. and
have received the standard treatment: enterosorbents-12
(I group); enterosorbents and one antibacterial medicament-7
(II group); two antibacterial medicaments-10 (III group).
MSMRB has been deﬁned on clirens hydrogen in cardiac
portion (CP), an average third of body (B) and pyloric portion
(PP) of a stomach.
Results: Full normalization of MSMRB in all portions of a
stomach was deﬁned in I group of patients: CP - (35.59 ± 2.03), B
- (71.18 ± 4.08), PP - (77.73 ± 4.47) ml/min 100 gr. I group of the
patients has been got positive dynamics of MSMRB in the course
of treatment: CP - (22.07 ± 2.83), B - (43.69 ± 5.60), PP -
(48.11 ± 6.16) ml/min 100 gr. The lowest and the poorest
parameters of MSMRB, in terms of prognosis, have been
received in III group of examined: CP - (21.24 ± 2.33), B -
(43.12 ± 4.73), PP - (46.98 ± 5.15) ml/min 100 gr. The patients
blood-groove was below age norm in all portions of a stomach:
(32.18 ± 2.53), (64.36 ± 4.06), (70.79 ± 4.76) ml/min 100 gr
accordingly. It did not differ from the data received in the
course of hospitalisation. MSMRB in this group was also
considerably below data of all examined and groups of
patients who received enterosorbents (D¯ < 0.05–0.001). Direct
strong correlation between a degree of MSMRB recovery is
revealed and therapy that has been performed in the sharp
period - enterosorbtion or antibacterial therapy.
Conclusion: In the course of late reconvalescation of shigellosis
normalization of MSMRB in all portions of a stomach occurred
to the examined in whose treatment enterosorbents have been
used, or enterosorbent and an antibacterial medicament. The
usage of two antibacterial medicaments in the sharp period of
treatment inﬂuenced MSMRB negatively.
P1191
In vitro model to analyse the effect of
mycobacteria infection on HIV replication
A. Boluda, R. Delgado, M.D. Folgueira (Madrid, ES)
Objectives: Macrophages are important cellular targets for both
HIV and mycobacterial infections. In vitro HIV infection of
human differentiated macrophages is difﬁcult and usually
required the addition of colony-stimulating factors that can
mask the role of Mycobacterium spp. confection on viral
replication. In this study we have developed an infection
model using recombinant retroviruses to analyse the role of
Mycobacterium spp. infection and the effect of diverse cytokines
on HIV replication in human macrophages.
Methods: A retroviral vector based on PNL4-3 luc/gfp R-E-
pseudotyped with vesicular stomatitis virus glycoprotein (VSV-
G) was used to infect macrophages differentiated from
peripheral blood monocytes (MDM) by culture for 7 days in
medium containing human serum; 24-well plates containing
5 x 10 5 cells/well were infected with the recombinant
retrovirus at MOI 1:100. After 5 days the cells were incubated
with 7 M. tuberculosis strains (H37 Rv and 6 clinical isolates that
presented different susceptibility patterns), M. avium and
M. fortuitum in a 1:1 ratio. Several cytokines (IL-1b, IL-4, IL-10,
TNF-a, IFN-g) and sonicates from M. tuberculosis, M. avium and
M. fortuitum ATCC strains were also tested. After 72 h of
stimulation or mycobacterial infection the effect of the cytokines
and Mycobacterium spp. on HIV replication was quantiﬁed
measuring luciferase activity or gfp expression. Each experiment
was made on cells from at least three different donors. Statistical
analysis was performed using one-way ANOVA test.
Results: The percentage of macrophages infected using
recombinant retrovirus was higher than 50%. The confection
with all Mycobacterium strains tested induced an increase on
HIV replication (from 1.58-fold to 4.2 -fold) that only presented
statistical signiﬁcance (p < 0.05) when the macrophages were
coinfected with M. tuberculosis strains. Proinﬂamatory cytokines
IL-1b, TNFa and IFNg showed a signiﬁcant effect on HIV
replication. Cell stimulation with Mycobacterium sonicates
augmented HIV replication at lower level than coinfection
with viable bacilli.
Conclusions: The HIV infection model described in this study
allowed to get a high grade of HIV infection in human
macrophages and to study the effects of cytokine production
driven by mycobacteria and Mycobacterium spp. coinfection on
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HIV replication. Proinﬂamatory cytokines IL-1b, TNFa and IFNg
and coinfection with M. tuberculosis strains increased
signiﬁcantly HIV replication.
P1192
Prevalence of non-tuberculosis mycobacteria in
Southeast of Iran
T. Naserpour Farivar, B. Shariﬁ Moud, M. Naderi, M. Salehi,
N. Salari, N. Naserfar (Zahedan, IR)
Objectives: Tuberculosis is one of the most important problems
in health and treatment in the entire world and especially in the
developing countries. Due to the importance of Tuberculosis
and its spread and with respect to the high incidence of
pulmonary tuberculosis in Sistan and Baluchestan which has the
highest rate of Tuberculosis in Iran and due to drug resistance
characteristics of Non Tuberculosis Mycobacteria (NTM) to the
ﬁrst line of anti TB drugs and with respect to this point that
NTM can produce diseases which may be similar to
Tuberculosis, we decide to study the prevalence of isolation of
NTM in this area which undoubtedly has special value on
treatment decision and present diagnostic procedure.
Materials: This study was done in two different years in 2000
and 2004 in patients referring to BOU-Ali hospital with
pulmonary symptoms which had a smear positive in ZNCF
staining and positive culture results in cultivation on
Lowenstein-Johnson and Middle brook 7H10 agar. The
isolated mycobacteria were identiﬁed on the basis of their
growth rate, pigmentation and biochemical testes.
Results: In our 2000 study, the results of cultural
characteristics(i.e. growth rate and pigmentation) and
biochemical testes in 91 specimens (60.7%) lead to isolation of
Mycobacterium tuberculosis and in 59 specimens (39.3%) to
isolation of NTM. In NTM isolates,38 specimens (64.4%) belongs
to females and 21 specimens (35.6%) belongs to males. In our
2004 study, the results of cultural characteristics (i.e. growth rate
and pigmentation) and biochemical testes in 60 specimens
(66.6%) lead to isolation of Mycobacterium tuberculosis and in
20 specimens (33.3%) to isolation of NTM and from these 20
NTM specimens, 13 specimens (65%)belongs to females and 7
specimens (35%) belongs to males. In our both studies (2000 and
2004), the most amount of isolation of NTM was in upper
60 years old group.
Conclusion: Due to reported anti TB drugs resistance of NTM
and with respect to our ﬁndings, it is suggested that in the ﬁrst
visit of patients suspected to tuberculosis, simultaneous study of
smear staining, cultivation, species identiﬁcation and
antibiogram, specially in this region and in similar geographic
conditions be done and treatment with the results of ZNCF
staining alone may be not a suitable diagnostic test.
P1193
Systemic inﬂammation in the ﬁeld of
experimental multiple trauma: when does
bacterial translocation and subsequent sepsis
occur?
P. Koutoukas, T. Tsaganos, N. Efstathopoulos, K. Panousis,
P. Kaldis, M. Klonaris, E.J. Giamarellos-Bourboulis,
A. Papalois (Athens, GR)
Objectives: To evaluate the role of bacterial translocation in the
sequences of events occurring in multiple trauma.
Methods: A total of 32 New Zealand rabbits were applied
divided in three groups as follows: A (n: 10), controls; B (n: 11),
rabbits subject to myotomy of the right femur; and C (n: 11),
rabbits subject to myotomy followed by crush injury of the right
femur. Blood was drawn at 0 time and at 2, 4, 24 and 48 hours
following intervention. Endotoxins (LPS) were estimated by the
QCL-1000 LAL assay, blood bacterial counts after quantitative
blood culture and tumour necrosis factor-alpha (TNF-a) by a
bioassay on L929 ﬁbrosarcoma cell line. Apoptosis of
lymphocytes and monocytes was estimated in heparinized
whole blood after red blood cell lysis, incubation of white
blood cell with ANNEXIN-V and propidium iodide and
subsequent passage by a ﬂow cytometer.
Results: Results are given as medians in the Table (*counts of
Pseudomonas aeruginosa).
Conclusions: Multiple traumas as applied in experimental
model are accompanied by early translocation of bacteria and
subsequent apoptosis of lymphocytes and monocytes. The
phenomenon is aggravated in relation to the degree of injury
from muscle injury to bone crush.
P1194
Identiﬁcation of Borrelia burgdorferi sensu lato
species in erythema migrans and cardial
involvement by real-time PCR and electron
microscopy
D. Hulinska, M. Bojar, V. Hulinsky, P. Bartunek (Prague,
Nymburk, CZ)
Background: Borrelia garinii, B. afzelii, B. burgdorferi s.s. and
recently B. valaisiana and B. spielmanii have been isolated from
humans. PCR typing methods are usually able to directly detect
in human samples three of these species only. Based on real time
PCR and on sequencing of the OspA gene we overcame
problems of sensitivity and speciﬁcity of PCR.
Materials and methods: Forty-nine patients of group 1 had
erythema migrans (EM), 21 patients of group 2 had cardial
involvement after EM and 17 patient were positive in BSK II
medium from tissue, blood and CSF We used direct sequencing
of OspA and OspC products by the dideoxy chain termination
procedure and quantitative analysis by using CEQ 200XL
sequencer and LightCycler real-time PCR (Roche).
Results : B. garinii was prevalent in the tissue of the inner
organs, heart, synovium, lung, brain. Electron microscopy
showed Borrelia in connective tissue far away of the
inﬂammation. B. afzelii was prevalent in the skin. Thirty ﬁve
percent of B. afzelii, 16.3% of B. burgdorferi, 22.4% of B. garinii,
and 4% of B. valaisiana were detected in patients of group 1.
Predominant causative agent in group 2 was B. garinii, OspA-
type 4.5 (26.3%) and B. valaisiana (14.2%) but only B. burgdorferi
s.s. was cultivated from heart. All genospecies were isolated in
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BSK II medium. Sequence OspA of B. bissetti- like and A14S
genospecies were found in ticks and blood. Quantitative data,
distances in phylogenetic trees showed differences not only
between OspA or OspC subtypes but also between wild Borrelia
and cultured strains. Further studies on the prevalence of this
species in clinical materials and ticks are necessary to clarify its
pathogenesis.
Partially supported by 6th Frame work Program of the
European Community-BOVAC.
P1195
Seroepidemiological study on toxoplasmic
infection among high-school girls by IFAT test in
Iran, 2002–2003
M. Mahmoudi (Esfahan, IR)
The purpose of this study was determination of the positive and
ascending serological titer of toxoplasmic infection in high-
school girls and effectiveness of some relevant factors.This
descriptive-analytic survey was performed with 414 sera collec-
ted from High –School girls of six region of Esfahan city by
cluster random sampling method. The specimens were taken
from the tip of the ﬁnger by haematocrite microtubes. The
samples were studied by Indirect Immunoﬂuorescent Assay
Test (IFAT) for the estimation of serological titers. Data were
analysed by two statistical methods: as (v2 and t test).In this
study, the overall sero – positive rate was 18.4% in 14–19 years
old girls. There was an increase in positivity with increasing the
age. IFAT titer of 98% of the positive samples was 1:100 and
remaining 2% were more than 1:100 to which were performed
another titration test to retrieve exact titer. Possible effective risk
factors were as follows: Age, region of living, educational factor
(parents and student), consumption of undercooked meat and
raw liver, occupation and their parents income, exposure to
contaminated sources such as cats and poultries. The most
contaminated group was in the region number One with
prevalence of 27.5% and the least one was in the region
number Two with prevalence of 14.5%. Signiﬁcant differences
were found in seropositivity and the exposure with cat and also
keeping poultry in the house (P > 0/05). No signiﬁcant differ-
ence was demonstrated in the seropositivity and the other
factors. There was a low level of knowledge about toxoplasma
and toxoplasmosis and relevant factors. Only 2.4% of the girls
were relatively aware regarding this subject. There was not any
acute case.
Conclusion: Toxoplasmic infection is very important because of
its socio-economic aspects, therefore control measurements
must be performed. All seronegative women should be aware
about this infection and its transmition routes. Education is the
most important way to prevention and must be progressed via
the mass media, training systems and administrations. The
study group in this survey were girls in marriage or premarriage
ages and it is suggested that managers should continue to offer
education about practices that help prevent these kinds of
diseases as well as information about preventing toxoplasmosis
speciﬁcally.
P1196
The faith of Shigella species during contact with
the water-borne free-living amoeba
Acanthamoebae castellanii
A. Saeed, H. Abd, G. Sandstro¨m (Stockholm, SE)
Objectives: Shigellosis is a global human health problem,
especially in developing countries with substandard hygiene
and unsafe water supplies. Shigellosis is caused by different
species of Shigella and the only reservoir known is human.
Shigella can be found in natural water in which also free-living
amoebae are inhabitants. The aim of this study is to obtain
knowledge about the interaction between one water borne free-
living amoeba Acanthamoeba and Shigella species.
Methods: Bacteria and amoebae were co-culture for 21 days
and viable counts of both microorganisms were performed.
Intra-amoebic growth of bacteria was estimated by gentamyacin
assay, and the faith of bacteria in amoeba was judged by
microscopy.
Results: The results show that S. sonnei multiplies and survives
inside trophozoites and cysts of A. castellanii and that the
bacterial internalisations occur in the cytoplasmic compartment
of the amoebae cells. On the contrary S. ﬂexneri and S. boydii
inhibit the growth of A. castellanii after three days. Thus,
S. sonnei and A. castellanii seem to have a symbiotic relation,
where S. ﬂexneri and S. boydii show predation.
Conclusions: Here we found that S. sonnei may have
Acanthamoebae as an environmental host, a ﬁnding that
did not included other Shigella species such as S. ﬂexneri and
S. boydii.
P1197
Mannose-rich capsular polysaccharides enhance
uptake and killing of Klebsiella pneumoniae by
human plymorphonuclear leukocytes
H. Sahly, Y. Keisari, U. Stallforth-Siegel, I. Ofek (Kiel, DE; Tel
Aviv, IL)
Objectives: Klebsiella capsular serotypes differently stimulate
polymorphonuclear leukocytes (PMNL) in a complement-
dependent manner but the molecular basis for this distinct
interaction is not clear. The aim of this study was to test the
relationship between the molecular structure of deﬁned
Klebsiella serotypes and the induction of complement-mediated
respiratory burst in PMNL.
Methods: We employed capsulated and non-capsulated
variants as well as capsule-switched derivatives of K-serotypes
bearing [K21a, K36, K50, K2 (K21a), K2 (K36)] or lacking [K2, K8,
K55, K21a (K2)] the Man-alph2/3Man or Rha-alpha2/3Rha
sugar repeats, and express either mannose-rich (O3) or
mannose-poor LPS (O1) to test their ability to induce
complement-dependent respiratory burst and survive in
PMNL. Respiratory burst was quantiﬁed by measuring the
luminol-enhanced chemiluminescence (CL) induced by the
bacteria.
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Results: The K2, K8 and K55 K-serotypes induced signiﬁcantly
lower CL-responses in PMNL than the capsular serotypes K21a,
K36 and K50. Similarly, the capsule-switched derivatives K2
(K21a) and K2 (K36), that exhibited Man-alpha2/3Man or Rha-
alpha2/3Rha containing capsular polysaccharides but retained
the K2 genetic background, induced signiﬁcantly higher CL-
responses than the K2 parental strain. Inversely, the K21a (K2)
capsule-switched derivative that expressed the K2 capsular
polysaccharides stimulated the PMNL signiﬁcantly less than the
K21a parental strain. The CL-responses induced by non-
capsulated variants were signiﬁcantly lower than those of the
capsulated parental strains, suggesting that the contribution of
LPS O-antigen is independent from the mannose-content of their
O-antigen. The intracellular survival of K-serotypes bearing the
Man-alpha2/3Man or Rha-alpha2/3Rha sugar repeat (K21a,
K36, K50), was signiﬁcantly higher than that of capsular
serotypes lacking these repeats (K2, K8, K55). Depletion of c1q
from serum did not affect the CL-response induced by K21a,
whereas factor B-depletion revealed a signiﬁcant reduction of
the CL-response not exceeding 60% of that induce by bacteria
opsonised by normal serum. EGTA signiﬁcantly reduced the
CL-responses but the values were higher than those induced by
K21a opsonised with factor B-depleted serum. The results
indicate a capsular Man-alpha2/3Man or Rha-alpha2/3Rha
pattern recognition by the complement lectin pathway that
leads to enhanced interaction between the capsulated Klebsiella
and PMNL.
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